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Summary 
Filamentous fungi are producers of small bioactive molecules termed secondary 
metabolites (SMs), which display a wide range of functional and structural diversity. The 
compounds have several important activities including antifungal, antibacterial, 
anticancer, antiparasitic, antiinsectan and immunosuppressive activities. The rapid 
increase in genomes sequences of filamentous fungi has revealed that the biosynthetic 
potential is enormous, due to the presence of huge numbers of biosynthetic gene clusters. 
Thus, there is an enormous potential of previously undiscovered SMs waiting to be 
exploited, which can potentially be used as pharmaceuticals.  
The work has focused on filamentous fungi from the important genus Aspergillus. It 
contains species that are both food and feed contaminants, some that are used for 
industrial applications for production of small compounds and enzymes, as well as model 
organisms for genetic studies and human opportunistic pathogens.  
The aim of this PhD study has been divided into two major topics:  
1) Discovery and characterization of novel SMs from filamentous fungi  
2) Linking of fungal SMs to genes and elucidation of biosynthetic pathways  
The first part of this study, the discovery of novel SMs, has resulted in characterization of 
22 novel SMs from selected Aspergilli. Two different approaches were undertaken: 
Dereplication based discovery and discovery by induction of sclerotium formation. The 
outcome included characterization of the following novel compounds: aculenes A-D, 
acucalbistrins A-B, acu-dioxomorpholine, okaramine S, and epi-10,23-dihydro-24,25-
dehydroaflavinin from A. aculeatus, aspiperidine oxide from A. indologenus, 
homomorphosins A-F from A. homomorphus, sclerotionigrins A-B from A. 
sclerotioniger, as well as emindole SC, sclerolizine and carbonarins I-J from A. 
sclerotiicarbonarius. In addition, several known compounds could be reported from the 
different species for the first time. Furthermore it was discovered how sclerotia formation 
could be induced in black Aspergilli, using a combination of natural substrates and by 
introduction of a pre-freezing step prior to inoculation. This is of general interest for the 
discovery of novel bioactive SMs, since sclerotia formation trigger otherwise silent 
biosynthetic pathways, resulting in greatly altered metabolic profiles. 
  
PhD Thesis 
Lene Maj Petersen 
 
iv 
 
The second part of the study, linking genes to SMs and elucidating biosynthetic 
pathways, led to insights into the biosynthetic potential of a number of Aspergilli. This 
included comparative metabolic profiling of A. oryzae and A. flavus, two species with an 
overall high homology of 99.5 % on genome level, but surprisingly high degree of 
chemical differences. Elucidation of structures from novel A. oryzae metabolites, 
however, revealed the chemical link between the two species. 
In two parallel projects, involving A. niger and A. aculeatus respectively, the polyketide 
6-methyl salicylic acid (6-MSA), and corresponding biosynthetic pathways, were 
investigated. In A. niger, 6-MSA was converted into meroterpenoid yanuthone D. The 
biosynthetic pathway was investigated by a multidisciplinary approach. As a result the 
cluster responsible for production of yanuthone D was identified and a biosynthetic 
pathway presented, where 6-MSA is converted into yanuthone D in eight steps. 
Furthermore a total of ten novel yanuthones were characterized, whereof two did not 
originate from 6-MSA, but did utilize several of the enzymes encoded by the cluster, 
defining a new class of yanuthones. In A. aculeatus the 6-MSA pathway was found to 
differ, with conversion of 6-MSA into the terpenoid/non-ribosomal peptide/polyketide 
hybrids aculins A-B, for which a biosynthetic pathway has been proposed. By 
overexpression of a TF located immediately downstream of the 6-MSA synthase gene, 
two non-6-MSA derived compounds were additionally discovered. 
In A. nidulans a supercluster consisting of a non-ribosomal peptide synthase and a 
prenyltransferase was predicted, by full genome gene expression comparison, which 
ultimately linked to the tetracyclopeptide nidulanin A, illustrating the strength of 
bioinformatic tools to predict superclusters and structures of NRPs. Finally, it was 
investigated how entire gene clusters from filamentous fungi could be reconstituted in the 
model organism A. nidulans. This project would improve discovery, and ease 
characterization, of genes. As proof of concept, the cytochalasin gene cluster from A. 
clavatus was successfully reconstituted in A. nidulans, allowing further biochemical 
characterization.  
The work of this thesis represents a major step forward in extending the chemical 
knowledge on the complex secondary metabolism of important filamentous fungi and at 
the same time illustrates the enormous potential for still discovering novel SMs.  
A focused collaboration between bioinformatics, molecular biology, analytical and 
natural products chemistry is critical for advances in both the linking of fungal SMs to 
genes and unraveling the biosynthetic pathways, as well as for the discovery of novel 
SMs hidden in a treasury of biosynthetic potential of filamentous fungi.   
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Sammenfatning 
Filamentiøse svampe producerer små bioaktive molekyler, betegnet sekundære 
metabolitter, som spænder bredt i både funktionel og strukturel diversitet. De sekundære 
metabolitter kan være biologisk aktive mod f.eks. bakterier, insekter, humane celler eller 
andre svampe. Genomerne for adskillige filamentiøse svampe er på det seneste blevet 
sekventeret, hvilket har afsløret et stort antal genklustre, der koder for biosynteser, og 
dermed blotlagt et enormt potentiale af hidtil uopdagede sekundære metabolitter, der 
potentielt kan udnyttes til medicinske formål.  
Arbejdet, der præsenteres i denne afhandling, har fokuseret på filamentiøse svampe 
indenfor den vigtige og spændende slægt Aspergillus. Den indeholder arter der; 
kontaminerer fødevarer og foder, bruges som modelsystemer til genetiske undersøgelser, 
er patogene overfor mennesker, og bruges til industrielle applikationer, f.eks. til 
produktion af både små molekyler og enzymer.  
 
Formålet for dette PhD studie har været opdelt i to hovedtemaer: 
1) Opdagelse og karakterisering af nye metabolitter fra filamentiøse svampe  
2) Kobling af svampe sekundære metabolitter til gener, samt udredning af 
biosynteseveje 
Den første del af dette studie, opdagelsen af nye sekundære metabolitter, har resulteret i 
karakterisering af 22 nye sekundære metabolitter fra udvalgte Aspergiller. To forskellige 
tilgange blev udforsket: Dereplikerings baseret opdagelse samt opdagelse ved induktion 
af sclerotium dannelse. Resultatet omfatter karakterisering af følgende nye metabolitter: 
aculene A-D, acucalbistrin A-B, acu-dioxomorpholine, okaramine S, samt epi-10,23-
dihydro-24,25-dehydroaflavinin fra A. aculeatus, aspiperidine oxide fra A. indologenus, 
homomorphosin A-F fra A. homomorphus, sclerotionigrin A-B fra A. sclerotioniger, 
emindole SC, sclerolizine samt carbonarin I-J fra A. sclerotiicarbonarius. Desuden blev 
flere kendte metabolitter, rapporteret i de forskellige arter for første gang. Et vigtigt 
resultat af dette studie, er opdagelsen af, hvordan svampe relaterede strukturer kaldet 
sclerotier, kan induceres i sorte Aspergiller, ved at kombinere brugen af naturlige 
substrater og indførelse af et frysningstrin forud for podning. Dette er af generel interesse 
for opdagelsen af nye bioaktive metabolitter, da sclerotiedannelse, aktiver biosynteseveje, 
der ellers ikke er udtrykte, og som en direkte konsekvens, ses en stor ændring i 
metabolitprofilen. 
 
Den anden del af PhD studiet, hvor gener kobles til sekundære metabolitter og 
biosynteseveje udledes, førte til indsigt i det biosyntetiske potentiale i en række 
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Aspergiller. Dette omfattede en sammenligning af den kemiske profil af A. oryzae og A. 
flavus, der er to nærtbeslægtede arter (99,5% homologi på genomniveau), men som viser 
en overraskende høj grad af forskelle i deres kemiske profiler. Opklaring af kemiske 
strukturer for nye stoffer fra A. oryzae, afslørede dog hidtil usete kemiske link mellem de 
to arter. 
  
I to parallelle projekter, i henholdsvist A. niger og A. aculeatus, blev polyketidet 6-
methyl-salicylsyre (6-MSA) og de respektive biosynteseveje med udgangspunkt i 6-MSA 
undersøgt. I A. niger blev 6-MSA omdannet til meroterpenoidet yanuthone D. Via en 
multidisciplinær tilgang kunne generne, i et genkluster, ansvarligt for produktionen af 
yanuthone D identificeres, og biosyntesevejen over 8 trin udledes. Desuden blev ti nye 
yanuthoner karakteriseret, hvoraf to viste sig ikke at være afledt af 6-MSA. Dog var 
produktionen af disse to yanuthoner afhængig af flere af enzymerne kodet af det 
pågældende genkluster ansvarlig for yanuthone D, hvilket, definererede en ny klasse af 
yanuthoner. A. aculeatus 6-MSA biosyntesevejen varierede. Her blev 6-MSA omdannet 
til aculiner, hybrider af terpener/ikke-ribosomale peptider/polyketider, for hvilke der blev 
foreslået en biosyntesevej, baseret på bioinformatiske og strukturkemiske betragtninger. 
En transskriptionsfaktor tæt på 6-MSA synthasen, blev overudtrykt, hvilket resulterede i 
karakterisering af yderligere to stoffer, der dog ikke var afledte fra 6-MSA. 
 
I A. nidulans blev to fysisk adskilte gener, bestående af en non-ribosomal 
peptidsynthetase og en prenyltransferase forudset til at være koblet til den samme 
biosyntesevej. Dette blev eftervist og forbundet med biosyntesen af tetra-cyclopeptidet 
nidulanin A, hvilket illustrerede styrken af bioinformatiske værktøjer til at forudsige 
sammenhænge mellem fysisk adskilte gener, samt strukturer af non-ribosomale peptider. 
Endelig blev det undersøgt, hvordan hele genklustre fra svampe kunne udtrykkes 
heterologt i modelorganismen A. nidulans. Dette projekt vil forbedre opdagelse samt 
karakterisering af gener involveret i biosynteser. Cytochalasin biosyntesevejen fra A. 
clavatus blev undersøgt og med succes rekonstrueret i A. nidulans.  
 
Resultaterne af dette PhD studie bringer ny kemisk viden om den komplekse sekundære 
metabolisme af vigtige filamentiøse svampe og illustrerer samtidig det enorme potentiale 
for at opdage nye sekundære metabolitter. Et målrettet samarbejde mellem bioinformatik, 
molekylærbiologi, analytisk kemi og naturstof kemi er afgørende for fremskridt i både 
koblingen af svampe metabolitter til gener og udledning af biosynteseveje, samt til 
opdagelsen af de mange nye metabolitter, der stadig ligger skjult i de filamentiøse 
svampe.  
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1 Introduction 
Natural products (NPs) have played a major role in the history of drug discovery, and 
they continue to be important as drugs and targets of study for synthetical and analytical 
chemists. NPs display a wide range of functional and structural diversity and the 
compounds have several important activities including antifungal, antibacterial, 
anticancer, antiparasitic, antiinsectan and immunosuppressive activities. Originating with 
the discovery of penicillin in 1929 [1], NPs have been used as a source of inspiration for 
drug discovery. Of all new approved drugs in a 30 years period from 1981 to the end of 
2010, 65% was either NPs or directly derived thereof [2][3]. Today the discovery of 
novel NPs is still important. First and foremost, since novel drugs are still needed. A 
growing problem is that bacteria become resistant to existing antibiotics, and at the same 
time fewer novel antibiotics are being approved [4].  
The major sources of NPs are bacteria, plants, and filamentous fungi; marine as well as 
terrestrial. The focus of this study has been on secondary metabolites (SMs) from 
filamentous fungi. The genus Aspergillus has been investigated due to the high 
importance of numerous species from this family. Several species produce relevant 
pharmaceutical compounds (e.g. cholesterol-lowering lovastatin from A. terreus [5]), 
others are used in the industry for production of small compounds or enzymes (e.g. citric 
acid and various enzymes from A. niger [6]) and finally another species is important for 
use as model organism for genetic studies (A. nidulans [7][8][9]). Yet others are 
pathogenic (A. flavus [10]) and some are food and feed contaminants (A. niger [11], A. 
aculeatus [11][12]). 
Genome sequencing projects have exposed a high amount of biosynthetic gene clusters in 
filamentous fungi and revealed an enormous potential of previously undiscovered SMs: 
The number of SM gene clusters by far exceeds the number of known metabolites, which 
can be linked to these clusters. Consequently, there is an unexplored potential of SM 
diversity in filamentous fungi. 
In this work, the aim has been two-sided: Partly to explore the SM potential of a number 
of black Aspergilli by discovery and characterization of novel SMs (chapter 3). Partly to 
link these compounds to their biosynthetic genes and pathways in the organism (chapter 
4). This first chapter gives a general introduction to SMs from filamentous fungi with 
emphasis on the biosynthesis of SMs (section 1.2), the genetics of SMs (section 1.3) and 
the metabolite analysis (section 1.4).  
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1.1 Filamentous fungi 
Filamentous fungi, or moulds, belongs to the kingdom of fungi, and constitute a large and 
diverse group of multicellular eukaryotes [13][14]. Fungi are widespread in nature and 
many species have more than one preferred habitat and can survive in very diverse 
environments; fungi are very tolerant to a range of pH and temperatures, and can degrade 
and consume a wide range of substrates. Filamentous fungi are essential to the ecosystem 
for degradation of organic matter. 
It has been estimated that as much as 1.5 million different fungal species exist [15], and 
of these only 75.000 have so far been collected and described [16], and hereof only a 
minority have been investigated for their chemical potential.  
The genus Aspergillus is one of the most significant due to both their role as food and 
feed contaminants (A. niger, A. aculeatus), for uses as industrial workhorses (A. niger, A. 
aculeatus, A. oryzae) and for use as model organisms for genetic studies (A. nidulans), 
see Figure 1.1.  
                    
 
Figure 1.1 Physical appearance on solid growth media of selected filamentous fungi used in this 
study. Heavy black sporulation is observed for the black Aspergilli A. aculeatus and A. niger. 
 
While some species, such as A. nidulans, has been widely studied, many of the black 
Aspergilli are unexplored. This group has been the focus in this thesis, and is described in 
the following section.   
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1.1.1 Black Aspergilli 
Within the genus Aspergillus are the black Aspergilli (Aspergillus section Nigri), which 
constitute an important group, with both species utilized for industrial purposes and 
species being food and feed contaminants [17]. Members of the group are further divided 
into clades; an overview is given in Table 1.1.  
Amongst the black Aspergilli, an important and widely studied species is A. niger. This 
species is industrially important and several processes using this fungus have been 
granted the “generally regarded as safe” (GRAS) certified status by the U.S. Food and 
Drug Administration (FDA) [6]. A. niger is utilized in several industrial processes and is 
used for production of organic acids such as citric acid and gluconic acid as well as 
enzymes such as amylases and lipases [6]. In addition to its wide use in the fermentation 
industry, A. niger is also a contaminant of food and feed [11]. Some strains are able to 
produce mycotoxins, such as fumonisins [18][19][20] and ochratoxin A [21]. 
Table 1.1 The black Aspergilli divided into clades [17][22]. Species in bold have been 
investigated in this thesis.   
Clade Species 
A. niger A. neoniger, A. costaricaencis, A. vadensis, A. eucalypticola,  
A. piperis, A. acidus, A. coreannus, A. tubingensis, A. awamori,  
A. niger, A. lacticoffeatus, A. foetidus, A. brasiliensis 
A. carbonarius A. ibericus, A. sclerotiicarbonarius, A. carbonarius,  
A. sclerotioniger 
A. heteromorphus A. ellipticus, A. heteromorphus 
A. homomorphus A. saccharolyticus, A. homomorphus 
A. aculeatus A. fijiensis, A. indologenus, A. flavus, A. violaceofuscus,  
A. aculeatus, A. aculeatinus, A. uvarum, A. japonicus 
   
Another black Aspergillus is A. aculeatus; which is also used by the industry for enzyme 
production. A. aculeatus has been used to produce enzymes such as cellulases [23], 
xylanases [24][25] and proteases [26], which are used commercially in food and feed 
industries. A. aculeatus is among the most common fungi in postharvest decay of fruit, 
beans and nuts [11][12]. Only a few SMs have been reported for this fungus, however, 
genome sequencing has revealed its large genetic potential for production of SMs (section 
3.1.1).   
In Table 1.2 an overview of metabolites for some of the black Aspergilli investigated in 
this study is given.  
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Table 1.2 Metabolites reported from selected black Aspergilli prior to and after this study. 
Species Metabolites This study 
A. aculeatus Aculeacins A–G [27][28] 
CJ-15,183 [29] 
Secalonic acids D and F [30] 
Okaramines H and I [31] 
Asperaculin A [32] 
Aspergillusol A [33] 
Aculeatusquinones A–D [34] 
Okaramine J and S (Paper 1) 
Aculene A-D (Paper 1) 
Acu-calbistrins A-B (Paper 1) 
Acu-dioxomorpholine (Paper 1) 
Epi-10,23-dihydro-24,25-
dehydroaflavinine (Paper 1) 
Calbistrin A and C (Paper 1) 
Aculins A and B (Paper 11) 
Aculinic acid (Paper 11) 
RKB-3384B (Paper 11) 
A. niger Yanuthone A-E [35] 
1-hydroxy yanuthone A [35] 
1-hydroxyyanuthone C [35] 
22-deacetylyanuthone A [35] 
Azanigerones A–F [36] 
Fumonisins [18][19][20] 
Ochratoxin A [21] 
Aurasperone B [37] 
And several more, see [38] 
Yanuthone F-J (Paper 9) 
Yanuthone X1 (Paper 9) 
Yanuthone K-L (Paper 10) 
Yanuthone X2 (Paper 10 
Anominine (formerly known as 
nominine [39]) (Paper 4) 
10,23-dihydro-24,25-
dehydroaflavinine (Paper 4) 
Aflavinine analogs (Paper 4) 
A. indologenus Okaramines A,B and H [22] Aspiperidine oxide (Paper 2) 
JBIR-74 (Paper 2) 
Fellutanine C (Paper 2) 
Aspergillicin A (Paper 2) 
A. homomorphus Dehydrocarolic acid [40] 
Secalonic acid D and F [40][41] 
Homomorphins A-F (Paper 3) 
Q-20547-E (Paper 3) 
L-valyl-L-tryptophan anhydride  
(Paper 3) 
α-pyrone A and B (Paper 3) 
A. sclerotioniger Ochratoxins A and B [38][41] 
 
Sclerotionigrin A (Paper 5) 
Sclerotionigrin B (Paper 5) 
Proxiphomin (Paper 5) 
A. sclerotieecarbonarius Naphtho-γ-pyrones [17] 
Pyranonigrin A  [17] 
Sclerolizine (Paper 6) 
Emindole SC (Paper 6) 
Carbonarin I (Paper 6) 
Carbonarin J (Paper 6) 
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1.1.2 Secondary metabolites from filamentous fungi 
Metabolites from filamentous fungi are divided into two types: Primary metabolites and 
secondary metabolites. In general primary metabolites are essential for growth and 
reproduction, whereas secondary metabolites, are not. Secondary metabolites are, 
however, produced by the organisms for specific purposes and often play essential roles 
in chemical communication, signaling or as defense compounds (antibiotics, insecticides, 
antifungals). Secondary metabolites are of great interest as pharmaceuticals, as they are 
often pharmacological active. The borders between primary and secondary metabolism 
are often hard to define. One reason is that most secondary metabolites are built up from 
primary metabolite precursors. The correlation between primary and secondary 
metabolites is presented in Figure 1.2.  
 
Figure 1.2 Simplified correlations between primary and secondary metabolism. MEP = 
methylerythritol phosphate. MVA = mevalonic acid. IPP = isopentenyl diphosphate. DMAPP = 
dimethylallyl diphosphate. CoA = coenzyme A. AA = amino acid. NRPs = nonribosomal peptides. 
PKs = polyketides.  
 
Filamentous fungi often live in competitive environments, and it is believed that their SM 
repertoire reflects selection pressures from other organisms and environment. It is 
therefore likely to find interesting biological activities amongst the fungal SMs, such as 
antifungal, antibacterial, insecticides and so forth. Furthermore the fungal SMs can be 
utilized as pigments and colorants [42], which is another reason for investigation these 
compounds.  
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Main classes of secondary metabolites with interesting biological activities are 
polyketides (PKs), nonribosomal peptides (NRPs), terpenoids or hybrids thereof. Figure 
1.3 displays examples of all three classes as well as combinations of the three types 
(hybrids). The SMs shown are all compounds discovered or investigated in this work, and 
will be further described in chapter 3 and 4. 
 
Figure 1.3 Illustration of three major classes of fungal SMs: PKs, NRPs and terpenoids; 
compound types found during this study. Compounds may also be hybrids. Here exemplified by 
SMs discovered or investigated in this thesis: The PK 6-MSA (section 4.3 and 4.4), NRP nidulanin 
A (section 4.1), terpenoid aculene C (section 3.1.1), PK-NRP sclerotionigrin A (section 3.2.2), 
NRP-terpenoid okaramine S (section 3.1.1), PK-terpenoid (meroterpenoid) yanuthone D (section 
4.3) as well as acucalbistrin A, a putative hybrid of all three classes (section 3.1.1). 
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1.2 Biosynthesis of secondary metabolites 
The SMs produced by filamentous fungi are, based on their mode of biosynthesis, divided 
into different groups. The general biosynthetic pathway for four main groups, polyketides 
(PKs), non-ribosomal peptides (NRPs)/alkaloids, terpenoids, and the shikimate derived 
SMs, are depicted in Figure 1.4.  
 
Figure 1.4 General biosynthetic pathways for polyketides, non-ribosomal peptides, terpenoids and 
shikimic acid derived compounds. Exemplified by the NPs lovastatin (cholesterol-lowering drug), 
penicillin-G (antibiotic), taxol (anti-cancer) and podophyllotoxin (anti-cancer) respectively.  
The biosynthesis of the four types is in brief as follows: PKs are synthesized by large 
multifunctional enzymes with individual functional domains, polyketide synthases 
(PKSs), by assembly of ketide units. NRPs are peptides not synthesized by a ribosome, 
but by NRP synthetases (NRPSs) which are multimodular enzymes, which select specific 
amino acids and forms peptide bonds. Terpenoids are hydrocarbons which are built up by 
C5 isoprene units. Shikimic acid is a C7 unit, which can be incorporated into other SMs. 
The focus of this thesis, and therefore the SMs that will be discussed in this chapter, are 
PKs, NRPs and terpenoids. The following sections will give a description of the three 
types of SMs and how they are biosynthesized in the organism (section 1.2.1, 1.2.2, 
1.2.3).     
1 Introduction 
8 
 
1.2.1 Polyketides 
PKs constitute one of the major classes of SMs and are known from fungi, but also 
bacteria, plants and animals [43][44]. It is an enormously diverse group spanning 
compounds with a wide range of functional and structural diversity. The many important 
biological activities covers antibacterial, anticancer, antifungal, antiparasitic, cholesterol 
lowering, and immunosuppressive properties. Examples of important fungal PKs are 
lovastatin (cholesterol lowering) [5], mycophenolic acid (antimicrobial and 
immunosuppressive) [45] and griseofulvin (antibiotic) [46]. 
The structures of PKs vary greatly and they are solely grouped based on the way they are 
biosynthesized. This is by enzymes called polyketide synthases (PKSs) [44], which 
resemble eukaryotic fatty-acid synthases (FASs) in domain architecture. The PKSs can be 
classified into three different types based on their different architectural organization; 
type I, II and III, see Table 1.3. 
Table 1.3 Division of PKSs. Adapted from [44]. 
 PKS type Description Mechanism Organisms 
I (modular)  Large multifunctional proteins 
with individual functional 
domains. Multiple modules. 
Linear assembly 
line. Active site 
only used once. 
Bacteria 
 
I (Iterative) 
Subtypes: NR-, 
PR- and HR-PKS 
 
Large multifunctional proteins 
with individual functional 
domains. One module. 
 
Iterative, active sites 
may be reused. 
 
Fungi 
Some bacteria 
 
II 
 
Complex of individual 
monofunctional proteins. Single 
active site for each. 
 
Iterative, active sites 
may be reused. 
 
Exclusively 
bacteria 
 
III 
 
Single protein with multiple 
modules.  
 
Iterative, active sites 
may be reused. 
 
Mainly plants 
Some bacteria 
and fungi 
 
PKs are assembled by repetitive decarboxylative Claisen condensations usually of an 
activated acyl starter unit with malonyl-CoA derived extender units. Most fungal PKs are 
synthesized by iterative type I PKSs. These are large multifunctional proteins containing 
a single module, which is used iteratively. The PKS module consists of different domains, 
where each domain has a specific catalytically function, see Table 1.4 and Figure 1.5 A. 
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Table 1.4 Overview of catalytic domains found in PKSs. 
Domain Function  
Necessary domains  
Acyl carrier protein (ACP) Holds the growing polyketide chain 
β-ketoacyl synthase (KS) Catalyzes the Claisen condensation  
(malonyl)acyl transferase (MAT)/(AT) Transfers acyl/malonyl units 
Reductive domains  
Ketoreductase (KR)  Reduction of β-ketone to hydroxyl 
Dehydratase (DH)  Reduction of hydroxyl yielding an enoyl group 
Enoyl reductase (ER) Reduction of enoyl group to saturated alkyl  
Other 
Product template (PT) 
 
Control folding pattern of non-reduced PKs 
Thioesterase (TE) Hydrolysis of the thiolester, releases PK 
Methyl transferase (MT) Methylation using S-adenosylmethionine (SAM) 
Cyclisation (CYC) 
Starter unit AT transacylase (SAT)  
Cyclisation of reduced polyketide 
Loading of the starter unit 
  
Three domains are essential for biosynthesis of PKs: the acyl carrier protein (ACP), the β-
ketoacyl synthase (KS), and the acyltransferase (AT). The ACP domain is responsible for 
holding the growing PK chain, hereby allowing loading of the extender units. The KS 
domain catalyzes C-C bond formation through decarboxylative Claisen condensations 
(Figure 1.5 B). The MAT or AT domain recognizes the specific extender unit that is 
going to be incorporated into the growing PK chain. 
 
PKSs can furthermore have reductive domains also known as β-keto processing domains, 
which can reduce the β-keto group, see Table 1.4 and Figure 1.5 C. The three domains are 
ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER), that reduces the keto 
group to a hydroxyl group, dehydrates the hydroxyl group to an enoyl group, and reduces 
the enoyl group to the saturated alkyl, respectively. PKSs are divided into three groups 
accordingly to the presence or absence of β-keto processing domains: nonreducing (NR), 
partly reducing (PR), and highly reducing (HR) PKSs [47]. The NR PKSs do not contain 
any of the reducing domains, whereas the reducing PKSs contain either KR or KR/DH 
(partly reducing), or all three domains (highly reducing). 
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Figure 1.5 A) Example of the domain organization of a HR-PKS. The blue domains are necessary 
for functionality of the PKS. B) Chain extension of the PK chain through Claisen condensations of 
the extender unit (here malonyl-CoA) and starter unit (here acetyl-CoA). C) β-keto processing. 
The KR reduces the keto group to a hydroxyl group, the DH dehydrates the hydroxyl group to an 
enoyl group, and the ER reduces the enoyl group to the saturated alkyl. KS = β-ketoacyl synthase, 
AT = acyl transferase, ACP = acyl carrier protein, KR = ketoreductase, DH = dehydratase, ER = 
enoyl reductase. 
 
Even with the presence of the reductive domains, the reductive steps can be partly of fully 
omitted in each round of elongation, see Figure 1.6. This will give rise to more diverse 
and complex functionalities in the final PK. The PK backbone can be further modified 
e.g. be methylation by a methyltransferase domain (MT), which catalyzes methylation of 
the growing PK chain using S-adenosylmethionine (SAM) as a carbon-donor [48]. 
Elongation and reduction cycles will be repeated until a defined chain length is obtained. 
The thioester bound substrates are then released from the enzyme complex, catalyzed by 
a thioesterase (TE), cyclase (CYC) or other enzymes [49][50].  
After release the PK product often undergoes additional modifications by tailoring 
enzymes. This post-PKS processing is another source of diversity in PKs. The 
modifications can range from small changes such as methylations, reductions and 
oxidations, to larger modifications including ring formation or linking to other 
metabolites such as sugar moieties or terpenoids.  
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Figure 1.6 Mechanisms involved in PK biosynthesis. In each chain elongation the PK chain is 
extended with one ketide unit as a result of the Claisen condensation. The reductive steps can be 
partly of fully omitted in each round of elongation. Enz = Enzyme, KS = Ketoacylsynthase, AT = 
Acyl Transferase, ACP = Acyl carrier protein, ER = Enoyl reductase, DH = Dehydratase, KR = 
Ketoreductase. Adapted from [44]. 
 
The iterative nature of the PKSs makes it difficult to predict the structure of the final PK 
product [51] both with respect to the degree of saturation, methylation pattern and size. It 
has been demonstrated, that there is a correlation between the volume of the active site 
pocket of the KS domain and the size of the final PK product [52], however, the number 
of the iterations in the PKS still cannot be predicted.   
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1.2.2 Non-ribosomal peptides 
In contrast to the ribosomal biosynthesis of peptides and proteins, many smaller natural 
peptides are non-ribosomally synthesized [53]. The biosynthesis happens in a sequence of 
enzyme-controlled processes, where each amino acid is added due to the specificity of the 
enzyme involved. The non-ribosomal peptides are assembled on multimodular enzymes 
called non-ribosomal peptide synthetases (NRPSs) [53][54].  
The NRPSs have a modular arrangement, where each module is responsible for 
incorporation and modification of one defined amino acid. The number of modules 
corresponds to the number of amino acids in the final NRP product and their order 
follows the order of the adenylation domains. Each module consists of several catalytic 
domains, see Table 1.5. Three domains are necessary for biosynthesis, which is a 
condensation (C) domain, an adenylation (A) domain and a thiolation (T) domain (also 
referred to as peptidyl carrier protein (PCP) domain) [54]. The A domain is catalyzing 
selection for each amino acid, which is adenylated and loaded onto the T domain, where 
the C domain catalyzes formation of the peptide bond between two amino acids, see 
Figure 1.7. 
Figure 1.7 Peptide bond formation catalyzed by the C domain is resulting in a growing peptide 
chain. Adapted from [54]. 
 
The residues are lined up to allow a sequential series of peptide bond formations until the 
peptide are released from the enzyme. The release can result in either a linear or a cyclic 
peptide depending on whether it is released by hydrolysis or lactamization. Release to 
give a linear peptide is often achieved by a thioesterase (TE) domain in the final module 
whereas cyclization occurs by terminal C-like domains [49][55][56][57]. Structural 
variance in NRPs occurs by tailoring domains, a brief description of some are given in 
Table 1.5. 
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Table 1.5 Overview of domains in NRPSs. 
Domain Description 
Necessary domains   
Adenylation (A)  Selection and activation of specific amino acids 
Condensation (C)  Catalyzes formation of peptide bond 
Thiolation (T)  Holds the growing chain. Also referred to as peptidyl carrier 
protein (PCP) domain  
Tailoring domains  
Epimerization (E)  Located downstream of T and catalyzes the generation of D-
configured amino acids from the corresponding L-isomers 
N-methyltransferase (Mt)  Responsible for the N-methylation of the peptide products. 
Usually integrated at the C-terminal region of the A-domains 
C-methyltransferase (C-Mt)  Responsible for the C-methylation of Cα atoms of cysteine 
residues. Located downstream of T domains 
Cyclization (Cy)  In addition to peptide bond formation it catalyzes a heterocyclic 
ring formation to the corresponding thiazoline or oxazoline rings 
Oxidation (Ox)  Catalyze the formation of thiazoles and oxazoles. Integrated 
within the C-terminal region of A-domains 
Reduction (R)  Catalyze the NADPH-dependent formation of thiazolidine 
andoxazolidine rings 
 
The structures of NRPs vary as a result of the tailoring domains, but also from 
incorporation of AAs (not necessarily proteogenic AAs) as well as variations in release 
from the enzymes.  
Prediction of the products of NRPSs is more straightforward than that of fungal PKSs, 
because of their modular nature, as also demonstrated in this thesis. For the peptide 
nidulanin A, discovered in A. nidulans, bioinformatic analysis could, based on the domain 
structure, predict a tetracyclic structure including suggestions for incorporated AAs, 
which was verified by isolation and structure elucidation of the compound (see section 
4.2 and Paper 8).  
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1.2.3 Terpenoids 
The terpenoids or isoprenoids, is a group of NPs build by activated C5 units [58][59]. 
What is now known as “the isoprene rule” was observed as far back as 1887, where 
Wallack noted that many NPs apparently were comprised of isoprene units (C5H8) [60], 
see Figure 1.8. The rule states that terpenoids are formed by linking isoprene units in a 
head-to-tail fashion. The typical terpenoid structure therefore contain a carbon skeleton 
built up of isoprene units (C5H8) represented by (C5)n, see Table 1.6. 
Most terpenoids are further modified by cyclisation reactions, and can also be oxidized, 
reduced or fused to other metabolites. However, in the final product it is most often 
possible to identify the original arrangement of the head-to-tail isoprene units.  
 
Figure 1.8 Structure of the isoprene unit, showing the head and tail, and a monoterpene consisting 
of two individual isoprene units marked in bold. DMAPP = dimethylallyl diphosphate. IPP = 
isopentenyl diphosphate. 
The isoprene units may be derived from two different pathways: either from 
intermediates of mevalonic acid or methylerythritol phosphate [61]. In both pathways the 
activated C5 isoprene units dimethylallyl diphosphate (DMAPP) and isopentenyl 
diphosphate (IPP) are utilized (Figure 1.8), which are condensed in a head to tail fashion. 
Table 1.6 Nomenclature of terpenoids [61]. 
Isoprenoid units Name 
1 Hemiterpenes (C5) 
2 Monoterpenes (C10) 
3 Sesquiterpenes (C15) 
4 Diterpenes (C20) 
5 Sesterterpenes (C25) 
6 Triterpenes (C30) 
8 Tetraterpenes (C40) 
≥ 9 Polyterpenes (≥ C45) 
 
Terpenoid elements are often incorporated into other types of NPs. This is true for PKs 
(section 1.2.1) and NRPs (section 1.2.2). In fungi this process is catalyzed by a class of 
enzymes called prenyltransferases that transfer allylic prenyl groups to acceptor 
molecules, as seen in e.g. nidulanin A and meroterpenoid yanuthone D in this thesis 
(section 4.2, Paper 8 and section 4.3, Paper 9, respectively).  
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1.3 Genetics of secondary metabolites biosynthesis 
The work of this thesis has been carried out in what is referred to as the post-genomic era. 
Before the genomic era, the study of biosynthesis of SMs were time consuming, difficult 
and limited to random mutations or purification of pathway enzymes followed by 
reconstruction of the biosynthetic steps in the lab [62]. The modern high-throughput DNA 
sequencing has exposed a high amount of biosynthetic gene clusters and revealed an 
enormous biosynthetic potential of previously undiscovered SMs in filamentous fungi, 
and opened for more genome driven research [63][64][65]. This section covers the 
genetics of SMs biosynthesis and different approaches to express/activate silent genes.   
1.3.1 Secondary metabolite gene clusters 
In contrast to primary metabolites, whose biosynthetic genes are distributed across the 
genome, the genes involved in biosynthesis of SMs in filamentous fungi are often 
clustered [66]. The compilation of genes, that together is responsible for production of a 
final SM, is referred to as a gene cluster. A typical gene cluster will usually consist of a 
synthase/synthetase gene such as a PKS or NRPS (see section 1.2.1 and 1.2.2), genes 
encoding enzymes for post modifications often referred to as tailoring enzymes, genes to 
regulate the expression of the gene cluster, and potentially genes necessary for exporting 
the final SM out of the cell.  
From the Aspergilli sequenced so far, those with a genome size of 28-40 Mb, typically 
contain around 50 gene clusters [67], where one cluster can span more than 10,000 bases. 
There are, however, exceptions from the physically clustered genes, such as the 
biosynthetic pathway for meroterpenoids austinol and dehydroaustinol in A. nidulans 
which requires two separate gene clusters located on separate chromosomes [68] or the 
biosynthetic pathway of nidulanin A, where the NRPS and a prenyltransferase are 
physically separated in the genome (section 4.2 and Paper 8). 
As briefly described in section 1.1.2, SMs are not necessary for cell growth, but exhibit 
other specific functions such as defense or signaling. Therefore a strict regulation of 
production is necessary to ensure that the SMs are only being produced when needed. 
This regulation can occur by regulatory genes, embedded in the SMs gene clusters, 
encoding transcription factors (TFs), that transcriptionally control the structural genes 
involved in biosynthesis. From fungi, a total of twelve TF superfamilies have been 
identified, and of these, three are exclusively present in fungi [69]. The TF can work in 
one of two ways: either by facilitating transcription (activators) or by blocking 
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transcription (repressors) [70]. In either way, experiments with expression of the TF may 
provide useful information about the pathway. 
1.3.2 Activation of silent genes 
Most of the gene clusters in filamentous fungi are silenced or expressed in minute 
amounts under standard laboratory conditions [71]. To this end, genomic sequencing has 
revealed, that there are many more genes for biosynthesis of SMs than metabolites 
already identified [19][72][73]. As a direct consequence the number of gene clusters by 
far exceeds the number of known metabolites, which can be linked to these clusters. Gene 
clusters encoding biosynthetic systems not associated with production of a known SM are 
often referred to as “cryptic.” There is a further difference between uncharacterized genes 
and genes that are not expressed. Orphan biosynthetic pathways are defined gene clusters 
for which the corresponding metabolite is unknown, while silent genes refers to genes 
which are not expressed under given growth conditions [74].  
The growing evidence, that fungal genomes contain a substantial number of SM genes 
that remains silent under standard laboratories conditions is especially true for PKS and 
NRPS genes [75][76]. Consequently there are therefore a large number of undiscovered 
NPs, representing a big pool of novel and possibly bioactive compounds just awaiting 
discovery.  
Some of the strategies used to trigger activation of silent genes are: 
 OSMAC [77][78] 
 Co-cultivation [79] 
 Epigenetic modifiers [80][81] 
 Transcription factors [82] 
 Heterologous expression [83] 
The classical way of triggering silent pathways in filamentous fungi is by the “one-strain 
– many compounds” (OSMAC) approach [77][78]. This is achieved by altering the 
cultivating conditions such as temperature, pH, cultivation time, light, aeration and/or 
media composition, since a change in these conditions can influence the production of 
SMs. One example of use of the OSMAC approach is by Nielsen and co-workers, who 
investigated the metabolic profile of A. nidulans on seven complex media resulting in a 
large difference in production of metabolites [84]. Although powerful, the OSMAC 
approach can be exhaustive, and it can be tedious to find the specific growth conditions 
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under a variety of parameters and organisms, and the exact mechanisms and 
understanding of the linkage between culturing conditions and metabolic profile are not 
fully understood and moreover difficult to predict.  
In this study it has been demonstrated that silent gene clusters can be activated by 
induction of sclerotia formation. It was here demonstrated that under sclerotium 
producing conditions, the metabolic profile was highly altered in a number of black 
Aspergilli. This is further described in section 3.2, Paper 4 and Paper 6. 
Another way to activate silent gene clusters is by genome mining. The more classical way 
to use genome mining for investigation of SMs is to delete or inactivate a biosynthetic 
gene followed by comparative metabolic profile analysis by HPLC-UV or –MS (see 
section 2.1.2). This is, however, restricted to the smaller number of SMs that are 
produced under laboratories conditions. Instead, two other ways of investigating the silent 
clusters are often utilized: The use of TFs and by heterologous expression. Employing 
TFs, these are (if activators) typically overexpressed in the native organism to ensure 
activation of the cluster. Using heterologous expression, one synthase/synthetase gene or 
an entire gene cluster is expressed heterologous in a host organism. 
For the filamentous fungus A. niger investigated in this study, sequencing and gene 
annotation suggests that there are 944 regulatory genes [19]. In the biosynthetic gene 
cluster for yanuthone D, one TF was embedded in the cluster, which was shown to work 
as a repressor, giving insights into the span of the cluster. For this, see section 4.3 and 
Paper 9. In A. aculeatus the overexpression of a TF activated a biosynthetic pathway 
leading to the discovery of diastereomers of RKB-3384B, see section 4.4 and Paper 11. 
This study exemplifies the use of TFs for discovery of novel SMs. Heterologous 
expression was also used in both of these projects for investigation of the pathways. 
Furthermore a way to quickly expressing genes or whole gene clusters from filamentous 
fungi has been investigated in this thesis (section 4.5). 
The use of genome mining for investigation of gene clusters [85] will be further discussed 
in the following section. 
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1.3.3 Genome mining 
Gene prediction  
To elucidate the biosynthetic pathway of fungal SMs in a genome sequenced organism, 
the first step is to predict the genes belonging to the gene cluster. Through computational 
analysis it is possible to identify putative SM genes within genomes. This is achieved by 
use of one or several gene prediction algorithms creating automated annotations based on 
domain predictions and homology search, followed by manual inspection. These 
predictions grow more powerful, but as it is merely predictions, these should always be 
followed up by experiments. In Table 1.7 the genome sequenced strains used in this study 
are displayed.  
Table 1.7. Overview of the fully genome sequenced strains used in this studies including the 
predicted number of synthase/synthetase genes and examples of metabolites that have been linked 
to genes. 
Species Strain Sequencing Predictions Linking of metabolites to genes  
A. niger ATCC 
1015 
DOE Joint 
Genome 
Institute [73] 
32 PKSs 
15 NRPSs 
9 hybrids 
[81] 
PKs 
Azaphilones [36] 
TAN-1612 [86] 
Dihydroxynaphthalene 
(DHN) Melanin [87]  
Naphtho-γ-pyrone [87] 
Fumonisin [18][19][20] 
  
PK-NRPs 
Pyranonigrin E [88]  
Ochratoxin A [19]  
 
Meroterpenoids 
Yanuthone D [89] 
 (see section 4.3) 
A. 
nidulans 
FGSC 
A4 
Broad 
institute[75] 
32 PKSs 
27 NRPSs 
1 hybrid 
[55][84] 
PKs 
Sterigmatocystin [90] 
Naphthopyrone [91] 
Asperthecin [92] 
Monodictyphenone/ 
emodin [93][94] 
austinol/dehydroaustinol[84], 
arugosins [84], 
Orsellinic acid/ 
Lecanoric 
acid/F9775A/F9775B [93] 
[79][95] 
Asperfuranone [96] 
Alternariol/cichorine [97] 
 
PK-NRPs 
Aspyridone A-B [82]  
Emericellamide [98]  
 
Meroterpenoids 
Aspernidine A-B [99] 
 
NRPs 
Nidulanin A [100]  
(See section 4.2) 
A. 
aculeatus 
ATCC 
16872 
DOE Joint 
Genome 
Institute 
[101] 
24 PKSs 
19 NRPSs 
9 terpenoid 
synthases  
5 hybrids 
[102] 
PK-NRP-terpenoid 
Aculins A-B, epi-aculin A 
and PK aculinic acid  
(Section 4.4, Paper 11) 
 
 
Many strategies exist for the investigation of biosynthetic pathways [74][103][104]. In 
the following only the approaches used in this study will be described: gene inactivation 
and heterologous expressions.   
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Genetic manipulations in fungal native host 
A widely used technique for discovery of novel metabolites is to delete or inactivate a 
biosynthetic gene, followed by comparative metabolic profile analysis by HPLC-UV or -
MS. This procedure can identify the compounds affected by the gene deletion and thereby 
link genes to compounds.  
To execute this experiment a knockout cassette containing a resistance marker or 
prototrophic gene is specifically integrated into the specified locus. The deletions of 
genes can, besides abolishment of production of the final SM also, lead to accumulation 
of intermediates, which can provide further insights into the biosynthetic pathway. 
Thereby a series of individual deletions of all genes in a cluster can lead to understanding 
of every step in a biosynthetic pathway from production of the first precursor through all 
modifications and intermediates into the final SM.  
There are limitations to these experiments, as they will depend on the ease of genetic 
manipulations of the fungal host. To improve efficiency of homologous recombination 
(HR) to ensure specific integration, strains can be engineered to favor HR over non-
homologues end-joining (NHEJ). In A. nidulans the deletion of the Ku70-Ku80 
heterodimer resulted in > 90 % gene targeting efficiencies [9][105], while the elimination 
of the homologue kusA in A. niger enhanced the efficiency in this species to > 80 % 
[106]. The efficiency can further be enhanced in combination with bipartite 
transformation substrates [8]. 
In this study the biosynthetic pathway of yanuthone D was investigated in the native host 
by gene deletions of all genes in the cluster. This is described in section 4.3 and Paper 9. 
Heterologous expression of individual genes or clusters in model organisms 
There can be many reasons why manipulations in the native host, is not the most optimal 
approach. The organism of interest can be difficult or hazardous to work with, expensive 
or impossible to cultivate in the laboratory, or insusceptible to genetic manipulations. In 
these cases it can be advantageous to move the gene or gene cluster of interest to a host 
organism. Some of the advantages of using a host organism include that it will be 
amenable to genetic modifications, the optimal conditions for growth will already be 
known and its genome sequence and metabolite profile are already known [107]. 
Furthermore, competing gene clusters can be deleted. Bacteria and yeast have been used 
as host organisms, but for production of fungal SMs, filamentous fungi are preferred as 
hosts. Both since they themselves are producers of SMs, why they have the required 
accessory enzymes to facilitate the products, and secondly since they are capable of 
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splicing introns, which is not the case for bacteria and yeast. Among filamentous fungi A. 
nidulans has been well-studied and is often used as host organism.  
 
Heterologous expression can be achieved by different methods. One way is by 
heterologous integration in a well-defined locus in the host organism, for example A. 
nidulans. For heterologous gene expression a genomic insertion site is needed. The 
foreign gene should be expressed from a specific well-characterized locus and preferably 
the new gene should be inserted with no interference with the strain and allowing high 
and stable expression. Investigations of such a site in A. nidulans have led to the insertion 
site IS1 [83], but several other sites have also been used [108][109]. An example of the 
strength of heterologous expression by integration is the reconstitution of the entire 
geodin cluster from A. terreus [109]. Heterologous expression was also used in this PhD 
study, where the cytochalasin gene cluster from A. clavatus was reconstituted in A. 
nidulans, (section 4.5, Paper 12), as well as for investigation of 6-MSA PKS gene from 
both A. niger (section 4.3, Paper 9) and A. aculeatus (section 4.4, Paper 11). 
 
Heterologous expression can also be achieved by use of non-integrative vectors; 
autonomously replicating plasmids. In this study AMA1 (Autonomous Maintenance in 
Aspergillus) plasmids [110] have been used. These are designed with the AMA1 
sequence with the purpose of doing extrachromosomal replication [102][110]. The 
autonomously replicating plasmids have the advantage over the integrative systems, in 
that transformation rates are high [111]. Drawbacks are that the plasmids are unstable and 
easily lost if selection is not maintained. The AMA1 based plasmids are hence good for 
rapid screenings. The AMA1 based self-replicating plasmids are not limited to A. 
nidulans but have become available for use in a number Aspergillus species such as A. 
niger [112][113], A. fumigatus [114], A. oryzae [110] and in this study also been used in 
A. aculeatus for the first time (section 4.4 and Paper 11). 
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1.4 Metabolite profile analysis  
Metabolite profile analysis refers to the qualitative analysis or identification of 
metabolites produced of an organism (the metabolome). In this thesis this is achieved by 
use of UHPLC-DAD-HRMS, utilizing the exact mass of the metabolite and hence the 
molecular formula as well as the UV spectrum, which serves as a fingerprint of the 
specific SM. This is exemplified under experimental work in section 2.1.2. In this section 
a description of the MS-based dereplication is described (section 1.4.1) as well as 
explorative solid phase extractions (E-SPE), (section 1.4.2), which can serve as an aid in 
dereplication.  
1.4.1 MS-based dereplication 
Filamentous fungi produce a wide variety of SMs, wherefore a fungal extract will be a 
complex mixture. A major goal in the discovery of novel NPs, is early in the process, to 
implement a strategy for detection of already known compounds, so time and resources 
are not wasted in purification hereof. The process of tentatively identifying the already 
known compounds is termed dereplication [115]. Different techniques can be used, for 
instance LC-NMR [116], but the core technology used for dereplication is LC-UV-MS in 
combination with subsequent database search [115].  
The process can roughly be divided into three steps:  
1. Identifying the pseudo molecular ion (MS data) 
2. Search based on the elemental composition in database of choice (Database) 
3. Evaluation of hits and final determination (UV data, RT, E-SPE) 
The dereplication approach is based on the MS data, first finding the monoisotopic mass 
and hence the elemental composition of the compound of interest. Caution must be taking 
in this part to identify the correct pseudo molecular ion. Some compounds can have 
strong sodiated or ammoniated adducts, others can predominantly form di- and trimeric 
ions, yet others will fragment easily or will simply ionize poorly. In all cases 
identification is prone to errors, since the mass spectrum is easily misinterpreted. The 
pseudo molecular ion should be assigned with care; the more adducts to confirm the 
mass, the better, and confirmation in positive as well as negative mode is preferable. 
Once the pseudo molecular ion is determined the monoisotopic mass and isotopic pattern 
should be used to generate the elemental composition [115][117], which is then used for a 
query in an appropriate database.   
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SciFinder and MarinLit are examples of databases used for NP dereplication; in this work 
the commercial database Antibase 2012 (40065 compounds) [118] has been used as well 
as an in-house library of microbial metabolites (7237 compounds) [115]. A high mass 
accuracy will ensure the database search to result in fewest possible candidates. The 
number of hits in the databases can, however, vary, and elimination of candidates may be 
necessary. This can be achieved by UV-data and the by using the RT. Many NPs have 
unique UV-spectra wherefore comparison of measured data with spectra from databases 
or the literature, can result in elimination of candidates [115][119]. On the same note, the 
RT may reduce the number of candidates. This can be by simple considerations of the 
polarity of the compound in question, or preferably if the RT is known for a given 
compound. The latter requires detection on the same instruments, since RT vary from 
different setups; a standard is optimal for reliable identification.    
As an aid in dereplication E-SPE can be used [120]. In the E-SPE approach, described in 
section 1.4.2, important information about the physical chemical properties of the 
compound such as acid and basic properties are attained; which can help to accelerate 
dereplication by reducing the number of potential candidates.  
Recent advances within dereplication speeds up the process by “aggressive dereplication” 
[121], which has also been used in this study. In this approach, TargetAnalysis (Bruker 
Daltonics), is used to screen extracts for several thousands of compounds, by use of the 
internal compound database, based on an in-house-built Excel application. This is 
achieved by comparison with the accurate mass, as well as isotope pattern and RT 
consistency. EICs are automatically generated for all compounds in the database and 
overlaid with the BPC. Compounds available as reference standards, previously identified 
compounds, known contaminants (from solvents, media, filters etc.) are labeled and 
potentially novel compounds are easily visualized. Manual inspection is still necessary as 
adduct formation and simple fragmentations may result in false-negative results. A way 
of optimizing the aggressive dereplication process, is by use of MS-MS libraries, as these 
will eliminate false-negative results [122]. This is a robust and reliable way of tentatively 
identifying known compounds, but is highly depended on MS-MS libraries of standards 
of NPs.   
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1.4.2 Explorative solid phase extractions 
Explorative solid phase extractions (E-SPE) is an approach of targeted exploration of 
chemical functionalities [120]. It uses small pre-packed columns with orthogonal 
stationary phases for a quick screening. The E-SPE strategy used in this project was 
developed by Månsson and co-workers [120] and uses ion-exchangers, size exclusion and 
normal phase columns. Three ion exchangers are tested: One strong anion-exchanger 
(SAX), a strong cation-exchanger (SCX) and a mixed mode anion-exchanger (MAX). 
The size exclusion chromatography is performed using self-packed columns of LH-20, 
and finally, two normal phase columns are used, a diol and one amino column. As 
illustrated in Figure 1.9, a test of all six columns, results in 27 fractions, which are 
subsequently analyzed by UHPLC-DAD-HRMS. Analysis of the fractions will reveal if a 
compound of interest carry any basic or acidic functionalities, a valuable information that 
can be exploited in the dereplication process. Furthermore, the use of orthogonal 
stationary phases enable separation of compounds with different functionalities, even 
though they would co-elute on traditionally RP chromatography, which can be used to 
easily establish a purification strategy.    
 
 
Figure 1.9 Overview of the columns used in the E-SPE setup. Three ion-exchangers are used 
(SAX, SCX, MAX), one size exclusion (LH-20), and two normal phases (diol and amino). 
The optimal outcome of a dereplication for the NP chemist is not to find hits matching a 
given compound, since this indicates a novel structure. There are, however, no guaranties. 
There are no databases with all compounds described in literature, and new structures are 
continuously being submitted both from natural sources and from synthetic approaches. 
Furthermore the compounds of interest may be novel but only contain smaller 
modifications compared to a known compound. For instance an additional methyl group 
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would result in no hits in the databases due to the change in mass, though the structure 
would merely be an analogue. 
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2 Overview of experimental work 
An overview of the experimental work performed and the resulting papers is given in 
Figure 2.1. The results are presented in chapter 3-4. 
 
Figure 2.1 Overview of the experimental work performed in this thesis. 
 
The following sections outline the workflow, strategies and instruments applied in this 
study. Detailed experimental descriptions are presented in Paper 1-12. 
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2.1 Workflow 
The workflow used throughout this study is summarized in Figure 2.2. Depending on the 
type of project, the first step was to genetically modify the strain. The strain of interest 
was then cultivated, typically on a set of different media, to get insight into the full 
metabolic repertoire. SMs were then extracted and often the next step was often E-SPE 
using a series of different columns. This step was introduced with two purposes: Firstly 
as an aid in dereplication as information of functional groups provide valuable 
information. Secondly, to provide a strategy for purification. Extensive dereplication was 
then performed mapping all SMs produced and identifying already known compounds. 
When the chemical analyses revealed new compounds or intermediates of interest, the 
cultivation was scaled up to allow for isolation and structure elucidation. After extraction 
of the metabolites a process of purification followed, using several consecutive  
purification steps and going back and forth between chemical analysis and purification. 
When pure compounds were obtained, their structures were elucidated by use of 1D and 
2D NMR experiments. 
 
Figure 2.2 The workflow and purification strategy used throughout this study. See text for details. 
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2.1.1 Purification strategy 
For isolations of all SMs in this work, solid cultures were used. Strains were inoculated as 
three point inoculations on 50-200 plates of selected media and incubated at 25-37 °C for 
5-7 days in the dark. The plates were harvested and extracted twice overnight with ethyl 
acetate (EtOAc) with or without 1 % formic acid. After extraction of the SMs, a step of 
removing both very polar (e.g. sugars from the media) as well as very apolar (e.g. fatty 
acids) compounds was accomplished through liquid-liquid extractions.  
A crude fractionation using an Isolera flash purification system (Biotage) followed. In 
this particular step, the data from the preliminary E-SPE experiments was used. This was 
crucial in order to find orthogonal purification methods to obtain a good separation of 
compounds. This is exemplified by the purification of two yanuthones (section 4.3). 
Chromatograms from the E-SPE are depicted in Figure 2.3. The BPC of the A. niger 
crude extract showed that two of the targets, 7-deacetoxyyanuthone A and yanuthone D, 
eluded close together on a traditional C18 column. Two of the fractions from the E-SPE 
experiment with a diol column, however, showed complete separation of the two 
compounds in two consecutive fractions; fraction four (DCM) and fraction five 
(DCM/EtOAC 1:1). A diol column was therefore used at the Isolera, providing optimal 
separation of the two compounds. 
 
Figure 2.3 ESI+ BPC chromatograms of A. niger extract showing the metabolic profile of the 
crude extract and two fractions from E-SPE using a diol column.  
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The Isolera fractions were subjected to further purification on a semi-preparative HPLCs 
which was either a Waters 600 Controller with a 996 photodiode array detector (Waters, 
Milford, MA, USA) or a Gilson 322 Controller connected to a 215 Liquid Handler, 819 
Injection Module and a 172 DAD (Gilson, Middleton, WI, USA). This was typically 
achieved using a Luna II C18 column (250 x 10 mm, 5 μm, Phenomenex) or a Gemini C6-
Phenyl 110A column (250 x 10.00 mm, 5 μm, Phenomenex). The choice of system, 
solvents, flow rate, column and gradients depended on the given sample mixture for the 
project.  
2.1.2 Metabolic analysis 
The chemical analysis performed during this study was primarily performed on a maXis 
3G QTOF (Bruker Daltonics). This was equipped with an electrospray ionization (ESI) 
source and connected to an Ultimate 3000 UHPLC system (Dionex). The column used 
was a reverse-phase Kinetex 2.6 µm C18, 100 mm x 2.1 mm (Phenomenex), and the 
column temperature was maintained at 40 ˚C. A linear water-acetonitrile (LC-MS grade) 
gradient was used (both solvents were buffered with 20 mM formic acid) starting from 
10% (v/v) ACN and increased to 100% in 10 min, maintaining this rate for 3 min before 
returning to the starting conditions in 0.1 min and staying there for 2.4 min before the 
following run. A flow rate of 0.4 ml/min was used. TOFMS was performed in ESI+ with 
a data acquisition range of 10 scans per second at m/z 100–1,000. The TOFMS was 
calibrated using Bruker Daltonics high precision calibration algorithm by means of the 
use of the internal standard sodium formate, which was automatically infused before each 
run. This provided a mass accuracy of better than 1.5 ppm in MS mode. UV-visible 
spectra were collected at wavelengths from 200 to 700 nm. Data processing was 
performed using Data Analysis 4.0 and Target Analysis 1.2 software (Bruker Daltonics). 
Comparative metabolic profiling was used for analysis of strains. This is illustrated for a 
PKS deletion strain and reference strain of A. niger (section 4.3, Paper 9), see Figure 2.4. 
It is here illustrated how a SM (RT = 9.4 min) is disappearing in the deletion strain. This 
was always verified by extracted ion chromatograms (EICs) of the m/z of the compound 
in question (not shown in Figure 2.4). The peak would then be analyzed by MS and UV 
data, and a search in the two databases Antibase 2012 (commercial database, 40065 
compounds) [118] and the in-house library of microbial metabolites (7349 
compounds)[115] conducted, in order to tentatively identify already known compounds, 
as described in section 1.4.1. 
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Figure 2.4 Example of comparative metabolic profiling, identifying abolishment of a SM in the 
deletion strain (RT = 9.4 min). Analysis by HRMS and UV and subsequent database search 
allowed for determination of the compound as the meroterpenoid yanuthone D. 
 
2.1.3 Structural analysis 
The structure elucidation of isolated metabolites was performed in combination of 
UHPLC-DAD-HRMS data and 1D- and 2D NMR experiments. The latter were achieved 
on a Varian Unity Inova-500 MHz spectrometer or a Bruker 400 MHz spectrometer, both 
located at DTU Chemistry. When minute amounts of compounds were obtained, NMR 
data was recorded on a 800 MHz Bruker Daltonics Avance spectrometer located at the 
Danish Instrument Centre for NMR Spectroscopy of Biological Macromolecules at 
Carlsberg Laboratory. Generally 
1
H, DQF-COSY, NOESY, HSQC and HMBC spectra 
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were recorded for all compounds. The general workflow is presented in Figure 2.5. It is 
noted that a 
13
C spectrum was generally not obtained; the 
13
CNMR chemical shifts were 
determined from HSQC and HMBC experiments. With some structures, for instance 
carbonarin I and J with molecular formulas of C34H31NO10 and C34H29NO9 respectively 
(section 3.2.5, and Paper 6), the few proton resonances made it impossible to assign all 
carbon resonances from the heteronuclear experiments, why 1D 
13
C spectra were 
recorded. Other experiments, which were utilized to confirm or aid an assignment, were 
H2BC, edited-HSQC and HSQC-TOCSY. 
To obtain the absolute configuration different techniques were used, depending on the 
compounds. These included optical rotation, CD, NOESY experiments and Marfey’s 
method.  
1H spectrum 
Information about protons.  
(Integral, multiplicity) 
 
  
Heteronuclear Single Quantum Correlation 
(HSQC)  
Information about proton correlations to directly bound 
carbons. 
 
 
 
  
COrrelation SpectroscopY (COSY) 
Determination of spin systems. 
 
 
  
Heteronuclear Multiple Bond Correlation (HMBC) 
Long range/multiple bonds correlation. 
Assignment of quaternary carbons. 
  
  
Nuclear Overhauser Effect SpectroscopY (NOESY) 
Identification of protons located close to each other in 
space. Determination of 3D structure. 
 
 
Figure 2.5 Workflow for structure elucidation by 1D and 2D NMR exemplified with yanuthone H. 
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3 Discovery of novel secondary metabolites 
A significant part of the experimental work performed during this thesis has focused on 
the discovery of novel SMs, and is the theme of this chapter. Two different approaches 
have been undertaken wherefore the chapter is parted in two. The discovery has been 
achieved by dereplication (section 3.1) as well as sclerotium formation (section 3.2). 
Several species of the black Aspergilli have been studied; however, the main efforts have 
been on A. aculeatus and A. niger.  
3.1 Dereplication based discovery 
The dereplication based discovery is driven by the premise that biodiversity leads to 
chemodiversity: by studying the more exotic or unstudied species belonging to the black 
Aspergilli, we hypothesized that novel chemistry would likely be discovered. Using 
dereplication for fast tentative identification of already known compounds (section 1.4.1), 
targets for unknown and uncharacterized compounds can be identified. These can 
subsequently be explicitly targeted for purification. This section describes three black 
Aspergilli, A. aculeatus, A. indologenus and A. homomorphus, for which the metabolic 
profile was analyzed and possible unknown metabolites, were isolated and characterized. 
3.1.1 Aspergillus aculeatus 
This section presents the manuscript “Dereplication guided discovery of secondary 
metabolites of mixed biosynthetic origin from Aspergillus aculeatus” (Paper 1), published 
in Molecules in 2014.  
The study presents a thorough investigation of the industrially important black 
filamentous fungi A. aculeatus by UHPLC-DAD-HRMS.  
From fungal species identified as A. aculeatus metabolites such as aculeacins A–G 
[27][28], CJ-15,183 [29], secalonic acids D and F [30] and okaramines H and I [31] have 
been reported. Furthermore asperaculin A [32], aspergillusol A [33] and 
aculeatusquinones A–D [34] have been reported from marine strains of A. aculeatus. 
From these, different biological activities are reported, such as antifungal (aculeacins A-G 
and CJ-15,183), enzymatic inhibitory (CJ-15,183 and aspergillusol A), antimicrobial 
activities (secalonic D and F) and cytotoxicity (aculeatusquinone B and D). 
The metabolic profile of A. aculeatus (IBT = 21030) is depicted in Figure 3.1, which also 
illustrates the results of the study: Complete assignment of all major metabolites. This 
entailed identification of four compounds already known to be produced by A. aculeatus, 
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identification of three compounds reported from A. aculeatus for the first time and last 
but not least, the discovery of nine novel compounds reported for the very first time.  
 
Figure 3.1 ESI+ base peak chromatogram illustrating the dereplication of some of the major 
compounds in the extract from A. aculeatus IBT 21030 as well as the results of purification and 
structure elucidation of novel compounds. Based on cultivation on YES media for 7 days at 25 °C 
in the dark. *Novel compounds reported for the first time. **Known compounds reported from A. 
aculeatus for the first time. 
 
The use of dereplication for discovery of novel SMs proved strong in this project, as 
known compounds could easily be identified by use of the HRMS and subsequent 
database search as described in section 1.4.1. Purification followed by structure 
elucidation may still be necessary for complete assignment. For instance, it was clear 
from both UV and HRMS data that A. aculeatus produced calbistrins, which have not 
been reported from this organism before. It was, however, unclear which two calbistrins 
were produced, as calbistrin A and B have the same molecular formula and likewise for 
calbistrins C and D. If standards of the compounds are available the identity can be 
decided by comparison of RT, adducts, fragmentation and if necessary MS/MS, but no 
standards were available for the calbistrins. Depending on the project this information 
may be enough. If the purpose is solely to discover novel structures, it does not matter 
exactly which calbistrin it is; it is enough to know that the compounds are calbistrins and 
therefore of no interest. In this project, we did, however, have an interest in knowing the 
identity; since the calbistrins were incorporated into the novel structures, the 
acucalbistrins. The two compounds were therefore isolated and their structures elucidated 
by 1D and 2D NMR, whereby it was shown that the two compounds produced by A. 
aculeatus were calbistrins A and C. The same situation was true for okaramine J, which 
could not be unambiguously dereplicated, since the HRMS and UV data pointed towards 
either okaramine C, J or L. The novel compounds discovered in A. aculeatus are depicted 
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in Figure 3.2. A detailed description of the structure elucidation of these compounds is 
given in Paper 1.  
 
Figure 3.2 Structures of the novel compounds isolated from A. aculeatus. The structures of 
aculenes A-C, acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinine 
has been verified by 1D and 2D NMR spectroscopy, while they remaining have been suggested 
based on UHPLC-DAD-HRMS data.  
 
As depicted, the novel A. aculeatus structures are of different biosynthetic origin. We 
propose that aculenes A-B are assembled from three isoprene units and the AA proline 
(further elaborated in section 4.4). The calbistrin part of the acucalbistrins has been 
hypothesized to be of PK origin [123], while acu-dioxomorpholine, okaramine S and epi-
10,23-dihydro-24,25-dehydroaflavinine are of NRP/indole terpenoid origin.  
Working on this project it was by serendipity discovered that A. aculeatus was capable of 
producing sclerotia, when spores were maintained at -18˚C prior to inoculation. This 
discovery was of great interest, as the metabolic profile was greatly altered under 
sclerotia producing conditions. This led to further investigations including other 
Aspergillus species, which are described in section 3.2.    
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3.1.2 Aspergillus indologenus 
This section presents the manuscript “Aspiperidine oxide, a new rare piperidine N-oxide, 
from the filamentous fungus Aspergillus indologenus” (Paper 2), intended for submission 
to Phytochemistry Letters. The structure elucidation of the novel compound aspiperidine 
oxide, was performed under supervision of professor Marcel Jaspars as part of a PhD 
course at the University of Aberdeen.  
In the same clade as A. aculeatus is another black Aspergillus: A. indologenus (IBT 3679 
= CBS 114.80) (see Table 1.1). This species was isolated from Indian soil in 2011 and 
was subsequently described by Varga and co-workers [22]. This work showed that A. 
indologenus is a producer of the insecticidal compounds okaramines A, B, and H, which 
is also the case for the closely related A. aculeatus (section 3.1.1). A further analysis of 
the metabolic profile showed that it produced indol-alkaloids related to aflavinines [22]. 
Being a relatively unstudied species, the hypothesis was that A. indologenus would likely 
produce new chemical entities, other than the SMs already reported from this clade. 
Initial dereplication revealed compounds, which were already known. This included the 
three compounds JBIR-74 [124], aspergillicin A [125] and fellutanine C [126], see Figure 
3.3.  
 
Figure 3.3 ESI+ Base peak chromatogram illustrating some of the major compounds in the extract 
from A. indologenus. Based on microscale extraction after cultivation on CYA media for 7 days at 
25 °C in the dark.  
 
These compounds have, however, not been described from A. indologenus before. JBIR-
74 was originally isolated from a sponge-derived Aspergillus species, aspergillicin A 
from a marine-derived A. carneus and fellutanine C from Penicillium fellutanum. 
Aspiperidine oxide, (RT = 3.65 min, Figure 3.3) was identified as a possible novel 
compound and isolated and structure elucidated from A. indologenus. The structure is 
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depicted in Figure 3.4, a thorough description of the structure elucidation is found in 
Paper 2. 
 
Figure 3.4 The chemical structure of aspiperidine oxide. 
 
Aspiperidine oxide was tested towards GRAM negative bacteria P. aeruginosa, A. 
baumannii and E. coli, GRAM positive MSSA and MRSA, the yeast C. albicans and for 
fungal activity against A. fumigatus, but did not display any biological activity.    
The structure of aspiperidine oxide was found to contain the N-oxide displayed in Figure 
3.4. This type of structure has, to the best of our knowledge, never been seen in any 
fungal SM. The piperidine N-oxide has recently been observed in two alkaloids isolated 
from the plant Microcos paniculata [127]. The chemical shifts were comparable to our 
observations. 
We hypothesized aspiperidine oxide to originate from amino acids, as the other 
metabolites JBIR-74, aspergillicin A and fellutanine C also produced by A. indologenus 
(Figure 3.3). We suggest aspiperidine oxide to originate from phenylalanine and the non-
proteinogenic amino acid pipecolic acid. The proposed biosynthetic pathway is depicted 
in Figure 3.5. The putative decarboxylation step of the carboxylic acid group of 
phenylalanine moiety, have been observed for the oryzamide A1-2 from A. flavus, 
described in section 4.1.    
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Figure 3.5 Proposed steps towards the biosynthesis of aspiperidine oxide. 
 
The A. indologenus extract was scrutinized for possible intermediates, see Paper 2. This 
resulted in tentative identification of both the dipeptide phenylalanine-pipecolic acid 
(trace amounts), de-methyl aspiperidine and aspiperidine. Phenylalanine was also 
observed, though no traces were found of the non-proteinogenic amino acids pipecolic 
acid. The tentative identification of the suggested intermediates supports the suggested 
biosynthesis of aspiperidine oxide. Further verification of the suggested biosynthetic 
pathway could be achieved by feeding experiments with labelled amino acids, testing if 
these were incorporated into aspiperidine oxide and the suggested metabolites.  
The finding of aspiperidine oxide in A. indologenus is an example of the potential of 
discovering novel SMs in the more unstudied species.  
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3.1.3 Aspergillus homomorphus 
This section presents the manuscript “Novel metabolites from Aspergillus homomorphus” 
(Paper 3), intended for submission to Magnetic Resonance in Chemistry.  
A. aculeatus and A. indologenus described in the previous sections belong to the same 
clade, the A. aculeatus clade. Another clade within the black Aspergilli, is the A. 
homomorphus clade, see Table 1.1. From this, the species Aspergillus homomorphus 
(IBT 21893) was investigated. A. homomorphus was originally identified from soil near 
the Dead Sea in Israel [128]. The SMs dehydrocarolic acid and secalonic acids D and F 
have earlier been reported to be produced from this species [40][41]. 
The metabolic profile of A. homomorphus is depicted in Figure 3.6. We were able to 
identify secalonic acids D and F, as well as other known compounds, not reported from A. 
homomorphus previously: Q-20547-E, L-valyl-L-tryptophan anhydride, originally 
isolated from the fungus Phoma lingam [129] and α-pyrone A and B, which has 
previously only been described from a synthetic study [130][131]. Dehydrocarolic acid 
was not identified from incubation on any medium. 
 
Figure 3.6 ESI+ base peak chromatogram illustrating compounds in the extract from A. 
homomorphus IBT 21893. Based on microscale extraction after cultivation on YES media for 7 
days at 25 °C in the dark. 
Furthermore we isolated and characterized six novel, related compounds, which we 
named by their fungal origin: homomorphosins A-F. A thorough description of the 
structure elucidations is given in Paper 3; their structures are depicted in Figure 3.7. 
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Figure 3.7 The chemical structures of homomorphosin A-F  
Homomorphosin A was unquestionable the major compound being product by A. 
homomorphus. It was isolated in a crude Isolera fraction during pre-fractionation in 
staggering 180.7 mg. The isolation of homomorphosin A led to a hypothetical 
biosynthesis proposed in Figure 3.8, which in turn led to the discovery of the other 
homomorphosins. The biosynthesis was proposed utilizing known reactions from organic 
and biochemical synthesis, starting from L-valine and L-tryptophan. The mechanisms 
needed to obtain the compounds are two C-prenylations and an epoxidation and 
subsequent intramolecular ring-closure. Both mechanisms have been previously described 
or suggested in the biosynthesis of other natural products 
[54][129][132][133][134][135][136].  
 
Figure 3.8 The suggested biosynthesis of homomorphosin A. 
 
Homomorphosins B and C (Figure 3.7) are believed to follow the same pathway, but with 
the exchange of L-valine for L-alanine as precursor for homomorphosin C, while 
homomorphosin B may originate from a non-proteinogenic AA, or from L-valine or L-
alanine which subsequently were demethylated or methylated respectively. 
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Homomorphosin F is most likely also derived from L-tryptophan and L-valine, but differs 
in the prenylation pattern, as it is N-prenylated, rather than C-prenylated.   
The bioactivity of compounds similar to the homomorphosins against bacteria, fungi and 
protozoa has been tested and bioactivities have been reported against e.g. S. aureus 
[137][138]. Homomorphosin A was tested against C. albicans and chronic lymphatic 
leukemia, but no activity was observed. 
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3.2 Production of sclerotium for discovery 
This section presents results from three different papers. Firstly, the manuscript 
“Formation of sclerotia and production of indoloterpenes by Aspergillus niger and other 
species in section Nigri” (Paper 4), published in Plos One in 2014, secondly, “Isolation, 
structural analyses and biological activity assays against chronic lymphocytic leukemia of 
two novel cytochalasins, sclerotionigrin A and B” (Paper 5), published in Molecules in 
2014, and finally, “Induced sclerotium formation exposes new bioactive metabolites from 
Aspergillus sclerotiicarbonarius” (Paper 6), intended for publication in Journal of 
Antibiotics. The section also presents additional previously unpublished data. 
3.2.1 Induction of sclerotium formation 
Paper 4 presents results from our study involving a range of natural substrates, as well as 
pre-freezing of spores prior to inoculation, in order to induce the formation of sclerotia in 
various members of the black Aspergilli as well as characterization of the metabolic 
profile during sclerotia formation.  
Sclerotial development in filamentous fungi is considered to be an important prerequisite 
for sexual development, wherefore the ability to induce sclerotium production could be a 
step forward towards finding a perfect state in a given Aspergillus species. Several 
species of the black Aspergilli have been reported as being able to produce sclerotia such 
as A. aculeatus, A. sclerotioniger, A. carbonarius, and A. sclerotiicarbonarius [41], 
whereas no sclerotia has been reported from the industrially important A. niger, and this 
organism is thought to be a purely asexual organism. Sclerotium production by A. niger 
and other black Aspergilli would have many biological, biotechnological and food safety 
consequences, due to possible production of mycotoxins such as aflatoxins and 
ochratoxin A [17][22][41][139][140][141][142].  
Besides the interesting biological aspects of this study another reason to pursue this 
project has been for the discovery of novel SMs from previously silent gene clusters. In 
section 1.3 it is described that genome sequencing projects have revealed that many 
organisms have a great genetic potential to produce a large range of SMs, many of which 
are currently unknown. Our hypothesis was, that the induction of sclerotium formation 
would alter the metabolic profile and lead to production of sclerotial related SMs, 
wherefore induction of sclerotium formation could be a way of inducing the production of 
new SMs, especially indoloterpenes, from previously silent gene clusters in black 
Aspergilli.  
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The attempt to induce sclerotium formation involved various members of the black 
Aspergilli. We presented data showing the metabolic profile of A. niger (IBT 29019) and 
A. tubingensis (IBT 16833 = CBS 161.79 = NRRL 4700) under growth conditions with 
and without sclerotium formation. Comparative metabolic studies were, besides for these 
two species, also performed for several other members of the black Aspergilli. Appendix 
A, Figure A1, shows some of the common SMs found in the black Aspergilli during this 
study, while Figure A2 shows the comparative metabolic profiles of several black 
Aspergilli.  
A common trend is production of more apolar compounds in the sclerotial extractions. 
These are apolar indoloterpenes; several tentatively identified as aflavinine analogous. 
Another common trend is production or upregulation of the naphtho-γ-pyrone 
aurasperone B. This was observed for A. carbonarius (IBT 21089), A. acidus (IBT 
24821), A. tubingensis (IBT 16833), A. tubingensis (IBT 23488), A. niger (IBT 28999), 
A. niger (IBT 24631), A. sclerotiicarbonarius (IBT 28362) and A. sclerotioniger (IBT 
22905). Aurasperone B thus seems to be an important sclerotial metabolite. It has earlier 
been demonstrated that aurasperone B is depending of the fwnA gene responsible for 
encoding the major PKS involved in formation of conidial melanin [143]. The work 
demonstrated a partial redundancy to synthesize aurasperone B. This also illustrates the 
importance of aurasperone B for the organism and could perhaps be connected to the 
upregulation observed during sclerotia formation.    
In the following sections a more detailed description of the changes in metabolic profile 
for four of the black Aspergilli is given: A. aculeatus, A. niger, A. sclerotioniger and A. 
sclerotiicarbonarius. 
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3.2.2 Aspergillus niger 
Sclerotia formation had prior to our study only been reported from a few strains of A. 
niger [144][145][146][147], however, these have later been assigned as other species 
[22][40][41]. The strains of A. niger that we tested in our study had not previously been 
shown to produce sclerotia. We first learned that several fruits stimulated sclerotium 
production. This included raisins, mulberry, blueberry, cranberry, apricot, prune, and 
mango peel. Inducing the sclerotial formation by raisins, was achieved by adding three, 
whole sterilized pieces of raisin on top of the CYA media (CYAR) and subsequently 
doing three-point inoculations close to each of the raisins, see Figure 3.9. If macerated 
raisins were added, no sclerotia were observed.  
 
Figure 3.9 Left: Numerous white to cream-colored sclerotia produced on CYAR agar can be seen 
surrounding the raisins (highlighted in yellow ellipses) and the usual heavy sporulation caused by 
A. niger IBT 29019 heads. Right: Close-up showing white to cream-colored sclerotia. The clear or 
brown exudate droplets associated with sclerotia are also visible. 
Sclerotium production was not fully consistent only by use of the CYAR medium. We 
learned that pre-freezing of spores used for inoculation in a freezer at -18 ˚C for minimum 
two weeks highly affected the production, which was originally discovered in the A. 
aculeatus work described in section 3.1.1. With the pre-freezing step, sclerotium 
production was entirely consistent in A. niger IBT 29190 and IBT 24631. From this first 
part of the study we therefore learned that sclerotium can be induced by a combination of 
using CYAR media and pre-freezing step. We were hereby able to induce sclerotium 
formation for the first time in the following other species of the black Aspergilli: A. 
brasiliensis, A. floridensis, A. ibericus, A. luchuensis, A. neoniger, A. trinidadensis, and 
A. saccharolyticus. 
A. niger is known to produce a wide range of SMs, but have never been reported to 
produce aflavinine related indoloterpenes [38]. However, with the induction of sclerotium 
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formation the metabolic profile changed noticeably. Figure 3.10 displays the metabolic 
profile of three different extractions of A. niger IBT 29019; A: Plug extraction from 
growing and sporulating culture with no sclerotium production (CYA agar with biotin); 
B: Plug extraction from growth with sclerotium production (CYAR with biotin); C: 
Sclerotium extraction (from CYAR with biotin). From the standard plug extraction with 
no sclerotium formation, several known metabolites could be tentatively identified using 
the UHPLC-DAD-HRMS data by comparison of retention time, monoisotopic mass for 
the pseudomolecular ion, adducts and UV spectrum to a standard. 
 
Figure 3.10 BPC chromatograms of A. niger (IBT 29019) A: Plug extraction from growing and 
sporulating culture with no sclerotium production (CYA agar with biotin). B: Plug extraction from 
growth with sclerotium production (CYAR with biotin). C: Sclerotium extraction (from CYAR 
with biotin). For structures of these compounds, see Appendix A. 
 
From both the plug extraction with sclerotia present and the true sclerotial extraction, 
several indoloterpenes were detected. This included anominine (formerly known as 
nominine [39]) and 10,23-dihydro-24,25-dehydroaflavinine, but also several other 
compounds which based on UV chromophore and elemental composition were identified 
as aflavinine analogs. It is interesting that these indoloterpenes are exclusively found in 
the sclerotia. Many indoloterpenes have been reported to be antiinsectan 
[148][149][150][151][152][153][154]; and sclerotia related indoloterpenes have been 
suggested to be produced to protect against insects.   
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3.2.3 Aspergillus aculeatus 
During the dereplication guided discovery of novel compounds from A. aculeatus, 
described in section 3.1.1 it was found that the strain was capable of producing sclerotia 
in vast amount, Figure 3.11.  
 
Figure 3.11 The figure shows production of sclerotia on YES (left) and CYA (right) media after 
growth for 7 days at 25 °C in the dark. The sclerotia are the white to cream-colored structures seen 
among the black conidial Aspergillus heads. 
 
Comparative metabolic profiling showed that some metabolites were highly upregulated 
inside the sclerotia, compared to the metabolites in the mycelium. Analyses of extracts of 
sclerotia from MM, CYA and YES showed large upregulations of okaramines, see Figure 
3.12. Aculenes A-C were still produced, though in smaller amounts. Furthermore the 
analysis showed that production of secalonic acids abolished on MM and CYA. The 
calbistrins were still produced and the same were acucalbistrins A-B, though in trace 
amounts. Some okaramine analogues have shown activity against silkworms 
[155][156][157] and the substantial upregulation of okaramines can be connected to 
sclerotium production as a defense mechanism to protect against insects. 
 
Figure 3.12 BPC chromatograms of A. aculeatus (IBT 21030) A: Plug extraction from growing 
and sporulating culture with no sclerotium production (CYA agar with biotin). B: Plug extraction 
from growth with sclerotium production (CYAR with biotin). C: Sclerotium extraction (from 
CYAR with biotin). For full description of metabolites produced by A. aculeatus, see section 3.1.1. 
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3.2.4 Aspergillus sclerotioniger 
From the study involving several black Aspergilli, described in section 3.2.1, the 
metabolic profile of A. sclerotioniger caught our attention, since several compounds were 
produced, tentatively identified as novel cytochalasans.  
The possible production of cytochalasins caught our attention as it is a diverse group of 
compounds with a wide range of biological functions [158], including inhibitory activities 
towards lung, ovarian, and human colon cancer as well as human leukemia [159,160]. 
Another reason to pursue this compound class is that our lab recently demonstrated that 
chaetoglobosin A, produced by Penicillium aquamarinum, selectively induce apoptosis in 
CLL cells with a median lethal concentration (LC50) value of 2.8 µM [161]. A more 
thorough description of cytochalasins can be found in section 4.5.1.  
It was furthermore interesting, since the only indication of production of any 
cytochalasans in Aspergillus subgenus Circumdati section Nigri is aspergillin PZ, for 
which the precursor aspochalasin C or D has been suggested [162][163]. However, in the 
sister clade Aspergillus subgenus Circumdati section Flavipedes, many cytochalasans 
have been reported, including aspochalasin A-D [164], E [165], F & G [166], D & H 
[167], I-K [168][169], L [170], U [171] and TMC-169 [172] in addition to aspochalamin 
A-D, aspochalasin D & Z [173], rosellichalasin [174], and cytochalasin E, 5,6-dehydro-7-
hydroxy cytochalasin E, and a Δ6,12-5,6-dehydro-7-hydroxy cytochalasin E, 10-phenyl-
[12]-cytochalasin Z16, 10-phenyl-[12]-cytochalasin Z17, cytochalasin Z11, cytochalasin 
Z13, Z16-Z20, and rosellichalasin [175][176][177][178][179]. In another species of 
Aspergillus subgenus Circumdati section Circumdati, Aspergillus elegans aspochalasin 
A1, B, D, H, I, J, cytochalasin Z24, zygosporin D, rosellichalasin and aspergillin PZ were 
found [180] supporting the view that aspochalasin D is a precursor of aspergillin PZ. 
Finally in the less closely related Aspergillus clavatus in Aspergillus subgenus Fumigati 
section Clavati, cytochalasin E and K have been isolated [181][182]. 
The chemical profiles of A. sclerotioniger did not display a great alteration in the 
different extractions (Figure 3.13), in contrary to many of the other black Aspergilli. This 
was a result of sclerotium being produced even without induction. The sclerotium 
extraction (trace C), did however show aurasperone B in higher amounts, also observed 
for many other black Aspergilli in this PhD study. Upregulation of the mycotoxin 
ochratoxin A has earlier been associated with sclerotium production in A. carbonarius 
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[139], and also in A. sclerotioniger [17][22][41]. Our observations were, however, quite 
opposite, as seen in Figure 3.13.  
 
Figure 3.13 BPC chromatograms of A. sclerotioniger (IBT 22905) A: Plug extraction from 
growing and sporulating culture with no sclerotium production (CYA agar with biotin). B: Plug 
extraction from growth with sclerotium production (CYAR with biotin). C: Sclerotium extraction 
(from CYAR with biotin).  
By cultivation of A. sclerotioniger in a larger scale, three cytochalasins were purified and 
their structures elucidated, see Figure 3.14.  One of the cytochalasins, proxiphomin, was 
previously isolated from cultures of Phoma species [183]. The other two were novel 
cytochalasins, which we named by their fungal origin: sclerotionigrin A and B. A 
thorough description of the structure elucidation is given in Paper 5, but one interesting 
structural feature, was the stereochemistry at the central carbon of the tricyclic core, 
which we found to differ compared to other cytochalasans.  
 
Figure 3.14 Structures of sclerotionigrin A, sclerotionigrin B, proxiphomin and chaetoglobosin A. 
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Based on the findings that chaetoglobosin A selectively induce apoptosis in CLL cells 
with a median lethal concentration (LC50) value of 2.8 µM, we wanted to test the effect of 
CLL cells of both sclerotionigrin A and B as well as proxiphomin. Sclerotionigrin B was 
found to have no effect, while sclerotionigrin A had a LC50 of 72 µM, and proximorphin 
48 µM. The decrease in activity observed for the sclerotionigrins, as compared to 
chaetoglobosin A, could be due to a number of things, since there are several structural 
differences. One suggestion could be the absence of the epoxide, the exchange of 
tryptophan to phenylalanine or perhaps the change of stereochemistry at the central 
carbon of the tricyclic core.    
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3.2.5 Aspergillus sclerotiicarbonarius 
During the sclerotial study another species that caught our attention was A. 
sclerotiicarbonarius, a black Aspergilli, originally isolated from Thai coffee beans [184] 
belonging to the A. carbonarius clade [22]. A. sclerotiicarbonarius has, as the name 
implies, been known as a producer of sclerotia. Nonetheless sclerotium formation was not 
observed for A. sclerotiicarbonarius (IBT 28362) on standard media, why the CYAR 
media as described in section 3.2.1 was utilized. Comparative metabolic profiling showed 
a great alteration in SMs, see Figure 3.15. 
 
Figure 3.15 UHPLC-TOF-HRMS ESI+ BPC chromatogram of Aspergillus sclerotiicarbonarius 
(IBT = 28362) extractions. Scaled to RT between 1-12 minutes, intensities are to scale. A: Plug 
extraction from growth with no sclerotium production. B: Plug extraction from growth with 
sclerotium production. C: Sclerotial extraction. The extractions under sclerotium production (B + 
C) show the presence of the four novel compounds sclerolizine, emindole SC, carbonarin I and J. 
 
Two general observations were made: firstly, the SMs produced under sclerotium 
producing conditions were more apolar, and secondly, the naphtho-γ-pyrone aurasperone 
B was produced, as also seen for other black Aspergilli (section 3.2.1). Several 
compounds could not be unambiguously dereplicated, thus a large scale extraction was 
prepared followed by purification and structure elucidation. This led to the four novel 
compounds depicted in Figure 3.16. A detailed description of the structure elucidations is 
given in Paper 6.   
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Figure 3.16 Structures of the novel compounds isolated from A. sclerotiicarbonarius. 
 
For verification of whether the compounds were true sclerotial metabolites, or if they 
were produced in trace amounts in the non-sclerotium extract, extracted ion 
chromatograms (EICs) were created in the UHPLC-HRMS data from the plug extractions 
with and without sclerotium formation as well as the sclerotial extraction, see Table 3.1. 
It was here found that all metabolites were present in both the sclerotial extracts and the 
plug extracts under sclerotium formation. In the plug extraction, where no sclerotium was 
formed, all compounds but sclerolizine were absent, strongly indicating that emindole 
SC, carbonarin I, and carbonarin J are true sclerotial metabolites.  
Table 3.1 Presence of compound 1-4 with and without sclerotium production. Detected by 
Extracted Ion Chromatograms (EICs) with a mass tolerance of m/z +/- 0.005. 
 Plug extraction CYA 
(No sclerotia formation) 
Plug extraction CYA 
(Sclerotia formation) 
Sclerotia extraction 
Sclerolizine  x x x 
Emindole SC  - x x 
Carbonarin I  - x x 
Carbonarin J  - x x 
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To further investigate this, a search for carbonarin A-H in the UHPLC-UV-HRMS data 
from the sclerotial extract was conducted. This showed trace amounts of carbonarin A-D, 
high production of carbonarin E and F, while no carbonarin G nor H could be detected 
(Tentatively identified by HRMS with a mass tolerance of m/z +/- 0.005). An equivalent 
search for carbonarins in the A. sclerotiicarbonarius extract with no sclerotium 
production showed no traces of any of the carbonarins, suggestion this group of 
compounds to be related to sclerotium production.   
As sclerotial compounds have often been found to possess insecticidal properties, all 
compounds were tested for larvicial activity towards Drosophila melanogaster larvae. 
The results showed that with increasing concentrations all compounds were affecting the 
survival of the insect larvae (p < 0.001), yet there was no compound-specific variation in 
this effect. Overall, at a concentration of only 1.83 ±0.08 µmol, 50 % of the larvae were 
found dead. The compounds were also tested for antifungal activity. Sclerolizine and 
carbonarin I displayed moderate antifungal activity, with sclerolizine as the most active 
(IC50 8.5 ± 2.0 µM).  
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3.3 Chapter 3 Summary and part conclusion 
The discovery of novel SMs from black Aspergilli has been addressed by two different 
approached: Traditional dereplication based discovery and by induction of sclerotium 
formation. 
The first mentioned approach, dereplication based discovery, utilizes dereplication by 
HRMS to get an overview of the metabolic profile of a species and identify putative novel 
SMs, so these can efficiently be targeted. Three fungi were investigated by this approach. 
For A. aculeatus this led to discovery of a number of new compounds: A 
dioxomorpholine, a unique okaramine, an aflavinine and related, novel structures of 
mixed biosynthetic origin, which were named aculenes A–D and acucalbistrins A-B. 
From A. indologenus, aspiperidine oxide was discovered, which entails a piperidine N-
oxide, a structural feature not seen in fungal SMs. From A. homomorphus five related 
compounds, homomorphosins A-F were characterized.  
The work with A. aculeatus led to the discovery, that when spores were maintained at  
-18 ˚C for a period of time prior to inoculation this resulted in production of sclerotium. 
This discovery was of great interest, as the metabolic profile was greatly altered under 
sclerotium formation conditions, and led directly to the second theme for this chapter: 
Induction of sclerotium formation for discovery. The pre-freezing step was combined 
with use of natural substrates and especially the addition of raisins to the solid media 
would lead to induction of sclerotium. By use of this combined approach, sclerotium 
formation, was observed for the first time for A. niger, A. brasiliensis, A. floridensis, A. 
ibericus, A. luchuensis, A. neoniger, A. trinidadensis and A. saccharolyticus. Two species 
were further investigated: A. sclerotioniger and A. sclerotiicarbonarius. From the first 
mentioned it was found that cytochalasins were produced when sclerotia was formed, 
which led to discovery of two novel cytochalasins: Sclerotionigrin A and B in addition to 
the known cytochalasin proxiphomin. For A. sclerotiicarbonarius the metabolic profile 
was also highly altered, and four novel SMs were discovered, whereof three were 
identified as true sclerotial metabolites. The finding that induction of sclerotium 
formation can trigger otherwise silent biosynthetic pathways in filamentous fungi, is of 
general interest for the discovery of novel bioactive SMs.  
Overall, the findings presented in this section confirm, that there are still many novel SMs 
to be discovered from filamentous fungi.    
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4 Linking genes to compounds 
The second big theme for this study has been to link fungal SMs to their 
synthase/synthetase genes and to elucidate biosynthetic pathways. The results are given in 
this chapter in separate sections for each of the studied fungi: A. oryzae (4.1), A. nidulans 
(4.2), A. niger (4.3), A. aculeatus (4.4), and A. nidulans/A. clavatus (4.5).  
4.1 Aspergillus oryzae 
This section presents some of the results from the manuscript “Comparative Chemistry of 
Aspergillus oryzae (RIB40) and A. flavus (NRRL 3357)” (Paper 7), published in 
Metabolites in 2012.  
4.1.1 Comparative metabolic profiling 
A. oryzae has been used for centuries in Asian food fermentation of e.g. soy sauce, sake 
and vinegar [185]. It has been assumed to be a domesticated form of the related species A. 
flavus, which contrary is a pathogenic species, capable of producing the carcinogenic 
aflatoxins. Due to their high importance, the two species were some of the first Aspergilli 
having their genome sequenced, and bioinformatic analysis revealed a high homology 
between the two species: 99.5 % genome homology and 98 % at the protein level for 
RIB40/ATCC 42149 and NRRL 3357 [186].  
Despite their high similarity only few metabolites had been reported from both species. 
The aim for this project has been to perform a comparative investigation of the metabolic 
profile of two genome sequenced strains of A. oryzae (RIB40) and A. flavus (NRRL 
3357), in order to get insights into possible similarities and differences in SM production 
for these two important species. 
The comparative metabolic profiling of the two strains and initial dereplication revealed a 
surprisingly high degree of chemical differences, as depicted in Figure 4.1. Besides kojic 
acid (shown in box) and analogues in the beginning of chromatogram and ergosterol in 
the end (not shown), there were very few identical compounds between the strains. This 
was in sharp contrast to the high gene homology.  
 
PhD Thesis 
Lene Maj Petersen 
   
   
53 
 
 
Figure 4.1 ESI+ BPI chromatogram of 7 day micro scale extract from WATM.  
Top: A. flavus NRRL 3357. Bottom: A. oryzae RIB40. 
 
Besides previously reported A. oryzae metabolites, aflavinine analogues were detected for 
the first time, and several metabolites were purified and characterized including 
parasiticolides and 13-desoxypaxilline for the first time from A. oryzae and the novel 
compounds oryzamide A1-2, and ditryptoleucine.  
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4.1.2 Metabolites in Aspergillus oryzae and the link to A. flavus 
During this project several A. oryzae metabolites were characterized, giving insights into 
the similarities as well as differences to A. flavus. Some of the findings are here briefly 
described.  
A shared pathway with different end products  
A known metabolite of A. flavus is the toxin aflatrem [187][188]; the last steps of the 
biosynthesis [189] are depicted in Figure 4.2. In A. oryzae no traces of aflatrem were 
detected, but one of the compounds we characterized in A. oryzae, was the aflatrem 
precursor 13-desoxypaxilline (13-dehydroxypaxilline). This was present in several media 
micro-scale extracts including YES, CYA, OAT and WATM. Furthermore no other 
intermediates in the biosynthetic pathway towards aflatrem were detected with the 
exception of one sample (WATM, 7d) showing traces of paspaline, a precursor for 13-
desoxypaxilline.    
 
Figure 4.2 The final steps in the proposed biosynthesis of aflatrem (in A. flavus). A. oryzae RIB40 
biosynthesis stops at 13-desoxypaxilline. 
 
The identification of 13-desoxypaxilline as the end-product in the pathway from A. 
oryzae was in agreement with the analysis of Nicholson and co-workers, who showed that 
a frame shift mutation in the atmQ gene presumably accounts for the 13-desoxypaxilline 
not being converted into paspalicine and paspalinine [189]. In the work by Nicholson and 
co-workers, it was demonstrated that AtmQ is a multifunctional cytochrome P450 
monooxygenase likely to catalyze several oxidative steps needed for biosynthesis of the 
acetal ring present in the structures of paspalicine, paspalinine and aflatrem, altogether 
pointing towards a more complex biosynthesis than shown in Figure 4.2.  
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Variation in incorporation of amino acids between the two species 
Depicted in Figure 4.3 are the novel A. oryzae metabolites compared to known A. flavus 
metabolites, miyakamides B1-2 [190] and ditryptophenaline [191]. Apparently, the A. 
oryzae metabolites have exchanged phenylalanine with leucine compared to the 
corresponding A. flavus metabolites. This could indicate a common trait in the 
domestication process.  
 
Figure 4.3 Novel metabolites from A. oryzae isolated and characterized in this study compared to 
known A. flavus metabolites. The A. oryzae metabolites have apparently exchanged phenylalanine 
with leucine compared to the similar A. flavus metabolites ditryptophenaline and miyakamides.  
 
Although A. oryzae and A. flavus are very closely related with highly similar genomes, 
their ESI+ profiles appeared very different. Novel compounds characterized from A. 
oryzae, however, revealed to be either closely related or precursors for metabolites in A. 
flavus. This connection between the metabolites emphasizes the genetic coherence, but 
also indicates a path for the domestication process.  
Altogether the findings show, how a combination of genome comparisons and 
comparative metabolic profiling, can exploit the chemical potential of different strains 
and give insights into differences at the genomic level, even without use of any genetic 
manipulations.    
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4.2 Aspergillus nidulans 
This section presents the manuscript “Accurate prediction of secondary metabolite gene 
clusters in filamentous fungi” (Paper 8), published in Proceedings of the National 
Academy of Sciences of the United States of America in 2013.  
The study presents a new method to predict fungal secondary metabolite clusters using 
DNA expression arrays in combination with legacy data, where expression profiles for 
neighboring genes are compared. As part of this study a “supercluster” (physically 
separated genes) consisting of a NRPS (AN1242) and a prenyltransferase (AN11080) was 
investigated in A. nidulans, which ultimately could be linked to the tetracyclopeptide 
nidulanin A.  
4.2.1 Investigation of a supercluster in A. nidulans 
A. nidulans is an important model organism for both biological model systems and 
genetic engineering. It was genetically characterized by Pontecorvo and co-workers in 
1953 [7] and has ever since been widely studied, wherefore there today is several 
efficient, genetic tools developed [8][9]. Genome sequencing in 2005 [75] has further 
facilitated the possibilities of genome mining within this organism. As a result several 
biosynthetic pathways have been investigated, such as sterigmacotycin [90], 
naphthopyrone [91], aspyridone A-B [82], asperthecin [92], emericellamide [98], 
monodictyphenone/emodin [93][94], austinol/dehydroaustinol [84], arugosins [84], 
orsellinic acid/lecanoric acid/F9775A/F9775B [93][79][95], asperfuranone [96], and 
alternariol/cichorine [97]. 
In filamentous fungi biosynthetic genes tend to be clustered as described in section 1.3.1. 
The genes can, however, also be located various places in the genome, in which case they 
are referred to as a supercluster. Our investigation of A. nidulans led to a discovery of 
such a supercluster, consisting of a NRPS (AN1242) located on chromosome VIII and a 
putative prenyltransferase (AN11080) located on chromosome V. The data indicated 
crosschemistry between the two, which could be verified by deletion experiments of the 
synthetase and the prenyltransferase. In Figure 4.4, UHPLC-DAD-HRMS data from the 
A. nidulans reference strain and ΔAN1242 and ΔAN11080 strains are shown. The first 
conclusion to be drawn, is the linking of both genes (AN1242 and AN11080) to the 
compound at RT = 8.74 min, as this compound was absent in both deletion strains. This 
confirmed the cross-chemistry between the two genes. The m/z for [M+H]
+
 of the affected 
compound (nidulanin A) was found to be 604.3493, corresponding to a molecular 
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formula of C34H45N5O5. The EICs in Figure 4.4 is for this m/z, but also for a related 
compound (nidulanin B), differing by the loss of a prenyl group. This compound is 
suggested to be the unprenylated precursor to nidulanin A. As seen in Figure 4.4 both 
nidulanin A and the precursor is present in the A. nidulans reference strain but neither in 
the NRPS deletion strain (ΔAN1242). In the prenyltransferase deletion strain 
(ΔAN11080) nidulanin A is not present, linking the gene to nidulanin A. However, the 
tentatively identified unprenylated precursor, nidulanin B, is still being produced; highly 
supporting the hypothesis, that AN11080 is responsible for prenylation of the NRPS 
product. 
 
Figure 4.4 Extracted ion chromatograms for nidulanin A (C34H45N5O5, [M+H]
+
 = 604.3493, 
black) and nidulanin B (nidulanin A – C5H8) ([M+H]
+
 = 536.2867, red) with a mass tolerance +/- 
0.005 Da. Data from UHPLC-DAD-HRMS of chemical extractions from the A. nidulans reference 
strain and ΔAN1242 and ΔAN11080 strains. 
Due to the modular nature of the biosynthesis of NRPs (section 1.2.2) the product 
(nidulanin A) could be predicted as a tetracyclopeptide. The NRPS was predicted to 
contain four modules and here both adenylation domains and epimerase domains were 
identified. The adenylation domain specificities were predicted using NRPS predictor 
[192], whereby the sequence -Phe-Aad-Val-Val- was predicted as likely. Aad is the non-
proteogenic amino acid 2-aminoadipicacid, and the prediction was “Aad-like”. The 
UHPLC-DAD-HRMS data deduced the molecular formula to be C34H45N5O5, which was 
in some agreement with this prediction, though with some doubt about the Aad-like 
moiety. Even though the assembly of nidulanin A, could be predicted, structure 
elucidation was still necessary to complete the structure and to investigate the location of 
the isoprene unit.     
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4.2.2 Structure elucidation of nidulanin A 
Purification and structure elucidation of the compound indeed confirmed this to be a 
tetracyclopeptide. It was found to have the sequence -L-Phe-L-Kyn-L-Val-D-Val- with an 
isoprene unit N-linked to the amino group of L-kynurenine unit. The absolute structure of 
nidulans A is depicted in Figure 4.5.  
 
Figure 4.5 The structure of nidulanin A isolated from A. nidulans. 
 
The classical approach for structure elucidation of peptides is to use COSY connectivities 
to link NH and Hα in the same residue and use NOESY connectivities to link NH from 
one residue to Hα in the neighboring residue. In this way the peptide backbone can be 
assembled. This approach was also used for nidulanin A. The 
1
H NMR spectrum 
displayed four resonances at δH 8.16, 7.91, 7.64, and 7.51 ppm, which were identified as 
amide protons. For each resonance, a COSY correlation to a proton further up-field in the 
α-proton area could be observed. This coupled each of the amide protons to Hα protons at 
resonances of δH 4.82, 3.92, 4.56, and 3.85 ppm, respectively. Investigation of the 
NOESY connectivities allowed for assembling of the peptide backbone, which revealed a 
cyclical tetrapeptide as illustrated in Figure 4.6. The amino acids Phe and the two Val 
residues were elucidated by use of the COSY, HSQC and HMBC experimental data. The 
prenylated Kyn residue consisted of three different spin system as well as two isolated 
methyl groups. These were linked together by the NOESY and HMBC connectivities as 
depicted in Figure 4.6. The first spin system consisted of the amide proton at δH 8.16 
ppm, the Hα proton at 4.82 ppm, and a diastereotopic pair of protons at δH 3.63 (1H, dd, 
17.7, 9.7) and 3.09 (1H, dd, 17.6, 4.9) ppm. The second spin system consisted of four 
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aromatic protons at δH 7.79 (1H, dd, 8.2, 1.5), 7.28 (1H, ddd, 8.6, 7.0, 1.5), 6.81 (1H, dd, 
8.7, 0.7), and 6.57 (1H, ddd, 8.6, 7.0, 1.1) ppm, whereas the third and final spin system 
contained three protons located in the double-bond area at δH 5.95 (1H, dd, 17.6, 10.7), 
5.13 (1H, dd, 10.7, 1.0), and 5.15 (1H, dd, 17.6, 1.0) ppm. The latter was shown to be 
connected to the two methyl groups at δH 1.39 (3H, s) and 1.38 (3H, s) ppm, and the 
presence of a quaternary carbon at δC 53.7 ppm linked this part as an isoprene unit. 
      
Figure 4.6 COSY (black) and NOESY (blue) connectivities that lead to the cyclic tetrapeptide, as 
well as the key HMBC (green) and NOESY connectivities used to link the different spin system.  
 
To obtain the absolute stereochemistry of nidulanin A, Marfey’s analysis was conducted. 
This is widely used for NRPs since this approach can differentiate between L- and D-
amino acids (AAs). The derivation agent is 1-fluoro-2,4-dinitrophenyl-5-L-alanineamide 
(FDAA), also called Marfey’s reagent and can react with AAs to give a diastereomer. L- 
and D AAs are enantiomers and can consequently not be distinguished on a HPLC setup; 
Marfey’s derived diastereomer can. NRPs can therefore be hydrolyzed, reacted with 
FDAA and a comparison to Marfey’s derived enantiomeric pure D- and L-AAs will 
thereby reveal the stereochemistry [193][194].   
For the case of nidulanin A, Marfey’s analysis was able to confirm the Phe residue 
present as L-Phe, whereas the analysis for Val showed equal amounts of L- and D-Val. 
As no standards for L- and D-Kyn was available, this was not investigated. These results 
did, however, not clarify which of the Val residues was L-form and which was in the D-
form. The final proposal for the stereochemistry of nidulanin A was therefore given as a 
combination of the experimental data from Marfey’s analysis and the bioinformatic 
studies. The latter predicted the Phe, Kyn and first Val module not to contain an 
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epimerase domain, while the last Val module did contain an epimerase domain. This 
resulted in the sequence -L-Phe-L-Kyn-L-Val-D-Val- which is also depicted in Figure 
4.5.  
The result found in this work illustrates how close collaboration of two fields: 
bioinformatics and structural chemistry, can lead to discoveries that neither could have 
achieved separately. The stereochemistry of nidulanin A was in the end suggested based 
on the results from both bioinformatic analysis and results of Marfey’s analysis. 
Furthermore the study illustrates how fungal NRPs can be predicted, due to their modular 
nature. Fungal PK pathways are more complicated, since the PKSs are functioning in an 
iterative way, and other experiments are needed, which will be demonstrated in the 
following two sections in elucidation of the PK 6-MSA related pathways in A. niger and 
A. aculeatus, respectively.    
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4.3 Aspergillus niger 
This section presents the manuscript “Molecular and chemical characterization of the 
biosynthesis of the 6-MSA derived meroterpenoid yanuthone D in Aspergillus niger” 
(Paper 9), published in Chemistry & Biology in 2013.  
The study was carried out in close collaboration with PhD Dorte Koefoed Holm and 
investigated the biosynthetic pathway of the meroterpenoid yanuthone D in A. niger. A 
multidisciplinary approach for solving the biosynthetic pathway was employed, applying 
gene deletions, heterologous gene expression, analytical chemistry covering UHPLC-
DAD-MS and MS/MS, structure elucidation by NMR spectroscopy and CD, as well as 
feeding experiments with labeled and unlabeled metabolites. As a result the cluster 
responsible for production of yanuthone D was identified, 6-MSA was determined as the 
precursor, the biosynthetic pathway for yanuthone D, where 6-MSA is converted into 
yanuthone D in eight steps, was presented, a novel enzymatic activity, an O-mevalon 
transferase, was found, six novel structures were characterized and finally a novel class of 
yanuthones (class II yanuthones) was defined, which utilizes some of the enzymes from 
the cluster, but does not origin from 6-MSA. Altogether the paper represents a major step 
forward in understanding the complex secondary metabolism in the industrially important 
filamentous fungus A. niger.  
Following this work we investigated the possible production of other analogues of class II 
yanuthones in A. niger. We scrutinized the A. niger KB1001 strain for other yanuthones 
and were able to isolate four further yanuthones, whereof one was a class II yanuthone. 
This resulted in the manuscript “Characterization of four novel antifungal yanuthones 
from Aspergillus niger” (Paper 10), published in Journal of Antibiotics in 2014.   
4.3.1 The biosynthesis of yanuthone D 
Our investigations of the biosynthesis of yanuthone D in A. niger originated with the gene 
PKS48/ASPNIDRAFT_44965 which had been predicted to encode a 6-MSA synthase 
[81]. The gene was transferred to our model organism A. nidulans into the integration site 
IS1 [83], which verified that the gene was indeed encoding a 6-MSA synthase as 6-MSA 
was produced. Next the gene was deleted in A. niger. This step was eased by the use of 
the ATCC1015-derived strain KB1001 (pyrGΔ kusA::AFpyrG). This resulted in 
abolishment of not just one, but two major A. niger metabolites: Yanuthone D and E were 
both depending on the 6-MSA synthase. In order to elucidate the entire biosynthetic 
pathway we predicted and deleted the genes surrounding the 6-MSA synthase gene. From 
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UHPLC-DAD-HRMS analysis of the resulting deletion strains we were able to deduce 
the boundaries of the gene cluster. Additionally eight genes were needed for yanuthone D 
production and a TF gene was also linked to the cluster resulting in a total of 10 genes in 
what was named the yan gene cluster. In the elucidation of the biosynthesis of yanuthone 
D, three deletion strains were essential: ΔyanH, ΔyanI, and ΔyanF. Large scale extracts 
were prepared of the three strains for purification and structure elucidation of 
intermediates, see Figure 4.7.  
 
Figure 4.7 BPC m/z 100-1000 of reference strain (KB1001), yanHΔ, yanIΔ, and yanFΔ. All 
NMR-elucidated compounds are shown for comparison of intensity and relative retention times. 
Below are structures of the novel yanuthones identified in this study. The structures of the 
remaining yanuthones are seen in Figure 4.8. 
From the ΔyanF strain we learned that YanF converts yanuthone E into yanuthone D, 
which we could conclude was the true end product of the pathway. From the ΔyanH and 
ΔyanI strains, we purified the intermediates 7-deacetoxyyanuthone A and 22-
deacetylyanuhone A respectively. These were key intermediates, and led to understanding 
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of the oxidating specificity of the cytochrome P450 YanH and the O-mevalon transferase 
YanI. Thereby the biosynthesis from 6-MSA to yanuthone D was deduced (Figure 4.8).    
 
Figure 4.8 Proposed biosynthesis of yanuthone D. Structures and enzymatic activities in brackets 
are hypothesized, activities in plain text have been proposed from bioinformatics, and activities in 
bold have been experimentally verified. The structure of yanuthone X1, utilizing YanC, YanD, 
YanE and YanG, is showed for reference.  
 
An important part of the investigation of the biosynthesis of yanuthone D was the feeding 
experiments using fully labeled 
13
C8-6-MSA. First and foremost the experiment was 
necessary to establish 6-MSA as a precursor for yanuthone D and later to establish 
exactly which yanuthones utilized 6-MSA. The execution of this experiment 
4 Linking genes to compounds 
64 
 
demonstrated the interdisciplinary approach we utilized, and the strengths of several 
specialists working together. When we learned we needed fully labeled 
13
C8-6-MSA, we 
found that this was not commercially available. Instead we had to produce it ourselves, 
starting with the molecular biology work of creating a 6-MSA producing A. nidulans 
strain, followed by fermentation using fully labeled glucose, purification of the product 
and finally the feeding experiments and HRMS analysis.  
4.3.2 Verification of intermediates  
A major challenge in the investigation of the biosynthesis of yanuthone D, was the lack of 
detecting any of the smaller intermediates preceding 7-deacetoxyyanuthone A, Figure 4.8. 
No intermediates were detected in either of the yanB, yanC, yanD, yanE and yan G 
deletion strains. To address this problem we tried optimizing our detection of small 
compounds (< 200 Da) on the UHPLC-DAD-HRMS setup, but as these efforts did not 
provide new information and since we could easily detect 6-MSA in the A. nidulans strain 
where we integrated the 6-MSA synthase gene, it became evident that it was not a 
problem of detecting these compounds, rather they were simply not present. We did not at 
any time detect 6-MSA or any of the other small aromatic compounds (e.g. m-cresol or 
toluqinol) in any A. niger deletion strain, and we suggest that they are toxic to the cell, 
why they are rapidly degraded, converted into other compounds, or they may be 
incorporated into insoluble material such as the cell wall.      
To gain information about this part of the biosynthesis, we instead used bioinformatics 
and feeding experiments. In the biosynthesis of patulin in A. floccosus (previously 
identified as A. terreus; Jens C. Frisvad, personal communication) and in A. clavatus, 6-
MSA is decarboxylated into m-cresol by the decarboxylase PatG and then further 
modified into toluquinol by the cytochrome P450 PatI [195][196]. Inspection of the yan 
gene cluster for similar activities resulted in the putative 6-MSA decarboxylase (YanB) 
and a cytochrome P450 (YanC). This suggested that m-cresol and toluquinol could be 
likely intermediates. To verify this we fed the two compounds to the yanA deletion strain 
and a subsequent analysis of the metabolic profile revealed that addition of either of the 
two compounds, restored production of yanuthone D, see Figure 4.9. 
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Figure 4.9 Feeding with unlabeled m-cresol and toluquinol. EICs of yanuthone D (1) 
503.2640±0.005 (red) and yanuthone E (2) 505.2791±0.005 (black) for KB1001 and the yanAΔ 
strain with and without feeding. Chromatograms are to scale.  
 
Besides this evidence for m-cresol and toluquinol as intermediates, we observed that the 
6-MSA production in the heterologous expression of YanA in A. nidulans would 
disappear if the strain also expresses YanB. This also indicated that 6-MSA was the 
substrate for the putative 6-MSA decarboxylase YanB.  
The intermediates and exact mechanisms from toluquinol to 7-deacetoxyyanuthone A 
including formation of the epoxide remain unclear, but could be investigated by 
purification of YanD and YanC followed by in vitro experiments with toluquinol.   
4.3.3 Branching points reveals novel yanuthones 
In the elucidation of the biosynthesis of yanuthone D, three deletion strains were central: 
ΔyanH, ΔyanI, and ΔyanF. Large scale extracts of the three strains were prepared for 
purification and structure elucidation of intermediates. The intermediates 7-
deacetoxyyanuthone A, 22-deacetylyanuhone A and yanuthone E were discovered from 
the three strains respectively, and were key intermediates in the elucidation of the 
pathway, as well as revealing the enzyme functions of YanH, YanI and YanF. 
A common trend for all three strains was that not only one new intermediate would be 
produced; rather 2-3 different intermediates were observed in each extract. This led to 
several branching points in the biosynthesis, as displayed in Figure 4.8. All three 
intermediates in the three different strains were oxidized: 7-deacetoxyyanuthone A and 
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22-deacetylyanuhone A at C1 resulting in yanuthone F and yanuthone H respectively, 
while yanuthone E was oxidized at C2 leading to yanuthone J.  
It is interesting to note that a disruption of the biosynthetic pathway toward yanuthone D 
results in formation of branch points, and in all cases, the first step is an oxidation of the 
sesquiterpene ether on C1 or C2. Since hydroxylation is a known detoxification mode 
[197], we speculate, if the abnormally high amount of potentially toxic intermediates, 
triggers the cell to initiate phase I type of detoxification processes, in which the toxic 
intermediates are hydroxylated. This hypothesis is supported by the fact that we could not 
link any enzyme to the hydroxylation processes.  
Besides the hydroxylated intermediates one further compound was found in each of the 
yanH and yanI deletion strains. A variant of yanuthone F was identified in the yanH 
deletion strain, in which yanuthone F is glycosylated at the hydroxyl group at C15 to 
form yanuthone G. The glucose moiety of yanuthone G is intriguing because sugar 
moieties are rare in fungal SMs. Besides detecting the compound in the deletion strain we 
also detected it in the KB1001 strain, which shows that it is a naturally occurring 
compound. Because yanuthone G production is upregulated in yanH deletion strain, we 
suggest that glycosylation poses a second (phase II conjugation) type of mechanism for 
further detoxification of possible toxic intermediates. 
Another variant of 22-deacetylyanuthone A, besides the oxidized yanuthone H, was 
detected in the yanI deletion strain. Yanuthone I, is identical to 22-deacetylyanuthone A 
and yanuthone H but with a shorter and oxidized sesquiterpene chain. A similar 
modification has been observed in the biosynthetic pathway for production of 
mycophenolic acid [198]. In the mycophenolic acid pathway it was proposed to occur by 
oxidative cleavage between C4 and C5 of the sesquiterpene chain, which could also be 
the case here, but alternatively, it could occur by terminal oxidation of a geranyl side 
chain.   
4.3.4 The diversity of yanuthones in Aspergillus niger 
It has earlier been reported how heterologous expression of a whole pathway revealed 
eight compounds in addition to the one already known from the pathway [199] (One 
pathway, many compounds). The biosynthetic potential of a single pathway was also 
demonstrated in this work in the native organism: In the elucidation process of the 
biosynthesis of yanuthone D, a total of nine yanuthones were purified from four different 
strains, Figure 4.8. We showed that all of these were derived from the small aromatic PK 
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6-MSA both by feeding fully labeled 
13
C8-6-MSA into the yanuthones in vivo, but also by 
investigation of the 6-MSA synthase gene deletion strain, where production of the 
compounds were shown to be abolished. One further compound, yanuthone X1, was also 
purified, and the structure elucidation revealed a structure very similar to the known 
yanuthones, see Figure 4.8. This compound was still present in the 6-MSA synthase gene 
deletion strain and the feeding studies showed that 6-MSA was not incorporated. This 
revealed, that not all yanuthones depend on 6-MSA and we therefore defined two classes 
of yanuthones: those based on 6-MSA (class I) and those who are not (class II).  
It was very interesting for us to learn that the two classes share several enzymatic steps: 
Yanuthone X1 was depending on YanC, YanD, YanE and YanG. Together this suggests 
that the precursor is a small aromatic compound similar to 6-MSA, but lacking the 
carboxylic acid, since it did not depend on the enzymatic activity of YanB, the 
decarboxylase. For instance it could be anisole, known to be produced by several 
Aspergillus species, or 3-methoxy phenol. 
Importantly, the main difference between yanuthone X1 and the other yanuthones are the 
group attached to C16. In the case of yanuthone X1, this position is oxidized, whereas in 
other yanuthones there is a carbon-carbon bond that originates from the methyl group of 
6-MSA. Consequently, yanuthone X1 cannot be mevalonated by YanI wherefore there is 
no class II analog with the mevalon side chain.  
In continuation of the study of yanuthone D biosynthesis, further four yanuthones were 
purified from the A. niger KB1001 strain: Yanuthone K-M, all class I yanuthones and 
yanuthone X2, which we showed was a class II yanuthone.   
Some of the yanuthones described in this study were only discovered as a consequence of 
the deletion strains: accumulation of intermediates and the branching points, as described 
in section 4.3.3. A great number was, however, found in the reference strain of A. niger. 
This included yanuthone D and E, yanuthone G and I in trace amounts, yanuthone K-M 
and both of the class II yanuthones, yanuthone X1 and X2. On top of, this A. niger has 
previously been reported to produce yanuthones A, B, and C, 1-hydroxyyanuthone A, 1-
hydroxyyanuthone C, and 22-deacetylyanuthone A [35]. The great variety of the 
yanuthones from a single species, plus the fact that yanuthone D is one of the main 
metabolites being produced of all compounds from A. niger, point towards that these 
compounds have a great significance for the organism.    
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We tested all 14 yanuthones towards the pathogenic yeast Candida albicans, which 
accounts for the highest source of fungal infections worldwide [200], wherefore it is of 
great interest to find new drug candidates. The result of the assay is displayed in Figure 
4.10.  
Figure 4.10 Overview of class I and II yanuthones as well as their IC50 towards Candida albicans. 
Our analysis identified yanuthone D as the most active compound, justifying it as the end 
product of the pathway. Otherwise several of the yanuthones displayed antifungal 
activities and due to the vast number tested, we gained valuable insights to structural 
features important for the potency towards C. albicans. A discussion on this topic can be 
found in Paper 9, but in summary we learned that the ketone at C15 for yanuthone D was 
of high importance for the activity. Hydroxylation of C22 and acetylation at C15 would 
increase the antifungal activity, while chain shortening of hydroxylation of C2 would 
decrease activity. This work demonstrates the strengths of having several natural analogs, 
to accommodate structure-activity relationship to identify key structural features for 
potency.   
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4.4 Aspergillus aculeatus 
This section presents the manuscript “Investigation of a 6-MSA synthase gene cluster in 
Aspergillus aculeatus reveals 6-MSA derived aculins A-B and non-6-MSA derived 
pyrrolidinones” (Paper 11), intended for publication in Chemistry & Biology.  
In parallel to the elucidation of the biosynthetic pathway from 6-MSA to yanuthone D in 
A. niger (section 4.3), a putative 6-MSA synthase was identified in A. aculeatus. We 
investigated the 6-MSA pathway in A. aculeatus, which turned out to be quite different 
from the yanuthone pathway. The results are described in this section.   
4.4.1 Investigation of 6-MSA synthase gene 
To verify that the putative 6-MSAS gene encoded a 6-MSA synthase, the gene was 
integrated into the IS1 locus of A. nidulans. Comparative metabolic profiling (see Figure 
4.11) of the resulting strain to a reference strain by UHPLC-DAD-HRMS indeed 
confirmed the 6-MSAS gene, as production of 6-MSA could be verified by comparison to 
an authentic standard.  
 
Figure 4.11 BPC of the A. nidulans strain expressing the putative 6-MSA synthase 1904397 
compared to an A. nidulans reference. 
We further investigated the 6-MSA synthase gene. We hypothesized that over-expression 
of the 6-MSAS would result in an up regulation of the end product of the pathway, either 
revealing a new compound or higher amounts of a known compound. The gene was 
expressed in A. aculeatus from an AMA1-based plasmid. The metabolic profile analysis 
verified that the strain produced 6-MSA (not normally produced by A. aculeatus), but 
otherwise there were no significant changes observed in the rest of the metabolite profile. 
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4.4.2 Over-expression of transcription factor  
Examination of the predicted gene cluster revealed that a putative TF was located 
immediately downstream of the 6-MSA synthase gene, why this could possibly be a 
regulator of the 6-MSA gene cluster. When the TF was overexpressed by AMA-1 based 
plasmids, two compounds were affected on MM, see Figure 4.12. 
 
Figure 4.12 BPC of A. aculeatus expressing putative transcription factor from plasmid (pDHX2-
TF) compared to a reference, cultivated on minimal medium (A) and YES (B). 
 
The two compounds were structure elucidated to be diastereomers of RKB-3384B [201]. 
They were produced by both the reference strain and the TF overexpression strain, when 
cultivated on YES, indicating that the biosynthesis of these compounds is normally active 
when cultivated on YES medium, but not on minimal medium. The two compounds only 
differ by the stereochemistry at one or both of the stereocenters, see Figure 4.13.  
 
Figure 4.13 The isolated compounds are diastereomers of RKB-3384B.  
Stereocenters are marked with *. 
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The backbone of the compounds have previously been observed e.g. in lucilactaene 
produced by a Fusarium sp. [202], epolactaene from a marine Penicilium sp. [203] and 
fusarin C from Fusarium moniliforme [204]. All of these compounds contain the long 
chain observed in RKB-3384B, but differs in the attached moiety. Lucilactaene contains 
two fused five-membered rings, epolactaene a single five-membered lactam entailing an 
epoxide, and the fusarins display different structures. The biosynthesis of the backbone 
chain has been investigated by labeling studies for the fusarins, which verified that it was 
of PK origin [205]. Furthermore, labeling and genetic studies [206] showed that the final 
part originates from a C4-unit. Assuming that RKB-3384B has the same PK chain, the 
final part must consist of a nitrogen-containing C3 unit e.g. serine. 
4.4.3 Identification of 6-MSA related compounds 
Based on the structure of RKB-3384B, a connection to 6-MSA was not immediately 
obvious. For the 6-MSA derived pathway in A. niger the end product of the pathway was 
established by gene deletion of the 6-MSA PKS gene. Gene deletions were not easily 
obtained in A. aculeatus, wherefore the biosynthetic pathway could not be investigated 
with the same approach. Instead, we fed fully labeled 6-MSA (
13
C8-6-MSA) to the strain 
to test whether 6-MSA was incorporated into the RKB-3384B diastereomers, see Figure 
4.14. 
 
Figure 4.14 A. BPC (black) of pDHX2-TF on YES+
13
C8-6-MSA, EIC 374.1963±0.005 (light 
grey), EIC 472.2333 ± 0.005 (dark grey), EIC 474.2484 ± 0.005 (black). B. Mass spectra of the  
6-MSA incorporating aculins. 
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Careful inspection of the metabolite profile revealed a mass shift of 7.023 Da for three 
related compounds, which we named aculins. Interestingly, but not surprisingly, 6-MSA 
was not incorporated into the diastereomers of RKB-3384B. Thus these compounds do 
not origin from 6-MSA although production of the two compounds appeared to be 
activated by expression of the TF located immediately downstream of the 6-MSA 
synthase gene. We therefore hypothesized the TF to be unrelated to the 6-MSAS and 
pathway. 
We now turned our attention to the 6-MSA incorporating compounds. The fact that a 
mass shift equivalent of seven 
13
C atoms, and not the eight 
13
C atoms that are present in 
13
C8-6-MSA, suggests that one carbon atom is eliminated from 6-MSA during 
modification into the end products. A mass shift of 7.023 Da was also observed in feeding 
studies of the yanuthone D biosynthesis, where one carbon atom is eliminated from 6-
MSA by decarboxylation (section 4.3, Paper 9). 
Isolation of the 6-MSA related compounds was challenging as the compounds degraded 
even at the mildest conditions during purification. It is noted that a similar trend was 
observed for the acu-calbistrins (section 3.1.1 and Paper 1), also produced by A. 
aculeatus. In the case of the aculins, aculin A these were degrading to a small acid 
(present as two diastereomers) and aculene A, a compound characterized from A. 
aculeatus (section 3.1.1 and Paper 1), see Figure 4.15. Likewise aculin B was degrading 
to aculene B and the same small acid. Although impossible to isolate the aculins, we 
solved the structure of the degradation products, see Figure 4.15. 
 
Figure 4.15 Structures of the degradation products of the aculins: Aculenes A-B and aculinic acid, 
and the suggested structure of the aculins.  
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The fragments were structure elucidated by 1D and 2D NMR from a mixture of aculin A 
and the degradation products, whereby a suggestion for their structures could be given. 
Resonances, identical to those we observed for aculene A, were identified as well as two 
set of signals for a smaller compound, we identified as aculinic acid. We suggest the two 
structures to be alike, and only differing at the stereocenter at C1. The degradation 
products of aculin B have not been confirmed by NMR experiments, but have been 
verified by UHPLC-DAD-HRMS data.  
4.4.4 Biosynthetic pathway from 6-MSA 
The 6-MSA synthase gene and surrounding genes are depicted in Figure 4.16. We define 
the acu gene cluster as the genes acuA-acuI spanning 23.6 kb with no disruption from 
unrelated genes. 
 
 
Figure 4.16 The acuA 6-MSA synthase encoding gene is flanked by eight genes, which we define 
as the acu gene cluster. The arnR TF is not part of the acu cluster, but is located immediately 
upstream of acuA. 
Utilizing knowledge of the two other 6-MSA derived pathways towards yanuthone D 
[207] and patulin [196], as well as the predicted activities encoded by the acu cluster, we 
proposed the biosynthetic pathway from 6-MSA towards aculin A, see Figure 8. 
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Figure 4.17 Proposed biosynthetic pathway of aculin A. 
Many of the enzymatic steps could be justified by high homologies to enzymes from the 
yanuthone D and patulin pathways. It is also noted that aculinic acid has a high resembles 
to neo-patulin, which only differs by having an additional double bond and a lactone 
formed from the oxygen at C3 to the carboxylic acid. 
The elucidation of the A. aculeatus 6-MSA derived pathway proved more challenging 
than the 6-MSA pathway in A. niger. This was a consequence of both molecular biology 
challenges (deletions not easily obtained) and chemical challenges (degradation of the 
end products). Nonetheless we were capable of proposing a biosynthetic pathway from 6-
MSA to aculin A, based on structures of the precursor and proposed end product as well 
as the predicted enzymatic activities of the cluster. Two diastereomers of RKB-3384B 
were found to be unrelated to the acu gene cluster, but none the less overexpression of the 
TF led to upregulation of the compounds on MM, whereby they caught our attention, and 
they were discovered as a direct consequence. 
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4.5 Reconstitution of gene clusters 
This section presents previously unpublished work, performed in Professor Yi Tang’s 
research group at UCLA, Los Angeles, USA. 
The aim of this work has been to reconstitute entire gene clusters from filamentous fungi 
in the model organism A. nidulans. Many microbes including filamentous fungi have not 
yet been cultured for investigation of the chemical profile, and of the microbes that have 
been cultured many are difficult to work with. They can either be difficult to propagate, 
hazardous to work with or expensive to cultivate. Cloning of genes or even whole gene 
clusters from these organisms would improve discovery and characterization. The 
reconstitution of gene clusters has the potential to provide access to the chemical diversity 
encoded in the genomes of otherwise uncultured filamentous fungi. In this section 
unpublished results are described, where reconstitution of entire gene clusters from 
filamentous fungi is investigated by the cytochalasin gene cluster from A. clavatus, which 
has been reconstituted in A. nidulans. Further details are presented in Paper 12. 
4.5.1 Biosynthesis of cytochalasins 
Cytochalasans constitute a class of PK-NRP hybrids containing a highly reduced PK 
backbone and an amino acid. In a parallel study of this thesis, three cytochalasans were 
characterized from A. sclerotioniger: Sclerotionigrin A, sclerotionigrin B and 
proxiphomin (Section 3.2.4, Paper 5 and Figure 4.18). Characteristic for the 
cytochalasans is their tricyclic core consisting of a macrocycle fused to a bicyclic lactam 
(isoindolone) system. The macrocycle origins from the reduced PK part and can be fused 
to the isoindolone system by a cyclic ketone, a lactone or a cyclic carbonate. The 
cytochalasans are classified based on the amino acid incorporated into the PK backbone.  
The name origins from Greek and refers to the best known property of the cytochalasans: 
Kytos (cell) and chalasis (relaxation) refers to the capping of actin filaments [208][209]. 
The group displays a wide range of biological functions. This is exemplified by the 
earliest reported cytochalasin A and B [210][211] which can repress glucose transport in 
human erythrocyte membrane [212] and cytochalasin E, which have been reported to 
show inhibitory activities towards ovarian, and human colon cancer [159] and possess 
strong anti-angiogenic activities [213]. 
A subclass of the cytochalasans is cytochalasins, distinguishing by having the amino acid 
phenylalanine. The structures of selected cytochalasins are depicted in Figure 4.18.  
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Figure 4.18 Structures of selected cytochalasins. Cytochalasin E and K are known from A. 
clavatus [214], while proxiphomin and sclerotionigrin A and B are known from A. sclerotioniger, 
see section 3.2.4 and Paper 5. 
 
Isotope labeling studies have revealed that the cytochalasans origin from malonyl 
building blocks as well as amino acid [215][216], suggesting the mixed biosynthetic 
pathway. The genetic and molecular basis of cytochalasin biosynthesis have been studied 
by Hertweck and co-workers for chaetoglobosin A, from Penicillium expansum [158] and 
by Tang and co-workers for cytochalasin E and K from A. clavatus [214][217]. The 
biosynthetic genes responsible for cytochalasin production in A. clavatus are depicted in 
Figure 4.19. The genes ccsA-ccsG and the TF ccsR comprises the ccs biosynthetic gene 
cluster spanning 29,819 kb of DNA. 
  
 
Figure 4.19 Organization of the ccs gene cluster in the genome of A. clavatus NRRL 1.  
Adapted from [214]. 
 
The proposed biosynthetic pathway towards cytochalasin K is depicted in Figure 4.20. 
The first step in the biosynthetic pathway is formation of the backbone by the PKS-NRPS 
(CcsA). A more thorough description of the biosynthesis is given in Paper 12.  
Hypothetical protein Enoyl Reductase 
Regulator Α-β Hydrolase 
G   C   F   E       D                         ccsA                              B             R  
PKS-NRPS P450 
Baeyer-Villiger Monooxygenase 
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Figure 4.20 Proposed biosynthesis of cytochalasin E. The PKS-NRPS CcsA is responsible for 
formation of the octaketide with incorporation of phenylalanine in combination with CcsC a 
functional enoyl reductase. After release an intramolecular condensation followed by a Diels-
Alder cyclisation is forming the tricycle core. The P450s CcsG and CcsD introduce a hydroxyl 
group, a keto group and the epoxide. Finally CcsB, a Bayer-Villiger oxidase, introduces two 
oxygens to form the carbonate moiety. CcsE converts cytochalasin E to cytochalasin K, while 
CcsF may be involved in a post-PKS-NRPS tailoring, resistance or transport. Adapted from [214]. 
 
4.5.2 Transformation-Associated Recombination (TAR) 
Transformation-Associated Recombination (TAR) [218][219] is becoming a generically 
useful tool for reconstructing large biosynthetic gene clusters from gDNA and eDNA 
[220]. With TAR it is possible to explore large gene clusters (~40 kb) by reassembling 
them from sets of smaller overlapping fragments in Saccharomyces cerevisiae. This yeast 
is used since it has an extremely efficient DNA recombination system [218]. TAR was 
developed as a recombinational cloning strategy, to isolate large genomic fragments from 
human DNA [219][221].  
TAR has been used to reassemble eDNA derived type II PKS gene cluster from 
Streptomyces albus for production of fluostatins [222]. General descriptions of how to 
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recover large NP biosynthetic gene clusters from eDNA using TAR have been described 
[220] and the TAR approach has been applied to several organisms including human 
[219][221], mouse [223], fish [224], parasites [225] and bacteria [222]. 
In this study TAR was used to reconstitute the cytochalasin gene cluster from A. clavatus 
and express it in the model organism A. nidulans.  
4.5.3 Reconstitution of the cytochalasin gene cluster from A. clavatus 
A CEN-based vector was designed for transformation in three different organisms: 
Transformation in S. cerevisiae, replication in E. coli and transformation in A. nidulans. It 
therefore contained elements for all three organisms. DNA fragments of 5 kb, spanning 
the entire ccs gene cluster, were first amplified by PCR. The primers were designed to 
create overlapping regions of 150-200 bp between each PCR fragment. This is illustrated 
in Figure 4.21. The resulting sets of overlapping PCR fragments and the linearized vector, 
engineered to carry small homolog regions corresponding to regions of the exterior 
primers, were introduced in S. cerevisiae by co-transformation. The fragments and vector 
undergo recombination to yield a stable plasmid containing the targeted genomic region. 
 
Figure 4.21 General illustration of the cluster reconstitution by PCR amplification and TAR in 
yeast. Primers are designed to create 150-200 bp overlapping regions between each PCR fragment, 
and with a 30-50 bp overlapping region to the linearized vector.  
The regulator gene ccsR was amplified separately and the plasmid was constructed with 
the strong constitutive promoter gpdA followed by the TF encoding gene ccsR and then 
the remaining cluster. The resulting plasmid, pLP1, is depicted in Figure 4.22. The 
plasmid was verified by four enzymatic digestions, PCR of pieces spanning the cluster 
and into the plasmid as well as sequencing.  
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Figure 4.22 The plasmid, pLP1, designed for rapid assembly and transformation in yeast 
(CEN/ARS, URA3), transformation in E. coli (ORI, ampR) and for integrative transformation in A. 
nidulans (pyrG, wA PKS gene targeting sequences). It contains the gpdA promoter directly 
followed by the TF encoding gene ccsR and the remaining ccs cluster.  
 
The plasmid was cleaved creating a linearized plasmid for transformation in A. nidulans. 
Transformation in A. nidulans was achieved as earlier described [226][8][227], disrupting 
the WA PKS gene wA, responsible for the green melanin production in A. nidulans, 
wherefore transformants appear white.  
To determine if the ccs cluster was transcribed; RT-PCR analysis was performed. In 
addition to the PKS-NRPS ccsA, all other genes believed to belong to the cluster were 
transcribed (ccsB-ccsG). The transformants were incubated on solid and liquid MM and 
extracted, and the metabolic profile examined by HPLC-MS. EICs of m/z corresponding 
to the sodiated adduct of cytochalasin E and K are depicted in Figure 4.23, from a liquid 
extraction after three days.  
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Figure 4.23 EIC of m/z = 518 (the most abundant adduct for both cytochalasin E and K, [M+Na]
+
) 
in A. clavatus, the A. nidulans reference and the A. nidulans mutant containing the ccs cluster. 
 
Cytochalasin E and K have the same molecular formula (see Figure 4.18) and hence the 
same m/z of 518 for the most abundant adduct [M+Na]
+
. EICs of extracts from the host 
organism A. clavatus, show this was producing small amounts of cytochalasin K and vast 
amounts of cytochalasin E. In the A. nidulans transformants no cytochalasin E was 
observed, however, cytochalasin K was detected. It is interestingly why cytochalasin E is 
favored in A. clavatus, while it is not produced even in trace amounts in A. nidulans. 
Cytochalasin E could be toxic to A. nidulans wherefore the biosynthesis is driven to the 
end product cytochalasin K. Nonetheless, the ccs gene cluster was successfully 
reconstituted and the end product cytochalasin K produced in A. nidulans. 
This work demonstrates how TAR can be used to fast and efficiently reconstitute gene 
clusters from filamentous fungi in the model organism A. nidulans. The major remaining 
challenge is how to express the product in significant amounts.   
  
Cytochalasin E 
Cytochalasin K 
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4.6 Chapter 4 Summary and part conclusion 
The theme for this chapter has been to link fungal SMs to their biosynthetic pathways and 
synthase/synthetase genes; the filamentous fungi studied were A. oryzae, A. nidulans, A. 
niger and A. aculeatus.  
Bioinformatic analysis revealed a high homology between A. oryzae and A. flavus (99.5 
% genome homology), but despite of this, comparative metabolic profiling revealed a 
surprisingly high degree of chemical differences. Investigation of metabolites in A. 
oryzae, however, revealed clear links to A. flavus metabolites. Both species for instance 
share genes for the aflatrem biosynthetic pathway, but in A. oryzae the pathway stops at 
13-desoxypailline. The novel compounds ditryptoleucine and the oryzamides A1-2 
discovered and characterized from A. oryzae, had high similarities to the A. flavus 
metabolites, ditryptophenaline and miyakamides. The latter incorporated phenylalanine 
while A. oryzae incorporated leucine.  
In A. nidulans a supercluster consisting of a NRPS (AN1242) and a prenyltransferase 
(AN11080) was investigated, which eventually was linked to the tetracyclopeptide 
nidulanin A. Due to the modular nature of the biosynthesis of NRPs the product of the 
NRPS could be predicted as a tetracyclopeptide, and this was confirmed by purification 
and structure elucidation, indeed revealing a tetracyclopeptide with an isoprene unit 
incorporated. 
In A. niger the entire biosynthetic pathway of the meroterpenoid yanuthone D was 
elucidated, starting with the 6-MSA PKS, and going from 6-MSA to yanuthone D in eight 
steps. Besides showing that 6-MSA is the precursor of yanuthone D, a novel enzymatic 
activity, an O-mevalon transferase, was discovered as well as six novel yanuthones. One 
of these were not derived from 6-MSA, why a novel class of yanuthones was defined. 
The new class of yanuthones was, however, utilizing several of the enzymes from the yan 
cluster. Another 6-MSA pathway was investigated in the related Aspergillus species A. 
aculeatus. This was found to differ significantly from the yanuthone pathway in A. niger. 
Here 6-MSA was modified into the terpenoid-NRP-PK hybrids, the aculins, and a 
biosynthetic pathway for this was suggested. Altogether these works represent a major 
step forward in understanding the complex secondary metabolism in the industrially 
important filamentous fungi A. niger and A. aculeatus. 
Linking of genes to compounds by genetic modifications is difficult for several 
organisms. In this study it was investigated how to reconstitute entire gene clusters of 
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filamentous fungi in the model organism A. nidulans. This project would improve 
discovery, and ease characterization of genes. As a proof of concept, the cytochalasin 
gene cluster from A. clavatus was investigated. This was successfully reconstituted in A. 
nidulans. The reconstitution has the potential to provide access to the chemical diversity 
encoded in the genomes of otherwise uncultured filamentous fungi.  
Overall the results of this chapter demonstrates important key points: The power of 
bioinformatic tools for prediction of superclusters (exemplified by nidulanin A), how to 
elucidate entire biosynthetic pathway and the small mysteries from nature that are 
unraveled along the way (exemplified by the 6-MSA pathways), and a method to explore 
the biosynthetic potential of uncultivable filamentous fungi (exemplified by the 
reconstitution of the cytochalasin pathway).  
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5 Overall discussion and conclusion 
The work of this thesis has been divided into two major topics: Discovery of novel 
secondary metabolites from filamentous fungi and linking of fungal compounds to genes 
and biosynthetic pathways.  
The discovery part (chapter 3) has led to extended chemical knowledge of important 
filamentous fungi and several novel SMs have been characterized. To achieve this, 
different approaches were undertaken: Dereplication based discovery and discovery by 
induction of sclerotium formation. The outcome included characterization of 22 novel 
compounds. From A. aculeatus this entailed aculenes A-D, acucalbistrins A-B, acu-
dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinin (Paper 1). 
The biological function of the A. aculeatus metabolites remain unclear, but nonetheless a 
great diversity of SMs from the species have been established, as compounds are both of 
PK, NRP and terpenoid origin including hybrids of all three classes. From A. indologenus 
aspiperidine oxide was discovered (Paper 2). This entailed a piperidine N-oxide, a 
structural feature not seen previously in fungal SMs. From A. homomorphus six related 
structures, the homomorphosins A-F were discovered (Paper 3). By scrutinizing of the 
fungal extracts for possible intermediates, a biosynthetic pathway was proposed for both 
aspiperidine oxide and homomorphosin A. In the latter case, the intermediates were 
verified by isolation and structure elucidation. In addition several known compounds 
could be reported from the three species for the first time. The use of dereplication for 
discovery of novel SMs proved strong in these projects, as known compounds could 
easily be identified, so laborative isolation efforts could be focused on the putative novel 
SMs 
 
The progress on how to induce sclerotium formation in black Aspergilli (Paper 4) is of 
general interest for the discovery of novel bioactive SMs, since formation of sclerotia 
trigger otherwise silent biosynthetic pathways, resulting in a great alteration in the 
metabolic profile. As a result of sclerotium formation, sclerotionigrins A-B from A. 
sclerotioniger (Paper 5), as well as emindole SC, sclerolizine and carbonarins I-J from A. 
sclerotiicarbonarius (Paper 6) were discovered. It would be interesting to investigate, 
which genes are responsible for the sclerotial formation and related metabolites. The 
novel compounds characterized from A. sclerotioniger and A. sclerotiicarbonarius, 
illustrate how novel slerotial compounds can be discovered utilizing inducion of sclerotial 
formation. 
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The A. carbonarius compounds, were found to possess both antifungal and larvicial 
activity. In addition, a general trend in other black Aspergilli was production of insectan 
aflavinines under sclerotium production. For A. aculeatus okaramines were upregulated, 
compounds that are active against silkworms. Altogether the sclerotial metabolites seem 
to posses insecticidal properties, in accordance with earlier reports 
[148][149][150][151][152][153][154]. 
 
Overall the combined findings of chapter 3 demonstrate, that there are still a vast 
biosynthetic potential in filamentous fungi and many novel SMs to be discovered. Both as 
a consequence of unexplored species, but also by utilizing different approaches such as 
the sclerotium formation.  
 
The second part, linking genes to SMs and elucidating biosynthetic pathways (chapter 4), 
led to several insights into the biosynthetic potential of industrially very important 
Aspergilli. The first study described was the comparative metabolic profiling of A. oryzae 
and A. flavus (Paper 7). Bioinformatic analysis revealed a high homology between the 
two species (99.5 % genome homology), but despite of this, initial dereplication revealed 
a surprisingly high degree of chemical differences. Characterization of metabolites in A. 
oryzae, however, revealed the link to A. flavus metabolites. For some, the end products in 
biosynthetic pathways of A. flavus, were not reached in A. oryzae. This was the case in 
the aflatrem pathway, that stops at 13-desoxypaxilline in A. oryzae, which could also be 
justified by bioinformatics: A mutation in the atmQ was observed in A. oryzae, the gene 
responsible for the final steps of the biosynthesis of aflatrem in A. flavus. Other A. oryzae 
metabolites were found to be very similar to A. flavus metabolites, only differing in the 
AAs incorporated. Ditryptoleucine and the oryzamides discovered and characterized from 
A. oryzae incorporated leucine while the corresponding A. flavus metabolite, 
ditryptophenaline and miyakamides, incorporated phenylalanine. This study is an 
example of how a combination of genome comparisons and comparative metabolic 
profiling can exploit the chemical potential of different strains and give insights at the 
genome level even without use of genetic modifications in the organisms. 
In another project a “supercluster” (physically separated genes) consisting of a NRPS 
(AN1242) and a prenyltransferase (AN11080) was investigated in A. nidulans, which 
ultimately could be linked to the tetracyclopeptide nidulanin A (Paper 8). The results of 
this work illustrated the strengths of collaboration between bioinformatics and structural 
chemistry; the stereochemistry of nidulanin A was suggested based on combined efforts 
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of the two fields. Furthermore the study illustrates how fungal superclusters can be 
predicted, and also NRP structures. Improvements of bioinformatic tools have made it 
easier to predict the structure of SMs. This is especially true for NRPs, due to the modular 
nature of the NRPSs. In the case of PKs it remains difficult to predict the end product 
since neither the size, degree of saturation or methylation pattern can be predicted as a 
consequence of the iterative mode of action of the fungal PKSs. Presence of tailoring 
enzymes further complicates the prediction.   
A key result of this thesis has been the characterization of the biosynthesis of the 
meroterpenoid yanuthone D, which was investigated by a multidisciplinary approach 
(Paper 9). We were able to identify the cluster responsible for production of yanuthone D, 
and to show that 6-MSA is the precursor. We presented a biosynthetic pathway, where 6-
MSA is converted into yanuthone D in eight steps and present a novel enzymatic activity, 
an O-mevalon transferase. In this work and a follow up study we characterized ten novel 
yanuthones (Paper 9 and Paper 10) and defined a novel class of yanuthones utilizing 
several of the tailoring enzymes from the cluster, but not originating from 6-MSA. 
Altogether the work represents a major step forward in understanding the complex 
secondary metabolism in the industrially important filamentous fungus A. niger and 
furthermore the results of this particular work are an example of the fruitful outcome of 
close collaborations between different fields, especially of natural product chemistry and 
molecular biology.  
In parallel to this project, a 6-MSA pathway in the related black Aspergillus A. aculeatus 
was also explored (Paper 11). Several obstacles were faced in this project. Firstly, gene 
deletions were not easily obtained in this species, wherefore the biosynthetic pathway 
could not be investigated with the same approach as the A. niger pathway. By 
heterologous gene expression of the PKS gene, this was, however, established as a 6-
MSA synthase gene. The end product of the pathway could not be established by gene 
knock-out and comparative metabolic profiling, but instead feeding experiments with 
fully labeled 6-MSA established incorporation into three related compounds, identifying 
these as pathways related products. The second complication was in the isolation of the 6-
MSA related compounds: These were degrading, wherefore the structures of these could 
not be established by traditional methods. Instead the fragments were structure elucidated 
by 1D and 2D NMR from a mixture of compounds, whereby a suggestion for their 
structures could be given. By combination of the structures and the information from the 
bioinformatic analysis of the surrounding genes, the biosynthetic pathway from 6-MSA to 
5 Overall discussion and conclusion 
86 
 
the end products, (novel compounds aculin A-B and epi-aculin A), was proposed, in spite 
of the obstacles in this project. The first steps of the pathway is proposed to be similar to 
the yanuthone D biosynthesis: decarboxylation of 6-MSA to m-cresol and oxidation by 
CYP450 enzymes with high homologies. Aside from this the pathways are divergent. In 
A. aculeatus it results in the aculins, which are PK-NRP-terpene hybrids. By 
overexpression of a TF located immediately downstream of the 6-MSA synthase gene, 
two non-6-MSA derived compounds, were additionally discovered. 
It was furthermore investigated how to reconstitute entire gene clusters from filamentous 
fungi in the model organism A. nidulans (Paper 12). This project would improve 
discovery, and ease characterization of genes. As a proof of concept, the cytochalasin 
gene cluster from A. clavatus was investigated and it was successfully reconstituted in A. 
nidulans. The reconstitution approach has the potential to provide access to the chemical 
diversity encoded in the genomes of otherwise uncultivable filamentous fungi and also 
allow for further biochemical characterization, but optimization of the titer of the target 
product is still necessary.   
Novel metabolites from A. aculeatus 
During the mapping of metabolites from A. aculeatus, the major metabolites were 
determined as aculene A and B, discovered during this work. The metabolites are 
possibly of terpenoid origin with incorporation of the amino acid proline. Two other 
metabolites from A. aculeatus (IBT 21030) were acu-calbistrins A and B. The structure 
elucidations of these two compounds were complicated by the fact that they were 
degrading even at mild conditions. Structures were, however, proposed based on the 
degradation products: aculenes A or B as well as calbistrin A. In an unrelated project, 
with another A. aculeatus strain, 6-MSA derived metabolites were explored. Purifying 
these other compounds it came as quite a surprise, that not only did these apparently 
unrelated compounds also degrade: furthermore they degraded also to aculene A or B and 
another part we identified as the small acid aculinic acid. In close proximity to the 6-
MSA cluster responsible for production of aculinic acid, we did not identify any 
terpenoid related genes we could connect to the biosynthesis of the aculenes. This could 
indicate a super cluster. Since the aculenes are produced in a higher amount than any of 
the remaining metabolites in both strains, these are hypothesized to be important 
metabolites for the organism. It is, however, interesting, why they are linked to two so 
different moieties as calbistrin A and aculinic acid respectively in two different strains, 
and why both hybrids are so chemically unstable, that purification has not been possible. 
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An explanation could also be that the hybrids are artefacts. Only few chimeric 
compounds are reported from filamentous fungi. Cryptoechinulin B and D [228] isolated 
from A. amstelodami have earlier been suggested to be artefacts formed by Diels-Alder 
addition.  
Improvements of techniques aiding NP drug discovery  
Analytical techniques for rapid dereplication of known compounds and their analogues 
are imperative to not waste time on already known metabolites. Dereplication is getting 
automated by “aggressive dereplication” [121], also used throughout this thesis, which 
can be further optimized by use of MS-MS libraries as these will eliminate false-negative 
results [122]. Furthermore multivariate data analysis is a great aid, since this method can 
identify small variations in large amounts of data.  
On the NMR side, several programs are now available for automated or computer assisted 
structure elucidation such as CMC-se structure elucidator from Bruker [229] or Structure 
Elucidator Suite from ACD/Labs [230]. The outcome of any of these is ideally to 
generate all possible structures that are consistent with a given set of spectroscopic data. 
An advantage of using this is that the bias of human interpretation is avoided, as one may 
have an idea of the structure e.g. based on a biosynthetic pathway. 
Discovering novel SMs 
When discovering novel SMs from filamentous fungi two things should be taking into 
consideration in order to ensure maximization of chemodiversity. One is the OSMAC 
approach [77][78], since variations in growth conditions (media, temperature, incubation 
time, pH, etc.) will lead to variations in the compounds produced. This is also 
exemplified during this work, as formation of sclerotia led to discovery of novel SMs 
(Paper 4, Paper 5 and Paper 6). The other aspect is “one pathway – many compounds” 
[199]. In filamentous fungi one biosynthetic pathway will seldom lead to just a single end 
product. Rather a series of compounds will be connected to the pathway. This was 
evident in the biosynthetic pathway of yanuthone D (Paper 9), where not only a number 
of intermediates were identified, but also several novel yanuthones as a result of 
branching in the pathway, only discovered due to the individual deletion strains.  
Even having the above in mind, not all metabolites are necessarily easily discovered. 
Some may not be extracted by the standard methods utilized in several labs. Others may 
not contain a chromophore, wherefore they would be missed in UV-guided purification. 
Yet others may be present in too low amounts for detection, and there can be challenges 
in the reproducibility as even small variations in media composition, temperature 
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fluctuations or similar, may alter the SMs being produced. Finally and maybe most 
importantly: not all SMs will be produced on any set of lab conditions, wherefore other 
ways of investigation will be necessary.  
The importance of NP chemistry and elucidation of pathways  
There can be no question that NPs have played a major role in the history of drug 
discovery. A more relevant question is: Will they keep their status and inspire new 
pharmaceuticals? And in that case – where will the new NPs come from? As illustrated in 
this thesis the answer to this question is not unambiguous. Novel NPs can come from 
more rare and unexploited species (as illustrated for A. aculeatus, A. homomorphus, A. 
indologenus), they can arise from triggering well-studied species into activating otherwise 
silenced gene clusters (as illustrated by induction of sclerotium formation in several black 
Aspergilli and overexpression of a TF in A. aculeatus), or it could be by investigation of 
pathways, both with known end products (as illustrated by the 6-MSA pathway in A. 
niger leading to characterization of 10 novel yanuthone analogs) or with unknown end 
products (as illustrated by the 6-MSA pathway in A. aculeatus). Altogether there are 
many different approaches; no matter what: There is still a vast potential for finding novel 
SMs in filamentous fungi.  
The second theme of this thesis, where entire biosynthetic pathways were elucidated, is 
important for several reasons. Firstly, novel SMs may be discovered in the process, as 
illustrated in both of the 6-MSA derived pathways (Paper 9 and Paper 11). Discovery of 
new SMs and structures enhances the possibility of discovering novel drugs. Secondly, on 
the basis of the growing knowledge, PK and NRP pathways may be manipulated or 
redesigned for the production of novel drug candidates. A growing research area is 
synthetic biology, where pathways are engineered by swapping of genes or domains, 
resulting in new, designed metabolites [231][232][233][234]. This field of research 
utilized enzymes that can carry out complicated chemical reactions and thereby create 
unnatural metabolites containing enhanced structural features otherwise inaccessible. 
Also, for the filamentous fungi used in industrial processes, it would be beneficial 
knowing the genetic potential, to avoid unwanted by-products, e.g. mycotoxins, and to 
easily identify new metabolites.   
NP chemistry – next steps 
PKs and NRPs are two groups of fungal SMs, which have attracted massive attention and 
have been widely studied. A more overlooked group is the terpenoids. A major reason for 
this can be limitations in detection of this type of compounds. Terpenoids are 
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hydrocarbons and though some undergo enzymatic modifications, e.g. oxidations, not all 
will contain heteroatoms, and consequently they will be difficult to detect by MS, the 
method of choice in many labs. Furthermore many are not giving rise to a chromophore 
detectable or standing out in a UV analysis, wherefore they might also be missed by this 
analytical method. To this end, it is noted that the structure of terpenoids are difficult to 
predict by bioinformatics. Altogether this leads to fewer discoveries of the terpenoids. 
None the less, their structures are highly diverse, and they do possess pharmaceutical 
relevant bioactivities, such as anticancer properties [235], why this group could very 
likely be the follower of the intensive studies currently directed towards PKs and NRPs. 
 
NP research was earlier more limited to chemists, purifying and elucidation structures; 
today and in the future NP research is highly linked with other areas, especially the 
disciplines of bioinformatics and synthetic biology. The still growing availability of entire 
genomes has changed the focus and it has become easier to predict biosynthetic products, 
especially with the bioinformatical accessibility of both PKs and NRPs. Manipulation 
with SMs in synthetic biology have further opened for both getting a better knowledge of 
existing biosynthetic pathways, but also to design new ones.  
Concluding remarks 
The work of this thesis represents a major step forward in extending the chemical 
knowledge on the complex secondary metabolism of industrially important filamentous 
fungi and at the same time illustrates the enormous potential for still discovering novel 
SMs. Through discovery 22 novel compounds were characterized, and in the elucidation 
of biosynthetic pathways, numerous other SMs have been characterized. On top of this, 
biosynthetic pathways for nidulanin A in A. nidulans, yanuthone D in A. niger and aculin 
A in A. aculeatus have been described, and the metabolites linked to genes. These 
findings, also illustrate the strengths, of close collaborations between fields. Interactions 
between bioinformatics, molecular biology, analytical and NP chemistry are crucial for 
advances in linking fungal SMs to genes and unraveling the biosynthetic pathways. A 
continued, focused collaboration is needed both for understanding the important known 
metabolites of a given species as well as for the discovery of novel SMs hidden in the still 
large biosynthetic potential of filamentous fungi.    
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7 Appendix A  
Sclerotium formation in black Aspergilli 
 
Figure A1 Chemical structures of selected SMs from the black Aspergilli and the sclerotium 
related indoloterpenes anominine (17) and 10,23-dihydro-24,25-dehydroaflavinine (18). For 
distribution, see Figure A2. 
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Figure A2 A: Plug extraction from growing and sporulating culture with no sclerotium production 
(CYA agar with biotin). B: Plug extraction from growth with sclerotium production (CYAR with 
biotin). C: Sclerotium extraction (from CYAR with biotin). 1) Nigragillin, 2) Pyranonigrin A, 3) 
Fonsecin, 4) Aurasperone/nigerasperone analog, 5) TMC-256A1, 6) Asperazine, 7) Tensidol B, 8) 
Fonsecin B, 9) AurasperoneC, 10) Aurasperone B, 11) Kotanin, 12) Flavasperone analog, 13) 
Rubrofusarin B, 14) Aflavinine analog, 15) Aflavinine analog, 16) Aflavinine analog, 17) 
Anominine, 18) 10,23-dihydro- 24,25-dehydroaflavinine, 19) Aflavinine analog, 20) Aflavinine 
analog, 21) malformin C, 22) Funalenone, 23) Aculene A, 24) Aculene B, 25) Aculene C, 26) 
Aculene D, 27) Carbonarin I, 28) Carbonarin J, 29) Emindole SC, 30) Sclerolizine, 31) Acu-
dioxomorpholine, 32) Okaramine analog, 33) Sclerotionigrin A, 34) Sclerotionigrin B, 35) 
Proxiphomin, 36) Ochratoxin A. For structures of a selection of these compounds, see Figure A1. 
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Abstract: Investigation of the chemical profile of the industrially important black 
filamentous fungus Aspergillus aculeatus by UHPLC-DAD-HRMS and subsequent 
dereplication has led to the discovery of several novel compounds. Isolation and extensive 
1D and 2D NMR spectroscopic analyses allowed for structural elucidation of a 
dioxomorpholine, a unique okaramine, an aflavinine and three novel structures of mixed 
biosynthetic origin, which we have named aculenes A–C. Moreover, known analogues of 
calbistrins, okaramines and secalonic acids were detected. All novel compounds were 
tested for antifungal activity against Candida albicans, however all showed only weak or 
no activity. Aspergillus aculeatus IBT 21030 was additionally shown to be capable of 
producing sclerotia. Examination of the sclerotia revealed a highly regulated production of 
metabolites in these morphological structures.  
Keywords: Aspergillus aculeatus; Aspergilli; natural products; secondary metabolism; 
dereplication; sclerotia 
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1. Introduction 
Aspergillus aculeatus is a filamentous fungus belonging to Aspergillus section Nigri—the black 
aspergilli. At least 145 metabolites have been characterized from the black aspergilli [1], many of which 
are biologically active. Naphtho-γ-pyrones (NGPs) such as aurasperone A and rubrofusarin B from A. 
niger are known to be antifungal [2], while other NGPs are reported to have antitumor activities [3]. 
Mycotoxins produced by A. niger, such as ochratoxin A [4] or the fumonisins [5] are also known.  
The black aspergilli can be divided into different clades. A. aculeatus belongs to the uniseriate  
black aspergilli and is closely related to A. aculeatinus, A. uvarum, A. japonicus, A. fijiensis,  
A. trinidadensis, A. floridensis, A. brunneoviolaceus and A. violaceofuscus [6,7]. These fungi differ 
from the other black aspergilli in their morphology, physiological behavior and in the production of 
secondary metabolites. The fungi belonging to this group can produce secondary metabolites, which can 
be both polyketide (PK) and nonribosomal peptide (NRP) derived or of mixed biosynthetic origin [1]. 
Several metabolites, including aculeacins A–G [8,9], CJ-15,183 [10], secalonic acids D and F [11] and 
okaramines H and I [12], have been reported in fungi identified as A. aculeatus. Furthermore, 
asperaculin A [13], aspergillusol A [14] and aculeatusquinones A–D [15] have been reported in marine 
strains of A. aculeatus. Different biological activities are reported for these metabolites, including 
antifungal (aculeacins A-G and CJ-15,183), enzyme inhibitory (CJ-15,183 and aspergilluson A), 
antimicrobial activities (secalonic D and F) and cytotoxicity (aculeatusquinone B and D). 
While some black aspergilli are important in the biotechnological industry for production of 
enzymes and organic acids [16,17], some species can also be food and feed contaminants [18]. In fact, 
the black aspergilli are among the most common fungi connected to postharvest decay of fruit, beans 
and nuts, and A. aculeatus is no exception [18,19].  
A. aculeatus is used to produce important industrial enzymes such as cellulases [20],  
xylanases [21,22] and proteases [23], which are used commercially in the food and feed industries. 
Moreover a marine strain of A. aculeatus has tested active against Staphylococcus aureus [24]. Based 
on both the industrial applications of A. aculeatus as well as food and feed contamination hazards it is 
of great importance to know what metabolites are being produced by this fungus. The aim of the 
current work has been to investigate the chemical profile of A. aculeatus seeking to discover novel 
compounds and to test for the antifungal activity of its metabolites. 
2. Results and Discussion 
Initial analysis of the chemistry of A. aculeatus involved two strains (IBT 21030 and IBT 3244) 
which were investigated on a series of solid media (YES, CYA, MEA, OAT and CREA) [25]. The 
strains were cultivated at 25 and 30 °C in the dark for 7 days and were investigated with micro-scale 
extractions [26]. The secondary metabolite profiles were analyzed with UHPLC-DAD-HRMS, which 
demonstrated that the strains showed highly similar chemical profiles. However, more metabolites 
were produced by the A. aculeatus IBT 21030 strain, hence this strain was chosen for further work. 
The medium used in the cultivations had varying effect on metabolite production. While cultivation on 
MEA, OAT and CREA did not lead to diverse production, cultivation on both CYA and YES lead to 
production of several different metabolites. The YES medium was selected for further work, and it was 
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found that the optimal cultivation temperature was 25 °C. The A. aculeatus strain was inoculated on 
YES media and incubated at 25 °C and analyzed after 2, 4, 7, and 10 days to test the effect of 
incubation time on the metabolite production. These experiments showed that 7 days of incubation 
gave the optimum production of secondary metabolites. Based on these initial experiments,  
A. aculeatus was inoculated on 200 plates of YES and incubated at 25 °C for seven days in the dark. 
The results of the dereplication as well as isolation and elucidation of novel compounds are depicted  
in Figure 1. 
Figure 1. Base peak chromatogram illustrating the dereplication of some of the major 
compounds in the extract from A. aculeatus IBT 21030 as well as the results of purification 
and structural elucidation of novel compounds. Based on cultivation on YES media for  
7 days at 25 °C in the dark. * Novel compounds reported here for the first time.  
** Compounds reported from A. aculeatus for the first time. 
 
Dereplication was performed by UV- and HRMS-data to identify known compounds. An in-house 
library of microbial metabolites [27] as well as the AntiBase 2012 natural products database [28] were 
used for identification. Many of the major peaks could be dereplicated as compounds already known to 
be produced by A. aculeatus (Figures 1 and 2). This included secalonic acids D and F [11], as well as 
okaramines A and H [12]. One further okaramine was produced, which could not be unambiguously 
dereplicated, since the HRMS and UV data pointed towards either okaramine C, J or L. The compound 
was isolated and the structure was elucidated by 1D and 2D NMR and the structure was established to 
correspond to okaramine J, which has previously been described from Penicillium ochrochloron 
(formerly identified as Penicillium simplicissimum) [29,30]. 
Two calbistrin analogues could also be dereplicated from A. aculeatus. Calbistrins A–D, have been 
described from Penicillium restrictum by Jackson et al. [31] and the structures of the four compounds 
were later elucidated by the same group [32]. Calbistrin A is biologically active as an antifungal agent, 
a promoter of nerve growth factor production and a cholesterol lowering agent. Identification of the two 
calbistrins was not possible solely based on HRMS and DAD data, as calbistrins pairwise have the same 
molecular formula (A and B have the same molecular formula and likewise for calbistrins C and D). The 
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two compounds were therefore isolated and their structures elucidated by 1D and 2D NMR, and it was 
shown that the two compounds produced by A. aculeatus were calbistrin A and C, Figure 2. 
Figure 2. Known compounds dereplicated from A. aculeatus. Okaramines A and H as well 
as secalonic acids have previously been reported from the organism, whereas the 
calbistrins and okaramine J are reported from A. aculeatus for the first time. 
 
2.1. A Novel Class of Compounds, Named the aculenes, Has a Mixed Biosynthetic Origin 
The two major metabolites produced by A. aculeatus, aculenes A and B (Figure 1) have previously 
been detected by UHPLC-DAD-HRMS in the related black aspergillus A. saccharolyticus [33], but the 
structures have not been elucidated. The molecular formulae of the two compounds were determined 
by HRMS to be C19H25NO3 and C19H27NO3, respectively. The mass difference of 2 Da and the fact that 
the two compounds eluted very close to each other suggested that the compounds were related and 
only differed by a double bond. The UV-spectra differed greatly as depicted in Figure 3, indeed 
indicating aculene A to contain a more conjugated chromophore. 
The structures of the two compounds were elucidated by 1D- and 2D NMR spectroscopy and the 
structures of aculenes A and B are depicted in Figure 4. The conjugation in aculene A was in 
agreement with the recorded UV spectrum. The only difference with aculene B is the absent double 
bond between C-11 and C-12 and as seen, this structure was also in accordance with the obtained UV 
spectrum. The 1H-NMR spectra of both aculenes A and B revealed the presence of one Hα proton  
(H-5), which was found to be in a COSY spin system with three methylene groups (H-2, H-3 and H-4), 
which where elucidated as a proline ring. The remaining resonances in the 1H-NMR spectra belonged 
to a fused five and seven membered ring system. The linking between the COSY spin systems for this 
part and assignments of the quaternary carbons were accomplished through detailed analysis of the 
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HMBC experimental data. Some of the important HMBC correlations for the elucidation of aculene B 
are depicted in Figure 5. 
Figure 3. UV-spectra of selected A. aculeatus metabolites. The remaining UV spectra can 
be found in the Supporting Information. 
 
Figure 4. The structure of aculenes A–D. The structures of aculenes A–C have been 
verified by 1D and 2D NMR spectroscopy, whereas the structure of aculene D has been 
suggested based on UHPLC-DAD-HRMS data. The stereochemistry shown is relative. 
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Figure 5. A. Important HMBC correlations in the elucidation of aculene B.  
B. The NOEs used to solve the stereochemistry. Similar HMBCs and NOEs were observed 
for aculenes A and C, see Table 1 and Supplementary Table S2. 
 
Table 1. 1H-NMR spectroscopic data (500 and 800 MHz, DMSO-d6) and HMBCs for aculenes A–C. 
 Aculene A Aculene B Aculene C 
Position δH (J in Hz) HMBC δH (J in Hz) HMBC δH (J in Hz) HMBC 
1 - - - -   
2 3.15 (m) - 3.21 (m) 3,4,5   
2' 3.09 (m) - 3.14 (m) 3,4,5   
3 1.83 (m) - 1.84 (m) 2,4,5   
3' 1.67 (m) - 1.76 (m) 2,4,5   
4 1.94 (m) 2,6 2.05 (m) 2,3,5,6   
4' 1.46 (m) 2,6 1.55 (m) 2,6   
5 4.23 (t 7.7) 6 4.31 (t 7.8) 2,3,4,6   
6 - - - -   
7 5.33 (dd 4.4, 2.4) - 5.28 (dd 5.3, 2.3) 6,9,12,16 3.95 (t 3.5) 9,13,15 
8 2.82(br.d 20.8) - 2.67 (br. d 19.1) 16 2.52 (br. d 20.1)  
8' 2.55 (m) 9,10,16 2.37 (m) 7,9,10,16 2.31 (m) 7,9,10,16 
9 - - - - - - 
10 5.98 (d 7.4) 8,12,18 5.56 (m) 8,11,12,18 5.87 (d 7.3) 8,12,18 
11 6.24 (d 7.4) 9,13,16 2.12 (m) - 6.08 (d 7.4) 9,13,16 
11' - - 2.52 (m) 18 - - 
12 - - 3.31 (m) 10,11,14 - - 
13 - - - - - - 
14 6.03 (s) 
12,13,15,16,1
9 
5.81 (q 1.8) 12,13,15,16,19 5.93 (s) 
12,13,15,16,
19 
15 - - - - - - 
16 - - - - - - 
17 0.96 (s) 7,12,15,16 0.96 (s) 7,12,15,16 0.79 (s) 7,12,15,16 
18 1.85 (s) 8,9,10 1.68 (s) 8,9,10 1.82 (s) 8, 9,10 
19 2.55 (m) 13,20 2.39 (m) 13,14,20 2.48 (m) 12,13,14,20 
20 1.16 (t 7.4) 13,19 1.11 (t 7.3) 13,19 1.14 (t 7.4) 13,19 
-OH - - - - 4.43 (s) - 
The NMR data for aculene A were very comparable to those of aculene B (Tables 1 and 2), yet 
differences were observed corresponding to the additional double bond in aculene A. The chemical 
shift of H-10 and H-14 is seen to differ slightly and furthermore an additional resonance was present in 
the 1H-NMR spectrum in the aromatic/alkene area for compound A. This was located at a chemical 
O O
O
HNCH3
H
O O
O
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H
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12
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shift of δH = 6.24 ppm and assigned H-11. The only other location where the spectrum differed 
significantly was due to the extra diastereotopic CH2 groups in the 7-membered ring of aculene B. For 
this, and the diastereotopic CH2 group H8/H8' present in both compounds, rather large coupling 
constants were observed due to the geminal coupling. In compound A the H-8 doublet had a coupling 
constant of 20.8 Hz. Another notable chemical shift is the carbon chemical shift of C-13. This was at 
δC = 175.3 and 183.8 ppm, respectively for the two compounds, which is rather far downfield.  
Table 2. 13C-NMR spectroscopic data (125 and 200 MHz, DMSO-d6) for aculenes A–C. 
Position 
Aculene A Aculene B Aculene C 
δC δC δC 
1 - - - 
2 45.1 44.7 - 
3 22.3 22.3 - 
4 27.6 27.6 - 
5 58.4 58.3 - 
6 168.0 167.8 - 
7 72.9 73.5 67.6 
8 36.5 35.5 40.2 
9 141.7 130.7 142.5 
10 120.0 122.7 119.7 
11 118.5 24.9 117.8 
12 142.5 44.6 144.3 
13 175.3 183.8 174.3 
14 125.3 122.8 125.6 
15 205.8 208.2 208.2 
16 51.7 54.4 53.6 
17 17.9 17.1 18.3 
18 26.9 28.3 27.1 
19 20.1 23.1 19.8 
20 12.0 10.8 11.8 
A third and related compound (aculene C) was also characterized. The UV spectrum was similar to 
the UV spectrum observed for aculene A (Figure 3) and the molecular formula was determined by 
HRMS to be C14H18O2. The NMR data was comparable to that of aculene A (Tables 1 and 2), though 
with an absence of resonances originating from the proline part. Elucidation of the structure revealed 
that the compound was related to the aculenes, therefore it was named aculene C (Figure 4). Aculene C 
is a likely precursor to aculene A, having the same carbon skeleton, but missing the proline moiety. 
Analysis of the UHPLC-DAD-HRMS data showed a fourth compound, eluting close by aculene C, 
present in minute amounts, with a mass difference of 2 Da compared to aculene C, and with a UV 
spectrum very similar to aculene B (Figure 3). The HRMS data displayed the same adducts and 
fragmentation pattern as observed for aculene C. This compound, aculene D, is believed to have a 
similar structure as aculene C, but with the absence of the double bond between C-11 and C-12, as 
seen with the relation between aculenes A and B. This structure has not been verified by  
NMR experiments. 
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The stereochemistry of aculenes A-C was elucidated by NOEs, J-couplings and Marfey’s reaction [34], 
from which it was determined that aculenes A and B contained L-proline. The stereocenters (C-5, C-7 
and C-16) of aculenes A and B could not be connected, due to lack of NOEs from the proline to the 
bicyclic system and the free rotation of proline. The relative stereochemistry of stereocenters C-7 and 
C-16, as well as C-12 for aculene B, is depicted in Figure 4, suggested by NOEs and backcalculated  
3J-couplings of H-7 (see Supplementary Figure S37 and Supplementary Tables S1 and S2). Relevant 
NOEs are depicted for aculene B in Figure 5. 
We hypothesize the biosynthesis of the aculenes to originate from a terpene pathway. Aculene C 
and D consist of fourteen carbons, which could originate from a sesquiterpene with the loss of one 
carbon atom, possibly at C9. Aculene A and B furthermore contain the amino acid proline. 
The two compounds marked as acucalbistrin A and B in Figure 1 were also targeted. These 
compounds were intriguing because they could not be dereplicated, and because the HRMS data 
suggested that the size were somewhat larger than typical secondary metabolites. The molecular 
formulas for the two compounds were determined to be C50H63NO10 and C50H65NO10, the mass spectra 
are depicted in Figure 6. 
Figure 6. Mass spectra of acucalbistrin A (top) and acucalbistrin B (bottom). A fragment 
corresponding to m/z of the molecular ion [M+H]+ of aculene A (*) and aculene B (**) are 
observed for acucalbistrin A and B respectively. 
 
A feature noted in both mass spectra was a fragment corresponding to the mass of aculenes A and 
aculene B, respectively. Different chromatographic approaches were taken to purify both compounds, 
which however proved challenging as the compounds were unstable even under mild conditions. 
Apparently acucalbistrin A was degrading to aculene A and another compound X, while acucalbistrin 
B was degrading to aculene B and the same compound X. Analysis by UHPLC-DAD-HRMS of a 
small semipreparative proportion of this degradation product revealed to our surprise this compound to 
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be calbistrin A. This was verified by the UHPLC-DAD-HRMS data by comparison to the known 
compounds, see Supplementary Figure S39. 
The combined mass of aculene A and calbistrin A is higher than that of acucalbistrin A (and the 
same for the case of acucalbistrin B), where the difference corresponds to a single water molecule. We 
therefore hypothezise that the acucalbistrins undergo hydrolysis and with knowledge on the structures 
of aculenes A–B and calbistrin A, a possible structure could therefore be an amide bond between the 
nitrogen in the proline moiety in aculene to the carbonyl in the carboxylic acid part of calbistrin A (see 
Supplementary Figure S38). This would account for the observed masses. These acucalbistrin structures 
have not been verified by NMR spectroscopy. We note that the UV spectra of acucalbistrin A and B 
have UVmax values comparable to those observed for calbistrin A (Figure 3). The slight shift observed 
may be due to the aculene moiety being attached directly to the carboxylic acid, which is part of the 
conjugated system in calbistrin A. The proposed structures are given in Supplementary Figure S38. 
2.2. Discovery of Novel Indole Terpenoids 
Three other compounds were isolated and structure elucidated resulting in the novel compounds 
acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinine with the structures 
shown in Figure 7. 
Figure 7. The structure of acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-
24,25-dehydroaflavinine. 
 
NMR data for the compounds are presented in Table 3, Table 4, and Table 5, respectively. The 
structure of acu-dioxomorpholine reminds one of a diketopiperazine, but this structure differs in that it 
contains a lactone. The chemical shift of the proton adjacent to the lactone oxygen (H-3) clearly differs 
compared to the chemical shift of a proton in ordinary diketopiperazines, which is typically reported to 
be around δH = 3.50–4.50 ppm [35,36]. For acu-dioxomorpholine the proton chemical shift is  
δH = 5.32 ppm. The carbon chemical shift of C-3 is also shifted significantly downfield, with δC = 78.1 
ppm for the acu-dioxomorpholine, compared to around 60 ppm for diketopiperazines. Two compounds 
have been reported by Wang et al. with the same lactone feature [37], but differ by having leucine 
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incorporated instead of phenylalanine and by lacking the N-methylation. Otherwise the NMR data  
are comparable.  
NOESY experiments enabled determination of the relative stereochemistry of acu-dioxomorpholine. 
NOE connectivities were found between H-3 and H-16 placing these protons on the same side of the 
ring system. These had no NOE connectivities to H-6, which however displayed NOE connectivities to 
H-22 as well as several of the protons in the prenyl moiety (H-18, H-19, H-19' and H-20), strongly 
indicating the positioning of the prenyl group and H-6 on the other side of the ring system as compared 
to H-3 and H-16. 
Table 3. NMR spectroscopic data (500 and 800 MHz, DMSO-d6) for acu-dioxomorpholine. 
Position δH (J in Hz) δC  HMBC Noesy 
1 - 168.0 - - 
2 2.96 (3H, s) 32.7 6, 8 6,9 
3 5.32 (1H, dd, 8.8, 3.4) 78.1 4, 22, 23 16, 22, 22', 24/28 
4 - 163.5 - - 
5 - - - - 
6 5.43 (1H, s) 81.9 2, 4, 8, 13, 14, 15, 16, 17 12, 18, 19, 19', 20, 22 
7 - - - - 
8 - 150.8 - - 
9 6.44 (1H, d, 7.6) 105.6 11, 13 2, 10 
10 7.09 (1H, td, 7.6, 0.8) 128.5 8, 12 9, 11 
11 6.64 (1H, t, 7.3) 116.9 9, 12, 13 10, 12 
12 7.17 (1H, d, 7.3) 124.1 8, 10, 14 11, 15, 18, 20, 21 
13 - 128.8 - - 
14 - 59.6 - - 
15 2.43 (1H, dd, 12.7, 6.6) 36.6 1, 6, 13, 14, 16 12, 15', 16 
15' 2.21 ( 1H, dd, 12.7, 11.1) 36.6 1, 13, 14, 16 15, 16, 18, 20, 21 
16 4.17 (1H, dd, 11.1, 6.6) 56.7 1, 15 3, 15, 15' 
17 - 40.1 - - 
18 5.87 (1H, dd, 17.4, 11.0) 143.3 14, 17, 21 6, 12, 15', 19, 19', 20, 21 
19 5.02 (1H, dd, 17.4, 1.1) 113.7 14, 17, 18  6, 18, 19', 20, 21 
19' 5.06 (1H, dd, 11.0, 1.1) 113.6 14, 17, 18 6, 18, 19, 20, 21 
20 0.82 (3H, s) 22.4 14, 17, 18, 21 6, 12, 15', 18, 19, 19', 21 
21 0.97 (3H, s) 21.7 14, 17, 18, 20 12, 15', 18, 19, 19', 20 
22 2.98 (1H, dd, 14.8, 8.8) 34.9 3, 4, 23, 28 3, 6, 22', 24/28 
22' 3.33 (1H, m) 34.9 3, 4, 23, 28 3, 22, 24/28 
23 - 136.3 - - 
24 7.26 (1H, m) 129.2 22, 26, 28 3, 22, 22' 
25 7.28 (1H, m) 127.7 - 26 
26 7.22 (1H, tt, 7.2, 1.6) 126.2 28 25 
27 7.28 (1H, m) 127.7 23, 25 - 
28 7.26 (1H, m) 129.2 - 3, 22, 22' 
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Table 4. NMR spectroscopic data (500 and 800 MHz, DMSO-d6) for okaramine S. 
Position δH (J in Hz) δC  Hmbc Noesy 
1 7.64 (1H, s) 114.7 2, 4, 14, 15 - 
2 - 123.8 - - 
4 - 137.6 - - 
5 4.26 (1H, q, 6.5) 43.2 4, 14, 18 18 
6 - 51.2 - - 
7 5.87 (1H, s) - 5, 9, 13, 17 9 
8 - 144.5 - - 
9 6.90 (1H, d, 7.6) 118.8 11, 13 10 
10 6.99 (1H, t, 7.6) 127.4 8, 12 9 
11 6.65 (1H, t, 7.6) 116.8 9, 13 12 
12 7.74 (1H, d, 7.6) 128.3 8, 10, 14 1,11 
13 - 115.3 - - 
14 - 124.9 - - 
15 - 153.4 - - 
16 0.95 (3H, s) 27.1 5, 6, 17 17 
17 1.39 (3H, s) 29.3 5, 6, 16 16 
18 1.18 (3H, d, 7.2) 18.1 4, 5, 6 - 
19 7.76 (1H, s) 117.5 20, 25, 32, 33, 34 - 
20 - 125.2 - - 
22 5.90 (1H, d, 8.3) 123.6 23, 24 23 
23 6.15 (1H, d, 8.3) 140.2 22, 24, 35/36 22 
24 - 35.8 - - 
25 - 149.8 - - 
26 11.70 (1H, s) - 25, 32, 33 - 
27 - 134.2 - - 
28 7.44 (1H, m) 112.3 - 29/30 
29 7.17 (1H, m) 121.7 31 28, 31 
30 7.17 (1H, m) 121.7 31 28, 31 
31 7.63 (1H, m) 116.1 27, 29/30 12, 29/30 
32 - 105.3 - - 
33 - 129.5 - - 
34 - 157.6 - - 
35 1.69 (3H, s) 26.7 23, 24, 25, 35/36 - 
36 1.69 (3H, s) 26.7 23, 24, 25, 35/36 - 
For okaramine S the molecular formula was by HRMS predicted to be C32H30N4O2. The 
azocinoindole part of the novel okaramine (Figure 7) is identical to that observed in okaramines A and 
H (Scheme 1), also produced by A. aculeatus [12]. The remaining part is highly similar, also 
originating from tryptophan and an isoprene unit, but in okaramine S, the terpene is fused with the ring 
system of the tryptophan moiety resulting in an intriguing, additional seven-membered ring, not 
previously reported in any okaramine. Key HMBCs from this part of okaramine S are depicted  
in Figure 8. 
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Table 5. NMR spectroscopic data (500 MHz, DMSO-d6) for epi-10,23-dihydro-24,25-
dehydroaflavinine. 
Position δH (J in Hz) δC  HMBC H2BC NOESY 
1 10.66 (s) - 2, 3, 4, 9 2 2,8 
2 7.07 (d 2.0) 122.7 3, 4, 9 - 1, 23, 25, 27 
3 - 114.4 - -  
4 - 126.7 - -  
5 7.38 (d 7.8) 116.8 7, 9 6 10, 11, 18 
6 6.96 (t 7.2) 117.7 4, 8 5, 7  
7 7.02 (t 7.3) 120.0 5, 9 6, 8  
8 7.29 (d 8.0) 110.9 4, 6 7 1 
9 - 135.5 - -  
10 3.59 (dd 13.3, 5.0) 33.4 2, 3, 11, 12, 23, 24 11, 23 5, 11, 19, 25, 26 
11 2.47 (m) 37.6 10, 12, 23 10, 12 5, 10, 12, 13, 16, 19 
12 1.27 (m) 28.9 - 17 11 
13 1.53 (m) 28.1 29 - 11, 13', 16 
13' 0.81 (d 12.9) 28.1 - - 13 
14 1.46 (m) 27.4 - -  
14' 1.08 (d 13.7) 27.4 27 - 28 
15 - 38.2 - -  
16 2.04 (m) 30.4 - 17, 28 11, 13, 17', 28 
17 1.71 (m) 24.8 - 18  
17' 1.22 (m) 24.8 - -  
18 1.99 (d 11.3) 29.6 - - 5, 19 
18' 1.74 (m) 29.6 - - 19, 30 
19 4.64 (s) 65.6 - - 10, 11, 18, 18', 22, 26
20 - 42.9 - -  
21 2.07 (m) 23.5 - - 29, 30 
21' 1.65 (m) 23.5 19, 23 - 27 
22 1.85 (m) 26.6 20, 24 21, 23 19, 30 
22' 1.54 (m) 26.6 - -  
23 3.13 (m) 42.3 24, 25, 26 10, 22 2, 25, 27 
24 - 149.8 - -  
25 4.81 (d 1.8) 110.4 23, 26 26 2, 10, 23, 25' 
25' 4.58 (d 1.8) 110.4 23, 26 26 25, 26 
26 1.45 (s) 17.7 23, 24, 25 - 10, 19, 25' 
27 1.21 (s) 21.1 11, 12 12 2, 21', 23 
28 0.71 (d 6.7) 15.4 15, 16, 17 16 14', 16, 17' 
29 0.92 (s) 17.7 13, 15, 16, 20 - 17, 21, 30 
30 4.28 (d 4.3) - 19, 20 19 18', 21, 22, 29 
The molecular formula of the aflavinine analogue was predicted by HRMS to be C28H39NO  
and dereplication indicated it could be aflavinine or an analogue. Since no aflavinine or analogue was 
previously described in A. aculeatus, this compound was also a target for isolation and structural 
elucidation. The NMR data, see Table 5, suggested the structure of 10,23-dihydro-24,25-dehydroaflavinine. 
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Figure 8. Key HMBCs substantiating the seven-membered ring in okaramine S. 
 
10,23-Dihydro-24,25-dehydroaflavinine has earlier been reported from sclerotia from A. flavus,  
A. parasiticus and A. tubingensis [38]. The compound has not been reported from A. aculeatus, but it is 
known to be produced by the related black Aspergillus A. costaricaensis [39]. The stereochemistry of 
epi-10,23-dihydro-24,25-dehydroaflavinine was solved by the use of NOEs and J-couplings. The 
relative stereochemistry was found to be equal to that of 10,23-dihydro-24,25-dehydroaflavinine [38]. 
For investigation of the absolute configuration of the purified compound, optical rotation was measured. 
Two different values were obtained, [α] = 63.58° and [α] = 9.08° in MeOH and CHCl3 respectively. 
These values were compared to the value of [α]D = −1.20°, which has earlier been reported for  
10,23-dihydro-24,25-dehydroaflavinine in CHCl3 [38]. Due to those opposite signs, our result suggests that 
the compound from A. aculeatus is the enantiomer of 10,23-dihydro-24,25-dehydroaflavinine, 
wherefore we have named it epi-10,23-dihydro-24,25-dehydroaflavinine. The 3D structure (see 
Supplementary Figure S40) was suggested by the isolated spin pair approximation [40]. 
2.3. Biological Testing of the Novel A. aculeatus Metabolites 
Aculenes A–C, acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinine 
were tested for antifungal activity against Candida albicans. Endpoint optical density from compound 
screens were normalized with the negative controls and susceptibility evaluated as percentage 
reduction in optical density. None of the compounds showed significant antifungal activity. 
2.4. Production of Sclerotia Reveals a Highly Regulated Metabolic Profile 
It has recently been demonstrated that sclerotium production can be prompted under specific 
conditions for a number of the black aspergilla [41]. This study showed that some metabolites are 
highly upregulated inside the sclerotia, compared to the metabolites in the mycelium. A. aculeatus is 
capable of producing sclerotia in vast amounts. Production was demonstrated on CYA and YES media, 
see Figure 9. 
Analysis of extracts of sclerotia from MM, CYA and YES showed large upregulations of 
okaramines, see Figure 10. Aculenes A–C were still produced, though in smaller amounts. 
Furthermore the analysis showed that production of secalonic acids abolished on MM and CYA. The 
calbistrins were still produced and the same were acucalbistrins A–B, though in trace amounts. Some 
okaramine analogues have shown activity against silkworms [42–44] and the substantial upregulation 
of okaramines can be connected to sclerotium production as a defense mechanism to protect  
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against insects. Sclerotia are survival structures and the production is often provoked by extreme  
conditions [41,45]. 
Figure 9. The figure shows production of sclerotia on YES (left) and CYA media (right) 
after growth for 7 days at 25 °C in the dark. The sclerotia are the white to cream-colored 
structures seen among the black conidial Aspergillus heads.  
 
Figure 10. Base peak chromatograms of extraction from sclerotia (top) and plug 
extractions of A. aculeatus IBT 21030 after cultivation on YES agar for 7 days at 25 °C in 
the dark (bottom) for reference. The chromatograms are to scale. Stars indicate okaramines 
produced in the sclerotium extract.  
 
3. Experimental Section  
3.1. Fungal Growth, Strains and Media 
For standard screening the fungal strain was inoculated as three point stabs on solid media and 
incubated for seven days at 25 °C. Media was prepared as described by Samson et al. [25] The strain 
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IBT 21030 was compared to the culture ex type IBT 3244 = CBS 172.66 = ATCC 16872 = IMI 
211388 = WB 5094, in order to authenticate the identity of the isolate.  
3.2. Large Scale Extraction 
For the large scale preparation, A. aculeatus (IBT 21030) was inoculated as three point stabs on 200 
plates of solid YES medium, and incubated in the dark for 7 days at 25 °C. The fungi were harvested 
and extracted. Ten Petri plates of fungi were transferred to separate stomacher bags. To each bag  
100 mL of ethyl acetate (EtOAc) containing 1% formic acid (FA) were added and the bags were 
subsequently crushed using a stomacher for 30–60 s. After one hour the liquid phase was filtered and 
concentrated in vacuo. The stomacher bags still containing the fungi were again filled with EtOAc 
containing 1% FA, and then left overnight. The following day the solution was filtered and then 
concentrated in vacuo. The combined extract was dissolved in 800 mL methanol (MeOH) and H2O 
purified and deionized by a Millipore system through a 0.22 μm membrane filter (MQ H2O) (9:1) and 
800 mL of heptane added, whereafter the phases were separated. To the MeOH/MQ H2O phase  
800 mL MQ H2O was added, and metabolites were then extracted with 4 × 400 mL dichloromethane 
(DCM). The phases were then concentrated separately in vacuo. 
3.3. Plug Extraction 
For standard screening three plugs were taken from one colony by use of a 6 mm plug drill; one 
from the center of the colony, one from the edge near the other colonies and one from the edge as far 
away from the other colonies. The plugs were transferred to 2 mL vials and 500 µL extraction solvent 
were added. A mixture of MeOH/DCM/EtOAc (1:2:3 v/v/v) containing 1% FA was used. To each 
sample 40 μL chloramphenicol in ethanol (500 μg/mL) was added as an internal standard. The vials 
were placed in an ultrasonic bath (Branson 2510 or 3520) for 60 min. The extract was then transferred 
to a clean vial and evaporated to dryness. This was either achieved by leaving the vials in a fume hood 
over night or by applying nitrogen airflow at 25–32 °C. After evaporation 500 µL MeOH was added 
and the sample was then ultrasonicated for 20 minutes. The extract was then filtered using a 0.45 μm 
PTFE filter. 
3.4. Sclerotium Extraction 
A. aculeatus IBT 21030 was three-point inoculated on YES, CYA and MM plates and incubated at 
30 °C for ten days and then at room temperature for eight days. Sclerotia were harvested by applying 
MQ H2O to the plate and carefully harvest with Drigalski spatula. The liquid including the sclerotia 
and spores was filtred through sterilised Miracloth and washed with MQ H2O, allowing for the spores to 
pass through, while sclerotia were staying in the filter. Sclerotia were transferred to true Eppendorf tubes 
and washed with water to remove remaining spores. After evaporation of excess MQ H2O, two big and two 
small steel balls was added to each tube and the tubes were shaken at 2000 rpm for 2 × 60 s. To each tube 
40 µL chloramphenicol (internal standard) and 1 mL MeOH/DCM/EtOAc (1:2:3 v/v/v) containing 1% 
FA was added and the extract was transferred to clean 2 mL vials. The samples were ultrasonicated for 
1 h and the extract was transferred to clean vials and solvent was evaporated by applying airflow at 
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25–32 °C. The samples were redissolved in 500 µL MeOH, ultrasonicated for 20 min and filtrated to 
fresh vials using 0.45 μm PTFE filters. 
3.5. UHPLC-DAD-HRMS Analysis 
Analysis was performed using ultra-high-performance liquid chromatography (UPHLC) UV/Vis 
diode array detector (DAD) high-resolution MS (TOFMS) on a maXis 3G orthogonal acceleration 
quadrupole time of flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an 
electrospray ionization (ESI) source and connected to an Ultimate 3000 UHPLC system (Dionex, 
Sunnyvale, CA, USA). The column used was a reverse-phase Kinetex 2.6-μm C18, 100 × 2.1 mm 
(Phenomenex, Torrance, CA, USA), and the column temperature was maintained at 40 °C. A linear  
water-acetonitrile (ACN) (LCMS-grade) gradient was used (both solvents were buffered with 20 mM 
FA) starting from 10% (vol/vol) ACN and increased to 100% in 10 min, maintaining this rate for 3 min 
before returning to the starting conditions in 0.1 min and staying there for 2.4 min before the following 
run. A flow rate of 0.4 mL·min−1 was used. TOFMS was performed in ESI+ with a data acquisition 
range of 10 scans per second at m/z 100–1000. The TOFMS was calibrated using Bruker Daltonics 
high precision calibration algorithm (HPC) by means of the use of the internal standard sodium 
formate, which was automatically infused before each run. UV/VIS spectra were collected at 
wavelengths from 200 to 700 nm. Data processing was performed using DataAnalysis 4.0 software 
(Bruker Daltonics). 
3.6. NMR 
The 1D and 2D spectra were recorded on a Varian Unity Inova-500 MHz spectrometer located at 
DTU, or on a Bruker Avance 800 MHz spectrometer located at the Danish Instrument Centre for NMR 
Spectroscopy of Biological Macromolecules at Carlsberg Laboratory. Spectra were acquired using 
standard pulse sequences. The deuterated solvent was DMSO-d6 and signals were referenced by 
solvent signals for DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. The NMR data was processed in 
MestReNova V.6.0.1–5391 or Bruker Topspin. Chemical shifts are in ppm (δ) and scalar couplings are 
reported in hertz (Hz). The sizes of the J coupling constants reported in the tables are the 
experimentally measured values from the 1D 1H and DQF-COSY spectra. There are minor variations 
in the measurements which may be explained by the uncertainty of J and the spectral digital resolution. 
Distances for the epi-10,23-dihydro-24,25-dehydroaflavinine were obtained from 2D NOESY 
experiments using the isolated spin pair approximation (ISPA) [40]. The linear range was increased by 
the method suggested by Macura et al. [46,47]. The used mixing time was 150 ms. Different mixing 
times were used to construct a buildup curve to ensure that only crosspeaks which fitted the ISPA  
were used.  
The 3J-couplings from angles in the 3D structures of epi-10,23-dihydro-24,25-dehydroaflavinine 
and the aculenes were calculated by the Haasnoot-DeLeeuw-Altona (HLA) equation and by DFT 
computations of the final structure [48,49]. 
The simulations were conducted using the program Maestro (Version 9.3.515, MMshare  
Version 2.1.515) from the Schrödinger suite. Conformational searches in implicit solvents (DMSO) 
were run by MacroModel (version 9.9, Schrödinger, LLC, New York, NY, USA, 2012) using the force 
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fields OPLS2005 and MMFFs. Monte Carlo torsional sampling was used to generate the structures and 
the minimization method was PRCG. The number of steps were 20,000, and only conformations 
within 30 kJ/mol of the found minimum were considered. The solvent DMSO was treated as a constant 
dielectric constant of 47.0. Both force fields gave similar results.  
Selected structures were further optimized by HF/3-21G using Jaguar (Jaguar, version 7.9, 2012, 
Schrödinger, LLC, New York, NY, USA,) followed by DFT (for epi-10,23-dihydro-24,25-
dehydroaflavinine) [50]. DFT calculations were carried out by Gaussian09 [51] using cam-B3LYP/6-
311++G(d,p) for optimization and B3LYP/6-31G(d,p) u+1s for calculating J-coupling constants (only 
Fermi Contact contribution considered, see reference [49]). 
3.7. Marfey’s Reaction 
Aculenes A and B (100 µg) were hydrolyzed with 6 M HCl (200 µL) in 2 mL analytical vials with 
lids, and were left at 110 °C for 22 h. The solvent was removed at a speedvac. For reference, 50 µL  
(2.5 µmol) standard L- and D-proline were prepared. To all vials 50 µL H2O, 20 µL 1 M NaHCO3 and  
100 µL 1% 1-fluoro-2,4-dinitrophenyl-5-L-alanineamide (FDAA) in acetone were added. The vials 
were left for 40 °C for 1 h. 10 µL 2 M HCl was added followed by 820 µL MeOH and HPLC-DAD-
MS data were acquired. 
3.8. Purification of Metabolites 
The DCM phase from the large scale extraction consisting of 2.375 g was absorbed onto Sepra  
ZT C18 (Phenomenex) and dried before packing into a 50 g (~66 mL) SNAP column (Biotage, 
Uppsala, Sweden) with Septra ZT C18 material. The extract was then fractionated using an Isolera 
flash purification system (Biotage). The gradient started with 15:100 MeOH/H2O in the first three 
column volumes (CV), then went to 100% MeOH over 18 CVs and stayed here for 3 CVs using a flow 
rate of 40 mL/min. MeOH was of HPLC grade and H2O was purified and deionized by Millipore 
system through 0.22 μm membrane filter (MQ H2O) and both were added 50 ppm trifluoroacetic acid 
(TFA). Fractions were automatically collected 1 CV at a time. The fractions were subjected to further 
purification on a semi-preparative HPLC, which was either a Waters 600 Controller with a 996 
photodiode array detector (Waters, Milford, MA, USA) or a Gilson 322 Controller connected to a 215 
Liquid Handler, 819 Injection Module and a 172 DAD (Gilson, Middleton, WI, USA). This was 
achieved using a Luna II C18 column (250 × 10 mm, 5 μm, Phenomenex). 50 ppm TFA was added to 
ACN of HPLC grade and MQ H2O. For choice of system, flow rate, gradients and yields see 
descriptions for the specific compound.  
Aculenes A and B. The three first Isolera flash chromatography fractions, eluding with 10%–25% 
MeOH, were subjected to further purification on the waters semi-preparative HPLC. A linear  
water-ACN gradient was used starting with 15% ACN and increasing to 100% over twenty minutes 
using a flow rate of 4 mL/min. Two compounds eluting with 54% and 56% ACN respectively, were 
collected. This yielded two pure compounds, 3.0 mg of aculene A and 3.7 mg of aculene B. 
Aculene A: HRMS: m/z = 316.1910. [M+H]+, calculated for [C19H25NO3+H]+: m/z = 316.1907.  
[α]20 D  = +0.63° (MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
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Aculene B: HRMS: m/z = 318.2068. [M+H]+, calculated for [C19H27NO3+H]+: m/z = 318.2064.  
[α]20 D  = +6.96° (MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
Aculene C. One of the Isolera flash chromatography fractions, eluding with 50% MeOH, was 
subjected to further purification on the waters semi-preparative HPLC. An isocratic water-ACN 
gradient was used starting with 40% ACN over twenty minutes using a flow rate of 4 mL/min. A 
compound eluding with 40% ACN was collected. This yielded 2.0 mg of aculene C. 
HRMS: m/z = 319.1382 [M+H]+, calculated for [C14H18O2+H]+: m/z = 319.1379. [α]20 D  = 0.00° 
(MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
Calbistrin A and C. One of the Isolera flash chromatography fractions, eluding with 100% MeOH, 
was subjected to further purification on the waters semi-preparative HPLC. An isocratic water-ACN 
method was used with 52% ACN over eighteen minutes using a flow rate of 4 mL/min. Two 
compounds eluding at 52% ACN were collected. This yielded 5.2 mg of calbistrin A and 4.6 mg of 
calbistrin C. 
Calbistrin A: HRMS: m/z = 563.2622 [M+Na]+, calculated for [C31H40O8+Na]+: m/z = 563.2615.  
[α]20 D  = +46.1° (MeOH). 1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.49 ppm): 0.77 (3H, d, J = 7.1 Hz), 
0.97 (3H, d, J = 7.1 Hz), 1.13 (3H, s), 1.22 (3H, s), 1.32 (1H, m), 1.69 (3H, s), 1.98 (3H, s), 2.02 (1H, m), 
2.30 (1H, dd, J = 13.8, 3.8 Hz), 2.37 (1H, m), 2.41 (1H, m), 2.69 (1H, dd, J = 13.8, 8.2 Hz), 2.80 (1H, 
m), 3.94 (1H, d, J = 9.4 Hz), 5.06 (1H, m, -OH), 5.10 (1H, m), 5.59 (1H, d, J = 9.6 Hz), 5.70 (1H, s), 
5.86 (1H, m), 5.88 (1H, d, J = 14.9 Hz), 5.97 (1H, d, J = 9.8 Hz), 6.05 (1H, d, J = 11.2 Hz), 6.30 (1H, 
d, J = 12.0 Hz), 6.38 (1H, d, J = 15.1 Hz), 6.68 (1H, dd, J = 15.1, 11.2 Hz), 7.51 (1H, dd, J = 14.9, 
12.0 Hz; 13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 10.9, 12.3, 13.0, 13.7, 20.6, 25.4, 26.0, 
34.7, 39.8, 43.6, 43.7, 56.2, 56.3, 68.3, 78.3, 121.2, 126.4, 127.0, 127.2, 130.8, 132.7, 133.8, 135.7, 
139.4, 140.9, 143.4, 173.9, 212.8. 
Calbistrin C: HRMS: m/z = 565.2776 [M+Na]+, calculated for [C31H42O8+Na]+: m/z = 565.2772.  
[α]20 D  = +8.67° (MeOH); 1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.49 ppm): 0.77 (3H, d, J = 7.1 Hz), 
0.95 (3H, d, J = 7.1 Hz), 1.01 (3H, s), 1.21 (1H, m), 1.27 (3H, s), 1.71 (3H, s), 1.93 (1H, m), 1.98 (3H, 
s), 2.35 (1H, m), 2.38 (1H, qin, J = 8.4), 2.56 (1H, m), 2.92 (1H, dt, J = 17.5, 7.5 Hz), 2.99 (1H, m), 
3.56 (2H, m), 3.95 (1H, dd, J = 9.4, 3.1 Hz), 5.09 (1H, br.d, J = 3.5 Hz, -OH), 5.05 (1H, s, -OH), 5.20 
(1H, m), 5.37 (1H, d, J = 9.9 Hz), 5.59 (1H, m), 5.88 (1H, d, J = 14.9 Hz), 5.90 (1H, d, J = 9.9 Hz), 
6.07 (1H, d, J = 11.1 Hz), 6.31 (1H, d, J = 12.0 Hz), 6.39 (1H, d, J = 15.1 Hz), 6.69 (1H, dd, J = 15.1, 
11.1 Hz), 7.51 (1H, dd, J = 14.9, 12.0); 13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 10.9, 
12.3, 13.0, 13.7, 20.6, 25.4, 26.0, 34.7, 39.8, 43.6, 43.7, 56.2, 56.3, 68.3, 78.3, 121.2, 126.4, 127.0, 
127.2, 130.8, 132.7, 133.8, 135.7, 139.4, 140.9, 143.4, 173.9, 212.8. 
Acu-dioxomorpholine. One of the Isolera flash chromatography fractions, eluding with 95% ACN, 
was subjected to further purification on the waters semi-preparative HPLC). A linear water-ACN 
gradient was used starting with 60% ACN increasing to 100% over twenty minutes using a flow rate of 
4 mL/min. A compound eluding with 85% ACN was collected. This yielded 2.1 mg of  
acu-dioxomorpholine. HRMS: m/z = 417.2176 [M+H]+, calculated for [C26H29N2O3+H]+: m/z = 417.2173. 
[α]20 D  = −49.23° (MeOH). 1H- and 13C-NMR (see Table 3). 
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Epi-10,23-dihydro-24,25-dehydroaflavinine. One Isolera flash chromatography fraction eluding 
with 100% MeOH, was subjected to purification on the waters semi-preparative HPLC. A gradient of 
15%–100% ACN over twenty minutes was used and the flow rate was 4 mL/min. A compound eluding 
with 100% ACN was collected. This yielded 8.7 mg of epi-10,23-dihydro-24,25-dehydroaflavinine. 
HRMS: m/z = 406.3113 [M+H]+, calculated for [C28H39NO+H]+: m/z = 406.3104. [α]20 D  = +63.58° 
(MeOH); 1H- and 13C-NMR (see Table 5). 
Okaramine S. One Isolera flash chromatography fraction, eluding with 100% MeOH, was subjected 
to purification on the Gilson semi-preparative HPLC. This was done using a gradient of 70%–100% 
ACN over fifteen minutes using a flow rate was 5 mL/min. A compound eluding with 80% ACN was 
collected. This yielded 1.7 mg of the pure compound. HRMS: m/z = 503.2447 [M+H]+, calculated for 
[C32H30N4O2+H]+: m/z = 503.2441. [α]20 D  = −15.29° (MeOH); 1H- and 13C-NMR (see Table 4). 
Okaramine J. One Isolera flash chromatography fraction, eluding with 74% MeOH, was subjected 
to purification on the waters semi-preparative HPLC. This was done using a gradient of 50%–100% 
ACN over twenty minutes using a flow rate of 4 mL/min. A compound eluding with 82% ACN was 
collected. This yielded 2.5 mg of the pure compound. HRESIMS: m/z = 525.2865 [M+H]+, calculated 
for [C32H36N4O3+H]+: m/z = 525.2860. [α]20 D  = +15.38° (MeOH); 1H-NMR (499.87 MHz, DMSO-d6, 
25 °C, 2.49 ppm): 1.52 (6H, s, H-17, H-18), 1.68 (3H, s, H-34), 1.73 (3H, s, H-35), 1.86 (1H, m,  
H-20), 2.42 (1H, dd, 13.2, 6.8, H-20'), 2.99 (1H, dd, 15.2, 9.4, H-1), 3.14 (1H, dd, 16.3, 7.1, H-31), 
3.23 (1H, dd, 16.8, 7.5, H-31'), 3.59 (1H, dd, 15.2, 4.2, H-1'), 4.46 (1H, dd, 9.1, 4.4, H-2), 4.67 (1H, 
dd, 11.3, 6.4, H-19), 5.05 (1H, dd, 10.5, 1.1, H-4), 5.08 (1H, dd, 17.4, 1.1, H-4'), 5.26 (1H, t, 7.4,  
H-32), 5.33 (1H, d, 4.5, H-29), 6.01 (1H, s , H-36), 6.12 (1H, d, 4.4, H-28), 6.22 (1H, dd, 17.4, 10.5, 
H-5), 6.32 (1H, s, H-3), 6.67 (1H, t, 7.5, H-24), 6.88 (1H, d, 7.5, H-25), 6.96 (1H, t, 7.5, H-12), 6.96 
(H-26), 7.05 (2H, H-11, H-23), 7.35 (1H, s, H-10), 7.53 (1H, s, H-13), 10.67 (1H, s, H-8); 13C-NMR 
(125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 17.5 (C-34), 24.7 (C-1), 25.2 (C-35), 27.6 (C-17,C-18), 
28.2 (C-31), 39.0 (C-6), 40.8 (C-20), 55.1 (C-2), 58.2 (C-19), 83.5 (C-29), 85.5 (C-21), 104.3 (C-15), 110.7 
(C-10), 110.9 (C-4), 117.6 (C-13), 118.4 (C-12, C-24), 118.9 (C-23), 120.0 (C-11), 121.5 (C-32), 122.7 
(C-22), 128.3 (C-14), 131.0 (C-26), 132.0 (C-33), 134.5 (C-9), 141.1 (C-7), 145.8 (C-27), 146.0 (C-5), 
167.5 (C-16), 169.7 (C-30). 
3.9. Antifungal Susceptibility Testing 
All compounds were screened for antifungal activity towards Candida albicans in accordance with 
the CLSI standards using RPMI-1640 medium adjusted to pH 7 with 0.165 M MOPS buffer [52]. The 
screening was performed as described by Holm et al. [53]. 
4. Conclusions  
Investigation of the chemical profile of Aspergillus aculeatus by UHPLC-DAD-HRMS has 
identified several novel compounds some of which have been selected, purified and their structure 
elucidated by 1D and 2D NMR spectroscopy. A novel class of related compounds – the aculenes – has 
been discovered. Aculenes A and B are hybrids containing the amino acid proline but also a fourteen 
carbon moeity we hypothesize to originate from a sesquiterpene with the loss of one carbon atom. 
Aculene C is believed to be a precursor to aculene A, missing the proline part of the molecule. 
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Moreover there is UHPLC-DAD-HRMS evidence suggesting a fourth structure, aculene D, a possible 
precursor to aculene B. Two other larger, however chemically unstable metabolites have been 
discovered. As they apparently were degrading to two known parts, aculene A and B respectively and 
calbistrin A, a tentative suggestion for their structures have been given. Two further novel compounds, 
acu-dioxomorpholine and okaramine S has also been discovered to be produced by A. aculeatus.  
Acu-dioxomorpholine has a remarkable structure, reminding of diketopiperazine, but with a lactone instead 
of the one lactame part and okaramine S displays a seven-membered ring, not previously seen in any 
reported okaramine. Furthermore the aflavinine analogue epi-10,23-dihydro-25,25-dehydroaflavinine 
was detected. Production of sclerotia was observed under specific conditions, and here an upregulation 
of okaramines was observed. Altogether the chemical profile of Aspergillus aculeatus has been 
examined and several novel compounds have been characterized. 
Supplementary Materials 
1H, DQF-COSY, HSQC, HMBC, NOESY and UV spectra for the novel compounds as well as 
suggestion for the structures of acucalbistrin A and B and elucidation of the stereochemistry of 
aculenes A–D and epi-10,23-dihydro-24,25-dehydroaflavinine are available in the supplementary. 
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/19/8/10898/s1. 
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Supplementary Materials 
Figure S1. 
1
H-NMR (500 MHz, DMSO-d6 spectrum) of the new compound aculene A. 
 
Figure S2. DQF-COSY spectrum of the new compound aculene A. 
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Figure S3. NOESY spectrum of the new compound aculene A. 
 
Figure S4. HSQC spectrum of the new compound aculene A. 
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Figure S5. HMBC spectrum of the new compound aculene A. 
 
Figure S6. UV spectrum of the new compound aculene A. 
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Figure S7. 
1
H-NMR (500 MHz, DMSO-d6 spectrum) of the new compound aculene B.  
 
Figure S8. DQF-COSY spectrum of the new compound aculene B. 
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Figure S9. NOESY spectrum of the new compound aculene B. 
 
Figure S10. HSQC spectrum of the new compound aculene B 
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Figure S11. HMBC spectrum of the new compound aculene B. 
 
Figure S12. UV spectrum of the new compound aculene B. 
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 Figure S13. 
1
H-NMR (800 MHz, DMSO-d6 spectrum) of the new compound aculene C. 
  
Figure S14. DQF-COSY spectrum of the new compound aculene C. 
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Figure S15. NOESY spectrum of the new compound aculene C. 
 
Figure S16. HSQC spectrum of the new compound aculene C. 
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Figure S17. HMBC spectrum of the new compound aculene C. 
 
Figure S18.UV spectrum of the new compound aculene C. 
 
Figure S19. 
1
H-NMR (500 MHz, DMSO-d6 spectrum) of the new compound acu-dioxomorhpoline. 
  
PhD Thesis 
Lene Maj Petersen
151
  S10 
 
Figure S20. DQF-COSY spectrum of the new compound acu-dioxomorhpoline. 
 
Figure S21. NOESY spectrum of the new compound acu-dioxomorhpoline. 
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Figure S22. HSQC spectrum of the new compound acu-dioxomorhpoline. 
  
Figure S23. MBC spectrum of the new compound acu-dioxomorhpoline. 
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Figure S24. UV spectrum of the new compound acu-dioxomorhpoline. 
 
Figure S25. 
1
H-NMR (500 MHz, DMSO-d6 spectrum) of the new compound okaramine S.  
 
* Impurity (Isolated spinsystem, not part of the compound). 
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Figure S26. DQF-COSY spectrum of the new compound okaramine S. 
 
Figure S27. NOESY spectrum of the new compound okaramine S. 
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Figure S28. HSQC spectrum of the new compound okaramine S. 
 
Figure S29. HMBC spectrum of the new compound okaramine S. 
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Figure S30. UV spectrum of the new compound okaramine S. 
 
Figure S31.
1
H-NMR (500 MHz, DMSO-d6 spectrum) of epi-10,23-dihydro-24,25-dehydroaflavinine.  
 
Figure S32. DQF-COSY spectrum of the new compound epi-10,23-dihydro-24,25-dehydroaflavinine. 
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Figure S33. NOESY spectrum of the new compound epi-10,23-dihydro-24,25-dehydroaflavinine. 
 
Figure S34. HSQC spectrum of the new compound epi-10,23-dihydro-24,25-dehydroaflavinine. 
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Figure S35. HMBC spectrum of the new compound epi-10,23-dihydro-24,25-dehydroaflavinine. 
 
Figure S36. UV spectrum of the new compound epi-10,23-dihydro-24,25-dehydroaflavinine. 
 
Figure S37. Selected NOEs for aculenes A and B. 
 
Stereochemistry of aculenes A–D: The relative stereochemistry of the stereocenters C-7 and C-16 
was investigated by performing conformational searches on the two diastereomers of aculenes A-C. 
285 
224 
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The strain of the ring resulted in mainly two possible configurations per structure. Only the 
configuration which is seen in Figure S37 will result in the observed 
3
J-coupling constants of H-7 as 
seen in Table S1. 
Table S1 for aculene A. A similar trend was observed for aculenes B and C. The observed NOESY 
peaks (Table S2) fit the suggested structures the best. The final stereocenter (C-12) of aculene B is 
suggested from NOEs and from the rather large J-coupling from H-12 to H-11, which displays an 
NOE to H-17. 
Table S1. Observed 
3
J-couplings in Hz of H-7 of aculene A compared to values calculated by DFT. 
Nucleus1 Nucleus2 Meas 
(RS) or (SR) 
conf. 1 
(RS) or (SR) 
conf. 2 
(RR) or (SS) 
conf. 1 
(RR) or (SS) 
conf. 2 
7 8 4.4 4.5 11.0 9.3 11.3 
7 8' 2.8 2.6 5.2 0.6 5.9 
Table S2. NOESY correlations for aculenes A–C. 
Position  Aculene A Aculene B Aculene C 
1    
2  2'  
2'  2  
3 3' 3'  
3' 3 3,4'  
4 4',5 4',5  
4' 4 3',4  
5 4 4,12  
6    
7 8,8',17 8,8',17 8,8',17 
8 7,8',17 7,8',17,18 7,8',17,18 
8' 7,8 7,8 7,8,18 
9    
10 11,18 11,11',18 11,18 
11 10,19 10,11',17 10,19,20 
11'  10,11  
12  5  
13    
14 19,20 17,19,20 17,19,20 
15    
16    
17 7,8 7,8,11,14 7,8,14 
18 10 8,10,19 8,8’,10 
19 11,14,20 14,18,20 11,14,20 
20 14,19 14,19 11,14,19 
-OH    
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Figure S38. Proposed structures of acucalbistrin A and B. 
 
A. BPC and EICs of a fraction from attempted purification of acucalbistrin A. Fraction contains aculene A 
([M+H]+ = 316.1907), calbistrin A ([M+Na]+ = 563.2615, ionizing poorly in positive ion mode)  and 
acucalbistrin A ([M+H]+ = 838.4524). Both acucalbistrin A and calbistrin A epimerize during purification. B. 
BPC and EICs of a fraction from attempted purification of acucalbistrin B. Fraction contains aculene B 
([M+H]+ = 318.2064), calbistrin A ([M+Na]+ = 563.2615, ionizing poorly in positive ion mode)  and 
acucalbistrin B ([M+H]+ = 840.4681). Both acucalbistrin B and calbistrin A epimerize during purification. 
Figure S39. Degradation of the acucalbistrins. 
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Figure S40. 3D-structure of 10,23-dihydro-24,25-dehydroaflavinine. Epi-10,23-dihydro-
24,25-dehydroaflavinine is suggested to be the enantiomer 
 
The relative stereochemistry of epi-10,23-dihydro-24,25-dehydroaflavinine was established by performing 
conformational searches on different diastereomers and comparing observed distances to the back-calculated 
distances from ISPA, as well as comparing 3J-couplings. The structure which fitted the data the best was 
further optimized by HF and DFT to give the reported structure.  
Table S3. ISPA derived distances in Å of epi-10,23-dihydro-24,25-dehydroaflavinine, a: 
reference, b: error due to freely rotating bond. 
Nucleus1 Nucleus2 Meas Calc Diff Lower bound Violation Upper bound Violation 
1 2 2.50 2.64 0.14 2.38 
 
2.90  
1 5 2.83 3.03 0.20 2.72 
 
3.33  
5 18 2.40 2.72 0.32 2.45 0.05 2.99  
5 11 2.37 2.41 0.04 2.17 
 
2.65  
5 10 2.67 2.54 0.13 2.29 
 
2.79  
2 27 2.54 2.48 0.06 2.23 
 
2.73  
2 23 2.46 2.58 0.12 2.32 
 
2.83  
2 25 2.96 3.01 0.05 2.71 
 
3.32  
25 23 2.31 2.39 0.07 2.15 
 
2.62  
25 10 4.58 2.78 1.80b 2.51 
 
3.06 1.52 
25 25' 1.85 1.85 0.00a 1.66 
 
2.03  
19 26 2.95 2.98 0.04 2.68 
 
3.28  
19 18' 2.43 2.51 0.08 2.25 
 
2.76  
19 22 2.14 2.02 0.12 1.82 
 
2.22  
19 18 2.41 2.32 0.08 2.09 
 
2.56  
19 11 2.83 3.37 0.53 3.03 0.20 3.70  
19 10 1.88 1.95 0.07 1.75 
 
2.14  
30 29 2.83 2.88 0.05 2.59 
 
3.17  
30 18' 3.32 2.48 0.84b 2.23 
 
2.73 0.59 
30 22 2.25 2.68 0.44b 2.41 0.16 2.94  
30 21 2.06 2.65 0.59b 2.39 0.33 2.92  
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Table S3. Cont. 
Nucleus1 Nucleus2 Meas Calc Diff Lower bound Violation Upper bound Violation 
10 26 2.33 2.28 0.05 2.05 
 
2.50  
10 11 2.32 2.24 0.08 2.02 
 
2.47  
23 27 2.05 2.06 0.02 1.86 
 
2.27  
11 12 2.24 2.12 0.12 1.90 
 
2.33  
11 13 2.61 2.70 0.09 2.43 
 
2.97  
11 16 2.21 1.86 0.35 1.68 
 
2.05 0.16 
16 28 2.37 2.23 0.14 2.01 
 
2.46  
21 29 2.18 2.05 0.12 1.85 
 
2.26  
16 17' 2.44 2.10 0.34 1.89 
 
2.31 0.13 
16 13 2.02 1.93 0.09 1.73 
 
2.12  
22 22' 1.74 1.75 0.01 1.58 
 
1.93  
17 29 2.33 2.31 0.02 2.08 
 
2.54  
17 17' 1.75 1.93 0.18 1.74 
 
2.13  
21' 27 2.07 2.12 0.04 1.91 
 
2.33  
13 13' 1.75 1.75 0.00 1.57 
 
1.92  
17' 28 2.46 2.35 0.11 2.12 
 
2.59  
14' 28 2.16 2.11 0.04 1.90 
 
2.33  
25’ 26 2.44 2.38 0.06 2.14 
 
2.62  
Table S4. HLA and DFT 
3
J-coupling constants in Hz of epi-10,23-dihydro-24,25-dehydroaflavinine. 
Nucleus1 Nucleus2 Meas Calc (HLA) Diff  Calc (DFT) Diff 
10 23 13.3 11.1 2.2  12.4 0.9 
10 11 5.0 5.4 0.4  5.1 0.1 
21' 22 13.5 11.8 1.7  11.9 1.6 
22 23 13.5 10.6 2.8  13.7 0.2 
16 17 11.3 11.4 0.1  13.7 0.2 
17 18 11.3 12.1 0.8  14.1 2.8 
21' 22' 3.4 4.9 1.5  4.4 1 
21 22 4.3 4.6 0.3  4.4 0.1 
22' 23 5.6 5.4 0.2  5.3 0.3 
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ABSTRACT: A novel secondary metabolite, aspiperidine oxide, was isolated from the filamentous fungus 
Aspergillus indologenus. The structure of aspiperidine oxide was determined from extensive 1D and 2D 
NMR spectroscopic analysis supported by high resolution mass spectrometry. The structure revealed a rare 
piperidine N-oxide, not observed in filamentous fungi before. A biosynthetic pathway of aspiperidine oxide 
is proposed, based on tentative identification of intermediates from UHPLC-DAD-HRMS data.  
1. Introduction 
Black Aspergilli constitute an important group of fungi within the genus Aspergillus. The group both entails 
species used for industrial production as well as common food and feed contaminants. A famous member of 
the group is A. niger, which is utilized in several industrial processes for production of organic acids such as 
citric acid and gluconic acid as well as enzymes such as amylases and lipases[1]. In addition, A. niger is also 
one of the most widespread food and feed contaminants[2]. This comprises a health hazard, since some 
strains are able to produce mycotoxins, such as fumonisins[3][4][5] and ochratoxin A[6]. Another member of 
the black Aspergilli is A. aculeatus, which similarly is both a contaminant and an industrial workhorse 
a[2][7].  
In the same clade as A. aculeatus is another black Aspergillus: A. indologenus (IBT 3679 = CBS 114.80). 
This species was isolated from Indian soil in 2011 and was subsequently described by Varga and co-
workers[8]. This work showed that A. indologenus is a producer of the insecticidal compounds okaramins A, 
B, and H, which is also the case for the closely related A. aculeatus[9]. A further analysis of the metabolic 
profile indicated that the species can produce indol-alkaloids related to aflavinines[8]. Being a relatively 
unstudied species and the only isolate of this species ever reported, our hypothesis was that A. indologenus 
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(IBT 3679 = CBS 114.80) would likely produce new chemical entities, other than the SMs already reported 
from this clade.  
2. Results and discussion 
Initial dereplication of a CYA derived extract, revealed production of the previously described metabolites 
JBIR-74, aspergillicin A and fellutanine C, see Figure 1.  
 
Figure 1 ESI+ Base peak chromatogram illustrating some of the major compounds in the extract from A. indologenus. Based on 
microscale extraction after cultivation on CYA media for 7 days at 25 °C in the dark.  
 
These compounds have not been described from A. indologenus before. JBIR-74 was originally isolated from 
a sponge-derived Aspergillus species[10] and displayed no cytotoxic activity against several cancer cell lines 
and no antimicrobial acitivity against Candida albicans, Micrococcus luteus or Escherichia coli. 
Aspergillicin A was isolated from a marine-derived Aspergillus carneus and showed modest cytotoxic 
activity (LD99 25–50 µg/mL) [11]. Fellutanine C was isolated from Penicillium fellutanum and showed no 
cytotoxic activity [12]. Dereplication of one of the major peaks eluting at 3.65 min gave no hits in 
Antibase[13], why a large extract was prepared for isolation and structural elucidation of what indeed turned 
out to be a novel compound, which we have named aspiperidine oxide. The resulting structure is depicted in 
Figure 2. 
 
Figure 2 The chemical structure of aspiperidine oxide. 
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2.1 Structural elucidation of aspiperidine oxide 
The ESI
+
 spectrum of aspiperidine oxide showed an adduct pattern consisting of [M+H]
+
 and [2M+H]
+
. The 
molecular formula C15H20N2O2 was obtained from HRMS of [M+H]
+
 of m/z 261.1588 (261.1597 calculated 
for [C15H20N2O2 + H]
+
). The UV spectrum displayed absorption maxima at 273 nm indicating a conjugated 
chromophore. For MS and UV spectra see Supporting Information. 
The 
1
H NMR spectrum revealed the presence of one amide proton, eight methines (one aliphatic, two 
vinylic and five aromatic), four methylenes, and one methyl group (Figure 3). The DQF-COSY spectrum of 
1 defined three spin systems besides the single methyl group; one spin system for the aromatic protons, one 
connecting the two vinylic protons with the amide proton, and the final spinsystem constituting the four 
methylene groups (three of these diastereotopic) and the aliphatic methine proton. The linking between these 
COSY spin systems and assignments of the remaining signals and quaternary carbons were accomplished 
through thorough analysis of HMBC experimental data (Figure 3). 
 
Figure 3 Important HMBC correlations connecting the three COSY spin systems (marked in bold) for aspiperidine oxide. The 
remaining HMBC correlations are found in Table 1.  
 
The aromatic protons H1, H2, H4, and H5 had overlapping resonances at δH 7.38 ppm and δC 128.9 ppm. 
From these both COSY and HMBC correlations were observed to the final aromatic proton H3 (δH 7.26 ppm, 
δC 127.5 ppm). Furthermore HMBC correlations were observed to the quaternary carbon at δC 135.2 ppm 
identified as H6. A further correlation was observed to this carbon from H8 (δH 6.73 ppm) connecting the 
aromatic part to the vinyllic part of the molecule. HMBC correlations were also observed from the aromatic 
system to C7 verifying this relation. The size of the vicinal coupling constants (
3
JHH) for H7/H8 was 
measured to 9.9 Hz, suggesting trans stereochemistry. A strong COSY correlation was observed between the 
two and one further COSY correlation was observed from H8 to what was identified as the amide proton at 
δH 10.23 ppm. Correlations to the C10 carbonyl (δC 164.9 ppm) was observed from H8, but also from 
protons at δH 4.64 ppm (H11), δH 2.04 ppm and 2.12 ppm (H12 and H12’). H11 and H12 could by COSY 
and HMBC correlations be connected to the three remaining methylene groups C13, C14 and C15. The 
chemical shift of H11 (δH 4.64 ppm) and H15/15’ (δH 3.58/4.07 ppm) indicated C11 and C15 to be directly 
connected to the remaining nitrogen, leading to the 6-membered aliphatic ring of aspiperidine oxide. Finally 
the methyl group appearing as a singlet at δH 3.56 ppm (H16) could be linked to this 6-membered ring 
through HMBC correlations to C11 and C15. The chemical shifts suggested it to be directly attached to the 
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nitrogen resulting in the N-oxide shown in Figure 3. This type of structure, has to the best of our knowledge, 
never been seen in any fungal SM. The piperidine N-oxide has recently been observed in two alkaloids 
isolated from the shrub Microcos paniculata[14]. The chemical shifts were comparable to our observations. 
Table 1. NMR data for aspiperidine oxide. 1H NMR data were obtained at 600 MHz in DMSO-d6 and 
13C data were obtained at 150 
MHz in DMSO-d6. 
13C-NMR chemical shifts determined from HSQC and HMBC experiments. It was not possible to distinguish 
between no. 1, 2, 4 and 5. 
Atom # 
1
H-chemical shift [ppm]/  
(Intg., mult., J [Hz]) 
13
C-chemical  
shift [ppm] 
COSY 
correlations 
HMBC 
connectivities 
1 7.38 (1H, m) 128.9 2/4, 3/5 2/4/5, 3, 6, 7  
2 7.38 (1H, m) 128.9 1/3/5, 2/4 1/4/5, 3, 6, 7  
3 7.26 (1H, m) 127.5 1/5, 2/4 1/2/4/5  
4 7.38 (1H, m) 128.9 1/3/5, 2 1/2/5, 3, 6, 7  
5 7.38 (1H, m) 128.9 1/3, 2/4 1/2/4, 3, 6, 7  
6 - 135.2 - - 
7 5.86 (1H, d, 9.9) 113.6 8 1/5, 8 
8 6.73 (1H, t, 9.9) 121.5 7, 9 6, 7, 10 
9 10.23 (1H, d, 9.9) - 8 10 
10 - 164.9  - 
11 4.64 (1H, m) 74.2 12, 12’ 10, 12/12’, 13/13’,  
12 2.04 (1H, m) 25.5 11, 12’, 13, 13’ 10, 11, 13/13’, 14 
12’ 2.12 (1H, m) 25.5 11, 12, 13, 13’ 10, 11, 13/13’, 14 
13 1.52 (1H, m) 19.3 12, 12’, 13’, 14 11, 12/12’, 14 
13’ 1.68 (1H, m) 19.3 12, 12’, 13, 14 11, 14 
14 1.91 (2H, m) 21.4 13, 13’ 15, 15’ 12/12’, 13/13’, 15/15’ 
15 3.58 (1H, m) 67.4 14, 15’ 11, 13/13’, 14, 16 
15’ 4.07 (1H, m) 67.4 14, 15 11, 13/13’, 14 
16 3.56 (3H, s) 51.4 - 11, 15/15’ 
 
2.2 Biological activity  
Aspiperidine oxide was tested towards GRAM-negative bacteria P. aeruginosa, A. baumannii and E. coli, 
GRAM positive MSSA and MRSA, the yeast C. albicans and for fungal activity against A. fumigatus, but did 
not display any biological activity. Plant related metabolites partly containing an piperidine N-oxide moiety, 
have been shown to display cytotoxic as well as nicotinic receptor antagonistic activities[14], why we 
speculate that aspiperidine oxide may play a role in fungal plant interactions. 
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2.3 Biosynthetic origin 
Aspiperidine oxide is likely to originate from amino acids, as are the metabolites JBIR-74, aspergillicin A 
and fellutanine C also produced by A. indologenus  (Figure 1). We suggest aspiperidine oxide to originate 
from phenylalanine and the non-proteinogenic amino acid pipecolic acid. The proposed biosynthetic pathway 
is depicted in Figure 4. The putative decarboxylation step of (4) to (5) have been observed for other fungal 
metabolites, e.g. in the oryzamide A1-2 from A. flavus[15]. The next step is the N-methylation to (6) and 
finally the N-oxide is formed, resulting in the final structure of aspiperidine oxide (1). We hypothesize that 
L- pipecolinic acid is incorporated into the compound; feeding studies is ongoing in our laboratory to reveal 
whether L- or D- pipecolinic acid is one of the amino acid precursors. 
  
 
 
Figure 4 Proposed steps towards the biosynthesis of aspiperidine oxide. NRPS = non-ribosomal peptide synthetase.  
 
The A. indologenus extract was scrutinized for the putative intermediates, see Figure 5. This resulted in 
tentatively identification of both the dipeptide phenylalanine-pipecolic acid (4) (trace amounts), de-methyl 
aspiperidine (5) and aspiperidine (6). Phenylalanine (2) was also observed, though no traces were found of 
the non-proteinogenic amino acid pipecolic acid (3).  
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Figure 5. Extracted ion chromatograms (EICs) for compounds 1–6 with a mass tolerance ± 0.005 Da. From UHPLC-
DAD-HRMS data of microscale extraction after cultivation of A. indologenus on CYA media for 7 days at 25 °C in the 
dark. The EICs are not to scale.  
The decreasing polarity of the intermediates is in accordance with the observed retention times. The tentative 
identification of the suggested intermediates supports the suggested biosynthesis of aspiperidine oxide.   
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3. Materials and methods 
3.1 Chemical analysis of strains.  
Strains were cultivated on solid CYA media at 25 °C for 7 days in the dark. Extraction of metabolites was 
performed as described by Smedsgaard[16]. Analysis was performed using reversed phase ultra-high-
performance liquid chromatography (UPHLC) UV/Vis diode array detector (DAD) high-resolution time-op-
flight mass spectrometer (TOFMS) on a maXis G3 orthogonal acceleration quadrupole time of flight (Q-
TOF) mass spectrometer (Bruker Daltonics, Bremen) as described by Holm et al.[17]. 
3.2 Strains, media and purification of metabolites.  
Solid plates with CYA media were prepared as described by Frisvad and Samson[18]. A. indologenus (IBT 
3679) was cultivated on 200 plates of CYA medium at 30 °C for 5 days in the dark. Extraction and workup 
was performed as described by Holm et al.[17]. Pre-fractionation of the extract was achieved by using an 
Isolera flash purification system (Biotage) using a 25g C18 Septra ZT column and a gradient of ACN and 
water going from 30 % to 100% ACN. ACN was of HPLC grade, and water was purified and deionized by a 
Millipore system through a 0.22 mmmembrane filter (Milli-Q water). The Isolera fractions were subjected to 
further purification on a semipreparative high-performance liquid chromatography (HPLC), which was a 
Gilson 322 controller connected to a 215 Liquid Handler, 819 Injection Module, and a 172 DAD (Gilson). 
This was achieved using a Luna II C18 column (250 310 mm, 5 mm; Phenomenex) and a gradient from 15 to 
20 % ACN over 20 minutes. 50 ppm TFA was added to ACN of HPLC grade and Milli-Q water. This 
yielded 2.3 mg of aspiperidine oxide.  
3.3 NMR and structural elucidation.  
The 1D and 2D spectra were recorded on a Varian VNMRS 600 MHz spectrometer. Spectra were acquired 
using standard pulse sequences and 
1
H spectra as well as DQF-COSY, ed-HSQC and HMBC spectra were 
acquired. The deuterated solvent was DMSO-d6 and signals were referenced by solvent signals for DMSO-d6 
at δH = 2.49 ppm and δC = 39.5 ppm. Chemical shifts are reported in ppm (δ) and scalar couplings in hertz 
(Hz).  
  
PhD Thesis 
Lene Maj Petersen
173
8 
 
References 
1. Schuster, E.; Dunn-Coleman, N. S.; Frisvad, J. C.; Van Dijck, P. W. M. On the safety of Aspergillus niger 
- a review. Appl. Microbiol. Biotechnol. 2002, 59, 426–435. 
2. Perrone, G.; Susca, A.; Cozzi, G.; Ehrlich, K. C.; Varga, J.; Frisvad, J. C.; Meijer, M.; Noonim, P.; 
Mahakarnchanakul, W.; Samson, R. A. Biodiversity of Aspergillus species in some important agricultural 
products. Stud. Mycol. 2007, 59, 53–66. 
3. Baker, S. E. Aspergillus niger genomics: past, present and into the future. Med. Mycol. 2006, 44, 17–21. 
4. Pel, H. J.; de Winde, J. H.; Archer, D. B.; Dyer, P. S.; Hofmann, G.; Schaap, P. J.; Turner, G.; de Vries, R. 
P.; Albang, R.; Albermann, K.; Andersen, M. R.; Bendtsen, J. D.; Benen, J. A. E.; van Den Berg, M.; 
Breestraat, S.; Caddick, M. X.; Contreras, R.; Cornell, M.; Coutinho, P. M.; Danchin, E. G. J.; Debets, A. J. 
M.; Dekker, P.; van Dijck, P. W. M.; van Dijk, A.; Dijkhuizen, L.; Driessen, A. J. M.; D’Enfert, C.; Geysens, 
S.; Goosen, C.; Groot, G. S. P.; de Groot, P. W. J.; Guillemette, T.; Henrissat, B.; Herweijer, M.; van den 
Hombergh, J. P. T. W.; van den Hondel, C. A. M. J. J.; van der Heijden, R. T. J. M.; van der Kaaij, R. M.; 
Klis, F. M.; Kools, H. J.; Kubicek, C. P.; van Kuyk, P. A.; Lauber, J.; Lu, X.; van der Maarel, M. J. E. C.; 
Meulenberg, R.; Menke, H.; Mortimer, M. A.; Nielsen, J.; Oliver, S. G.; Olsthoorn, M.; Pal, K.; van Peij, N. 
N. M. E.; Ram, A. F. J.; Rinas, U.; Roubos, J. A.; Sagt, C. M. J.; Schmoll, M.; Sun, J. B.; Ussery, D. W.; 
Varga, J.; Vervecken, W.; de Vondervoort, P. J. J.; Wedler, H.; Wosten, H. A. B.; Zeng, A. P.; van Ooyen, 
A. J. J.; Visser, J.; Stam, H. Genome sequencing and analysis of the versatile cell factory Aspergillus niger 
CBS 513.88. Nat. Biotechnol. 2007, 25, 221–231. 
5. Frisvad, J. C.; Smedsgaard, J.; Samson, R. A.; Larsen, T. O.; Thrane, U. Fumonisin B2 production by 
Aspergillus niger. J. Agric. Food Chem. 2007, 55, 9727–9732. 
6. Lucchetta, G.; Bazzo, I.; Cortivo, G. D.; Stringher, L.; Bellotto, D.; Borgo, M.; Angelini, E. Occurrence of 
black Aspergilli and ochratoxin A on grapes in Italy. Toxins (Basel). 2010, 2, 840–855. 
7. Adisa, V. A. Pectic enzymes of Aspergillus aculeatus associated with post-harvest deterioration of citrus 
sinensis fruit. J. Food Biochem. 1989, 13, 243–252. 
8. Varga, J.; Frisvad, J. C.; Kocsubé, S.; Brankovics, B.; Tóth, B.; Szigeti, G.; Samson, R. A. New and 
revisited species in Aspergillus section Nigri. Stud. Mycol. 2011, 69, 1–17. 
9. Petersen, L. M.; Hoeck, C.; Frisvad, J. C.; Gotfredsen, C. H.; Larsen, T. O. Dereplication guided discovery 
of secondary metabolites of mixed biosynthetic origin from Aspergillus aculeatus. Molecules 2014, 19, 
10898–10921. 
10. Takagi, M.; Motohashi, K.; Motohashi, K.; Shin-ya, K. Isolation of 2 new metabolites, JBIR-74 and 
JBIR-75, from the sponge-derived Aspergillus sp. fS14. J. Antibiot. (Tokyo). 2010, 63, 393–395. 
11. Capon, R. J.; Skene, C.; Stewart, M.; Ford, J.; O’Hair, R. a J.; Williams, L.; Lacey, E.; Gill, J. H.; 
Heiland, K.; Friedel, T. Aspergillicins A-E: five novel depsipeptides from the marine-derived fungus 
Aspergillus carneus. Org. Biomol. Chem. 2003, 1, 1856–1862. 
12. Kozlovsky, A. G.; Vinokurova, N. G.; Adanin, V. M.; Burkhardt, G.; Dahse, H. M.; Gräfe, U. New 
diketopiperazine alkaloids from Penicillium fellutanum. J. Nat. Prod. 2000, 63, 698–700. 
8   Papers 1-12
174
9 
 
13. Laatsch, H. Antibase 2012. http://www.wiley-vch.de/stmdata/antibase.php (accessed on 1 February 
2014). 
14. Still, P. C.; Yi, B.; González-Cestari, T. F.; Pan, L.; Pavlovicz, R. E.; Chai, H.-B.; Ninh, T. N.; Li, C.; 
Soejarto, D. D.; McKay, D. B.; Kinghorn, D. A. Alkaloids from Microcos paniculata with cytotoxic and 
nicotinic receptor antagonistic activities. J. Nat. Prod. 2013, 76, 243–249. 
15. Rank, C.; Klejnstrup, M. L.; Petersen, L. M.; Kildgaard, S.; Frisvad, J. C.; Gotfredsen, C. H.; Larsen, T. 
O. Comparative chemistry of Aspergillus oryzae (RIB40) and A. flavus (NRRL 3357). Metabolites 2012, 2, 
39–56. 
16. Smedsgaard, J. Micro-scale extraction procedure for standardized screening of fungal metabolite 
production in cultures. J. Chromatogr. A 1997, 760, 264–270. 
17. Holm, D. K.; Petersen, L. M.; Klitgaard, A.; Knudsen, P. B.; Jarczynska, Z. D.; Nielsen, K. F.; 
Gotfredsen, C. H.; Larsen, T. O.; Mortensen, U. H. Molecular and chemical characterization of the 
biosynthesis of the 6-MSA derived meroterpenoid yanuthone D in Aspergillus niger. Chem. Biol. 2014, 21, 
519–529. 
18. Samson, R. A.; Houbraken, J.; Thrane, U.; Frisvad, J. C.; Andersen, B. Food and Indoor Fungi; CBS-
KNAW Fungal Biodiversity Centre: Utrecht (NL), 2010.  
 
PhD Thesis 
Lene Maj Petersen
175
Supporting information 
1
H NMR (600 MHz, DMSO-d6 spectrum) of the new compound aspiperidine oxid  
 
DQF-COSY spectrum of the new compound aspiperidine oxid 
 
Edited HSQC spectrum of the new compound aspiperidine oxid 
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HMBC spectrum of the new compound aspiperidine oxid 
 
MS and UV spectra of the new compound aspiperidine oxid 
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Introduction 
Aspergilus homomorphus (A. homomorphus) is a lesser known fungus of the Aspergillus genus 
residing in section Nigri (or the black Aspergilli), which includes fungi such A. niger and A. 
carbonarius.
1
 A. homomorphus was first identified by R. Steiman et al. from soil near the Dead Sea 
in Israel.
2
 Black aspergilli are commonly known to cause food spoilage and are also of industrial 
use.
3
 An example of the latter is A. niger which is used in large scale production of citric acid but 
may also produce ochratoxin A and fumonisin B2.
4,5
 A. homomorphus belong in a clade which, 
among other species, includes the industrially important A. aculeatus.
1
 
Through the years a wide variety of secondary metabolites (SMs) have been reported from black 
Aspergilli.
6
 The continued search for new chemical entities (NCEs) in the section is thus spurred by 
the ability of related species to produce quite different SMs.
7,8
 A. homomorphus have previously 
been reported to produce the SMs secalonic acid D and F as well as dehydrocarolic acid.
1
 Here the 
SM chemistry of A. homomorphus is explored using UHPLC-DAD-MS and NMR spectroscopy in 
the continued search for both NCEs and the elucidation of their biosynthetic origin.  
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Most of these structures share features and were identified through a proposed shared biosynthetic 
relationship, which was used to guide the identification and isolation of novel precursor 
compounds. This is proposed without any knowledge from genetics, as the genome of A. 
homomorphus has not yet been sequenced. 
 
Results and discussions 
The structures of metabolites isolated and characterized from A. homomorphus are shown in Figure 
1. Most of these are non-ribosomal peptides (NRPs) with attached isoprene units. They are thereby 
related to other natural compounds such as okaramines, which are produced by other black 
aspergilli, e.g. A. aculeatus and A. indologenus, as well as Penicillium simplicissimum.
9–14
 All 
relevant MS, UV and NMR data are found in the Supporting Information.  
  
  
Figure 1 Novel compounds from A. homomorphus (1-6), compounds previously reported as “unnatural” (8,9) 
and rediscovered compounds (7,
15
 10-12). 7 is included due to biosynthetic relationship with 1, 4, 5 and 6. Data 
of 8-10 may be found in the Structural data section. Also secalonic acid D and F were reconfirmed to be 
produced via UHPLC-DAD-MS in accordance with previous publications.
1
 Dehydrocarolic acid was not 
identified from incubation on any medium. 
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Novel metabolites 
The common name of the novel compounds, homomorphosin, was chosen due to their fungal 
origin. The NMR data for the related compounds 1-6 is found in Table 1 and Table 2. 
Table 1. 
1
H-NMR data for the homomorphosins A-F acquired in DMSO-d6 at 500 or 800 MHz. Chemical shifts 
in ppm and J-coupling constants in Hz. 
 A (1) B (2) C (3) D (4) E (5) F (6) 
# δH (I, mult, J) δH (I, mult, J) δH (I, mult, J) δH (I, mult, J) δH (I, mult, J) δH (I, mult, J) 
1 3.77 (1H,d,1.9) 3.84 (1H,t,4.5) 3.89 (1H,q,6.8) 3.57b (1H,m) 3.48 (1H,m) 4.02 (1H, m) 
2       
3    6.84 (1H,s) 7.49 (1,d,3.0)  
4      5.31 (1H,s) 
5 6.72 (1H,s) 6.69 (1H,1,s) 6.66 (1H,s) 10.59 (1H,s) 10.51 (1H,s)  
6       
7 6.56 (1H,d,7.8) 6.57 (1H,d,7.6) 6.57 (1H,d,7.4) 7.21 (1H,d,7.9) 7.30 (1H,d,8.0) 6.45 (1H, d, 7.9) 
8 6.99 (1H,t,7.7) 6.99 (1H,t,7.7) 6.99 (1H,t,7.7) 6.92 (1H,t,7.6) 7.00 (1H,t,7.1) 7.11 (1H, t, 7.5) 
9 6.47 (1H,d,7.6) 6.47 (1H,d,7.4) 6.47 (1H,d,7.4) 6.69 (1H,d,7.1) 6.92 (1H,t,7.1) 6.72 (1H, t, 7.4) 
10     7.42 (1H,d,7.8) 7.17 (1H,d, 7.2) 
11       
12       
13a 2.54 (1H,m) 2.53 (1H,m) 2.53 (1H,m) 3.13 
(1H,dd,14.8,10.7) 
2.99 
(1H,dd,14.5,9.2) 
1.78 (1H, m) 
13b 2.62 (1H,dd,13.0,7.4) 2.62 (1H,m) 2.63 
(1H,dd,11.5,7.4) 
3.57a (1H,m) 3.41 
(1H,dd,14.5,4.3) 
2.40b (1H, m) 
14 3.66 (1H,dd,11.5,7.3) 3.68 
(1H,dd,11.5,7.3) 
3.72 
(1H,dd,11.5,7.5) 
4.03 (1H,d,10.4,) 3.99 (1H,m) 4.57 (1H, dd, 
11.6, 6.3) 
15       
16 7.95 (1H,s) 8.05 (1H,s) 8.10 (1H,s) 8.12 (1H,s) 8.18 (1H,d,2.7) 7.98 (1H, s) 
17a 2.32 
(1H,septd,7.1,2.0) 
1.68 (1H,m) 1.16 (3H,m) 2.13 (1H,m) 1.98 
(1H,dd,12.4,6.8) 
2.40a (1H, m) 
17b  1.71 (1H,m)     
18 0.86 (3H,d,6.8) 0.85 (3H,t,7.3)  0.91 (3H,d,6.7) 0.89 (3H,d,6.8) 0.87 (3H, d, 6.8) 
19 0.98 (3H,d,7.2)   0.99 (3H,d,7.0) 0.96 (3H,d,6.9) 1.02 (3H, d, 7.2) 
20a      3.93 (1H, m) 
20b      4.00 (1H, m) 
21 6.27 
(1H,dd,17.6,10.8) 
6.27 
(1H,dd,17.6,10.9) 
6.26 
(1H,dd,17.6,10.8) 
6.16 
(1H,dd,17.5,10.5) 
6.15 
(1H,dd,17.5,10.5) 
5.08 (1H, t, 5.8) 
22a 4.85 (1H,m) 4.84 (1H,d,11.1) 4.85 
(1H,dd,12.8,1.7) 
5.03 (1H,d,14.2) 5.00 (1H,m) 
 
22b 4.85 (1H,m) 4.87 (1H,d,17.6) 4.88 
(1H,dd,17.9,1.7) 
5.04 (1H,d,17.2) 5.03 (1H,m) 
 
23 1.17 (3H,s) 1.17 (3H,s) 1.17 (3H,s) 1.49 (3H,s) 1.47 (3H,s) 1.60 (3H, s) 
24 1.20 (3H,s) 1.20 (3H,s) 1.19 (3H,s) 1.52 (3H,s) 1.48 (3H,s) 1.67 (3H, s) 
25a 3.33 (1H,m) 3.34 (1H,m) 3.34 (1H,m) 3.67 (1H,m)   
25b 3.47 (1H,dd,15.6,7.3) 3.46 
(1H,dd,15.7,6.9) 
3.47 
(1H,dd,15.7,7.5) 
3.75 (1H,m)   
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26 5.22 (1H,t,6.9) 5.23 (1,td,6.7,1.4) 5.23 (1H,t,6.9) 5.21 (1H,t,6.7)   
27       
28 1.70 (3H,s) 1.70 (3H,s) 1.71 (3H,s) 1.68a (3H,s)   
29 1.70 (3H,s) 1.69 (3H,s) 1.70 (3H,s) 1.68b (3H,s)   
30 5.70 (1H,s) 5.69 (1H,s) 5.69 (1H,s)    
 
Table 2. 
13
C-NMR data for the homomorphosins A-F acquired in DMSO-d6 at 500 or 800 MHz. Chemical shifts 
in ppm. 
 A (1) B (2) C (3) D (4) E (5) F (6) 
# δC δC δC δC δC δC 
1 60.4 56.1 51.3 59.2 59.6 60.4 
2 171.8 172.1 172.8 168.3 166.1 170.1 
3       
4 90.8 90.7 90.3 141.2 140.9 88.0 
5       
6 149.6 149.5 149.4 135.7 134.6 148.8 
7 107.8 108.1 108.2 108.9 110.6 108.7 
8 129.4 129.3 129.5 120.4 120.3 129.7 
9 119.3 119.5 119.6 119.2 118.2 118.5 
10 139.3 139.3 139.3 132.7 117.8 122.3 
11 127.3 127.1 127.2 125.7 128.9 131.8 
12 89.1 89.2 89.0 105.6 104.8 85.5 
13 34.6 34.9 34.6 30.2 31.2 40.6 
14 57.0 57.3 57.4 55.9 55.4 59.2 
15 170.4 170.2 169.7 166.2 167.6 171.8 
16       
17 26.7 21.2 14.9 31.3 31.87 27.9 
18 15.8 8.7  17.4 17.4 16.5 
19 18.1   18.5 18.4 18.5 
20 44.6 44.4 44.5 38.9 39.4 46.0 
21 145.2 145.4 145.6 146.7 146.3 119.9 
22 110.6 110.6 110.7 110.7 110.8 134.8 
23 24.2 24.2 24.2 27.3 27.5 26.0 
24 24.5 24.6 24.6 27.8 27.5 18.4 
25a 28.6 28.5 28.8 31.0   
25b 28.6 28.5 28.8 31.0   
26 123.0 123.1 123.2 123.9   
27 131.5 131.5 131.4 131.1   
28 17.7 25.2 25.3 17.7   
29 25.2 17.6 17.6 25.5   
Homomorphosin A (1) was isolated as a white solid. The [M+H]
+
 of 1, m/z 438.2754, corresponds 
to a constituent formula of C26H35N3O3 (theoretical m/z 438.2751). The 35 protons found in the 1D 
1
H spectrum were divided among six methyl groups at δH 0.86 (3H, d,), 0.98 (3H, d, J=7.2, H3-19), 
1.17 (3H, s, H3-19), 1.20 (3H, s, H3-19) and 1.70 (6H, s, H3-19/20), three aromatic protons at δH 
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6.47 (1H, d, J=7.6, H-9), 6.56 (1H, d, J=7.8, H-7) and 6.99 (1H, t, J=7.7, H-8), four olefinic protons 
at δH 4.85 (2H, m, H2-22), 5.22 (1H, t, J=6.9, H-26) and 6.27 (1H, dd, J=17.6, 10.8, H-21), two 
methines with neighboring heteroatoms at δH 3.66 (1H, dd, J=11.5, 7.3, H-14) and 3.77 (1H, d, 
J=1.9, H-1), two diastereotopic methylenes at δH 2.54 (1H, m, H-13a), 2.62 (1H, dd, J=13.0, 7.4, H-
13b), 3.33 (1H, m, H-25a) and 3.47 (1H, dd, J=15.6,7.3, H-25b), a methine at  δH 2.32 (1H, septd, 
J=7.1, 2.0, H-17) along with exchangeable protons at δH 5.70 (1H, s, H-30), 6.72 (1H, s, H-5) and 
7.95 (1H, s, H-16). All protons could be coupled to their respective carbons (as in Table 1) through 
gHSQC correlations with the exception of the exchangeable protons. The diastereotopic protons and 
the resonance at 1.70 ppm could thus be elucidated. Five spin systems were established from the 
DQF-COSY experiment; an aromatic, an olefinic and three aliphatic, and the spin systems and 
quaternary carbons were joined through gHMBC correlations as illustrated in Figure 2a. 
The relative stereochemistry of 1 is suggested from a network of NOEs obtained from NOESY and 
ROESY experiments with the key NOEs being H-1/H-14. This NOE established that the amino 
acids share handedness. NOEs H-13b/H-14, H-13a/H-30, H-13a/H3-23/24 and H-21/H-30 were 
used to solve the remaining relative stereochemistry. The couplings constants of H-13a/b and H-14 
fit to the proposed diastereotopicity of the methylene group with a smaller J-coupling originating 
from H-13b/H-14 in comparison to H-13a/H-14 which shows a large J-coupling constant. Figure 2b 
includes the important NOEs, while c shows the 3D structure with the best fit to the correlating 
distances obtained by the isolated spin pair approximations (ISPA). The absolute configuration was 
solved by hydrolyses and reaction with Marfey’s reagent which suggested an L-configuration of 
valine.
16
 The 
3
J-coupling of H-1 and H-13 is 2.0 Hz which suggests a restriction in the rotation of 
the isopropane group attached to C-1.  
 
Figure 2 a: COSY spin systems (-) and chosen HMBC correlations (→) of 1. b: Chosen NOEs  (→) of 1. c: The 
3D structure of 1 which fit the NOESY data the best. 
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Biosynthesis of the homomorphosins 
The isolation of 1 led to a hypothetical biosynthesis proposed in Figure 3, which in turn led to the 
discovery of more NRPs. This methodology of discovering new metabolites was used, as 1 was by 
far the main metabolite produced on the used media. The biosynthesis was proposed utilizing 
known reactions from organic and biochemical synthesis, starting from L-valine and L-tryptophan 
(not shown in figure). The mechanisms needed to obtain the compounds are two C-prenylations and 
an epoxidation and subsequent intramolecular ring-closure. Both mechanisms have been previously 
described or suggested in the biosynthesis of natural products. 
17–26
 
 
Figure 3 The suggested biosynthesis of (1). Compound 6 is proposed to be made by the cyclization of 
L-valine and L-tryptophan (not shown). [1] C-prenylation, [2] epoxidation/ring closure. 
A dereplication, utilizing UHPLC-DAD-MS (chromatograms in Figure 4), was then conducted for 
proposed stable intermediates, which were all isolated and structure elucidated. 
 
Figure 4 Chromatogram of extract of A. homomorphus (top) and extracted ion chromatograms (EICs) of the m/z 
values for suggested compounds in the biosynthesis of (1). Chromatograms are scaled. 
Homomorphosins D (4), E (5) and L-valyl-L-tryptophan anhydride (7) were isolated as white 
solids. The NMR data resembles that of 1 where structural features are shared. The 
homomorphosins are novel diketopiperazines. The data of the rediscovered 7 corresponds to that 
found in the literature.
15
 The NMR data and UV
max
 suggested that these compounds contain an 
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indole ring which differentiates them from 1.
27
 The compounds 4, 5 and 7 are suggested to share 
biosynthetic pathway though the genome have yet to be sequenced. 
Due to the successful identification of precursors for 1, a new dereplication to identify structural 
analogues of 1 was conducted, with tryptophan coupled to other amino acids, which revealed 
compounds 2 and 3.  
Homomorphosins B (2) and C (3) were both white solids. The NMR data corresponds to that of 1, 
except that valine is exchanged with alanine (3) or the “unnatural” amino acid 2-aminobutyrate (2). 
The latter amino acid is not commonly found in natural diketopiperazines of amino acids, and 
though some have been published, these were functionalized at the α-position.28–30 The 3J-coupling 
of H-1 and H-16 increases as the size of the substituent attached to C-1 decreases which may 
support the suggested rotational restriction for 1. 
Homomorphosin F (6) was isolated as a white solid (data found in supporting info). The compound 
differs from the other homomophosins, and compound isolated from A. homomorphus in general, as 
it is N-prenylated. As for 1, 2 and 3 the UV
max
 of 6 showed a reduction of the indole ring. The 
resonance from the alcohol proton did not appear in the NMR spectra, probably due to a high water 
content of the sample. The structure was thus suggested due to the constituent formula obtained 
from HRMS, the chemical shift of C-11 and the UV spectrum. The respective UV-spectra are 
compared in Supporting Information. 
The absolute stereochemistry of 2-6 is believed to be the same as that of 1 due to a similar relative 
stereochemistry in between the compounds, and the possible involvement of 4 and 5 in the 
biosynthesis of 1. The absolute stereochemistry of 7 was established by Marfey’s to be that of 1. No 
NOE between H-1 and H-13 was found in the NOESY spectra of 3, which might suggest another 
relative configuration. The reason for this could also be due to the sparse amount of compound, as 
the sign of the optical rotation is equal to 1 and 2. 
Bioactivity 
The bioactivity of compounds similar to the homomorphosins against bacteria, fungi and protozoa 
has been tested and bioactivity have been reported against e.g. S. aureus.
31,32
 Homomorphosin A 
was tested against C. albicans and chronic lymphatic leukaemia but no activity was observed. 
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Conclusion 
A large scale cultivation of A. homomorphus led to the discovery of six novel NRPs based 
metabolites with a diketopiperazines skeleton. They were all characterized using UHPLC-DAD-MS 
and NMR spectroscopy. Based on NOESY and ROESY NMR data, J-coupling constants and 
structural simulations the relative stereochemistry and a possible 3D structure for the compounds 
are proposed. For compound 1 the absolute stereochemistry relations were obtained using Marfey’s 
analysis. It is speculated that all the new compounds have a shared biosynthetic origin. The 
proposed biosynthesis were used to identify new metabolites and gained credibility by the isolated 
structures.   
Experimental 
Fungal growth, extraction and the isolation of compounds. 
A. homomorphus (IBT 21893) was inoculated on different media to determine the preferred growth 
media and time in order to get as diverse a chemical profile as possible. The used media were Yeast 
Sucrose Agar (YES), Czapek yeast extract agar (CYA), Malt Extract Agar (MEA), Oatmeal agar 
(OAT) and Creatine sucrose agar (CREA) for 2, 5, 7 and 9 days.
33
 The major metabolites from most 
growth media were homomorphosin A (1) and a 4-methoxy-α-pyrone (9) which could originate 
from polyketide and Shikimi pathways.
34
 The chosen media and time were YES for 7 days. 
A. homomorphus was inoculated as three-point stabs on agar plates and incubated in the dark at 30 
°C for 7 days. The used media were YES for the NRPs (200 plates) and MEA for the other isolated 
metabolites (50 plates). The fungi were harvested and extracted twice with EtOAc (1 % FA) (once 
overnight), m(YES) = 7.8 g, m(MEA) = 217.1 mg. The combined extract was dissolved in 9:1 
MeOH:H2O and washed with heptane. Water was added to give 1:1 MeOH/H2O and compounds 
were extracted with DCM followed by concentration in vacuo, m(YES) = 4.90 g, m(MEA) = 36.3 
mg. The DCM phase (YES) was absorbed onto reverse phase column material and fractioned by an 
Isolera One flash chromatography system by Biotage with auto-fractionation and a 120 g Biotage 
Snap KP-C18-HS column. The column volume used 132 mL and fractions of 115 mL (max) were 
collected. The gradient ranged from 30 to 100 % MeCN/H2O with a flow rate of 40 mL/min over 65 
min.   
The fractions (see table below) which showed possible targets after UHPLC-DAD-MS analysis 
were further purified on a semi-preparative HPLC; the Waters 600 Controller coupled to a Waters 
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996 Photodiode Array Detector with a flow rate of 5 mL/min. The columns used were Luna II C18, 
5 μm, 250 × 10 mm by Phenomenex and Gemini C6-Phenyl, 5 μm, 250 × 10 mm by Phenomenex. 
 
 
 
Isolera 
fraction 
%MeCN/H2O 
m [mg] 
Waters run 
%MeCN/H2O 
Time [min] 
Waters elution 
time [min] 
%MeCN/H2O 
Yield [mg] 
1 15/70-74 180.7 - - 180.7 
2 13/64-68 72.0 Iso/65/15 7.3/65 2.7 
3 11/56-60 14.6 Grad/40-70/20 14.5/63 0.9 
4 13/64-68 72.0 Iso/65/15 7.7/65 3.6 
5 8/45-49 36.9 Iso/45/15 7.5/45 1.7 
6 4/30-34 72.6 Grad/30-40/15 5.3/34 8.1 
7 10/52-56 27.0 Iso/40/20 15.5/40 1.9 
8 - 36.3 Iso/55/20 13.4/55 1.7 
9 - 36.3 Iso/55/20 15.8/55 2.5 
10 8/45-49 36.9 Iso/45/15 6.35/45 3.5 
 
NMR 
All NMR spectra were acquired using standard pulse sequences on a Unity Inova 500 by Varian or 
on a Bruker Avance 800 spectrometer of the Danish Instrument Center for NMR Spectroscopy of 
Biological Macromolecules at 298 °C. The deuterated solvent used for all compounds was DMSO-
d6 which was used as internal standard (δH = 2.49 ppm, δC = 39.5 ppm). Typical acquisition 
conditions were as follows (conditions for homomorphosin A). 1D 
1
H: Spectrometer frequency (sf) 
= 499.87 MHz, Spectral width (sw) = 5000.0 Hz, Fourier transform size (si) = 20480, acquisition 
time (aq) = 2.05 s, 90 ° pulse width (pw) = 7.0 µs, line broadening (lb) = 0.3, relaxation delay (rd) = 
2 s, number of scans (ns) = 32, number of dummy scans (ds) = 8. gHSQC: sf = 499.87 MHz, 
sw(
1
H) = 5000.0 Hz, sw(
13
C) = 30007.7 Hz, si = 2048, ni = 512, aq = 0.20 s, pw = 6.9 µs, rd = 1.5 
s, ns = 8, ds = 64. DQF-COSY: sf = 499.87 MHz, sw = 5000.0 Hz, si = 2048, ni = 1024, aq = 0.20 
s, pw = 6.9 µs, rd = 1.5 s, ns = 8, ds = 16. gHMBC: sf = 499.87 MHz, sw(
1
H) = 5000.0 Hz, sw(
13
C) 
= 34999.7 Hz, si = 2048, ni = 512, aq = 0.20 s, pw = 6.9 µs, rd = 1.5 s, ns = 8, ds = 64. 
NOESY/ROESY: sf = 499.87 MHz, sw = 5000.0 Hz, si = 2048, ni = 512, aq = 0.20 s, pw = 7 µs, rd 
= 2 s, ns = 8, ds = 16. 
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Structural parameters from NMR 
To check the stereochemical assignment of homomorphosin A the isolated spin-pair approximation 
(ISPA) method, with increased linear range as suggested by Macura et al., was applied.
35
 The 
mixing time was 150 ms which was found to be within the linear range (50, 100, 150, 200 ms was 
used). The volumes from the peaks in the ROESY spectra were extracted by integration in 
Topspin3.1. For the calculation of J-couplings from dihedral angles the Karplus equation for amino 
acids was used.
36,37
 Experimental couplings constants were measured in 1D 
1
H or DQF-COSY 
spectra. Structures were generated using Macromodel in the Maestro (Schrödinger Release 2013-2: 
Maestro, version 9.5, Schrödinger, LLC, New York, NY, 2013). A conformational search was 
conducted in implicit DMSO, treated as a constant dielectric constant of 46. The mixed mode 
option was used with 10,000 steps and PRCG as minimization method using the force field 
MMFFs. Structures within 25 kJ of the found minimum was considered. From the conformational 
search 364 conformations was found. The structure which fitted the data the best was found by 
comparing back-calculated distances and J-couplings with the found values. Averaging of NMR 
parameters was done iteratively over 10,000 steps were each step included the structure which 
would give the best average fit to the data. NOE to J-couplings were weighted 10:1. Distances was 
averaged according to      〈  
  〉   . The script was written in-house in Matlab (R2013b, 
8.2.0.701, The MathWorks, Inc., Natick, MA). 
UHPLC-DAD-MS 
UHPLC-DAD-MS data was acquired by the Maxis 3G UHR-QTOF-MS by Bruker Daltonics 
(Bremen, Germany) with an electrospray ionization (ESI) source combined with an UltiMate 3000 
Rapid Separation LC by system Thermo Scientific Dionex (Sunnyvale, CA, USA). The column 
used was a Kinetex C18, 100x2.1 mm, 2.6 μm, by Phenomenex (Torrance, CA, USA) maintained at 
40 °C. Solvents were acetonitrile (ACN) and H2O (buffered with 20 mM FA) and a linear gradient 
from 10 to 100 % (v/v) ACN over 10 min with a flow rate was 0.4 mL/min was used. MS was run 
in positive mode (ESI+) with a mass range of m/z 100–1000. Sodium formate was used as internal 
standard for mass calibration. UV/VIS spectra from the DAD were collected at wavelengths from 
200-700 nm. 
Marfey’s reagent 
Stereoisometry of the amino acid valine was elucidated using Marfey’s method.16 100 μg of 1 and 7 
was hydrolyzed with 200 μL of 6 M HCl at 110 °C for 20 h. To the hydrolysis product and vials 
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with 2.5 μmol of standard D- and L-amino acids were added 50 μL of water, 20 μL of 1 M NaHCO3 
solution, and 100 μL of 1 % 1-fluoro-2-4-dinitrophenyl-5-L-alanine amide (FDAA) in acetone and 
left at 40 °C for 1 h to react. The reaction mixture was removed from the heat and neutralized with 
10 μL of 2 M HCl, and the solution was diluted with 820 μL of MeOH. See supporting information. 
Structural data 
Homomorphosin A (1): HRMS:  m/z = 438.2754. [M+H]
+
, calculated for [C26H35N3O3+H]
+
: m/z = 
438.2751. Adducts: 460 [M+Na]
+
.         
     = -1.37°. 
Homomorphosin B (2): HRMS:  m/z = 422.2803. [M+H]
+
, calculated for [C26H35N3O2+H]
+
: m/z = 
422.2802. Adducts: 444 [M+Na]
+
.         
     = -0.14°.  
Homomorphosin C (3): HRMS:  m/z = 354.2181. [M+H]
+
, calculated for [C21H27N3O2+H]
+
: m/z = 
354.2176. Adducts: 376 [M+Na]
+
, 707 [2M+H]
+
, 729 [2M+Na]
+
.         
     = -0.15°. 
Homomorphosin D (4): HRMS:  m/z = 424.2599. [M+H]
+
, calculated for [C25H33N3O3+H]
+
: m/z = 
424.2595. Adducts: 446 [M+Na]
+
, 869 [2M+Na]
+
.         
     = -0.55°.  
Homomorphosin E (5): HRMS:  m/z = 410.2446. [M+H]
+
, calculated for [C24H31N3O3+H]
+
: m/z = 
410.2438. Adducts: 432 [M+Na]
+
, 841 [2M+Na]
+
.         
     = -0.66°. 
Homomorphosin F (6): HRMS:  m/z = 370.2128. [M+H]
+
, calculated for [C20H19N3O2+H]
+
: m/z = 
370.2125. Adducts: none.         
     = -0.01°.  
L-valyl-L-tryptophan anhydride (7): HRMS:  m/z = 286.1548. [M+H]
+
, calculated for 
[C16H19N3O2+H]
+
: m/z = 286.1550. Adducts: 308 [M+Na]
+
, 571 [2M+H]
+
, 593 [2M+Na]
+
.          
     
= -0.14°. 
1
H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.50 ppm):  δ 10.82 (s, 1H), 7.95 (s, 1H), 7.85 (s, 1H), 
7.58 (d, J = 7.8 Hz, 1H), 7.27 (d, J = 8.1 Hz, 1H), 7.06 (d, J = 2.1 Hz, 1H), 7.00 (t, J = 7.5 Hz, 1H), 
6.92 (t, J = 7.4 Hz, 1H), 4.12 (t, J = 4.4 Hz, 1H), 3.47 (dd, J = 3.6, 2.1, 1.6 Hz, 1H), 3.19 (dd, J = 
14.4, 5.0 Hz, 1H), 3.06 (dd, J = 14.4, 4.5 Hz, 1H), 1.63 (sept-d, J = 6.9, 4.0 Hz, 1H), 0.59 (d, J = 7.0 
Hz, 1H), 0.17 (d, J = 6.8 Hz, 1H).  
13
C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): δ 166.8, 166.2, 135.5, 127.8, 124.2, 120.4, 
118.6, 118.0, 110.8, 108.5, 59, 54.9, 30.7, 28.4, 28.4, 18, 15.8. 
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4-Methoxy-6-(4-phenyl-1,3-butadienyl)-2H-pyran-2-one (8): HRMS:  m/z = 255.1018. [M+H]
+
, 
calculated for [C16H14O3+H]
+
: m/z = 255.1016. Adducts: 277 [M+Na]
+
, 531 [2M+Na]
+
.  
1
H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.50 ppm):  δ 7.55 (d, J = 7.4 Hz, 2H), 7.38 (t, J = 7.5 Hz, 
2H), 7.30 (t, J = 7.3 Hz, 1H), 7.13 (mult, 2H), 7.01 (d, J = 14.8 Hz, 1H), 6.44 (d, J = 14.6 Hz, 1H), 
6.31 (d, J = 2.1 Hz, 1H), 5.63 (d, J = 2.1 Hz, 1H), 3.83 (s, 3H). 
13
C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): 170.7, 162.3, 157.7, 137.4, 136.1, 134.0, 
128.5, 128.3, 127.2, 126.6, 122.5, 100.8, 88.3, 56.1 
3-Methyl-4-Methoxy-6-(4-phenyl-1,3-butadienyl)-2H-pyran-2-one (9): HRMS:  m/z = 269.1171. 
[M+H]
+
, calculated for [C17H16O3+H]
+
: m/z = 269.1172. Adducts: 291 [M+Na]
+
, 559 [2M+Na]
+
. 
1
H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.50 ppm):  δ 7.56 (d, J = 7.4 Hz, 2H), 7.38 (t, J = 7.6 Hz, 
2H), 7.30 (t, J = 7.3 Hz, 1H), 7.15 (mult, 2H), 7.00 (d, J = 14.6 Hz, 1H), 6.72 (s, 1H), 6.46 (d, J = 
14.5 Hz, 1H), 3.92 (s, 3H), 1.82 (s, 3H). 
13
C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): 165.9 , 163.3, 156.7, 137.4, 136.4, 
134.5, 128.8, 128.5, 127.4, 126.9, 123.0, 100.8, 96.9, 56.6, 8.8 
Q-20547-E (10): HRMS:  m/z = 645.2821. [M+H]
+
, calculated for [C37H36N6O5+H]
+
: m/z = 
645.2820. Adducts: 667 [M+Na]
+
.          
     = -0.86°.  
1
H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.50 ppm):  8.91 (1H, s), 8.05 (1H, s),  7.96 (1H, s), 7.73 
(1H, m), 7.54 (1H, m), 7.27 (1H, m), 7.24b (1H, m), 7.24a (1H, m), 7.21 (1H, m), 7.18 (1H, m), 
7.15b (1H, m), 7.15a (1H, m), 7.07 (1H, m), 6.93 (1H, m), 6.70 (1H, s), 6.50 (1H, m), 6.47 (1H, m), 
5.97 (1H,  s), 5.09 (1H, s), 4.35 (1H, t,  4.6), 3.94 (1H,  s), 3.80 (1H, m), 3.78 (1H, m), 3.08 (1H, 
m), 2.97 (1H, m), 2.73 (1H, m), 2.67 (1H, m), 2.32 (1H, m), 2.25 (1H, m), 2.03 (1H,  t,  12.0), 0.92 
(3H, d,  6.0), 0.73 (3H, d,  6.4). 
13
C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): 167.8 (2C), 165.8, 164.7, 161.9, 150.6, 141.0, 
137.0, 131.2, 130.4, 129.3, 129.1, 129.0, 128, 126.6, 126.3 (2C), 124.7, 124.5, 123.9, 117.6, 115.6, 
108.7, 76.7, 76.6, 59.3, 58.5, 57.7, 57.4, 57.2, 55.1, 36.3, 35.9, 35, 28.7, 18, 16.3 
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Spectra of homomorphosin A 
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gHSQC 
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ROESY (150 ms)
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Marfey’s reagents 
 
Figure S1 The retention times of the FDAA derivatives compared with retention times of the standard amino acid 
derivatives.UV data 
 
UV data 
 1, 2, 3 and 9 probably share a similar chromophore. This is different than the chromophore of 4, 5 
and 6 which corresponds to the absorption of an indole ring.  
        
Figure S2 UV data of the homomorphosins 
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Stereochemistry of homomorphosin A 
 
Figure S3 Numbering of homomorphosin A 
Table S1. Distances of homomorphosin A from ISPA in Å. a: used as reference. 
Nucleus 
1 
Nucleus 
2 
Calculated 
distance 
Lower 
bound 
Violation Upper 
bound 
Violation 
16 17 2.94 3.33 0.39 4.07  
16 1 2.72 2.46  3.00  
8 7 2.48
a
 2.23  2.73  
5 21 2.88 4.18 1.3 5.11  
5 23 2.47 2.10  2.56  
9 25a 2.78 2.70  3.30  
9 26 2.79 2.71  3.31  
9 28/29 3.67 3.32  4.05  
30 23 2.29 2.38 0.09 2.91  
30 13a 2.84 1.92  2.35 0.49 
30 25b 2.8 2.89 0.08 3.53  
26 28/29 2.46 2.15  2.63  
22b 23 2.26 2.07  2.53  
21 23 2.3 2.26  2.77  
21 13a 2.87 2.44  2.98  
21 30 2.77 2.96 0.19 3.62  
22b 18 3.92 3.69  4.51  
1 18 2.85 3.17 0.32 3.88  
1 19 2.29 2.25  2.75  
1 17 2.25 2.27 0.02 2.77  
25b 28/29 2.59 2.46  3.00  
25b 13b 2.18 1.88  2.30  
14 1 2.53 2.20  2.69  
17 18 2.34 2.08  2.54  
17 19 2.29 2.07  2.53  
5 7 2.61 2.39  2.92  
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Table S2 Coupling J-constants in Hz for homomorphosin A. 
Nucleus 
1 
Nucleus 
2 
Theoretical Measured Diff 
13b 14 8.0 7.3 0.7 
1 17a 2.3 2.0 0.3 
13a 14 10.3 11.5 1.2 
 
When averaging over the 364 structures from a conformational search, and only taking the 
structures into account which leads to increased fit iteratively over 10,000 steps, the errors are all 
but eliminated as seen below. This serves to show that the errors seen for a single structure is 
probably due to flexibility and subsequent conformational averaging. 
 
Figure S4 Superposition of the ten structures which give the lowest averaged error 
Table S3 Average distances for homomorphosin A from ISPA in Å. a: used as reference. 
Nucleus 
1 
Nucleus 
2 
Calculated 
distance 
Averaged 
distance 
Diff (Å) Diff (%) 
16 17 2.94 2.94 0.00 0.00 
16 1 2.72 2.72 0.00 0.04 
8 7 2.48
a
 2.48 0.00 0.00 
5 21 2.88 2.88 0.00 0.00 
5 23 2.44 2.48 0.04 1.52 
9 25a 2.78 2.78 0.00 0.00 
9 26 2.92 2.79 0.13 4.49 
9 28/29 3.67 3.67 0.00 0.00 
30 23 2.41 2.29 0.12 4.86 
PhD Thesis 
Lene Maj Petersen
203
24 
 
30 131 2.84 2.84 0.00 0.01 
30 252 2.95 2.81 0.14 4.74 
26 28/29 2.39 2.46 0.07 3.12 
22b 23 2.28 2.26 0.02 0.84 
21 23 2.47 2.30 0.17 7.02 
21 13a 2.87 2.87 0.00 0.00 
21 30 2.80 2.77 0.03 0.96 
22b 18 4.30 3.92 0.38 8.75 
1 18 3.05 2.85 0.20 6.61 
1 19 2.58 2.30 0.29 11.05 
1 17 2.53 2.25 0.28 11.02 
252 28/29 2.59 2.59 0.00 0.00 
25b 13b 2.26 2.18 0.08 3.59 
14 1 2.46 2.53 0.07 2.96 
17 18 2.30 2.34 0.04 1.60 
17 19 2.30 2.29 0.01 0.48 
5 7 2.66 2.61 0.05 1.89 
 
Table S4 Average J-coupling constants in Hz for homomorphosin A. 
Nucleus 
1 
Nucleus 
2 
Theoretical Measured Diff 
13b 14 8.1 7.3 0.8 
1 17 2.2 2.0 0.2 
13a 14 10.3 11.5 1.2 
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Formation of Sclerotia and Production of Indoloterpenes
by Aspergillus niger and Other Species in Section Nigri
Jens C. Frisvad*, Lene M. Petersen, E. Kirstine Lyhne, Thomas O. Larsen
Chemodiversity Group, Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark
Abstract
Several species in Aspergillus section Nigri have been reported to produce sclerotia on well-known growth media, such as
Czapek yeast autolysate (CYA) agar, with sclerotia considered to be an important prerequisite for sexual development.
However Aspergillus niger sensu stricto has not been reported to produce sclerotia, and is thought to be a purely asexual
organism. Here we report, for the first time, the production of sclerotia by certain strains of Aspergillus niger when grown on
CYA agar with raisins, or on other fruits or on rice. Up to 11 apolar indoloterpenes of the aflavinine type were detected by
liquid chromatography and diode array and mass spectrometric detection where sclerotia were formed, including 10,23-
dihydro-24,25-dehydroaflavinine. Sclerotium induction can thus be a way of inducing the production of new secondary
metabolites from previously silent gene clusters. Cultivation of other species of the black aspergilli showed that raisins
induced sclerotium formation by A. brasiliensis, A. floridensis A. ibericus, A. luchuensis, A. neoniger, A. trinidadensis and A.
saccharolyticus for the first time.
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Introduction
Certain strains in several species of Aspergillus section Nigri
have been reported to produce sclerotia, notably Aspergillus
sclerotioniger, A. carbonarius, A. tubingensis, A. sclerotiicarbo-
narius, A. costaricaensis, A. ellipticus, A. japonicus, A. piperis, A.
aculeatus, A. aculeatinus, A. brunneoviolaceus and A. violaceo-
fuscus [1–9]. Some species were originally described as producers
of sclerotia, for example A. heteromorphus [10]. However Al-
Musallam [3] could not induce sclerotium production in this
species, despite several attempts. A. indologenus (as A. aculeatus
CBS 114.80) was reported as a producer of abundant sclerotia [3],
but Samson et al. [6] did not observe sclerotia in that strain.
Concerning Aspergillus niger, only a few strains have been
reported to produce sclerotia, WB 346 [1,11–12], WB 5121 = CBS
553.65 [1], CBS 425.65 [3] and WB 4700 [13]. However these
strains represent other species than Aspergillus niger sensu stricto,
for example CBS 553.65 was allocated to Aspergillus costarican-
esis by Samson et al. [6] and WB 346 is representative of
Sterigmatocystis fusca Bain., now regarded as Aspergillus
carbonarius [3], CBS 425.65 is an A. tubingensis [14] and WB
4700 is also an A. tubingensis [13]. Sclerotium-producing strains
from Tu¨bingen and other German cities, identified as A. niger
[15], are probably also A. tubingensis.
Genome sequencing projects [16,17,18] have shown the
presence of predicted secondary metabolite gene clusters with no
known expression and some of these could code for strictly
sclerotium-associated metabolites such as aflavininins, aflavarins
and aflatrems in Aspergillus flavus sclerotia [19] Sclerotium-
producing strains in section Nigri that have been examined
produced many sclerotium-borne secondary metabolites. Aspergillus
tubingensis NRRL 4700 was reported to produce tubingensin A &
B, dihydrotubingensis A & B, 14-epi-14-hydroxy-10,23-dihydro-
24,25-dehydroaflavinine, 10,23-dihydro-24,25-dehydroaflavinine
and 10,23-dihydro-24,25-dehydro-21-oxo-aflavinine [20–23]. In
order to induce sclerotium production in Aspergillus carbonarius,
Raper and Fennell [1] stated that steep agar, Czapek agar
containing corn steep liquor, was a most suitable medium. Indeed
A. carbonarius produced large amounts of sclerotia containing
ochratoxin A on corn kernels [24]. Al-Musallam [3] reported that
A. tubingensis CBS 425.65 produced sclerotia only when grown on
French beans, while A. tubingensis WB 4700 produces sclerotia
freely on most media [1,13]. This shows that sclerotium
production may be strain-specific, but can be induced by plants
parts such as beans, corn kernels in those isolates that do not
produce them on standard identification media such as those
based on Czapek, malt extract or oat meal.
Sclerotial development is considered to be an important
prerequisite for sexual development in Aspergillus section Circumdati,
and sclerotia might also have a role in dormancy [25]. Since a
sexual state has been found in species in closely related sections of
Aspergillus, i.e. in A. flavus, A. parasiticus and A. nomius in Aspergillus
section Flavi [26–28] and A. muricatus [29] in Aspergillus section
Circumdati [30] the ability to induce sclerotium production could be
a first step towards finding a perfect state in Aspergillus niger.
Rajendran and Muthappa [2] showed that Aspergillus japonicus has a
perfect state and is a homothallic species with cleistothecia formed
in one or two cavities (loculi) in sclerotia. This species was named
Saitoa japonica. Later A. sclerotiicarbonarius [31] and A. tubingensis [32]
were found to be heterothallic. These species also produced
cleistothecia within one or two loculi within the sclerotia [31–32].
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Some strains from section Nigri produce sclerotia on commonly
used media, so Horn et al. [32] were able to induce the perfect
state in Aspergillus tubingensis after determining the mating types of
sclerotial strains and cross them on mixed cereal medium. A. niger
is closely related to A. tubingensis and is probably also heterothallic,
but the lack of sclerotia in A. niger hinders the test of whether a
perfect state can be induced in this important industrial species
[33]. A. niger is a very common spoilage organism on grapes, dried
fruits, peanuts, maize, coffee and many other plants, so we wanted
to test whether any of these fruits could induce sclerotium
production in A. niger and other species in Aspergillus section Nigri.
We also hypothesized that by inducing sclerotium production we
could activate silent gene clusters for fungal indolo-terpenes, and
thereby find new secondary metabolites in these fungi.
Even though many secondary metabolites have been reported
from Aspergillus niger, this species has never been reported to
produce aflavinin related indoloterpenes [34]. It is known,
however, that sclerotium production may be associated with
increased ochratoxin A production, at least in A. carbonarius [24],
and other sclerotium producing species such as A. sclerotioniger also
produce ochratoxin A [5-6,8]. The species in the A. carbonarius
clade have been reported to only produce ochratoxin A, and no
aflavinines, whereas A. tubingensis and A. costaricaensis produce
aflavinins in the sclerotia [6,22] and no ochratoxins. If A. niger
produces sclerotia when induced by different fruits and other plant
parts they may also produce increased amounts of ochratoxin A,
which would have important consequences for food safety.
Possible sclerotium production by A. niger and other black
Aspergilli would have many biological, biotechnological and food
safety consequences [33,35–42]. One paper has indicated that A.
niger might be able to produce sclerotia, as it was found that certain
poorly sporulating UV mutants of A. niger produced sclerotium-like
structures [43]. We wanted to test our hypothesis that natural
substrates for fungi might induce sclerotium production and
thereby confirm that previously identified ‘‘silent’’ gene clusters do
indeed have a functional role in A. niger and other species in section
Nigri.
Materials and Methods
Media and fungi
Representatives of all species in Aspergillus section Nigri were
selected with an emphasis on isolates from plants substrates, and
identified to species level using a polyphasic approach [5–
6,8,14,44–45]. A series of strains of Aspergillus niger sensu stricto
and A. tubingensis from raisins were isolated from the medium
DG18 (dichloran glycerol 18% agar) [46] on which raisins from
different countries have been plated out [36]. All black aspergilli
were isolated, and pure cultures were identified and accessioned in
the IBT collection (Collection of fungal strains at the Department
of Systems Biology, Technical University of Denmark, Lyngby,
Denmark). Aspergillus section Nigri strains from other collections
were also tested (Table 1 and 2). All strains were 3-point
inoculated on the media Czapek yeast autolysate agar (CYA),
CYA with three autoclaved black raisins (CYAR) (or other plant
parts). During identification the strains were also inoculated on
malt extract agar according to Blakeslee (MEA), yeast extract
sucrose (YES) agar, creatine-sucrose (CREA) agar, oat-meal agar
(OA), and some isolates were also inoculated on Wickerhams
antibiotic test medium (WATM), and potato dextrose agar (PDA).
All media were poured in 11 cm plastic Petri dishes, inoculated
and incubated at 25uC for 7 days in darkness [47–48].
In the first experiments A. niger IBT 29019 and IBT 24631
produced sclerotia on CYA agar with scattered whole raisins. The
black conidia used for inoculation were taken directly from silica
gel tubes. However when conidia from colonies grown on CYA for
a week at 25uC were used for inoculation, the isolates lost the
ability to produce sclerotia on CYA with raisins. Since some raisins
are treated with sunflower oil, CYA with 1% sunflower oil was also
prepared. To possibly enhance sclerotium production in A. niger
CYA agar was added 1 mL of biotin solution giving a final
concentration of 6.4 mg biotin/L medium and raisins added as
biotin induced ascoma formation in Penicillium rubens [49–50]. The
A. niger strains IBT 29019, 24631 and 24634 were also inoculated
on 40% and 50% white and brown rice (in water) in 200 ml
Erlenmeyer flasks, on 50% corn kernels, and on 4% and 40%
macerated mango or papaya in water with 2% agar added. Since
the sunflower oil or biotin treatments did not induce sclerotium
formation, experiments were done to compare non-frozen and
frozen inoculum in the three strains of Aspergillus niger, as freezing of
the inoculum had earlier been shown to enhance sclerotium
formation in A. aculeatus IBT 21030. This freezing-step consistently
helped inducing sclerotium production in A. niger IBT 29019 and
IBT 24631. The black aspergilli tested were therefore pretreated
by placing CYA agar slants in Eppendorf tubes with sporulating
fungal strains (6 mm agar plugs, one week old) in a 218uC freezer
for at least 3 weeks before inoculation on the Petri plates with and
without raisins or other plant parts. In the first series of
experiments A. niger IBT 29019, IBT 24631 and IBT 24634 were
tested on a series of different substrates: CYA agar with and
without raisins (of different kinds), dried mulberry, dried blueber-
ry, dried cranberry, dried goji berry, dried apricot, dried prune,
mango peel, papaya peel, dried green coffee beans, and dried
kidney beans, all organically grown (Table S1 in File S1). All
substrates were autoclaved for 20 min at 121uC. In the second
series of experiments many strains of A. niger and A. welwitchiae were
tested for sclerotium production in addition to representatives of
all other known species in Aspergillus section Nigri.
Plug extraction
For standard screening three plugs were taken from one colony,
by use of a 6 mm steel plug drill, close to the center of the colony,
beside the raisin or other fruit, if added. If any sclerotia could be
observed, the agar plugs were taken to include the sclerotia. For
comparison between sclerotial extracts and agar colony extracts
five plugs were taken from one colony, covering the diameter of
the colony (only when HPLC-MS analysis was intended). The
plugs were transferred to 2 mL vials and 750 mL methanol:
dichloromethane: ethyl acetate (1:2:3 v/v/v) containing 1% formic
acid was added. For HPLC-MS analysis each sample was added
40 mL chloramphenicol in ethanol (500 mg/mL) as an internal
standard. The vials were placed in an ultrasonic bath (Branson
3210) for 60 minutes. The extracts were then transferred to clean
vials and evaporated to dryness. This was either achieved by
leaving the vials in a fume hood over night or by applying nitrogen
airflow at 25–32uC. After evaporation, 500 mL MeOH was added
and the samples were then ultrasonicated for 20 minutes to re-
dissolve the fungal metabolites. The extracts were then filtered
using a 0.45 mm polytetrafluoroethene (PTFE) filter into clean
vials [51].
Sclerotium extraction
The fungi were three-point inoculated on solid CYA plates with
biotin and raisins and incubated at 25uC for 7 days in the dark.
Sclerotia were harvested by applying pure H2O to the plate and
carefully harvested with a Drigalski spatula. The liquid including
the sclerotia and spores was filtered through sterile Miracloth and
washed with pure water and ethanol. This allowed for spores to
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pass through, while sclerotia stayed in the filter. Sclerotia were
transferred to Eppendorf tubes and washed with water to remove
remaining spores. After evaporation of excess H2O, two big (diam.
4 mm) and two small steel balls (diam. 2 mm) were added to each
tube. The tubes were cooled with liquid nitrogen and shaken using
a frequency of 2000/min for 2660 seconds in a sonic Micro
Dismembrator U homogenizer (Sartorius). The tubes were then
heated to 30uC and shaken again for 2660 second. To each tube
40 mL chloramphenicol and 0.750 mL methanol: dichlormethane:
ethyl acetate (1:2:3 v/v/v) containing 1% formic acid was added
and the extracts were transferred to clean 2 mL vials. The samples
were ultrasonicated (Branson 3210 sonicator) for 1 h and the
extracts were then transferred to clean vials and the solvent was
evaporated. The samples were re-dissolved in 500 mL MeOH,
Table 1. Production, or not, of sclerotia by Aspergillus niger strain IBT 29019, IBT 24631, and IBT 24634, and production of apolar
indoloterpenes on Czapek yeast autolysate agar with or without added plant parts.
CYA + additional
fruit/cereal grain
Aspergillus
niger strain
Sclerotia
produced
10,23-dihydro-24,25-
dehydroaflavinine produced
Number of apolar indoloterpenes detected
by liquid chromatography diode array
detection (LC-DAD)
None IBT 29019 -* - 0/0
None IBT 24631 - - 0/0
None IBT 24634 - - 0/0
Raisin (CYAR) IBT 29019 ++* + 2/2/2/4**
Raisin (CYAR) IBT 24631 +* + 1/1/1/2**
Raisin (CYAR) IBT 24634 - - 0/0
Mulberry IBT 29019 ++ + 2
Mulberry IBT 24631 - - 0
Mulberry IBT 24634 - - 0
Blueberry IBT 29019 ++ + 2/3
Blueberry IBT 24631 - - 0
Blueberry IBT 24634 - - 0
Cranberry IBT 29019 ++ + 2/7
Cranberry IBT 24631 - - 0
Cranberry IBT 24634 - - 0
Goji berry IBT 29019, 24631, 24634 - - 0
Apricot IBT 29109 ++ + 2/7
Apricot IBT 24631 2/+*** + 0/1
Apricot IBT 24634 - - 0/0
Prune IBT 29019 ++ + 2/3
Prune IBT 24631 2/+*** + 0/1
Prune IBT 24634 - - 0/0
Mango, 40% IBT 29019 ++ + 3/5
Mango, 40% IBT 24631, 24634 - - 0/0
Mango peel IBT 29019 ++ + 2
Papaya, 40% & 4% IBT 29019 - - 0/0
Corn IBT 29019 - - 0
Corn IBT 24631 + + 1
Corn IBT 24634 - - 0
White rice, 50% IBT 29019 ++ + 11/12
White rice, 50% IBT 24631 + + 2
White rice, 50% or 40% IBT 24634 - - 0
Brown rice, 50% IBT 29019 ++ + 13/13
Brown rice, 40% IBT 29019 + + 2/1
Brown rice, 50% IBT 24631 + + 1
Brown rice, 50% IBT 24634 - - 0
*-: no sclerotia produced, +: few scattered sclerotia, ++: many sclerotia (.10) surrounding each piece of fruit, or directly on the rice or corn.
**More indoloterpenes were detected using mass spectrometric detection than diode array detection in this case where both methods were compared. In IBT 29019 on
CYAR, 4 recognizable indoloterpenes were detected using LC-mass spectrometric detection (in bold), but only two according to DAD.
***2/+: sclerotia not produced in one experiment, but produced in the other
The conidia were frozen at 218uC for three weeks before inoculation.
doi:10.1371/journal.pone.0094857.t001
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Table 2. Aspergillus section Nigri: Production of sclerotia on CYA agar or CYA with raisins (most sclerotia were formed around the
raisins on the agar surface, and few sclerotia if any on the raisins themselves, see footnotes).
Species Isolates
Sclerotia on
CYAR
Sclerotia
on CYA
Predominantly sclerotial apolar
metabolites and/or ochratoxin A
A. aculeatinus CBS 121875 = IBT 29118, IBT
30576
++* - Indoloterpenes produced
A. aculeatus IBT 21030, IBT 13519, IBT
32735 = IMI 240698**
++/+++* -, ++ in sectors
for IBT 21030,
+++ for IMI
240698
10,23-dihydro-24,25-dehydroaflavinine, an
okaramine, paspa***
A. brasiliensis IBT 28177 ++ - 10,23-dihydro-24,25-dehydroaflavinine and 4
other aflavinins No apolar sclerotial
metabolites detected in other strains
A. brunneoviolaceus (A. fijiensis) IBT 13989 =CBS 313.89 ++ ++ Paspa
A. carbonarius IBT 21089 =NRRL 369, WB
346, IBT 31277, IBT 29172
= IBT 4916 = CBS 117.49
(on mango)
+* - Ochratoxin A
A. costaricaensis IBT 23401 =CBS 115574=
ITEM 7555
+++ + 10,23-dihydro-24,25-dehydroaflavinine,
aspernomine,12 other aflavinines
A. ellipticus ( =A. helicothrix) IBT 29172 =CBS 707.79, IBT
13963 =CBS 677.79
+ - No apolar sclerotial metabolites detected
A. eucalypticola IBT 29274 =CBS 122172 - - No apolar sclerotial metabolites detected
A. floridensis IBT 32546 =NRRL 62478 ++ - 10,23-dihydro-24,25-dehydroaflavinine
A. heteromorphus IBT 13691 =CBS 117.55, IBT
14352 =CBS 312.89
+**** - No apolar sclerotial metabolites detected
A. homomorphus IBT 21893 =CBS 101889 - - No apolar sclerotial metabolites detected,
several apolar unique extrolites are present
A. ibericus IBT 26612 =CBS 121593 + - An aflavinine
A. indologenus CBS 114.80 = IBT 3679 2/(+)***** - Mid-polar indoloterpenes indicate that
sclerotia could be produced
A. japonicus IBT 5718 =CBS 114.51 - - No apolar sclerotial metabolites detected
A. lacticoffeatus IBT 22031 =CBS 101803 - - No apolar sclerotial metabolites
A. luchuensis (A. acidus) IBT 24821, IBT 24825, CBS
553.65 = IBT 28612
+ - 10,23-dihydro-24,25-dehydroaflavinine, 3 other
aflavinins
A. neoniger IBT 30603, IBT 20973 ++ - 10,23-dihydro-24,25-dehydroaflavinine,
aspernomine, 10 other aflavinin
A. niger (the majority of strains
did not produce sclerotia, see
Table S2 in File S1)
IBT 24631 =CBS 133816,
IBT 26389 =NRRL 599, IBT
28998, IBT 28999, IBT 29000,
IBT 29001, IBT 29003, IBT
29005, IBT 29006, IBT 29007,
IBT 29019 =CBS 133818, IBT
29020
++/+ - 10,23-dihydro-24,25-dehydroaflavinine, 5 other
aflavinins
A. piperis IBT 24630 =CBS 112811 +++ +++ 10,23-dihydro-24,25-dehydroaflavinine, 11
other aflavinins
A. sclerotiicarbonarius IBT 28362 =CBS 121057 ++/+++ ++/+++ Paspa (3 different)
A. saccharolyticus IBT 30881, IBT 28231 ++ - Paspa (one)
A. sclerotioniger IBT 22905 +++ +++ Ochratoxin A
A. trinidadensis IBT 32570 =NRRL 62480 ++ - Paspa (one)
A. tubingensis (the majority of
strains did not produce sclerotia,
see Table S2 in File S1)
IBT 23488 = IBT 16833 = CBS
161.79 =NRRL 4700, IBT 20950,
IBT 29022, IBT 29557 =CBS
122.35X, CBS 425.65, IBT 29022,
IBT 31740
++/for NRRL
4700 +++
2, +++ for
NRRL 4700
14-epi-14-hydroxy-10,23-dihydro-24,25-
dehydroaflavinine, 10,23-dihydro-24,25-
dehydroaflavinine, 10,23-dihydro-24,25-
dehydro-21-oxo-aflavinine, tubingensin A & B,
dehydrotubingensin A & B, aspernomine, 20
other aflavinines
A. uvarum IBT 26606 =CBS 121591 - - No apolar sclerotial metabolites detected
A. vadensis CBS 113365 =CBS 102787=
IBT 24658
- - No apolar sclerotial metabolites detected
A. violaceofuscus CBS 115571 = IBT 14708 ++ + Mid-polar sclerotial metabolites detected
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ultrasonicated for 20 minutes and filtered into fresh vials using
0.45 mm PTFE filters.
UHPLC-DAD analysis
The analyses of the 3 plug extracts were performed using Ultra
High Performance Liquid Chromatography-diode array detection
(UHPLC-DAD) as described by Frisvad and Thrane [52] as
modified by Houbraken et al. [53]. UV spectra were recorded
from 190 to 700 nm. For florescence detection, the excitation
wavelength was 230 nm and the emission wavelength was
333 nm. This allows for a sensitive detection of extrolites with
an indole chromophore, including aflavinins.
UHPLC-DAD-HRMS analysis
The analyses were performed using a Ultra High Performance
Liquid Chromatograpy-UV/Vis-High Resolution Mass Spectrom-
eter (UHPLC-DAD-HRMS) on a maXis G3 oa Qq-TOF mass
spectrometer (Bruker Daltonics, Bremen, Germany) equipped with
an electrospray (ESI) source and connected to an Ultimate 3000
UHPLC system (Dionex, Sunnyvale, CA). The column used was a
reverse-phase Kinetex 2.6 mm C18, 10062.1 mm (Phenomenex,
Torrance, CA) and the column temperature was maintained at
40uC. A linear water-acetonitrile gradient was used (both buffered
with 20 mM formic acid) starting from 10% acetonitrile and
increased to 100% in 10 minutes and maintaining this for 3
minutes before returning to the starting conditions in 0.1 minute
and staying there for 2.4 minutes before the following run. A flow
rate of 0.4 mL min21 was used. HRMS was performed in ESI+
with a data acquisition range of 10 scans per second at m/z 100–
1000. The MS was calibrated by use of the internal standard
sodium formate, which was automatically infused prior to each
run. UV spectra were collected at wavelengths from 200–700 nm.
Data processing was performed using the Bruker software
DataAnalysis and TargetAnalysis.
Results
Aspergillus niger and sclerotia
No strains of Aspergillus niger sensu stricto, tested in this study or in
our earlier studies, produced sclerotia on any of the conventional
media tested. The closely related sibling phylospecies A. welwitchiae
[54], formerly called A. awamori [54–55] also did not produce
sclerotia on any medium. Initially A. niger IBT 29019 and IBT
24631 produced sclerotia on a medium made with dark
Californian raisins added to the medium. Interestingly sclerotia
were only formed on CYA medium with whole raisins, and not on
the same medium with macerated raisins. It was decided to add
Table 2. Cont.
Species Isolates
Sclerotia on
CYAR
Sclerotia
on CYA
Predominantly sclerotial apolar
metabolites and/or ochratoxin A
A. welwitchiae (‘‘A. awamori’’),
(further strains were tested, none
produced sclerotia, see Table S2
in File S1)
CBS 139.54 - - No apolar sclerotial metabolites detected
*-: no sclerotia formed, +: Few scattered sclerotia (,10), ++: Several (.10) sclerotia surrounding the raisins, +++: numerous sclerotia formed all over the medium, both
with and without raisins.
**Homothallic sexual state reported [2], this strain readily produced abundant sclerotia, both with and without raisins.
***Paspa is probably an indoloterpene with a paspalinine chromophore.
****In this species, sclerotia were only produced on the raisins, not on the medium.
*****Abundant sclerotia reported by Musallam [3].
Isolates not producing sclerotia in A. brasiliensis, A. niger, and A. welwitschiae and are listed in Table S2 in File S1. The conidia were frozen at 218uC for three weeks
before inoculation.
doi:10.1371/journal.pone.0094857.t002
Figure 1. Numerous cream-coloured sclerotia produced on
CYAR agar can be seen surrounding the raisins and the usual
heavy sporulation caused by black Aspergillus niger IBT 29019
heads. The ellipses added show the position of the raisins, which are
covered with black aspergilla.
doi:10.1371/journal.pone.0094857.g001
Figure 2. Approximately 41 white sclerotia can be observed on
a close-up of Aspergillus niger IBT 29019 growing on Czapek
yeast autolysate agar with raisins. Note the clear or brown exudate
droplets associated with most sclerotia.
doi:10.1371/journal.pone.0094857.g002
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three whole sterilized pieces of raisin on top of the CYA medium
(CYAR), and the experiments were repeated with several brands
of raisins from California, Turkey, Chile and Argentina (Table S1
in File S1). IBT 29019 and IBT 24631 produced sclerotia
surrounding all organic and conventional dark raisins tested, but
not white raisins (the latter had been treated with sulfur dioxide),
and did not produce sclerotia on the control CYA agar medium.
The sclerotia formed in A. niger (Fig. 1 and 2) were similar to those
produced by Aspergillus carbonarius and A. tubingensis, i.e. large
cream-coloured sclerotia, which were globose to ovoid and 500–
700 mm in diameter. The strain A. niger IBT 24634 did not
produce sclerotia under any conditions. The experiments using
CYA agar with raisins were repeated several times and in nearly
all cases sclerotia were formed. In few experiments sclerotia were
not produced on CYA agar with whole raisins by IBT 29019, and
in those cases sclerotium production could then be induced by
keeping the conidia used for inoculation (conidia on agar plugs
from a colony) of the media in a freezer at218uC for at least three
weeks. When this freezing step was done, sclerotium production
was entirely consistent in IBT 29109 and IBT 24631.
A set of three isolates of Aspergillus niger (IBT 29019, IBT 24631
and IBT 24634) were first tested on the medium CYA and CYA
with different pieces of whole fruits added or inoculated on whole
rice (Table 1). Certain fruits stimulated sclerotium production in
IBT 29019, including raisin, mulberry, blueberry, cranberry,
apricot, prune, and mango peel, all placed on CYA agar, but also
on 40% mango macerate in agar, and 50% white rice or 50%
brown rice (rice media without added agar). Sclerotia were not
formed on media with goji berries, green coffee beans, red kidney
beans, black pepper, 4% or 40% papaya macerate in agar, 4%
mango macerate in agar or on any of the media CYA, malt extract
agar (MEA), yeast extract sucrose (YES) agar, oatmeal agar
(OAT), potato dextrose agar (PDA), or Wickerhams antibiotic test
medium (WATM). However regarding the latter 5 media, conidia
were not frozen before inoculation, so it cannot be excluded that
these media may be inducing sclerotium production if inoculated
after a freeze treatment. The strain A. niger IBT 24631 only
produced sclerotia on some of the media: CYA agar with raisins
(CYAR), in some cases on CYA with prune or apricot, and on
whole white or brown rice (50%). Furthermore in one case
sclerotium production was seen on whole corn (50%, no agar
added) in A. niger IBT 24631 but not in IBT 29019. Neither strain
produced sclerotia on whole unpolished rice, polished rice, dried
whole corn or dried kidney beans, except for the single incidences
mentioned above. If produced, sclerotia were observable after 7
days of incubation, and only rarely were additional sclerotia
produced after 7 days. All sclerotia produced were cream-white
first, and darkening becoming beige to steel grey in age.
Strains of Aspergillus niger producing sclerotia and
sclerotial indoloterpenes
In all cases the presence of sclerotia in Aspergillus niger was
confirmed chemically by the presence of sclerotium associated
aflavinin-type apolar indoloterpenes. Consistently, indoloterpenes
of the 10,23-dihydro-24,25-dehydroaflavinine type were produced
in all sclerotium containing media, but indoloterpenes were not
produced in any cases on media where sclerotia were not present
(Table 1). Two major indoloterpenes were produced by the strains
of A. niger IBT 29019, and one major indoloterpene was produced
by A. niger IBT 24631 as determined by both diode array and
fluorescence detection. The total number of indoloterpenes ranged
from one to 13, with highest numbers of indoloterpernes produced
on brown rice (Table 2). Most of the indoloterpenes produced had
an ordinary indol chromophore, but there were also apolar
sclerotial metabolites with UV spectra not seen earlier, indicating
that some of these had a somewhat modified chromophore but still
quite similar to the normal indol chromophore. Aspergillus niger IBT
29019 produced 10,23-dihydro-24,25-dehydroaflavinine and two
additional aflavinines, in addition to a fourth indoloterpene, which
had the same formula (C28H39NO), UV spectrum and retention
time as anominine (Fig. 3). On brown rice IBT 29019 produced 13
different apolar sclerotial metabolites, but most of them are as yet
not structure elucidated. Anominine was formerly known as
nominine [56].
Ten recently isolated strains isolated from Californian raisins
produced sclerotia on CYAR, including IBT 29019 = CBS
133818, IBT 28998, IBT 28999, IBT 29000, IBT 29001, IBT
29003, IBT 29005, IBT 29006, IBT 29007 and IBT 29020
(Table 1), whereas four strains from the same raisin sample did not
(IBT 29002, IBT 29004, IBT 29021, and IBT 29023) (Table S2 in
File S1). One strain from black pepper, IBT 24631 = CBS 133816
could produce sclerotia on CYAR, while another strain from the
Figure 3. Ultra high performance liquid chromatography time of flight high resolution mass spectrometry electrospray ionization +
base peak (UHPLC-TOF-HRMS ESI+ BP) chromatogram of Aspergillus niger (IBT 29019) extracts. A: Plug extraction from growing and
sporulating culture with no sclerotium production (CYA agar with biotin). B: Plug extraction from growth with sclerotium production (CYAR with
biotin). C: Sclerotium extraction (from CYAR with biotin). 1) Nigragillin, 2) Pyranonigrin A, 3) Fonsecin, 4) Aurasperone/nigerasperone analog, 7)
Tensidol B, 11) Kotanin, 12) Flavasperone analog, 13) Rubrofusarin B, 14) Aflavinine analog, 15) Aflavinine analog, 17) Anominine, 18) 10,23-dihydro-
24,25-dehydroaflavinine.
doi:10.1371/journal.pone.0094857.g003
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same pepper sample, IBT 24634 = CBS 133817, could not. A
number of culture collection strains of A. niger were also tested on
CYAR and only 1 strain, NRRL 599, previously reported to
produce high levels of citric acid formed sclerotia on CYAR, while
other industrial and genome sequenced strains CBS 513.88 and
NRRL 328, the culture ex type of A. niger NRRL 326 and other
strains: CBS 139.52, CBS 119725, NRRL 363, NRRL 593,
NRRL 611, NRRL 612, NRRL 2372, NRRL 3112, and NRRL
4757 did not produce sclerotia on CYAR (Table S2 in File S1).
14 strains of the sibling species of A. niger, A. welwitchiae were also
tested on CYAR, and did not produce sclerotia: CBS 102.12, CBS
618.78, IBT 29098, ITEM 7097, NRRL 320, NRRL 340, NRRL
362, NRRL 372, NRRL 567, NRRL 595, NRRL 604, NRRL
2001, NRRL 4851, and NRRL 6408 (Table S2 in File S1).
All 12 A. niger strains producing sclerotia also produced 1–13
detectable aflavinins or related apolar indoloterpenes, including
10,23-dihydro-24,25-dehydroaflavinine (Table 2), while none of
the non-sclerotium producing strains produced any aflavinin-like
molecules.
In A. niger IBT 29019, sporulating cultures contained known A.
niger extrolites including nigragillin, pyranonigrin A, tensidol B,
kotanin and naphtho-c-pyrones. However in the sclerotia alone,
only aflavinin molecules and an indoloterpene tentatively identi-
fied as anominine were produced, with only traces of nigragillin
(Fig. 3).
Strains of Aspergillus series Nigri producing sclerotia and
sclerotial indoloterpenes
In Aspergillus series Nigri [44], four species did not produce
sclerotia or indoloterpenes under any conditions: A. eucalypticola, A.
lacticoffeatus, A. vadensis and A. welwitchiae. On the other hand A.
costaricaensis and A. piperis produced sclerotia on all media at the
expense of black conidiophores heads and sclerotial metabolites
included 10,23-dihydro-24,25-dehydroaflavinine and 12 to 13
other apolar indoloterpenes. A costaricaensis also produced asper-
nomine [57]. Some strains of A. tubingensis (NRRL 4700) and A.
luchuensis (IBT 24821, IBT 24825) produced sclerotia readily on
CYA agar, while other strains of these two species needed raisins
to induce sclerotium formation. The sclerotia of A. luchuensis
formed readily on CYA tended to aggregate, they were cream
coloured and very large, 800–1300 mm in diameter. The sclerotia
of A. costaricaensis were also very large, from 1200–1800 mm, and
those of A. piperis were yellowish to pinkish brown, 1000–1700 mm
in diameter [5]. The sclerotia in A. tubingensis were the smallest in
this series, 500–800 mm, first cream-coloured, later becoming
pinkish to light brown. While sclerotium producing A. luchuensis
produced 10,23-dihydro-24,25-dehydroaflavinine and 3 other
apolar indoloterpenes, sclerotial A. tubingensis strains produced
10,23-dihydro-24,25-dehydroaflavinine, aspernomine and up to
19 additional apolar indoloterpenes on CYAR. We did not detect
tubingensin A and B [21–22] and dehydrotubingensin A and B
[23] on CYAR, but we have formerly identified these in NRRL
4700 cultures on the media CYA and YES agar. Furthermore 14-
epi-14-hydroxy-10,23-dihydro-24,25-dehydroaflavinine and
10,23-dihydro-24,25-dehydro-21-oxo-aflavinine, earlier detected
in A. tubingensis NRRL 4700 [22] were not detected on CYAR.
This indicates that at least 26 different sclerotial indoloterpenes
can be produced by A. tubingensis. In the conidial areas of A.
tubingensis IBT 16833 ( = NRRL 4700) we detected nigragillin,
asperazine, and naphtho-c-pyrones (Fig. 4). In the sclerotia, and
sclerotial parts of the agar cultures (CYAR) we detected 6
aflavinins by UHPLC-TOF-HRMS and UHPLC-DAD and a
compound tentatively identified as anominine. These indoloter-
penes were not found in cultures with conidial heads only. It
appears that the indoloterpenes and the naphtho-c-pyrone,
aurasperone B, are up-regulated in sclerotial cultures (Fig. 4).
Sclerotia were detected for the first time in A. brasiliensis and A.
neoniger. A. brasiliensis IBT 28177 produced two detectable sclerotial
indoloterpenes, while A. neoniger IBT 30603 and IBT 20973
produced 12 sclerotial apolar indoloterpenes on CYAR, including
10,23-dihydro-24,25-dehydroaflavinine and aspernomine
(Table 2). Aspernomine was tentatively identified for the first time
in A. tubingensis, A. neoniger and A. costaricaensis, based on comparison
with aspernomine in extracts of Aspergillus nomius and an identical
characteristic UV spectrum and retention time in all extracts of
these fungi.
Figure 4. Ultra high performance liquid chromatography time of flight high resolution mass spectrometry electrospray ionization +
base peak (UHPLC-TOF-HRMS ESI+ BP) chromatogram of Aspergillus tubingensis (IBT 16833=CBS 161.79=NRRL 4700) extracts. A:
Plug extraction from colony area with no sclerotia (CYAR with biotin). B: Plug extraction from colony area with sclerotia (CYAR with biotin). C:
Sclerotium extraction (from CYAR with biotin). 1) Nigragillin, 3) Fonsecin, 5) TMC-256A1, 6) Asperazine, 7) Tensidol B, 8) Fonsecin B, 9) Aurasperone C,
10) Aurasperone B, 12) Flavasperone analog, 14) Aflavinine analog, 15) Aflavinine analog, 16) Aflavinine analog, 17) Anominine, 18) 10,23-dihydro-
24,25-dehydroaflavinine, 19) Aflavinine analog, 20) Aflavinine analog. From this strain TePaske et al. [20,21,22] isolated 14-epi-14-hydroxy-10,23-
dihydro-24,25-dehydroaflavinine, 10,23-dihydro-24,25-dehydro-21-oxo-aflavinine, 10,23-dihydro-24,25-dehydroaflavinine, tubingensin A and B, and
dehydrotubingensin A and B.
doi:10.1371/journal.pone.0094857.g004
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Strains of Aspergillus series Carbonaria producing
sclerotia and sclerotial indoloterpenes
In Aspergillus series Carbonaria two species, A. sclerotiicarbonarius
and A. sclerotioniger produce sclerotia readily on most media. The
sclerotia of A. sclerotioniger were 1000–1600 mm in diameter, and
were yellow to red brown [5], while those of A. sclerotiicarbonarius
were of the same colours as A. sclerotioniger and 600–1600 mm in
diameter [7]. The sclerotia of A. carbonarius were cream coloured to
light brown to pinkish to greyish brown in age, with a diameter of
800–1300 mm [1]. The sclerotia of A. ibericus were cream to light
brown, and smaller than those of A. carbonarius: 700–1000 mm in
diameter. A. sclerotioniger produces ochratoxin A, but not indolo-
terpenes on CYA or CYAR. A. sclerotiicarbonarius produced three
indoloterpenes with a paspalinine chromophore, but none of these
have been structure elucidated. Like A. sclerotioniger, strains of A.
carbonarius produced ochratoxin A in the sclerotia and no
indoloterpenes were detected (Table 2). While non-sclerotial
strains of A. carbonarius can produce ochratoxin A, sclerotium
production increases the ochratoxin A titre in this species [19]. In
A. ibericus CBS 121593, CYAR induced production of sclerotia and
production of one indoloterpene in those sclerotia. As is the case
for A. lacticoffeatus and A. niger in series Nigri, no isolate has been
found that produce both ochratoxin A and apolar indoloterpenes
in series Carbonaria. This is the first report on sclerotium
production and presence of an aflavinine in A. ibericus (Table 2).
Strains of Aspergillus series Heteromorpha producing
sclerotia and sclerotial indoloterpenes
Aspergillus ellipticus and A. heteromorphus produced sclerotia when
grown on CYAR. Both species have earlier been reported to
produce sclerotia. A sclerotium producing sector of A. ellipticus was
separated and named as a new species, A. helicothrix, by Al-
Musallam [3]. Later research has shown that A. ellipticus and A.
helicothrix are the same species [6]. We could induce sclerotium
formation in A. ellipticus on CYAR, but we did not detect any
sclerotium associated extrolites in that species. A. heteromorphus was
originally claimed to produce sclerotia [10], but Al-Musallam [3]
and Samson et al. [6] could not confirm this. We observed
sclerotium production in A. heteromorphus CBS 101889 on CYAR.
In this single case the sclerotia were only produced on the raisins
and the sclerotia were the smallest observed in this study (300–
500 mm) and becoming darker (steel grey) in age than those of the
other species in Aspergillus section Nigri. We did not detect any
sclerotium associated extrolites in this species, however (Table 2).
Strains of Aspergillus series Homomorpha producing
sclerotia and sclerotial indoloterpenes
We did not detect any sclerotia in A. homomorphus, but we did
observe sclerotia in A. saccharolyticus when isolates of this species
(IBT 30881 and IBT 28231) grew on CYAR. The sclerotia of A.
saccharolyticus were small, 300–500 mm in diameter and white to
cream coloured. One apolar indoloterpene with a paspalinine
chromophore was detected in A. saccharolyticus (Table 2). This is the
first report on sclerotium production by A. saccharolyticus, as
sclerotia were not reported in the original description of this
species [58].
Strains of Aspergillus series Aculeata producing sclerotia
and sclerotial indoloterpenes
We did not detect sclerotia in A. indologenus or A. uvarum when
isolates of these species were grown on CYAR. A. indologenus did
produce extrolites that indicate the possibility that this species may
eventually produce sclerotia given the right culturing conditions as
reported by Al-Musallam [3], i.e. okaramins, also produced by
sclerotial A. aculeatus and mid-polar indol-alkaloids, in common
with sclerotial A. violaceofuscus. Strains of three species occasionally
produced sclerotia on CYA agar, but produced them regularly on
CYAR: A. aculeatinus, A. aculeatus and A. brunneoviolaceus/A. fijiensis
and A. japonicus. The sclerotia of all the species in this group were
small (300–500 mm) and white to cream coloured. All species
produced apolar indoloterpenes of the aflavinine or paspalinine
type, but they produced different profiles of apolar indoloterpenes.
The only known aflavinine identified was 10,23-dihydro-24,25-
dehydroaflavinine in A. aculeatus and A. japonicus. A. aculeatus also
produced one apolar indoloterpene of the paspalinine type and
okaramins. A. violaceofuscus produced sclerotia, but only mid-polar
indol-alkaloids were detected. A. floridensis and A. trinidadensis also
produced sclerotia on CYAR. A. floridensis produced 10,23-
dihydro-24,25-dehydroaflavinine and A. trinidadensis produced an
apolar indoloterpene with a paspalinine chromophore (Table 2).
The extype strain of Saitoa japonica (IMI 240698) [2] produced
abundant sclerotia on all media, and was allocated to Aspergillus
aculeatus based on chemotaxonomic evidence, however S. japonica
IMI 240698 also has many similarities with Aspergillus brunneovio-
laceus. This strain should be sequenced to allow a final
identification. IMI 240698 produced three okaramins, one
calbistrin, but in contrast to A. brunneoviolaceus it did not produce
aspergillimide. After two month of incubation of Saitoa japonica IMI
240698 on MEA at room temperature the sclerotia were examined
for ascocoma production, but these were not observed. This is the
first report of sclerotium production in A. floridensis and A.
trinidadensis, not reported in the original description of the two
species [9].
Discussion
Aspergillus niger is one of the most important industrial
microorganisms used, but is also a common contaminant of foods,
so it is of high importance whether this organism can recombine or
whether it is a clonal fungus. Sclerotia are necessary structures if a
fungus has to produce a perfect state, at least in Aspergillus sections
Flavi, Nigri and Circumdati which will produce one to several
ascomata within a sclerotium [25–27,31–32,59], either homo-
thallically or heterothallically. Even though mating-type genes
have been found in A. niger [16,18], the absence of sclerotia in
strains of A. niger has precluded the discovery of a perfect state in
this species. We show here that addition of whole raisins or other
plant parts to the medium CYA can induce sclerotium production
in certain strains of A. niger.
Since indoloditerpenes are exclusively found in the sclerotia of
Aspergillus sections Nigri, Flavi and Circumdati and since these
indoloterpenes have been reported to be antiinsectan extrolites
[19–23,57,60] they appear to be produced to protect sclerotia
from being eaten by insects. As can be seen from the results
obtained here, the sclerotia may contain a high number of
indoloterpenes, many of which have been shown to be antiinsectan
[60]. Sclerotium formation seems to be lost in Aspergillus strains
cultured for a long time, but may also be lost in nature because
these fungi are ever more depending on asexual conidial survival
in domesticated landscapes [19,25]. Ascospore formation inside
hard sclerotia in Aspergillus subgenus Circumdati is a very slow
process, often taking from 3–12 month, and apparently requiring
special physical and chemical factors to be initiated, irrespective of
homothallism or heterothallism [2,26–29,31–33,59], and so the
sexual potential of these fungi appears to be weak. This is also seen
in this study: often it is only a minority of strains in the ubiquitous
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species A. niger and A. tubingensis that can produce sclerotia, even
after stimulation by plants parts such as seeds and fruits.
It was observed that no isolates of A. niger producing ochratoxin
A could produce sclerotia or indoloterpenes, but more OTA
producing isolates need to be examined before a conclusion on this
interesting phenomenon can be made.
The first observation of a perfect state in any species of Aspergillus
section Nigri was reported by Rajendran and Muthappa in 1980
[2]. In this case ascomata were found after 3 month of growth on
malt extract agar. Since this fungus is homothallic, no mating
partners needs to be used. It should be examined whether other
sclerotium producing strains in the uniseriate black aspergilla are
also homothallic. Twenty three years later Darbyshir et al. [31]
succeeded to induce a perfect state in A. sclerotiicarbonarius and
Horn et al. [32] one in A. tubingensis, and they used opposite mating
types of naturally sclerotium producing isolates and plated these
on a mixed cereal agar. Our experience has shown that cereal
based media are not the most effective for sclerotium formation in
species in Aspergillus section Nigri, but that the medium CYA with
whole black raisins could be an ideal medium for crossing of
opposite mating types of A. niger. It is important to note the
freezing of the conidia for 3 weeks before inoculation was often
necessary to induce sclerotium production on CYAR. In the initial
experiments freezing was not used, and we still observed
sclerotium production in A. niger IBT 29019. We suspect these
original observations of sclerotia in A. niger were based on the fact
that the cultures came directly from silica gel, because after several
conidial transfers A. niger IBT 29019 failed to produce sclerotia on
CYAR. The ability to produce sclerotia was restored when conidia
were frozen before inoculation, so we used this treatment when
testing other species for sclerotium production on CYAR. Even
though sclerotium production has been reported from A. niger
earlier [1,3,61,62], the strains reported to produce them were
actually later shown to be A. costaricaensis, A. tubingensis or A.
carbonarius [5,6,8]. Other fruits than raisins, such as blueberries,
cranberries, mulberries, apricot, prune, mango were also useable
for inducing sclerotium formation by A. niger IBT 29019 on CYA
agar, while goji berries, white raisin preserved with sulfur dioxide,
papaya, kidney beans, black pepper and green coffee beans were
not. Whole white or brown rice also was effective for inducing
sclerotium and indoloterpene production. Kjer et al. [63]
recommended using whole rice in the screening for secondary
metabolites in fungi, and whole rice may be a valuable addition for
screening purposes to known effective media for secondary
metabolite production, such as CYA agar and YES agar [64].
However, most of our experiments were done with the CYAR
medium. When tested on several types and brands of black raisins,
they all induced sclerotium production on CYA agar. However,
macerated raisins did not induce sclerotium production, so it
appears that the skin or waxy skin coating of the raisins may be the
crucial factor. In grape wax oleanolic acid and octacosanoic acid
are predominant [65], while in wheat leaves the wax 1-octacosanol
is dominant [66] so it is not unlikely that such wax compounds,
when present in high concentrations as on the surface of a fruit,
are influencing sclerotium production. We tried to add sunflower
oil to CYA, as this oil is often used for coating raisins to give a
shiny surface, but on such a medium no sclerotia were formed. It
remains to be seen what the sclerotium inducing factors are, but
they appear to be based on a complicated mechanism, as some
species in Aspergillus section Nigri produce sclerotia readily, while
others only produce them under very specific conditions, even
within the same species. Wicklow et al. [24] used whole corn
kernels for inducing sclerotium formation in A. carbonarius, and
concerning A. niger IBT 24631, few sclerotia were produced on
whole corn kernels, but in general raisins on CYA agar is a more
effective alternative. Raper and Fennell [1] induced sclerotium
formation in A. carbonarius WB 346 by using steep agar, which is
Czapek agar with 5 g/l corn steep liquor, so it appears that corn
ingredients has a certain positive effect on sclerotium formation.
Batista and Maia [10] also reported sclerotium production by A.
heteromorphus on Czapek agar with 1% corn steep liquor. We tried
another corn steep liquor containing medium, WATM, for
inducing sclerotium formation in A. niger and A. tubingensis, but
this medium did not work as well as in Aspergillus section Flavi,
where it induces sclerotium formation effectively [67].
Conclusion
Adding whole autoclaved fruits or grains to an agar medium
stimulates sclerotium production in some strains of many species of
the black Aspergilli, notably A. niger, but also A. brasiliensis, A.
heteromorphus, A. ibericus, A. luchuensis, A. neoniger, and the uniseriate
black Aspergilli A. aculeatinus, A. aculeatus, A. brunneoviolaceus/A.
fijiensis, A. floridensis, A. japonicus, A. saccharolyticus, A. trinidadensis and
A.violaceofuscus. Pre-freezing of the conidium inoculum enhanced
sclerotium production. Raisins also stimulated sclerotium produc-
tion further in species that often produced them readily, such as
some strains of A. tubingensis and A. carbonarius, and all strains of A.
costaricaensis, A. piperis, A. sclerotiicarbonarius and A. sclerotioniger
leaving A. eucalypticola, A. lacticoffeatus, A. uvarum, A. vadensis and A.
welwitchiae the only species in Aspergillus section Nigri where sclerotia
have not yet been detected. 10,23-dihydro-24,25-dehydroaflavi-
nine-type apolar indoloterpenes were produced by most sclerotial
species, but species related to A. carbonarius preferentially produced
ochratoxin A in the sclerotia. The aflavinin and other apolar
indoloterpene type metabolites were produced in the sclerotia
only.
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 Supplementary material 
Formation of sclerotia and production of indoloterpenes by Aspergillus 
niger and other species in section Nigri. 
 
Jens C. Frisvad, Lene M. Petersen, E. Kirstine Lyhne, and Thomas O. Larsen 
Table S1. List of fruits or seeds used to induce sclerotium production  in Aspergillus niger strains.  
Plant part* Type Brand Country of origin Imported to 
Raisins Dark Sun-Maid California, USA Denmark 
Sultanas raisins Dark, organic Unknown Turkey Urtekram, 
Denmark 
Raisins Dark Unknown Turkey Urtekram, 
Denmark 
Raisins Dark, organic Unknown Argentina Biogan A/S, 
Denmark 
Raisins Dark, organic Unknown California, USA Biogan A/S, 
Denmark 
Raisins Dark, organic Naturata Slovenia Bought in Slovenia 
Raisins Dark, organic Unknown California, USA Helios A/S, 
Denmark 
Raisins Dark, organic Sun-Maid California, USA Denmark 
Raisins Dark Frutexa Chile Denmark 
Sultana raisins Dark Unknown Unknown X-tra, COOP, 
Denmark 
Jumbo raisins Dark Delicata Unknown System Frugt A/S, 
Tilst, Denmark 
Raisins (two 
batches) 
Dark Unknown Turkey Irma, COOP, 
Denmark 
Raisins Dark, organic  Thompson California, USA Irma, COOP, 
Denmark 
Raisins Green  Thompson California, USA Denmark 
Raisins Green Unknown Unknown System Frugt A/S, 
Tilst, Denmark 
Small dry apricots Stoneless, organic Unknown Unknown Biogan A/S, 
Denmark 
Small dry prunes Stoneless, organic Unknown California, USA Helios, Denmark 
Dry goji berries   China Superfruit, Sweden 
then to Denmark 
Dry craneberries 60%, apple juice, Unknown Unknown System Frugt, 
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sunflower oil Denmark 
Dry red kidney 
beans 
organic Unknown Unknown Urtekram, 
Denmark 
Dry white 
mulberries 
Wild-crafted and 
sundried 
Unknown Asia Superfruit / Rich 
Nature, Denmark, 
batch S090225-
0410-160 
Dry blueberries 55%, with apple 
juice and 
sunflower oil 
Unknown USA Superfruit, Sweden 
then to Denmark 
Dry green coffee Arabica Unknown Brazil Denmark 
Black pepper  Unknown Indonesia Denmark 
Rice white Uncle Ben USA Denmark 
Rice Brown, long grain Organic Cuisine Unknown Nordic Food 
Partners A/S, 
Denmark 
Corn Canned Unknown USA Denmark 
Mango Fresh Unknown Brazil Denmark 
Papaya Fresh Unknown Brazil Denmark 
Sunflower oil Organic, cold-
pressed 
Unknown Unknown Produced in the 
Netherlands, then 
imported to 
Denmark 
 
*All raisins were added up to 0.5% sunflower oil according to the producer. All fruits were placed 
as whole fruits / seeds in the same pattern as a three point inoculation of fungal colonies. The fungi 
were inoculated just beside the fruit parts (approximately 2 mm from the fruits). The rice was 
suspended in water and autoclaved. An approximately 10
7
 conidia / ml suspension was used for 
inoculation of the rice. Pieces of mango and papaya peel (approximately 1 x 2 cm were also placed 
in the CYA plates in three points before inoculation. For the 4% and 40% macerated mango and 
papaya in agar, both fruit flesh and peel was used, but the kernel / seeds were discarded.  
 
 
Table S2. Aspergillus section Nigri List of isolates in Aspergillus brasiliensis, A. niger and A. welwitchiae 
that do not produce sclerotia even when stimulated by whole raisins in CYA agar in addition to a pre-
freezing step. 
 
Species Isolates with no sclerotia 
A. brasiliensis IBT 28083 = CBS 246.65 
IBT 21946 = CBS 101740 
A. niger IBT 27878 = NRRL 328, IBT 24637, IBT 29899 = 
NRRL 363, IBT 29884 = NRRL 4757, IBT 29885 = 
NRRL 612, IBT 28099 = CBS 139.52, IBT 23540 = 
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NRRL 3112, IBT 21853, IBT 23680 = IMI 041871, 
IBT 29887 = NRRL 611, IBT 24634 = CBS 133817, 
IBT 29709 = CBS 513.88, IBT 27876 = NRRL 326, 
IBT 24637, NRRL 2372 = IBT 29890, NRRL 328 = 
IBT 27878, CBS 119725 = IBT 28098, NRRL 593 = 
IBT 29891, IBT 29021, IBT 29023, IBT 29002, IBT 
29004 
A. welwitchiae (“A. awamori”), phylospecies IBT 26343 = CBS 102.12; IBT 26387 = NRRL 567; 
IBT 26392 = NRRL 2001; IBT 3277 = CBS 618.78; 
IBT 28086 = ITEM 7097; IBT 28861 = NRRL 320; 
IBT 29098; IBT 29882 = NRRL 362; IBT 29894 = 
NRRL 595; IBT 29881 = NRRL 4851; IBT 29879 = 
NRRL 340; IBT 29888 = NRRL 6408; IBT 29890 = 
NRRL 372; IBT 29895 = NRRL 604 
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Abstract: Two new cytochalasins, sclerotionigrin A (1) and B (2) were isolated together 
with the known proxiphomin (3) from the filamentous fungus Aspergillus sclerotioniger. 
The structures and relative stereochemistry of 1 and 2 were determined based on 
comparison with 3, and from extensive 1D and 2D NMR spectroscopic analysis, supported 
by high resolution mass spectrometry (HRMS). Compounds 2 and 3 displayed cytotoxic 
activity towards chronic lymphocytic leukemia cells in vitro, with 3 being the most active.  
Keywords: cytochalasins; apergilli; Apsergillus sclerotioniger; chronic lymphocytic leukemia 
 
1. Introduction 
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia among adults in the 
Western World. CLL is considered an incurable disease and today’s applied treatment strategies 
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primarily aim at prolonging patient survival [1,2]. Consequently discovery of compounds that act 
against CLL and other types of cancer cells is crucial. Numerous types of anticancer compounds have 
been reported in the literature [3,4], and with the increase in specific biological assays, both novel and 
previously described compounds might display promising novel bioactivities [5,6]. An important and 
diverse group of fungal anticancer compounds that have caught our interest due to their wide range of 
biological functions are the cytochalasans [7]. In particular this includes inhibitory activities towards 
lung, ovarian, and human colon cancer as well as human leukemia [8,9]. Recently, we have demonstrated 
that chaetoglobosin A, produced by Penicillium aquamarinum, selectively induces apoptosis in CLL 
cells with a median lethal concentration (LC50) value of 2.8 µM [10]. Encouraged by this finding we 
searched for potential novel cytochalasan type of compounds in black aspergilli.  
The only documented indication of production of cytochalasans in Aspergillus subgenus Circumdati 
section Nigri is aspergillin PZ, for which aspochalasin C or D has been suggested as precursor [11,12]. 
However in the sister clade Aspergillus subgenus Circumdati section Flavipedes, numerous 
cytochalasans have been reported [13–26] including aspochalasin A–D [27,28]. Also in another 
species of Aspergillus subgenus Circumdati section Circumdati, Aspergillus elegans several 
cytochalasins were found, including aspergillin PZ [29], supporting the view that aspochalasin D is a 
precursor of aspergillin PZ. Finally in the less closely related Aspergillus clavatus in Aspergillus 
subgenus Fumigati section Clavati, cytochalasin E and K have been isolated [30,31]. 
Here we report the target-guided isolation and structure elucidation based on UV, MS, and NMR data of 
the two novel cytochalasins sclerotionigrin A (1) and B (2). Compounds 1 and 2 were isolated from 
Aspergillus sclerotioniger (IBT 22905) together with the known cytochalasin proxiphomin (3) [32]. We 
have previously reported ochratoxin A, ochratoxin B and pyranonigrin A from this isolate [33]. 
2. Results and Discussion 
The structure of compound 3 (Figure 1) was tentatively identified through UHPLC-DAD-HRMS 
based dereplication of the crude extract. The pseudomolecular ion, [M+H]+, was recognized from the 
mass spectrum due to the presence of the sodiated adduct, [M+Na]+ and the corresponding dimeric 
adducts [2M+H]+ and [2M+Na]+. The molecular formula C29H37NO2 was established with an accuracy 
of 0.8 ppm through the monoisotopic mass of [M+H]+ of m/z 432.2901. The formula was used for a 
query in Antibase2012 [34] with one resulting hit, proxiphomin (3). NMR data and optical rotation of 
3 matched published data [32]. 
Figure 1. Structures of sclerotionigrin A (1), sclerotionigrin B (2) and proxiphomin (3). 
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Compound 1 was purified as a yellow powder. The UV spectrum displayed an absorption maximum  
at 210 nm. The ESI+ spectrum showed a distinct adduct pattern consisting of [M+H]+, [M+Na]+, 
[2M+H]+ and [2M+Na]+. The molecular formula C29H37NO3 (12 double-bond equivalents) was 
obtained from HRMS of [M+H]+ (m/z 448.2843) with an accuracy of 2.3 ppm. The 1H-NMR spectrum 
revealed the presence of one amide proton, 15 methines (five which were vinylic and five aromatic), 
six methylenes, and three methyls (Table 1). 
Table 1. NMR data for sclerotionigrin A (1) †. 
No. δH (Integral, Mult., J [Hz]) δC HMBC NOESY 
1 - 170.6 - - 
2 8.00 (1H, s) - 1, 3, 4, 9 3, 10 
3 3.09 (1H, td, 5.8, 3.1) 54.2 - 2, 4, 10, 11, 12, 26/30 
4 2.53 (1H, dd, 4.2, 3.1) 49.1 3, 5, 6, 9 3, 10, 11, 26/30 
5 2.57 (1H, m) 33.6 - 7, 8, 11 
6 - 140.0 - - 
7 5.25 (1H, m) 123.6 - 5, 8, 12 
8 3.15 (1H, m) 45.8 - 5, 7, 13, 14 
9 - 85.4 - - 
10 2.82 (2H, m) 42.6 3, 4, 25, 26/30 3, 4, 26/30 
11 0.68 (3H, d, 7.1) 12.8 4, 5, 6 3, 4, 5, 12, 26/30 
12 1.65 (3H, s) 19.4 5, 6, 7 3, 7, 11 
13 5.85 (1H, ddd, 14.8, 10.0, 1.2) 128.9 15 8, 15 
14 5.22 (1H, m) 132.6 8 8, 15', 16 
15 1.60 (1H, d, 13.5) 40.7 13, 14, 16 13, 15' 
15' 2.07 (1H, dd, 13.5, 2.1) 40.7 - 14, 15, 16, 20', 24 
16 1.36 (1H, m) 31.9 - 14, 15', 19' 
17 0.61 (1H, m) 33.8 - 17', 18', 24 
17' 1.66 (1H, m) 33.8 - 17 
18 1.14 (1H, m) 25.9 - 18' 
18' 1.53 (1H, m) 25.9 - 17, 18 
19 1.29 (1H, m) 25.3 - 24 
19' 1.68 (1H, m) 25.3 - 16, 21 
20 2.23 (1H, m) 33.1 - 20', 21 
20' 2.29 (1H, m) 33.1 - 15', 20, 22 
21 6.96 (1H, ddd, 15.5, 8.6, 6.8) 151.7 23 19', 20, 22 
22 5.65 (1H, d, 15.5) 120.6 20, 23 20', 21 
23 - 163.5 - - 
24 0.84 (3H, d, 6.3) 20.0 15, 16, 17 15', 17, 19 
25 - 137.8 - - 
26 ‡ 7.14 (1H, app. d, 7.5) 129.5 10, 26/30, 28 3, 4, 10, 11 
27 ‡ 7.26 (1H, app. t, 7.4) 128.0 25, 29 - 
28 7.18 (1H, app. t, 7.5) 126.1 26, 30 - 
29 ‡ 7.26 (1H, app. t, 7.5) 128.0 25, 27 - 
30 ‡ 7.14 (1H, app. d, 7.5) 129.5 10, 26/30, 28 3, 4, 10, 11 
† 1H NMR data were obtained at 500 MHz in DMSO-d6 and 13C data were obtained at 125 MHz in DMSO-d6. 
13C-NMR chemical shifts were determined from HSQC and HMBC experiments; ‡ It was not possible to 
distinguish between No. 26 and 30 as well as No. 27 and 29. 
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The DQF-COSY spectrum of 1 defined four spin systems. The linking between COSY spin systems 
and assignments of the remaining signals and quaternary carbons were accomplished through detailed 
analysis of HMBC experimental data (Figure 2). 
Figure 2. Important HMBC correlations connecting the four COSY spin systems (marked 
in bold) in 1. The remaining HMBC correlations are found in Table 1. 
1 
The HMBC correlations from the protons at δH 2.82 ppm (H10) and 7.26 (H27 and H29) to a 
quaternary carbon at δC 137.8 (C25), together with HMBC correlations from the protons at δH 7.14 
(H26 and H30) to the carbon at δC 42.6 (C10) linked two of the spin systems belonging to the Phe 
moiety in 1. The amide proton at δH 8.00 ppm (H2) displayed HMBC correlations to the carbons  
at δC 54.2 (C3) and 170.6 ppm (C1). Combination of these HMBC correlations established the Phe 
moiety of 1, which was incorporated on the polyketide (PK) part of the molecule. 
The PK part of 1 could be established through a large COSY spin system (from H7 to H22), equal 
to that seen in 3. Furthermore a COSY coupling was found between the proton at δH 2.57 ppm (H5) 
and a methyl group at 0.68 ppm (H11). This part was coupled to the PK part by a weak COSY 
coupling between H5 and H7 identified as a 4J alyllic coupling. The COSY spin system could 
furthermore be connected via HMBC correlations to the above mentioned Phe moiety as well as the 
PK part. The protons at δH 1.65 (H12) correlated to the carbons at δC 33.6 (C5) and 123.6 ppm (C7) 
where the proton at δH 0.68 (H11) correlated to the carbons at δC 49.1 (C4) and 140.0 ppm (C6). The 
proton at 2.53 ppm (H4) correlated to C5, C6 and the quaternary carbon at δC 85.4 ppm (C9). Finally 
the PK chain was closed via an ester bond assigned from HMBC correlations from the vinylic protons 
at δH 5.65 (H22) and 6.96 ppm (H21) to the carbonyl carbon at δC 163.5 ppm (C23) supported by the 
high chemical shift of the quaternary carbon at δC 85.4 ppm (C9) indicating that C9 is bound to 
oxygen, and a carbonyl group, similar to what is seen in several other cytochalasans [7].  
This structure accounted for all the degree of unsaturation required by the formula allowing the 
assignment of 1 as sclerotionigrin A. The size of the vicinal coupling constants (3JHH) for H13/H14 and 
H21/H22 were rather large (14.8 and 15.5 Hz respectively) suggesting a trans stereochemistry. 
NOESY experiments enabled determination of the relative stereochemistry for most of the stereogenic 
centers of 1. NOE connectivities were found between the proton at δH 3.09 ppm (H3), δH 2.53 (H4) and 
the methyl at δH 0.68 ppm (H11) placing these protons at the same side of the central ring system, 
which to the best of our knowledge has not been reported for other cytachalasins. Other NOE 
connectivities were observed between the protons at δH 2.57 ppm (H5), 5.25 (H7) and 3.15 (H8), 
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whereas no NOE connectivities could be seen from either of these to H3, H4 or H11, strongly 
indicating the positioning of H5, H7 and H8 on the opposite side of the central ring system  
compared to H3, H4 and H11. The stereocenters at C9 and C16 could not be assigned through  
NOESY connectivities; however being biosynthesized by the same fungus we propose that the 
stereochemistries at these centers are identical to those of 3. Especially we note that the extra oxidation 
between C9 and C23 in other cytochalasans never leads to a change in stereochemistry at C9 [7,15]. 
We do however note that the optical rotation of 1 and 2 are positive as opposed to that of 3 and other 
similar cytochalasans [15], indicating a possible difference in stereochemistry, which could be 
accounted for by the change of stereochemistry at C4. Further experiments, e.g., X-ray crystallography 
or circular dichroism (CD) are therefore needed to clarify the absolute stereochemistry of 1. 
Compound 2 was isolated as a yellow powder, and displayed a UV absorption maximum at 212 nm 
and the ESI+ MS adducts [M+H]+, [M+Na]+, [2M+H]+ and [2M+Na]+. The molecular formula of 2, 
C29H37NO4 was deduced from the monoisotopic mass obtained from the [M+H]+ ion (m/z 464.2797) 
with an accuracy of 1.2 ppm. Examination of the NMR spectra of 2 displayed a high similarity 
compared to 1. Comparison of the NMR spectra of 1 and 2 (see Tables 1 and 2, respectively) revealed 
that the difference between them is located in positions five, six and seven. The Phe moiety in 2 was 
identified through a connection of the two COSY spin systems linked by HMBC correlations as 
demonstrated for 1. The COSY spin system of the PK chain terminated with a proton at δH 3.68 ppm 
(H7), indicating a binding to a hydroxyl group instead of the vinylic methine group observed for 1 at 
this position. This was also evident from the carbon chemical shift moving to δC 69.1 ppm (C7). 
HMBC correlations from the three protons of the methyl group at δH 1.52 ppm (H12) to the  
carbons at δC 123.9 (C5), 134.2 (C6) and 69.1 (C7), combined with correlations from the protons at  
δH 1.16 ppm (H11) to the carbons at δC 47.1 (C4) and 123.9 ppm (C5) and 134.2 (C6) linked the Phe 
moiety to the spin system in the polyketide chain (Figure 3). The remaining chemical shifts in 2 
matched the chemical shifts of 1 (Tables 1 and 2) and the structure of 2 was established altogether 
giving a classic methylated cytochalasin carbon skeleton [7]. 
The relative stereochemistry of 2 was established partly through NOE connectivities (Table 2) and 
shown to be very similar to that of 1. Connectivities between H3 and H4 were however not confirmed 
in 2, since these resonances were overlapping with the water resonance (Supplementary Figure S10). 
The optical rotation of 2 was positive like the optical rotation of 1, also indicating that the two 
compounds have the same relative stereochemistry. The absolute stereochemistry of 2 has not yet been 
solved. 
Biological testing of the cytotoxicity of compounds 1–3 towards CLL cells in vitro was performed 
using a CellTiter-Glo® assay [10]. Compound 3 displayed the strongest effects, with estimated LC50 
values of ca. 48 µM whereas no effect was found towards healthy B-cells in concentrations <100 µM. 
Compounds 1 showed minor activity at a concentration of 72 µM, while 2 did not have any effect 
(Table 3 and Supplementary Table S2, Figures S17, S18), indicating that the novel stereochemistry in 
the central ring system of 1 and 2 has a negative effect on target interactions. Due to the low anticancer 
activities of the sclerotionigrins, no further investigations proving their exact mode of action  
were undertaken. 
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Table 2. NMR data for sclerotionigrin B (2) †. 
No. δH (Integral, Mult., J [Hz]) δC  HMBC NOESY 
1 - 171.2 - - 
2 8.34 (1H, br. s) - 3, 4, 9 3, 10' 
3 3.39 (1H, m) 57.7 1, 4, 5, 9 2, 10, 10', 11, 26/30 
4 3.32 (1H, m) 47.1 1, 5, 6, 9 13, 26/30 
5 - 123.9 - - 
6 - 134.2 - - 
7 3.68 (1H, d, 9.7) 69.1 - 8, 12, 13 
8 3.05 (1H, t, 10.0) 48.3 1, 4, 7, 9, 13, 14 7, 13, 14 
9 - 83.6 - - 
10 2.55 (1H, dd, 13.0, 10.1) 42.5 3, 4, 25, 26/30 3, 10', 26/30 
10' 2.92 (1H, dd, 13.0, 5.0) 42.5 3, 4, 25, 26/30 2, 3, 10, 26/30 
11 1.16 (3H, s) 16.7 4, 5, 6 3, 26/30 
12 1.52 (3H, s) 14.3 5, 6, 7 7 
13 6.03 (1H, dd, 15.0, 11.3) 128.4 8, 15/15’ 4, 7, 8, 14, 15 
14 5.00 (1H, ddd, 15.0, 10.8, 3.4) 132.7 8, 15/15’ 8, 13, 15, 15' 
15 1.58 (1H, dt, 13.0, 11.1) 41.6 16 13, 14, 15', 16, 17' 
15' 2.00 (1H, m) 41.6 - 14, 15, 16, 24 
16 1.13 (1H, m) 32.5 - 15, 15', 17', 18, 24 
17 0.52 (1H, m) 34.5 - 17' 
17' 1.67 (1H, m) 34.5 24 15, 16, 17, 18, 24 
18 0.86 (1H, m) 26.1 - 16, 17', 18' 
18' 1.68 (1H, m) 26.1 20 18, 19, 21 
19 1.30 (1H, m) 25.4 - 18', 19' 
19' 1.73 (1H, m) 25.4 - 19 
20 2.11 (1H, m) 33.4 - 20', 22 
20' 2.41 (1H, m) 33.4 - 20, 21 
21 6.89 (1H, ddd, 15.7, 10.8, 5.0)  151.4 20, 23 18', 20', 22 
22 5.79 (1H, d, 16.1) 121.3 20, 23 20, 21 
23 - 163.8 - - 
24 0.83 (3H, d, 6.6) 19.9 15, 16, 17 15', 16, 17' 
25 - 137.4 - - 
26 ‡ 7.08 (1H, app. d, 7.1) 128.9 10, 28, 30 3, 4, 10, 10', 11, 27/29 
27 ‡ 7.31 (1H, app. t, 7.5) 128.2 25, 29 26/30, 28 
28 7.23 (1H, app. t, 7.4) 126.3 26, 30 27/29 
29 ‡ 7.31(1H, app. t, 7.5) 128.2 25, 27 26/30, 28 
30 ‡ 7.08 (1H, app. d, 7.1) 128.9 10, 26, 28 3, 4, 10, 10',11, 27/29 
† 1H-NMR data were obtained at 500 MHz in DMSO-d6 and 13C data were obtained at 125 MHz in DMSO-
d6. 13C-NMR chemical shifts were determined from HSQC and HMBC experiments; ‡It was not possible to 
distinguish between no. 26 and 30 as well as no. 27 and 29. The hydroxyl group at C7 is not observed, 
presumable because it overlaps with the water resonance. 
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Figure 3. Important HMBC correlations establishing the quaternary carbon C5 and C6  
in 2. The remaining HMBC correlations are found in Table 2. Individual COSY spin 
systems are marked in bold. 
 2 
Table 3. Estimated LC50 values for compound 1–3. 
Compound CLL Healthy B-Cells 
Sclerotionigrin A (1) 72 µM No effect 
Sclerotionigrin B (2) No effect No effect 
Proxiphomin (3) 48 µM No effect 
3. Experimental Section  
3.1. Fungal Growth and Extraction 
Aspergillus sclerotioniger (IBT 22905 = CBS 115572) is from the IBT culture collection at 
Department of Systems Biology, Technical University of Denmark. A. sclerotioniger was inoculated as 
three point inoculations on Czapek yeast agar (CYA) on 100 plates at 25 °C for 7 days in the dark. 
CYA plates were prepared as described by Samson et al. [35]. The plates were harvested and extracted 
twice overnight with ethyl acetate (EtOAc) containing 1% formic acid (FA). The extracts were filtered 
and concentrated in vacuo. Work up: The combined extract was dissolved in methanol (MeOH)/ 
milliQ-water (water purified and deionized by a Millipore system through 0.22 μm membrane filter) 
(9:1) and an equal amount of heptane was added followed by separation of phases. Additional  
milliQ-water was added to the MeOH/water phase until a ratio of 1:1 was reached, and metabolites 
were extracted with dichloromethane (DCM). The phases were then concentrated separately in vacuo. 
The DCM phase was used for further fractionation.  
3.2. Preparative Isolation of Cytochalasins 
The extract was dry-loaded on diol resin and fractionated on a 50 g pre-packed diol column using 
an Isolera One automated flash purification system (Biotage, Uppsala, Sweden). The compounds were 
eluted using a seven step gradient of heptane-DCM-EtOAc-MeOH with a flow rate of 40 mL/min. 
Fractions were collected automatically (1 column volume in each fraction). The Isolera fractions were 
subjected to further purification on a semi-preparative HPLC Waters 600 Controller with a 996 
photodiode array detector (Waters, Milford, MA, USA) on a Luna II C18 column 250 × 10 mm, 5 μm 
(Phenomenex, Torrance, CA, USA). A flowrate of 5 mL/min was used and 50% acetonitrile (ACN) 
OHN
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isocratic for 5 min, then to 100% in 15 min. 50 ppm trifluoroacetic acid (TFA) was added to ACN and 
milliQ-water. This yielded 1 (7.8 mg), 2 (2.1 mg), and 3 (1.3 mg). 
Sclerotionigrin A (1) Yellow solid; [α]589.3nm: +4° (c 0.8, MeOH); UV (ACN) λmax: 210 nm; HRMS 
m/z 448.2843 ([M + H]+ calculated for C29H38NO3, m/z 448.2853; 2.3 ppm); 13C- and 1H-NMR:  
see Table 1. 
Sclerotionigrin B (2) Yellow solid; [α]589.3nm: +41° (c 0.2, MeOH); UV (ACN) λmax: 212 nm; HRMS m/z 
464.2797 ([M + M]+ calculated for C29H38NO4, m/z 463.2724; 1.2 ppm); 13C- and 1H-NMR: see Table 2. 
Proxiphomin (3) Yellow solid; [α]589.3nm: −21° (c 0.1, MeOH); UV (ACN) λmax: 244 nm; HRMS m/z 
432.2901 ([M + H]+ calculated for C29H38NO2, m/z 432.2904; 0.8 ppm); 1H-NMR (DMSO-d6, 500 MHz): 
δ 0.77 (3H, d, 7.2, H11), 0.85 (3H, d, 6.7, H24), 1.13 (2H, m, H18), 1.23 (2H, m, H17), 1.38 (1H, m, 
H16), 1.41 (1H, m, H19), 1.56 (1H, m, H19'), 1.66 (3H, s, H12), 1.67 (1H, m, H15), 1.99 (1H, m,, 
H15'), 2.02 (1H, m, H20), 2.20 (1H, m, H5), 2.28 (1H, m, H20'), 2.40 (1H, dd, 13.2, 7.3, H10), 2.60 
(1H, dd, 13.2, 4.9, H10'), 2.63 (1H, m, H8), 2.80 (1H, dd, 5.8, 2.6, H4), 3.25 (1H, m, H3), 5.11 (1H, 
ddd, 14.6, 10.3, 3.2, H14), 5.27 (1H, m, H7), 6.18 (1H, ddd, 15.2, 9.8, 1.7, H13), 6.54 (1H, ddd, 15.4, 
10.2, 5.3, H21), 6.86 (1H, d, 15.5, H22), 7.10 (1H, d, 7.5, H26), 7.10 (1H, d, 7.5, H30), 7.16 (1H, d, 
7.5, H28), 7.25 (1H, dd, 7.4, 1.0, H27), 7.25 (1H, dd, 7.4, 1.0, H29), 7.94 (1H, s, H2). 13C-NMR 
(DMSO-d6, 125 MHz) δ 12.6 (C11), 19.3 (C12), 20.8 (C24), 23.1 (C18), 25.2 (C19), 28.5 (C17), 31.1 
(C20), 31.9 (C16), 33.7 (C5), 39.7 (C15), 43.1 (C10), 47.0 (C8), 47.2 (C4), 53.0 (C3), 65.7 (C9), 125.8 
(C7), 126.0 (C28), 127.3 (C22), 127.9 (C27), 127.9 (C29), 129.3 (C13), 129.5 (C26), 129.5 (C30), 
131.6 (C14), 136.7 (C25), 139.1 (C6), 145.7 (C21), 173.6 (C1), 196.9 (C23). 
3.3. Chemical Analysis 
Analysis of extracts was performed using ultra-high-performance liquid chromatography (UHPLC) 
UV/Vis diode array detector (DAD) high-resolution MS on a maXis 3G orthogonal acceleration 
quadrupole time of flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an 
electrospray ionization (ESI) source and connected to an Ultimate 3000 UHPLC system (Dionex, 
Sunnyvale, CA, USA). The mass spectrometer was calibrated using sodium formate automatically 
infused prior to each analytical run, providing a mass accuracy below 1 ppm. Separation was achieved 
on a Kinetex C18, 2.6 µm, 2.1 × 100 mm column (Phenomenex) with a flow rate of 0.4 mL∙min−1 at 40 °C 
using a linear gradient 10% ACN in milliQ water going to 100% ACN in 10 min. Both solvents were 
buffered with 20 mM formic acid. 
3.4. NMR and Optical Roation 
One-dimensional and two-dimensional NMR experiments were acquired on a 500 MHz Varian 
Unity Inova (Palo Alto, CA, USA) equipped with a HCP probe. 1H, DQF-COSY, edHSQC, HMBC 
and NOESY experiments were acquired using standard pulse sequences. Optical rotation values were 
obtained on a Perkin-Elmer 241 Polarimeter at 589 nm. 
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3.5. CLL Cells, Cell Viability and Apoptosis Assays 
Whole blood samples were obtained from healthy donors or patients that matched the standard 
diagnostic criteria for CLL after informed consent in accordance with the Declaration of Helsinki.  
All studies performed were approved by the ethics committee of the University of Ulm. Peripheral 
blood B cells were isolated by Ficoll density gradient followed by magnetic cell enrichment using 
CD19-MACS beads (Miltenyi Biotech, Bergisch Gladbach, Germany). Healthy donor B cells or CLL 
cells were cultured in conditioned medium of HS-5 cells, which was harvested after 3–4 days of 
culture and 80% confluency and depleted of HS-5 cells and debris by centrifugation. Cells were seeded 
in duplicates at a density of 3 × 105 cells/well in opaque-walled 96-well plates. Pure compounds were 
added in different concentrations and incubated for 24 h. A final concentration of 0.1% DMSO was 
used as negative control and 100 µM fludarabine as positive control. Cell viability was assessed using 
CellTiter-Glo® assay (Promega, Madison, WI, USA) according to manufacturer’s protocol. Luminescence 
signals were recorded using a Mithras LB940 plate reader (Berthold Technologies, Bad Wildbad, 
Germany). Relative cell viability was calculated as described by Knudsen et al. [10]. All compounds were 
tested on the same patient cells under the same conditions. For patient data, see Supplementary  
Table S2, Figures S17, S18. 
4. Conclusions  
In summary the two new cytochalasins, sclerotionigrin A (1) and B (2) have been isolated from A. 
sclerotioniger, together with the known proxiphomin (3). Compound 3 displayed the strongest 
cytotoxic effects towards CLL, however not as promising as recently demonstrated for chaetoglobosin 
A [10]. This is the first report of cytochalasan production from one of the currently more than twenty-
five known black Aspergillus species [36,37], even though cytochalasans are very common in the 
related yellow Aspergillus species such as A. flavipes, A. terreus and A. elegans [29,38]. Further 
species in Aspergillus section Nigri should be examined for cytochalasan production, as the 
cytochalasan related metabolite, aspergillin PZ, has also been found in this group in addition to 
proxiphomin, and sclerotionigrin A and B. This may be important for both drug discovery and food 
safety, as the black Aspergilli are common in foods. 
Supplementary Materials 
1H, DQF-COSY, HSQC, HMBC and NOESY spectra for all three compounds, as well as bioassay 
results are available in the supporting information. Supplementary materials can be accessed at: 
http://www.mdpi.com/1420-3049/19/7/9786/s1. 
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Figure S1.1H-NMR spectrum for Sclerotionigrin A (1) at 500 MHz in DMSO-d6. 
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Figure S2. DQF-COSY spectrum for Sclerotionigrin A (1) in DMSO-d6. 
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Figure S3. edHSQC spectrum for Sclerotionigrin A (1) in DMSO-d6 
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Figure S4. HMBC spectrum for Sclerotionigrin A (1) in DMSO-d6. 
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Figure S5. NOESY spectrum for Sclerotionigrin A (1) in DMSO-d6 
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Figure S6. 1H-NMR spectrum for Sclerotionigrin B (2) at 500 MHz in DMSO-d6. 
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Figure S7. DQF-COSY spectrum for sclerotionigrin B (2) in DMSO-d6. 
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Figure S8. edHSQC spectrum for Sclerotionigrin B (2) in DMSO-d6. 
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Figure S9. HMBC spectrum for Sclerotionigrin B (2) in DMSO-d6. 
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Figure S10. NOESY spectrum for Sclerotionigrin B (2) in DMSO-d6. 
 
Figure S11. NMR data for proxiphomin (3). 
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Table S1. NMR data for proxiphomin (3). 
No. δH (integral, mult., J [Hz])† 
13C-chemical 
shift [ppm]†
HMBC 
correlations 
NOESY connectivities
1 - 173.6 - - 
2 7.94 (1H, s) - 3, 4, 9 3 
3 3.25 (1H, m) 53.0 - 2, 10, 10', 11, 12, 26, 30
4 2.80 (1H, dd, 5.8, 2.6) 47.2 1, 3, 5, 6, 9, 10, 23 5, 10, 10', 11, 26, 30 
5 2.20 (1H, m) 33.7 1 4, 8, 11 
6 - 139.1 - - 
7 5.27 (1H, m) 125.8 - 8, 12, 13 
8 2.63 (1H, m) 47.0 1 7, 5, 13, 14, 22 
9 - 65.7 - - 
10 2.40 (1H, dd, 13.2, 7.3) 43.1 1, 3, 4, 25, 26, 30 3, 4, 10', 26, 30 
10' 2.60 (1H, dd, 13.2, 4.9) 43.1 1, 3, 4, 25, 26, 30 3, 4, 10, 26, 30 
11 0.77 (3H, d, 7.2) 12.6 4, 5, 6 3, 4, 5 
12 1.66 (3H, s) 19.3 5, 7 3, 7, 13 
13 6.18 (1H, ddd, 15.2, 9.8, 1.7) 129.3 15 7, 8, 12, 14, 22 
14 5.11 (1H, ddd, 14.6, 10.3, 3.2) 131.6 8 8, 13, 15' 
15 1.67 (1H, m) 39.7 16 15' 
15' 1.99 (1H, m) 39.7 16 14, 15, 16, 17 24 
16 1.38 (1H, m) 31.9 - 15' 
17 1.23 (2H, m) 28.5 - 15', 18 
18 1.13 (2H, m) 23.1 - 17 
19 1.41 (1H, m) 25.2 - 19' 
19' 1.56 (1H, m) 25.2 - 19 
20 2.02 (1H, m) 31.1 - 20', 21, 22 
20' 2.28 (1H, m) 31.1 - 20 
21 6.54 (1H, ddd, 15.4, 10.2, 5.3) 145.7 20, 23 20 
22 6.86 (1H, d, 15.5) 127.3 20, 23 8, 13, 20 
23 - 196.9 - - 
24 0.85 (3H, d, 6.7) 20.8 15, 16 15' 
25 - 136.7 - - 
26‡ 7.10 (1H, d, 7.5) 129.5 10, 28, 30 3, 4, 10, 10' 
27‡ 7.25 (1H, dd, 7.4, 1.0) 127.9 25, 29  
28 7.16 (1H, d, 7.5) 126.0 26, 30  
29‡ 7.25 (1H, dd, 7.4, 1.0) 127.9 25, 27  
30‡ 7.10 (1H, d, 7.5) 129.5 10, 26, 28 3, 4, 10, 10' 
† 1H-NMR data were obtained  at 500 MHz in DMSO-d6 and 13C data were obtained at 125 MHz in DMSO-d6.  
‡It was not possible to distinguish between 26 and 30 as well as 27 and 29. 
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Figure S12. 1H-NMR spectrum for proxiphomin (3) at 500 MHz in DMSO-d6. 
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S13
Figure S13. DQF-COSY spectrum for proxiphomin (3) in DMSO-d6. 
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S14
Figure S14. edHSQC spectrum for proxiphomin (3) in DMSO-d6. 
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S15
Figure S15. HMBC spectrum for proxiphomin (3) in DMSO-d6 
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S16
Figure S16. NOESY spectrum for proxiphomin (3) in DMSO-d6. 
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S17
Table S2. Patient data, including age, clinical stage, IGHV mutational status and 
fluorescence in situ hybridization (FISH) results.  
Number Age Binet IGHV FISH 
1 55 A unmutated 13q- 
2 64 A mutated 13q- 
3 48 A mutated 13q-, Tris 18 
4 53 A mutated 13q- 
Mean values ± SEM of four CLL samples and three healthy donor samples are depicted. 
Figure S17. Effects of 1–3 on CLL cell viabiltiy. CLL cells were treated for 24 h with 
increasing concentrations of 1–3 and cell viability was analyzed by CellTiter-Glo® assay. 
Relative cell viability is compared to DMSO control (0.1%). 
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S18
Figure S18. Effects of 1–3 on healthy B-cells cell viabiltiy. Healthy B-cells were treated 
for 24 h with increasing concentrations of 1–3 and cell viability was analyzed by CellTiter-
Glo® assay. Relative cell viability is compared to DMSO control (0.1%). 
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ABSTRACT 1 
Sclerotia are known to be fungal survival structures, and induction of sclerotia may prompt 2 
production of otherwise undiscovered metabolites. Aspergillus sclerotiicarbonarius (IBT 3 
28362) was investigated under sclerotium producing conditions, which revealed a highly 4 
altered metabolic profile. Four new compounds were isolated from cultivation under 5 
sclerotium formation conditions and their structures elucidated using different analytical 6 
techniques (HRMS, UV, 1D and 2D NMR). This included sclerolizine, an alkylated and 7 
oxidized pyrrolizine, the new emindole analog emindole SC and two new carbonarins; 8 
carbonarins I and J. We have identified the three latter as true sclerotial metabolites. All 9 
metabolites were tested for antifungal and antiinsectan activity, and sclerolizine and 10 
carbonarin I displayed antifungal activity against Candida albicans, while all four showed 11 
antiinsectan activity. These results demonstrate induction of sclerotia as an alternative way of 12 
triggering otherwise silent biosynthetic pathways in filamentous fungi for the discovery of 13 
novel bioactive secondary metabolites.    14 
INTRODUCTION 15 
Natural products and their derivatives have historically been widely used as a source of 16 
therapeutic agents and amongst these are secondary metabolites (SMs) produced by 17 
filamentous fungi. In general SMs represent a wide array of structural diversity and display a 18 
broad range of biological activities, which can be utilized for pharmaceutical purposes.   19 
The classical approach for natural product discovery has typically involved screening of 20 
crude extracts from various natural sources followed by purification and structural 21 
elucidation. With recent advances in genome sequencing projects, it has however become 22 
evident that several microorganisms have a far greater biosynthetic potential and metabolic 23 
diversity than previously assumed. In order to discover all metabolites that an organism is 24 
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capable of producing, several approaches can be taken such as the OSMAC (One Strain 1 
Many Compounds)[1], use of epi-genetic inducers[2], co-culturing experiments[3] or various 2 
methods within genome mining[2].  3 
We have recently reported conditions triggering sclerotium production in filamentous 4 
fungi[4], where we demonstrated that under these circumstances a great alteration in the 5 
chemical profile can be acchieved[4]
,
[5]. In this study we follow up and show that the 6 
metabolic profile of A. sclerotiicarbonarius (IBT 28362) is greatly altered, when sclerotia are 7 
produced, leading to the discovery of four novel compounds.  8 
MATERIALS AND METHODS 9 
Media. The CYA media used were prepared as described by Frisvad and Samson[6]. To 10 
trigger sclerotia production, raisins were added to the media (CYAR media) as described by 11 
Frisvad et al.[4]  12 
Fungal growth and extraction. Plates were incubated at 25 °C for 7 days in the dark. For 13 
standard screening three-five plugs were taken from one colony by use of a 6 mm plug drill, 14 
covering the diameter of one colony and extracted by the micro-scale extraction method 15 
described by Smedsgaard[7]. Sclerotia were harvested and extracted as described by Frisvad 16 
et al.[4] 17 
Chemical analysis of strains. Analysis was performed using reversed phase ultra-high-18 
performance liquid chromatography (UPHLC) UV/Vis diode array detector (DAD) high-19 
resolution time-op-flight mass spectrometer (TOFMS) on a maXis G3 orthogonal 20 
acceleration quadrupole time of flight (Q-TOF) mass spectrometer (Bruker Daltonics, 21 
Bremen, Germany) as described by Holm et al.[8] 22 
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Purification of metabolites. A. sclerotiicarbonarius (IBT 28362 = CBS 121057) was 1 
inoculated as three point inoculations on 112 plates of CYAR medium and incubated at 25 °C 2 
for 7 days in the dark. The plates were harvested and extracted twice overnight with ethyl 3 
acetate (EtOAc) with 1 % formic acid and workup was performed as described by Holm et 4 
al.[8] The extract was fractionated using an Isolera flash purification system (Biotage) by 5 
adsorption onto C18 column material and packing into a SNAP column (Biotage, Uppsala, 6 
Sweden) with C18 material. The extract was then fractionated using a linear gradient of ACN-7 
water starting at 30 % ACN and increasing to 100 %. ACN used were of HPLC grade and 8 
H2O was purified and deionized by a Millipore system through a 0.22 μm membrane filter 9 
(milliQ-water). The flow rate used was 40 mL/min, the column volume 124 mL, and 10 
fractions were collected automatically one column volume at a time.  11 
The Isolera fractions were subjected to further purification on a semi-preparative HPLC  12 
which was either a Waters 600 Controller with a 996 photodiode array detector (Waters, 13 
Milford, MA, USA) or a Gilson 322 Controller connected to a 215 Liquid Handler, 819 14 
Injection Module and a 172 DAD (Gilson, Middleton, WI, USA). This was achieved using a 15 
Luna II C18 column (250 x 10 mm, 5 μm, Phenomenex) or a Gemini C6-Phenyl 110A column 16 
(250 x 10.00 mm, 5 μm, Phenomenex). 50 ppm TFA was added to ACN of HPLC grade and 17 
milliQ-water. For choice of system, flow rate, column, gradients and yields see Table 4. 18 
Spectroscopic data for all compounds are given in the supporting information.  19 
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Table 1 Purification details for compound 1-4  1 
Compound 
name 
Isolera 
fraction  
System Column Flow rate Gradient Yield 
Sclerolizine 14/15 Waters Gemini 4 mL/min 90 % ACN isocratic for 15 
min, then to 100 % ACN  
13.0 mg 
Emindole SC 10/15 Waters Luna II C18 5 mL/min 60-80% ACN for 18 min, then 
to 100 % CAN 
20.3 mg 
Carbonarin I 4/15 Gilson Luna II C18 5 mL/min 30-50 % ACN for 15 min, 
then to 100% CAN 
9.6 mg 
Carbonarin J 4/15 Gilson Luna II C18 5 mL/min 30-50 % ACN for 15 min, 
then to 100% ACN 
3.9 mg 
 2 
NMR and structural elucidation. 
1
H and 2D spectra were recorded on a Varian Unity 3 
Inova-500 MHz spectrometer, while 
13
C spectra were recorded on a Bruker Ascend 400 MHz 4 
spectrometer. Spectra were acquired using standard pulse sequences. The deuterated solvent 5 
was DMSO-d6 and signals were referenced to the solvent signals for DMSO-d6 at δH = 2.49 6 
ppm and δC = 39.5 ppm. The NMR data was processed in MestReNova v.6.0.1-5391. 7 
Chemical shifts are in ppm (δ) and scalar couplings are reported in hertz (Hz). Optical 8 
rotation was measured on a Perkin Elmer 321 Polarimeter. 9 
Antifungal susceptibility testing. All compounds were screened for antifungal activity 10 
towards Candida albicans in accordance with the CLSI standards, as described by Holm et 11 
al.[8] 12 
Drosophila larval testing. All compounds were screened for larvicidal activity towards 13 
Drosophila melanogaster larvae as described by Trienens et al.[9], but using MeOH as a 14 
solvent.   15 
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RESULTS AND DISCUSSION 1 
The metabolic profile of A. sclerotiicarbonarius (IBT 28362) was investigated under 2 
conditions both with and without conditions favoring sclerotium formation. The latter was 3 
achieved using media containing raisins (CYAR), as earlier described[4]. Without presence 4 
of sclerotia, the metabolic profile (Figure 1A) displayed only few metabolites. One of the 5 
most abundant metabolites, pyranonigrin A (pyranopyrrol A) (verified with UHPLC-DAD-6 
HRMS by comparison of retention time, monoisotopic mass for the pseudomolecular ion, 7 
adducts and UV spectrum to an authentic standard), is known from other black 8 
aspergilli[10]
,
[11]. With formation of sclerotia, a more diverse production of secondary 9 
metabolites was observed, both in a mycelium plug extraction and by true sclerotial 10 
extraction (Figure 1B and 1C). Known black aspergilli secondary metabolites such as 11 
aurasperone B[12] and malformin C[13]  were detected (verified by UHPLC-DAD-HRMS). 12 
In our previous studies we observed several aflavinines in the sclerotial extracts, and 13 
production of aurasperone B as a common trend[4], which was indeed also the case for A. 14 
sclerotiicarbonarius. 15 
 16 
 17 
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 1 
Figure 1 UHPLC-TOF-HRMS ESI+ BPC chromatogram of Aspergillus sclerotiicarbonarius (IBT = 28362) extractions. 2 
Scaled to RT between 1-12 minutes, intensities are to scale. A: Plug extraction from growth with no sclerotium production. 3 
B: Plug extraction from growth with sclerotium production. C: Sclerotial extraction. The extractions under sclerotium 4 
production (B + C) show the presence of the four novel compounds sclerolizine (1), emindole SC (2), carbonarin I (3) and 5 
carbonarin J (4). 6 
 7 
From the sclerotial extract several putative unknown compounds were detected. From a 8 
larger extract cultivated under sclerotium formation conditions, these compounds were 9 
purified and their structures solved by 1D and 2D NMR spectroscopy, Figure 2 and Table 2. 10 
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  1 
Figure 2 Structures of the novel compounds isolated from A. sclerotiicarbonarius. 2 
Table 2. 1H (500 MHz) and 13C (125 MHz) NMR Spectroscopic Data for compounds 1-4. 3 
 1  2  3  4 
# δH (J in Hz) δC  δH (J in Hz) δC  δH (J in Hz) δC  δH (J in Hz) δC 
1 - 175.2  10.57 (1H, s) -  1.43 (3H, s) 26.9  2.16 (3H, s) 20.0 
2 - 103.1  - 140.3  - 99.9  - 168.3 
3 - 188.7  7.25 (1H, d, 7.1) 111.8  3.11 47.6  6.18 (1H, s) 106.4 
3’       2.78 47.6    
4 - 194.5  6.93 (1H, t) 119.4  - 155.6  - 149.8 
5 3.98  (1H, dd, 9.8, 
6.6) 66.8 
 
6.89 (1H, t) 118.4  - 110.2  - 109.2 
6 1.40 (1H, m) 26.4  7.27 (1H, d, 7.1) 117.8  - 141.5  - 161.0 
6’ 2.01 (1H, m) 26.4          
7 1.99 (2H, m) 26.3  - 124.6  6.22 (1H, s) 97.6  6.41 (1H, d, 2.1) 96.5 
8 3.09 (1H, m) 42.7  - 115.9  - 161.1  - 160.5 
8’ 3.52 (1H, dt, 10.9, 
7.8) 42.7 
 
        
9 
2.73 (2H, t, 7.5) 32.9 
 2.55 (1H, dd, 13.1, 
6.5) 26.8  6.42 (1H, s) 95.3  6.52 (1H, d, 2.0) 96.5 
9’ 
  
 2.26 (1H, dd, 13.1, 
11.0) 26.8       
10 1.53 (2H, m) 24.4  3.20 (1H, m) 41.9  - 161.2  - 106.7 
11 1.32 (2H, m) 28.4  1.78 (1H, m) 34.7  - 106.1  - 107.4 
11’    1.68 (1H, m) 34.7       
12 1.93 (2H, m) 31.5  4.14 (1H, br. s.) 66.2  - 163.4  - 161.6 
13 5.34 (1H, m) 129.7  1.49 (1H, br.s) 42.6  - 102.4  - 103.2 
14 5.35 (1H, m) 129.8  - 40.5  - 198.2  - 184.1 
15 
1.92 (2H, m) 31.5 
 4.68 (1H, dd, 11.2, 
3.9) 75.5  - 122.5  - 120.3 
16 1.27 (2H, m) 28.4  1.87 (1H, m) 23.5  - 154.9  - 154.9 
16’    1.69 (1H, m) 23.5       
17 
1.22 (2H, m) 28.4/21.9* 
 
1.83 (1H, m) 32.5  
7.00 (1H, dd, 8.4, 
2.8) 115.3  7.07 (1H, d, 8.4) 115.6 
17’    1.72 (1H, m) 32.5       
18 
1.22 (2H, m) 28.4/21.9* 
 
- 52.4  
7.32 (1H, dd, 8.4, 
2.1) 129.9  
7.43 (1H, dd, 8.4, 
2.1) 129.9 
19 1.22 (2H, m) 28.4/21.9*  - 39.6  - 121.9  - 122.5 
20 
1.22 (2H, m) 28.4 
 
- 151.3  
7.21 (1H, dd, 4.0, 
2.2) 133.4  7.27 (1H, d, 2.0) 133.2 
21 1.22(2H, m) 28.4/21.9*  0.90 (3H, s) 14.2  - 130.9  - 130.9 
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22 1.25 (2H, m) 21.9     - 152.1  - 152.2 
23 0.84 (3H, t, 6.9) 13.7     3.74 (2H, s) 47.2  3.75 (2H, s) 47.2 
24       8.15 (1H, s) -  8.12 (1H, s) - 
25       - 172.9  - 172.6 
26       3.76 (2H, s) 33.2  3.76 (2H, s) 33.4 
27       - 129.2  - 128.7 
28       6.65 (1H, m) 112.3  6.64 (1H, m) 112.4 
29       - 147.4  - 147.2 
30       - 144.6  - 145.0 
31       6.64 (1H, m) 115.3  6.63 (1H, d, 8.5) 115.3 
32      
 6.51 (1H, m) 120.2  
6.49 (1H, dd, 8.0, 
1.6) 120.3 
33       3.57 (3H, s) 55.8  3.90 (3H, s) 55.8 
34       3.88 (3H, s) 54.5  3.61 (3H, s) 54.7 
35       3.60 (3H, s) 54.9  3.59 (3H, s) 54.9 
36       14.38 (1H, s) -  15.09 (1H, s) - 
37       9.15 (1H, s) -  9.36 (1H, s) - 
38       8.80 (1H, s) -  8.81 (1H, s) - 
39       6.92 (1H, s) -    
*Due to overlapping signals the specific carbon chemical shift could not be determined. 1 
 2 
Structural elucidation of four new compounds. The UV spectrum of sclerolizine displayed 3 
absorption maxima at 280 nm, and the ESI+ HRMS spectrum displayed one adduct, with m/z 4 
= 376.2855, from which the molecular formula could be deduced to C23H37NO3 (376.2846 5 
calculated for [C23H37NO3 + H]
+
).   The 
1
H NMR spectra revealed the presence of one Hα 6 
proton (H5), which was found to be part of a COSY spin system with three methylene groups 7 
(C6, C7 and C8), which altogether were elucidated as the pyrrolidine ring. The remaining 8 
resonances in the 
1
H NMR spectra belonged to a larger spin system with two overlapping 9 
protons in the double bond area, one methyl and 12 methylene groups, whereof five (H17, 10 
H18, H19, H20 and H21) where overlapping at δH 1.22 ppm. The linking between the two 11 
COSY spin systems and the assignment of four quaternary carbons (two carbonyls, two 12 
double bond carbons) were accomplished through detailed analysis of the HMBC spectral 13 
data (Figure 3). It is noted that there was no HMBC correlations linking the two spin systems, 14 
but to justify the chemical shifts observed, the suggested structure was the only appropriate 15 
proposal. The resonances originating from the C13-C14 double bond were very close in 16 
chemical shift leading to a second order spin system. Consequently it was not possible to 17 
accurately determine the size of the J coupling constant. A value of J could however be 18 
measured to 15.2 Hz in the second order system, suggesting a trans double bond. 19 
Furthermore the chemical shifts for the neighboring allylic carbons at 31.5 ppm (C12 and 20 
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C15) were also in consistence with a trans configuration as allylic carbons in cis fatty acids 1 
would be further up field, typically at values below 30 ppm[14]. The stereochemistry of the 2 
C2-C3 double bond and C5 has not been investigated, but we hypothesize that L-proline is 3 
incorporated into the molecule. Similar synthetic structures have been patented[15]
,
[16], 4 
however to the best of our knowledgethis is the first report of an oxidized pyrrolizines from a 5 
natural source.. 6 
 7 
Figure 3 Key HMBC correlations of sclerolizine (1) 8 
The UV spectrum of emindole SC displayed absorption maxima at 283 nm, and the ESI+ 9 
HRMS spectrum displayed one adduct, with m/z = 464.3164, from which the molecular 10 
formula could be deduced to C30H41NO3 (464.3159 calculated for [C30H41NO3 + H]
+
). The 11 
backbone of emindole SC display the same skeleton as emindole SB from Emericella 12 
striata[17]. The main difference of emindole SC is an extra hydroxyl group (C12) and an 13 
acetylation at C15. This gives rise to additional signals in the 
1
H NMR spectrum from the 14 
methyl group C31, and HMBC correlations to the carbonyl at δC 170 ppm (C30) from H15 15 
and H31. The chemical shift of H12 is shifted downfield to δH 4.14 ppm, and the addition of 16 
the hydroxyl is also evident from the carbon chemical shift, which is moved downfield to δC 17 
66.2 ppm. Otherwise the NMR data is very comparable to those of emindole SB[17]. NOESY 18 
experiments enabled determination of the relative stereochemistry for the stereogenic centers. 19 
NOE connectivities were found from H13 to H12, H15 and H21 placing these on the same 20 
side of the ring systems, which is also observed for other emindoles. This was further verified 21 
by strong NOESY connectivities between H10 and H22 as well as H23 and H32. 22 
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The UV spectra of carbonarin I and J displayed absorption maxima at 410 nm suggesting a 1 
highly conjugated chromophore. Analysis of the HRMS data showed m/z of 614.2025 and 2 
596.1923, which was used to determine the molecular formula to C34H31NO10 and C34H29NO9 3 
(614.2021 and 596.1915 calculated for [C34H31NO10 + H]
+
 and [C34H29NO9 + H]
+ 
4 
respectively). Structural elucidation of the two related compounds revealed structures similar 5 
to those of carbonarin A-H, which are metabolites from A. carbonarius[18]
,
[19]. Carbonarin I 6 
and J differ at C2 and C3, with a single bond in the former and a double bond in the latter. C2 7 
has furthermore a hydroxyl group shifting the carbon chemical shift dramatically downfield 8 
to δC 99.9 ppm. No HMBC correlations were observed to the carbons at C6 for carbonarin I 9 
and C4, C6 or C14 for carbonarin J, wherefore these were assigned from resonances in the 10 
1D 
13
C carbon spectrum. The upper part of carbonarin I and J is alike (Figure 2), including 11 
two partly substituted aromatic rings and a five membered lactam ring. This part is unique for 12 
carbonarin I and J compared to other carbonarins, which show different substitution patterns 13 
in the aromatic rings. The bottom part consists of a three ring system polyketide part present 14 
in both carbonarin I and J, similar to what is seen in other naphthopyrones such as 15 
aurasperone B[12] and fonsecin B[20]. By comparison to an authentic standard, we found 16 
trace amounts of fonsecin B being produced under conditions with sclerotium formation (data 17 
not shown), why we hypothesize that fonsecin B is the likely precursor of the new 18 
carbonarins described here. 19 
A search for carbonarin A-H in the UHPLC-UV-HRMS data from the sclerotial extract 20 
showed trace amounts of carbonarin A-D, high production of carbonarin E and F, while no 21 
carbonarin G nor H could be detected (Tentatively identified by HRMS with a mass tolerance 22 
of m/z +/- 0.005). An equivalent search for carbonarins in the A. sclerotiicarbonarius extract 23 
with no sclerotium production showed no traces of any of the carbonarins, clearly indication 24 
that this group of compounds is be related to sclerotium production.   25 
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Three of the new compounds are true sclerotial metabolites. For verification of whether 1 
the compounds are true sclerotial metabolites, extracted ion chromatograms (EICs) with a 2 
mass tolerance of +/- 0.005 were performed based on plug extraction from growth conditions 3 
with and without sclerotium formation as well as the sclerotium extraction, Table 3 and 4 
supporting information. It was here found that all metabolites (1-4) were present in both the 5 
sclerotial extracts and the plug extracts under sclerotium formation. In the plug extraction 6 
where no sclerotia were formed, all compounds, but sclerolizine were absent, strongly 7 
indicating that emindole SC, carbonarin I, and carbonarin J are true sclerotium metabolites.  8 
Table 3. Presence of compound 1-4 with and without sclerotium production. Detected by 9 
Extracted Ion Chromatograms (EICs) with a mass tolerance of m/z +/- 0.005. 10 
 Plug extraction CYA 
(No sclerotium formation) 
Plug extraction CYA 
(Sclerotium formation) 
Sclerotial extraction 
Sclerolizine (1) x x x 
Emindole SC (2) - x x 
Carbonarin I (3) - x x 
Carbonarin J (4) - x x 
  11 
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Bioactivities 1 
Compounds 1-4 were tested for antifungal and insecticidal activity. The half maximal 2 
inhibitory concentrations (IC50) for Candida albicans treated with compound 1-4 are 3 
displayed in Table 4. The IC50 values were calculated based on duplicate experiments carried 4 
out in at least two independent trials and annotated with their respective standard deviation. 5 
Sclerolizine and carbonarin I displayed moderate antifungal activity, with sclerolizine as the 6 
most active. 7 
Table 4. Antifungal activities of compound 1-4 against Candida albicans.  8 
  Compound Origin IC50 (µM)   
 Sclerolizine (1) A. sclerotiicarbonarius 8.5 ± 2.0  
 Emindole SC (2) A. sclerotiicarbonarius >100  
 Carbonarin I (3) A. sclerotiicarbonarius 85.8 ± 13.1  
 Carbonarin J (4) A. sclerotiicarbonarius >100  
 9 
As sclerotial compounds have often been found to possess insecticidal properties[21], all 10 
compounds were furthermore tested for larvicial activity towards Drosophila melanogaster 11 
larvae. The results are depicted in Figure 4. With increasing concentrations all compounds 12 
were affecting the survival of the insect larvae (p < 0.001), yet there was no compound-13 
specific variation in this effect. Overall, at a concentration of 1.83 ±0.08 µmol, 50% of the 14 
larvae were found dead. 15 
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 1 
Figure 4. Mean proportional survival of Drosophila larvae to the pupal stage as a function of 2 
different concentrations (µmol) of the A. sclerotiicarbonarius new compounds in the insect's 3 
food. Error bars depict the standard error. 4 
CONCLUSION 5 
We here show that the chemical profile of A. sclerotiicarbonarius is greatly altered when 6 
cultivated under conditions favoring production of sclerotia. By cultivation of a large scale 7 
extract under these conditions we have isolated four novel secondary metabolites of mixed 8 
biosynthetic origin and elucidated their structures leading to the new compounds sclerolizine, 9 
emindole SC, carbonarin I and J. Our analysis has shown that the three latter compounds 10 
were locally restricted to the sclerotia, which indicates that these are true sclerotial 11 
metabolites.  12 
Sclerolizine and carbonarin I displayed antifungal activity against Candida albicans and all 13 
four compounds antiinsectan activity. This study thus provides an alternative way of 14 
triggering silent biosynthetic pathways in filamentous fungi for the discovery of novel 15 
bioactive secondary metabolites. With the discovery of a perfect state in Aspergillus 16 
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sclerotiicarbonarius[22], further secondary metabolites may be discovered in the progeny of 1 
this species. 2 
 3 
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S 1. Extrated Ion Chromatograms of compounds 1-4 
Extracted Ion Chromatograms to check the presence of compound 1-4 with and without sclerotia 
production. Detected by Extracted Ion Chromatograms (EICs) with a m/z of 376.2846, 464.3159, 
614.2021, and 596.1915 respectively with a tolerance of m/z +/- 0.005. A: Plug extraction from 
growth with no sclerotia production. B: Plug extraction from growth with sclerotia production. C: 
Sclerotia extraction. Scaled to relevant RT for each compound; intensities are to scale.  
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S 2. UV spectra of compounds 1-4 
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S 3. Spectroscopic data for sclerolizine (1) 
HRESIMS: [M+H]
+
 = 376.2855, calculated for [C23H37NO3+H]
+ 
= 376.2846,       
           
 
 
Atom assignment 
1
H-chemical shift [ppm]/  
(integral, mult., J [Hz])  
13
C-chemical shift  
[ppm] 
HMBC 
correlations 
1 - 175.2  
2 - 103.1  
3 - 188.7  
4 - 194.5  
5 3.98  (1H, dd, 9.8, 6.6) 66.8 1, 4, 7 
6 1.40 (1H, m) 26.4 4, 5, 7 
6’ 2.01 (1H, m) 26.4 5, 7, 8 
7 1.99 (2H, m) 26.3 5, 6 
8 3.09 (1H, m) 42.7 1, 5, 6 
8’ 3.52 (1H, dt, 10.9, 7.8) 42.7 1, 5, 6 
9 2.73 (2H, t, 7.5) 32.9 2, 3, 10, 11 
10 1.53 (2H, m) 24.4 3, 9, 11, 12 
11 1.32 (2H, m) 28.4 9, 10, 12, 13 
12 1.93 (2H, m) 31.5 10 
13 5.34 (1H, dd, 15.2, 5.2) 129.7 14, 15 
14 5.35 (1H, dd, 15.2, 5.2) 129.8 13, 15 
15 1.92 (2H, m) 31.5 16/17/18/19/20/21**, 14 
16 1.27 (2H, m) 28.4 16/17/18/19/20/21** 
17 1.22 (2H, m) 28.4/21.9* 22, 23, 16/17/18/19/20/21** 
18 1.22 (2H, m) 28.4/21.9* 22, 23, 16/17/18/19/20/21** 
19 1.22 (2H, m) 28.4/21.9* 22, 23, 16/17/18/19/20/21** 
20 1.22 (2H, m) 28.4 22, 23, 16/17/18/19/20/21** 
21 1.22(2H, m) 28.4/21.9* 22, 23, 16/17/18/19/20/21** 
22 1.25 (2H, m) 21.9 20, 21, 23 
23 0.84 (3H, t, 6.9) 13.7 21, 22  
*Due to overlapping signals the specific carbon chemical shift could not be determined 
**Due to many carbon chemical shifts at Cδ = 28.4 ppm, this HMBC correlation could not be unambiguously 
assigned. 
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S 4. 
1
H NMR (500 MHz, DMSO-d6 spectrum) of the new compound sclerolizine (1) 
 
 
S 5. DQF-COSY spectrum of the new compound sclerolizine (1)
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S 6. HSQC spectrum of the new compound sclerolizine (1)
 
S 7. HMBC spectrum of the new compound sclerolizine (1) 
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S 8. Spectroscopic data for emindole SC (2) 
HRESIMS: [M+H]
+
 = 464.3159, calculated for [C30H41NO3+H]
+ 
= 464.3159,       
        
 
 
Atom 
assignment 
1
H-chemical shift [ppm]/  
(integral, mult., J [Hz]) 
13
C-
chemical 
shift  
[ppm] 
HMBC 
correlations 
NOESY 
1 10.57 (1H, s) - 2, 7, 8, 20 3, 17 
2 - 140.3 -  
3 7.25 (1H, d, 7.1) 111.8 5, 7 1, 4 
4 6.93 (1H, t) 119.4 2, 6 3 
5 6.89 (1H, t) 118.4 3, 7 6 
6 7.27 (1H, d, 7.1) 117.8 2, 4, 8 5 
7 - 124.6 -  
8 - 115.9 -  
9 2.55 (1H, dd, 13.1, 6.5) 26.8 8, 10, 18, 20 9’,10 
9’ 2.26 (1H, dd, 13.1, 11.0) 26.8 8, 10, 11/11’, 20 9,10,21 
10 3.20 (1H, m) 41.9 9/9’, 11/11’, 12, 18, 19, 21 9,9’,22 
11 1.78 (1H, m) 34.7 18 12 
11’ 1.68 (1H, m) 34.7 12, 13, 18 12 
12 4.14 (1H, br. s.) 66.2 10, 19 11,11’,13 
13 1.49 (1H, br.s) 42.6 12, 14, 15, 18 12,15,21 
14 - 40.5 -  
15 4.68 (1H, dd, 11.2, 3.9) 75.5 14,16/16’,17/17’,23,24/24’,30 13,16’ 
16 1.87 (1H, m) 23.5 15  
16’ 1.69 (1H, m) 23.5 14, 15, 18, 19, 22 15 
17 1.83 (1H, m) 32.5 13, 15, 16/16’, 19, 22 1 
17’ 1.72 (1H, m) 32.5 14, 15, 19 21 
18 - 52.4 -  
19 - 39.6 -  
20 - 151.3 -  
21 0.90 (3H, s) 14.2 10, 18, 19, 20 9’,13,17’ 
22 1.33 (3H, s) 20.5 13, 17/17’, 18, 19 10 
23 1.26 (3H, s) 19.3 13, 14, 15, 24/24’ 32 
24 1.54 (1H, m) 37.5 -  
24’ 1.22 (1H, m) 37.5 -  
25 1.93 (1H, m) 21.0 26, 27 26 
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25’ 1.76 (1H, m) 21.0 26, 27 26 
26 5.04 (1H, t, 7.0) 124.6 24/24’ 25/25’, 28, 29 24’,25,25’,28,29 
27 - 130.6 -  
28 1.53 (3H, s) 17.4 26, 27 26 
29 1.64 (3H, s) 25.4 24/24’, 26, 27, 28  26 
30 - 170.0 -  
31 2.01 (3H, s) 20.7 15, 30  
32 4.42 (1H, br.s) - 12, 13 23 
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S 9. 
1
H NMR (500 MHz, DMSO-d6 spectrum) of the new compound emindole SC (2) 
 
S 10. DQF-COSY spectrum of the new compound emindole SC (2) 
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S 11. Ed-HSQC spectrum of the new compound emindole SC (2) 
 
S 12. HMBC spectrum of the new compound emindole SC (2) 
  
  
PhD Thesis 
Lene Maj Petersen
281
Supporting information 
11 
 
S 13. Spectroscopic data for carbonarin I (3) 
HRESIMS: [M+H]
+
 = 614.2025, calculated for [C34H31NO10+H]
+ 
= 614.2021,       
          
 
 
 
Atom assignment 
1
H-chemical shift [ppm]/  
(integral, mult., J [Hz]) 
13
C-chemical shift  
[ppm] 
HMBC 
correlations 
NOESY 
1 1.43 (3H, s) 26.9 2, 3/3’, 14  
2 - 99.9 -  
3 3.11 47.6 1, 2, 14 3’ 
3’ 2.78 47.6 1, 2, 14 3 
4 - 155.6 -  
5 - 110.2 -  
6 - 141.5 -  
7 6.22 (1H, s) 97.6 5, 8/10, 9, 11 33 
8 - 161.1 -  
9 6.42 (1H, s) 95.3 7, 8/10, 11 33, 34 
10 - 161.2 -  
11 - 106.1 -  
12 - 163.4 -  
13 - 102.4 -  
14 - 198.2 -  
15 - 122.5 -  
16 - 154.9 -  
17 7.00 (1H, dd, 8.4, 2.8) 115.3 15, 16, 19 18 
18 7.32 (1H, dd, 8.4, 2.1) 129.9 16, 20, 21 17 
19 - 121.9 -  
20 7.21 (1H, dd, 4.0, 2.2) 133.4 5, 16, 18, 21  
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21 - 130.9 -  
22 - 152.1 -  
23 3.74 (2H, s) 47.2 21, 22 24 
24 8.15 (1H, s) - 21, 22, 23, 25 23 
25 - 172.9 -  
26 3.76 (2H, s) 33.2 21, 22, 23, 28, 32  
27 - 129.2 -  
28 6.65 (1H, m) 112.3 26, 30, 32  
29 - 147.4 -  
30 - 144.6 -  
31 6.64 (1H, m) 115.3 27, 29 32 
32 6.51 (1H, m) 120.2 26, 28, 30 31 
33 3.57 (3H, s) 55.8 8 7, 9 
34 3.88 (3H, s) 54.5 10 9 
35 3.60 (3H, s) 54.9 29  
36 14.38 (1H, s) - 11, 12, 13, 14  
37 9.15 (1H, s) - 15, 16, 17  
38 8.80 (1H, s) - -  
39 6.92 (1H, s) - 2, 3, 4  
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S 14. 
1
H NMR (500 MHz, DMSO-d6 spectrum) of the new compound carbonarin I 
(3) 
 
S 15. DQF-COSY spectrum of the new compound carbonarin I (3) 
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S 16. HSQC spectrum of the new compound carbonarin I (3) 
 
S 17. HMBC spectrum of the new compound carbonarin I (3) 
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S 18. Spectroscopic data for carbonarin J (4) 
HRESIMS: [M+H]
+
 = 596.1923, calculated for [C34H29NO9+H]
+ 
= 596.1915,       
          
 
 
Atom assignment 
1
H-chemical shift [ppm]/  
(integral, mult., J [Hz]) 
13
C-chemical shift  
[ppm] 
HMBC 
correlations 
NOESY 
1 2.16 (3H, s) 20.0 2, 3 3 
2 - 168.3 -  
3 6.18 (1H, s) 106.4 1, 2, 13 1 
4 - 149.8 -  
5 - 109.2 -  
6 - 161.0 -  
7 6.41 (1H, d, 2.1) 96.5 5, 9, 11  
8 - 160.5 -  
9 6.52 (1H, d, 2.0) 96.5 7, 10, 11  
10 - 106.7 -  
11 - 107.4 -  
12 - 161.6 -  
13 - 103.2 -  
14 - 184.1 -  
15 - 120.3 -  
16 - 154.9 -  
17 7.07 (1H, d, 8.4) 115.6 15, 16, 19 18, 37 
18 7.43 (1H, dd, 8.4, 2.1) 129.9 15, 16, 20, 21  17 
19 - 122.5 -  
20 7.27 (1H, d, 2.0) 133.2 5, 15, 21  
21 - 130.9 -  
22 - 152.2 -  
23 3.75 (2H, s) 47.2 21, 22, 25 24 
24 8.12 (1H, s) - 21, 22, 23, 25 23 
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25 - 172.6 -  
26 3.76 (2H, s) 33.4 23, 27, 28, 32  28 
27 - 128.7 -  
28 6.64 (1H, m) 112.4 26, 30, 32 26, 35 
29 - 147.2 -  
30 - 145.0 -  
31 6.63 (1H, d, 8.5) 115.3 27, 29, 30 38 
32 6.49 (1H, dd, 8.0, 1.6) 120.3 26, 28, 30  
33 3.90 (3H, s) 55.8 8 34 
34 3.61 (3H, s) 54.7 10 33 
35 3.59 (3H, s) 54.9 29 28 
36 15.09 (1H, s) - 11, 12, 13   
37 9.36 (1H, s) - 15, 16, 17 17 
38 8.81 (1H, s) - 29, 30, 31 31 
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S 19. 
1
H NMR (500 MHz, DMSO-d6 spectrum) of the new compound carbonarin J 
(4) 
 
S 20. DQF-COSY spectrum of the new compound carbonarin J (4) 
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S 21. Ed-HSQC spectrum of the new compound carbonarin J (4) 
 
S 22. HMBC spectrum of the new compound carbonarin J (4) 
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Abstract: Aspergillus oryzae and A. flavus are important species in industrial 
biotechnology and food safety and have been some of the first aspergilli to be fully genome 
sequenced. Bioinformatic analysis has revealed 99.5% gene homology between the two 
species pointing towards a large coherence in the secondary metabolite production. In this 
study we report on the first comparison of secondary metabolite production between the 
full genome sequenced strains of A. oryzae (RIB40) and A. flavus (NRRL 3357). 
Surprisingly, the overall chemical profiles of the two strains were mostly very different 
across 15 growth conditions. Contrary to previous studies we found the aflatrem precursor 
13-desoxypaxilline to be a major metabolite from A. oryzae under certain growth 
conditions. For the first time, we additionally report A. oryzae to produce parasiticolide A 
and two new analogues hereof, along with four new alkaloids related to the A. flavus 
metabolites ditryptophenalines and miyakamides. Generally the secondary metabolite 
capability of A. oryzae presents several novel end products likely to result from the 
domestication process from A. flavus. 
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ditryptoleucine; oryzamide 
 
1. Introduction 
Aspergillus oryzae is one of industry’s most used “workhorses” and has been used for centuries in 
food fermentation for the production of e.g., sake, soy sauce and other traditional Asian foods [1].  
A. oryzae is also a widely used organism for production of amylase, lipases and proteases and more 
recently also for heterologous expression of secondary metabolite genes and non-fungal proteins [2–4]. 
For many years, A. oryzae has been suspected to be a domesticated form of A. flavus, a plant and 
mammalian pathogenic saprophyte, capable of producing some of the most carcinogenic compounds 
known: the aflatoxins. Genetic work and subsequent genome sequencing of strains of both species 
have verified the tight link between the species [1,5–8]. 
The relationship of the two species has resulted in extensive screening of the toxic potential of  
A. oryzae, but no genuine evidence of aflatoxin production in validated A. oryzae isolates has ever 
been shown. Other important toxins, known from A. flavus, have on the other hand been shown in  
A. oryzae: 3-Nitropropionic acid [9] and cyclopiazonic acid (CPA) [10] along with kojic acid [11,12] 
(Figure 1). Additional metabolites previously reported from A. oryzae are asperfuran [13], sporogen 
AO1 [14,15], maltoryzine [16], and aspergillomarasmine A [17,18]. Aspirochlorine has been found in 
A. flavus, A. oryzae and A. tamarii [19–23] (Figure 1). For reviews on the safety and taxonomy of  
A. oryzae, see [7,24–26]. 
Figure 1. Known compounds from Aspergillus flavus or A. oryzae. 
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The few predicted differences between the genomes of A. oryzae and A. flavus (ca. 99.5% genome 
homology and 98% at the protein level for RIB40/ATCC 42149 and NRRL 3357 [27]), could lead one 
to expect A. oryzae to produce most of the metabolites found in A. flavus [1,28–31], but published 
metabolic data indicates a very low chemical correlation [32]. It is with reference to the established 
genetic heritage of A. oryzae from A. flavus remarkable that maltoryzine, sporogen AO1, asperfuran 
and aspergillomarasmine A have never been unambigously identified in A. flavus. Though research on 
A. flavus chemistry has focused primarily on toxic compounds, one would expect that these 
metabolites should be part of its chemical potential as they are for the domesticated A. oryzae. The 
preliminary bioinformatic studies in conjunction with the genome sequencing shows roughly the same 
number of predicted genes: 32 Polyketide synthases (PKSs) and 28 non-ribosomal synthases (NRPSs) 
for A. flavus and 32 PKSs and 27 NRPSs for A. oryzae with 2 NRPSs apparently unique for each  
strain [33]. The exclusiveness of these genes in terms of end product has yet to be verified chemically. 
Most of the predicted genes for secondary metabolites of A. oryzae (or A. flavus) have not been 
mapped to specific metabolic products, despite the genome sequencing of RIB40 in 2005 [27]. Only 
genes of the most important toxins: Aflatoxin [31,34,35], CPA [36,37] and aflatrem [38] have been 
fully annotated in both species, which leaves much to be explored. The full chemical potential of either 
species is unknown and epigenetic modifiers [39–43] may be necessary, alongside with the use of 
different growth conditions to aid triggering the full potential of secondary metabolite expression in 
these two closely related species. 
The aim of the current work has been to perform an initial comparative investigation of the 
chemistry from the two genome sequenced strains of A. oryzae (RIB40) and A. flavus (NRRL 3357), in 
order to get further insights into possible homologies and differences in secondary metabolite 
production for these two important species. 
2. Results and Discussion 
2.1. De-Replication of A. oryzae RIB40 
For the analysis of A. oryzae RIB40 chemistry, we investigated a series of solid media (YES, 
YESBEE, DRYES, CYA, CYAS, CY20, CY40, DUL, GAK, GMMS, MEA, OAT, PDA, TGY, 
WATM (see Methods and Materials for explanation) cultivations with micro-scale extractions [44,45] 
and subsequently analyzed with HPLC-DAD-MS for selection of optimal conditions. The different 
media were tested on a collection of A. oryzae (RIB40, IBT 28103) and A. flavus (NRRL 3357, IBT 
23106, IBT 3642) and these strains were cultivated at 25 °C in the dark for 7 and 14 days. The media 
screening for A. oryzae and A. flavus indicated the greatest chemodiversity and metabolite production 
from CYA, YES and WATM agar for our purpose. 
The comparison of the secondary metabolite profiles of the two strains, NRRL 3357 and RIB40, 
exposed a surprisingly high degree of chemical difference on all media as illustrated in Figure 2 and 
Table 1 for the WATM medium. The major metabolite repetitions between the two genome sequenced 
strains were merely kojic acid and ergosterol, like a number of minor metabolites (not analyzed here) 
seemed to be shared between the two strains. Altogether, this is in sharp contrast to the high gene 
homology, particularly for the secondary metabolite genes. 
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Figure 2. ESI+ BPC chromatogram of 7 day micro scale extract from WATM, bottom:  
A. oryzae RIB40, top: A. flavus NRRL 3357. Besides kojic acid (shown in box) and analogues 
in the beginning of chromatogram and ergosterol in the end (not shown), there are very few 
identical compounds between the genetically almost identical strains. Note that aspirochlorine 
is only detectable in negative ionization, and therefore not visible in this chromatogram. 
 
Table 1. LC-MS de-replication of some of the important secondary metabolite pathways 
from the two full genome sequenced siblings, A. flavus (NRRL 3357) and A. oryzae 
(RIB40). Based on 7 day fermentation on solid WATM agar in the dark. (+) indicates the 
presence of these types of compounds in A. flavus based on UV spectroscopic analysis.  
* New compounds reported here for the first time. 
Metabolite A. flavus NRRL 3357 A. oryzae RIB40 
Kojic acid + + 
Aflatoxin + - 
Aflavinines (+) + 
Aflatrem + 13-desoxypaxilline 
Miyakamides (+) Oryzamides * 
Aspirochlorine - + 
Cyclopiazonic acid + - 
Ditryptophenaline + Ditryptoleucine * 
Parasiticolide A - 14-deacetyl parasiticolide A * 
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Known metabolites to A. oryzae were de-replicated and we found that the RIB40 strain did not 
produce detectable levels (LC-MS) of CPA (as also noted by Tokuoka et al. [36]), asperfuran, 
sporogen AO1, maltoryzine or aspergillomarasmine under these growth conditions. It did, however, 
produce kojic acid and aspirochlorine and a series of potentially new metabolites of which some were 
isolated, structurally characterized and reported here. 
2.2. New Metabolites to A. oryzae RIB40 
During fermentation of the chemically potent RIB40 strain, we have been interested in the 
tremorgenic compounds, allegedly coupled to fungal sclerotia [46–54] and whether these could be 
found in A. oryzae as they have been in A. flavus. The RIB40 strain produces large and abundant 
sclerotia, especially on WATM agar, a fact not widely announced in literature although sclerotia have 
been observed in A. oryzae sporadically [55–57]. No sclerotia were observable after 14 days on YES 
agar, but although these metabolites are often characterized as sclerotial metabolites, there is not a 
strict correlation between the biosynthesis of these metabolites and the formation of sclerotia, as also 
noted by Wilson [58], and this extract was used for the described isolations. 
Here, we report the discovery of the aflatrem precursor 13-desoxypaxilline (13-dehydroxypaxilline) 
in A. oryzae RIB40, originally isolated from Penicillium paxilli [59–63]. Aflatrem is known from  
A. flavus and was discovered by Wilson and Wilson in 1964 [64] and structure elucidated by  
Gallagher et al. in 1978 and 1980 [65,66]. 13-desoxypaxilline was present in YES, CYA, OAT and 
WATM agar 7 day old micro-scale extracts. From the 14 days old YES 200 plate extract used for 
isolation, 13-desoxypaxilline was recovered as an intermediate metabolite. LC-MS, LC-MS/MS and 
NMR data analysis (Supplementary Material) confirmed the structure. Naturally the prospect of 
finding aflatrem itself was investigated, though no apparent peak was visible in HPLC-DAD data files. 
The use of a LC-MS/MS method further confirmed 13-desoxypaxilline as an end-product of A. oryzae 
RIB40 for the above cultivation conditions, since none of the proposed intermediate steps towards 
aflatrem could be detected (LC-MS/MS) and only one sample (WATM, 7d) showed traces of 
paspaline, a precursor for 13-desoxypaxilline (Figure 3). 
Figure 3. The final steps in the proposed biosynthesis of aflatrem (in A. flavus). A. oryzae 
RIB40 biosynthesis stops at 13-desoxypaxilline [38]. 
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A second extract was made from 100 plates of a 14-day old A. oryzae RIB40 culture grown on 
WATM agar with abundant sclerotia formation to validate the findings from the YES extract. The 
analysis of the WATM extract showed 13-desoxypaxilline as a major metabolite alongside other 
sclerotium-related metabolites, such as aflavinines (based on UV-data not shown). The discovery of 
13-desoxypaxilline as the apparent end-product of A. oryzae RIB40 is in agreement with the analysis 
of Nicholson et al. [38], who showed that a frameshift mutation in the atmQ gene presumably accounts 
for 13-desoxypaxilline not being converted into paspalicine and paspalinine. This mutation is therefore 
likely responsible for terminating the aflatrem biosynthesis in RIB40 prematurely, short of the acetal 
ring closure, C-13 hydroxylation and isoprene attachment. Nicholson et al. [38] demonstrated that 
AtmQ is a multifunctional cytochrome P450 monooxygenase likely to catalyze the several oxidative 
steps needed for biosynthesis of the acetal ring present in the structures of paspalicine, paspalinine and 
aflatrem, altogether pointing towards a more complex biosynthesis than shown here. Contrary to our 
discovery, Nicholson et al. did not find the aflatrem gene cluster of RIB40 to be transcribed during 
their fermentations [38]. 
The isolated 13-desoxypaxilline is a member of the paspalitrem tremorgens, a widely distributed 
group of metabolites that have been isolated from several genera: Penicillium, Eupenicillium, 
Claviceps, Emericella, Aspergillus and Phomopsis [67–69]. Besides the tremorgenic activity in 
animals, these metabolites have been shown to be insecticides [68], which is believed to be their 
ecological function together with aflatoxin and CPA for protection of the sclerotia against fungivorous 
insects [46,47]. 
In addition to 13-desoxypaxilline, two new analogues of parasiticolide A were also isolated and are 
here reported for the first time. The metabolites showed to be dide- and 14-deacetoxy analogues, and 
are most likely precursors to the sesquiterpene parasiticolide A (= astellolide A) (see Figure 4). The 
metabolites were present in CYA, YES and WATM extracts and isolated from the same 14 day old 
YES extract as 13-desoxypaxilline, and the dide- and 14-deacetyl analogues were also found in the 
sclerotia enriched WATM extract. Again the metabolites were analyzed using LC-MS and NMR. 
Several different extraction procedures were tested to verify the correctness of the compounds as 
genuine metabolites and not as in vitro degraded parasiticolide A products, but all samples showed 
only dide- and 14-deacetyl parasiticolide A and no traceable (LC-MS) levels of parasiticolide A itself, 
even with different non-acidic extractions. Parasiticolide A have been isolated from A. flavus var. 
columnaris (FKI-0739) once [71] and was originally isolated and characterized from A. parasiticus 
(IFO 4082) [72,73] and later also from a mutant of Emericella variecolor (= A. stellatus Curzi) [74]. 
Recently parasiticolides have been detected in the newly described species A. arachidicola (CBS 
117610) and A. minisclerotigenes (CBS 117635) [75]. There have to our knowledge not been 
published any toxic studies on the parasiticolides, but the related peniopholides from the fungus 
Peniophora polygonia have been reported to have antifungal properties [76]. 
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Figure 4. Structures of dide- and 14-deacetyl parasiticolide A and parasiticolide A. 
 
In our observations parasiticolides are more often detectable metabolites of A. oryzae than of  
A. flavus under the same fermentation conditions, suggesting that the pathway is partly silenced for  
A. flavus and may need epigenetic modification to be expressed under otherwise normal growth 
conditions. It is interesting that parasiticolide A is scarcely observed in A. flavus, when it is an 
important product of A. oryzae and also of A. parasiticus. As for 13-desoxypaxilline, dide- and  
14-deacetyl parasiticolide A are almost certainly products of a prematurely ended biosynthesis, here 
parasiticolide A. We also isolated and elucidated a third parasiticolide A analogue; a formyl variant of 
parasiticolide A, but it was not possible to exclude the possibility of in vitro chemistry due to the 
formic acid added during the ethyl acetate extraction, so the correctness of this metabolite remains 
tentative. (Hamasaki et al. used benzene to extract parasiticolide A [77]). All paraciticolide analogues 
were structure elucidated by NMR and shift values correlated with the published data for parasiticolide 
A, except for the missing signals of the acetate units and their minor influence on the chemical shifts 
values of adjacent protons and carbons (See Supplementary Material for NMR data). 
To further verify these observations, a MS/MS method was used to analyze several different 
microscale extracts of RIB40 for parasiticolide A itself. Trace amounts of parasiticolide A was found 
under these conditions and compared to an isolate of A. parasiticus (IBT 4387) capable of producing 
parasiticolide A. In the A. parasiticus isolate no dide- or 14-deacetyl parasiticolide A could be 
measured, indicating a complete transformation into the end-product (Figure 4). The small amount of 
parasiticolide A in RIB40 (roughly 1:1.000 ratio compared to 14-acetyl parasiticolide A, presuming the 
same response factor) might be the result of spontaneous acetylation involving the first acetylating 
enzyme. When the gene cluster of this metabolite is mapped, it is likely that the gene responsible for 
the last (specific) acetylation will be found to be mutated. Except for the section Nidulantes member 
Emericella variecolor, all other producers of these metabolites have been members of section Flavi. 
No indication points to these metabolites being part of the previously mentioned sclerotium 
metabolites since they are not found in selective sclerotium extracts, but are found for example in  
A. arachidicola, which is not known to produce sclerotia. 
Four new A. flavus related NRPS compounds were also isolated from A. oryzae RIB40 and 
characterized based on standard interpretation of 1H, COSY, HMQC and HMBC NMR data (see 
Supplementary Material). The compounds showed to be two isomeric metabolites named ditryptoleucine 
related to the ditryptophenalines [78–81] and the two indole-enamides named oryzamides A1-2 (cis- 
and trans-forms) structurally similar to the antibiotic miyakamide B1-2 [71] (Figure 5). 
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Figure 5. Structure of the new A. oryzae metabolites: Ditryptoleucine and oryzamide A1-2. 
 
It proved difficult to unambiguously isolate the cis- and trans-isomer of oryzamide A in a pure form 
due to isomerization around the double bond. Due to this the structure elucidation has been performed 
on mixtures of compounds. It is evident from the structure elucidation that oryzamides A1-2 only differ in 
the configuration around the double bond of the enamine as evident from the size of the coupling constant. 
Marfey analysis of the amino acid derived compounds only established the presence of L-tyrosine in 
the oryzamides. NMR structural data on the trans isomer (A1) is present in the supporting material. 
Intriguingly, these A. oryzae metabolites have apparently exchanged phenylalanine with leucine 
compared to the similar A. flavus metabolites, indicating either a common trait in the domestication 
process or a coupling between the two pathways. The diketopiperazine ditryptoleucine was isolated in 
two variants with 1H-NMR shifts varying around the C-C dimeric bond, but with the same base 
structure. This unspecific dimerization is in line with previously isolated compounds. A hybrid 
between the ditryptophenaline and ditryptoleucine was isolated from an Aspergillus sp. as WIN 64745, 
with both a phenylalanine and leucine moiety, but with no N-methylation [79]. These compounds were 
tested and proved antagonistic against substance P at the NK1 receptor [82]. The oryzamides A1-2 are 
variants of the miyakamides B1-2 [71]. The exchanged phenylalanine has been substituted with leucine 
between a tryptophan and a tyrosine in the oryzamides. However this exchange of phenylalanine and 
leucine has often been found for compounds produced within the same species. Penicillium polonicum 
(= P. fructigenum) [83-85] produces both fructigenine A = puberuline = rugulosuvine A, containing 
phenylalanine and fructigenine B = verrucofortine, containing leucine. We could also detect two 
slightly later eluting compounds in the A. oryzae RIB40 extracts likely to be two further indole-enamides 
having phenylalanine incorporated instead of tyrosine as evident from LC-DAD-MS analysis (data not 
shown) as also seen for the miyakamides [71]. 
3. Experimental 
General procedures and methods for analysis are described in [43,44,86]. 
Mass spectrometric analysis was performed using a Agilent HP 1100 liquid chromatograph with a 
DAD system (Waldbronn, Germany) on a LCT oaTOF mass spectrometer (Micromass, Manchester, 
UK) with a Z-spray ESI source and a LockSpray probe. For general procedures see [87]; method 1 for 
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LC-DAD-TOF was used in this study. All solvents used were HPLC grade from Sigma-Aldrich  
(St. Louis, MO, USA). 
3.1. Fungal Material and Fermentation 
A. oryzae RIB40 (IBT28103); A. flavus NRRL3357 (IBT3696), (IBT15934), NRRL 13462;  
A. parvisclerotigenus IBT16807 and A. minisclerotigenes IBT13353 were obtained from the IBT 
Culture Collection at DTU Systems Biology, Technical University of Denmark. The RIB40 isolate 
used for isolation of 13-dehydroxypaxilline was cultured for 14 days at 25 °C in the dark on 200 Petri 
dishes with Yeast Extract Sucrose agar (YES). All strains were grown for 1 week at 25 °C on YES, 
Czapek Yeast Autolysate (CYA), Wickerhams Antibiotic Test Medium (WATM) agar [88], YESBEE [89] 
(YES+50 g Bee pollen Type III, granulate, Sigma, P-8753, pr. 1 L medium), DRYES (Dichloran rose 
Bengal chloramphenicol agar), AFPA (Aspergillus flavus, A. parasiticus agar), CYAS (CYA + 50 g 
NaCl pr. 1 L medium), CY20 (CYA + 170 g sucrose pr. 1 L), CY40 (CYA with added 370 g sucrose 
pr. 1 L medium), DUL (Dulaney’s medium for Penicillin), GAK (Potato-carrot agar), GMMS (Glucose 
minimal media (GMM) + 2% sorbitol), MEA (Malt extract agar), OAT (Oat meal agar), PDA (Potato-
dextrose agar). For medium formulations see Samson et al. [90]. 
3.2. Extraction and Isolation of Pure Compounds 
13-Desoxypaxilline. The plates were homogenized using a Stomacher and 100 mL EtOAc with 1% 
HCO2H pr. 10 plates. The extract was filtered and dried down on a freeze drier. The crude extract was 
separated on a KP-C18-HS 60 g SNAP column using a Biotage Isolera One (Biotage, Uppsala, 
Sweden), resulting in a 22 mg fraction. The fraction was segmented with a 10 g ISOL Diol column, 
using 12 steps of stepwise Heptane-dichloromethane-EtOAc-MeOH. 13-desoxypaxilline was 
predominant in a 100% EtOAc fraction (6 mg), and purified on a Waters HPLC W600/996PDA 
(Milford, MA, USA) and a RP column (Phenomenex Luna C18(2), 250 × 10 mm, 5 µm, Torrance, CA, 
USA) using a gradient of 80% MeCN (H2O–Milli-Q (Millipore, MA, USA)) to 90% over 10 min. with 
50 ppm TFA added to the solvents. The collection was concentrated on a rotary evaporator (Büchi V-855/ 
R-215, Flawil, Switzerland) and dried under N2 to yield 0.5 mg of white, amorphous 13-desoxypaxilline. 
Dideacetyl-, 14-deacetyl-, and 18-formyl parasiticolide A. From the same fermentation described for 
13-desoxypaxilline a more polar, 90 mg fraction was fractionated with a 10 g ISOL Diol column, using 
12 steps of stepwise Heptane-dichloromethane-EtOAc-MeOH. The parasiticolide A-analogues were 
predominant in a 100% EtOAc fraction (10 mg), and purified on a Waters HPLC W600/996PDA 
(Milford, MA, USA) and a RP column (Phenomenex Luna C18(2), 250 × 10 mm, 5 µm, Torrance, CA, 
USA) using a gradient of 72% MeCN (H2O–Milli-Q (Millipore, MA, USA)) to 87% over 15 min. with 
50 ppm TFA. The collection was concentrated on a rotary evaporator (Büchi V-855/R-215) and dried 
under N2 to yield 0.3, 1.0 and 0.8 mg of white, amorphous di-, 14-deactyl- and 18-formyl 
parasiticolide A, respectively. See Supplemental Material for NMR data. 
Ditryptoleucine. 400 plates of A. oryzae RIB40 were cultured on YES medium. The plates were 
homogenized using a Stomacher and 100 mL EtOAc pr. 10 plates. The extract was filtered and dried 
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down on a freeze drier. The crude extract were separated into three phases by dissolving it in 9:1 
MeOH:H2O–Milli-Q and extracted into a heptan phase and afterwards a DCM phase. The DCM phase 
was separated on a KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, 
Sweden) using a gradient of 10% MeOH (H2O–Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs 
(column volumes) resulting in a 402 mg fraction. The fraction was further separated on another  
KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a gradient 
of 10% MeOH (H2O–Milli-Q (Millipore, Ma, USA)) to 25% over 2 CVs, 25% MeOH to 50% over 8 
CVs and 50% to 100% over 4 CVs resulting in a 60.1 mg fraction. The fraction was fractionated on a 
LH-20 column using 100% MeOH. The ditryptoleucines were present in the earlier fractions and were 
purified on a Waters HPLC W600/996PDA (Milford, MA, USA) using a RP column (Phenomenex 
Luna C18(2), 250 × 10 mm, 5 µm, Torrance, CA, USA) using a gradient of 50% MeCN (H2O–Milli-Q 
(Millipore, MA, USA)) to 100% over 20 min. with 50 ppm TFA and a flow of 4 mL/min. The 
collections were concentrated on a rotary evaporator (Büchi V-855/R-215) and dried under N2 to yield 
4.0 mg of the two isomers. See Supplemental Data for NMR data. 
Oryzamides A1-2. The remaining broth from the fermentation described for ditryptoleucine was 
extracted with EtOAc + 1% HCO2H for 24 h. The extract was filtered and dried down on a freeze 
drier. The crude extract were separated into three phases by dissolving it in 9:1 MeOH:H2O–Milli-Q 
and extracted into a heptan phase and afterwards a DCM phase. The DCM phase was separated on a  
KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a gradient 
of 10% MeOH (H2O–Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs (column volumes) 
resulting in a 654 mg fraction. The fraction was fractionated with a 10 g ISOL Diol column, using  
13 steps of stepwise Hexane-dichloromethane-EtOAc-MeOH. The miyakamides were predominant in 
the 40:60 DCM:EtOAc and 20:80 DCM:EtOAc fractions (43.8 mg), and purified on a Waters HPLC 
W600/996PDA (Milford, MA, USA) and a RP column (Phenomenex Luna C18(2), 250 × 10 mm, 
5µm, Torrance, CA, USA) using a gradient of 45% MeCN (H2O–Milli-Q (Millipore, MA, USA)) to 
62% over 15 min. with 50 ppm TFA. The collection was concentrated on a rotarvap (Büchi V-855/ 
R-215) and dried down under N2 to yield 4.0 and 2.0 mg of oryzamide A1 and A2, respectively. See 
Supplemental Data for NMR data. 
3.3. Marfeys Method 
100 µg of each peptide was hydrolysed with 200 µL 6 M HCl at 110 °C for 20 h. To the hydrolysis 
products (or 50 µL (2.5 µmol) solutions of standard D- and L-amino acids) was added 50 µL water,  
20 µL 1 M NaHCO3 solution and 100 µL 1% FDAA in acetone, followed by reaction at 40 °C for 1 h. 
The reaction mixture was removed from the heat, neutralized with 10 µL 2 M HCl and the solution 
was diluted with 820 µL MeOH to a total volume of 1 mL. The FDAA derivatives were analysed by 
UHPLC-DAD on a Dionex Ultimate 3000 RS DAD equipped with a Kinetex C18 column (2.6 μm, 
150 × 2.10mm, Phenomenex). The analyses were run with a gradient elution of MeCN/H2O–Mili-Q 
(Millipore, MA,USA) added 50 ppm TFA from 15 to 100% MeCN over 7 min (60 °C, 0.8 mL/min). 
The retention times of the FDAA derivatives were compared to retention times of the standard amino 
acid derivatives. 
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3.4. Selective Extraction of Sclerotium Metabolites 
The selective extraction of sclerotia from IBT 15934, NRRL 13462, IBT 16807 and IBT 13353 was 
made from harvested sclerotia of a 7 day old cultivation on WATM and CYA agar (25 °C in dark). 
The sclerotia were washed several times with Milli-Q (Millipore, Millford, USA) 0.22 µm H2O and 
dried. The sclerotia were transferred to a 2 mL Eppendorf tube together with three stainless steel balls 
(2 × 1 mm and 1 × 5 mm) and frozen with liquid N2 before mechanical crushed. The pulverized 
sclerotia were suspended in 1mL methanol and transferred to a 2 mL vial with 1 mL of 1:2:3 
methanol:dichloromethane:ethylacetate and left for evaporation overnight in a fume hood. The dried 
extract was resolved in 1 mL methanol in ultrasonicated for 10 min and then filtered with a 0.45 µm 
PTFE filter to a clean vial for analysis. 
3.5. HPLC-DAD-TOF Method 
Mass was measured using a Agilent HP 1100 liquid chromatograph with a DAD system 
(Waldbronn, Germany) on a LCT oaTOF mass spectrometer (Micromass, Manchester, UK) with a  
Z-spray ESI source and a LockSpray probe. For general procedures see [86], method 1. 
3.6. NMR Instrumentation 
NMR spectra were recorded on a Varian Unity Inova 500 MHz spectrometer equipped with a 5 mm 
probe using standard pulse sequences. The signals of the residual solvent protons and solvent carbons 
were used as internal references (δH 2.50 and δC 39.5 ppm for DMSO). In cases where higher field was 
needed the NMR spectra were recorded on a Bruker Avance 800-MHz spectrometer equipped with a 
5-mm TCI Cryoprobe at the Danish Instrument Center for NMR Spectroscopy of Biological 
Macromolecules. 
3.7. MS/MS Method Used for Aflatrem and Parasiticolide Screening 
Liquid chromatography was performed on an Agilent (Torrence, CA, USA) 1100 HPLC system 
coupled to a triple-quadropole mass spectrometer (Waters-Micromass, Manchester, UK) with a Z-spray 
ESI operated in positive mode source using a flow of 700 L/h nitrogen desolvated at 350 °C. The 
hexapole was held at 50 V. The system was controlled by MassLynx v4.1 (Waters-Micromass). 
Nitrogen was used as collision gas, and the MS operated in MRM mode (dwell time = 100 ms) with 
the parameters listed in Table 2. Extracts of 2 µL were injected and separated on a Phenomenex 
Gemini C6-phenyl, 3 µm, 2 × 50 mm column with a flow of 0.3 µL/min. Water contained 20 mM 
ammonium formate. Oven temperature 40 °C. Two different methods were applied to the aflatrem- and 
parasiticolide screen: Aflatrem inlet method: Linearly gradient from 50 to 100% MeCN over 5 min, 
increased to 0.5 µL/min over 1.5 min. The column was washed additionally 1.5 min with 100% MeCN at 
0.5 µL/min, followed by a return to 50% MeCN over 2.5 min and kept at this level for another 1 min 
with a linearly decrease in flow to 0.3 µL/min, prior to the next sample. Standards used for analysis of 
this pathway were from Sigma-Aldrich Aldrich (St. Louis, MO, USA). Parasiticolides: linearly gradient 
from 20 to 90% MeCN over 15 min, increased to 0.5µL/min from 90 to 100% MeCN in additional  
1 min. The column was washed from 2 min with 100% MeCN at 0.5 µL/min, followed by a return to 
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20% MeCN over 1.5 min and kept at this level for another 3.5 min with a linearly decrease in flow to  
0.3 µL/min, before the next sample. Standards were internal standards from other extracts of the known 
parasiticolide A producer A. parasiticus: IBT 4387 (= CBS 260.67) and IBT 11863 (= CBS 115.37). 
Table 2. MS/MS method including scan event, retention times, transition ions and the cone 
and collision energies used. 
Compound Scan 
event 
RT 
(min) 
Ion type Transition 
(m/z) a 
Cone 
(V) 
Collision energy 
(eV) 
Paxilline 1 4.0 Quantifier 
Qualifier 
436 → 130 
436 → 182 
25 
25 
30 
30 
Paspalinine 2 4.3 Quantifier 
Qualifier 
434 → 130 
434 → 376 
25 
25 
20 
20 
13-
desoxypaxilline 
3 4.8 Quantifier 
Qualifier 
420 → 182 
420 → 130 
25 
25 
30 
30 
Aflatrem 4 5.2 Quantifier 
Qualifier 
502 → 198 
502 → 445 
25 
25 
20 
20 
Paspaline 5 5.5 Quantifier 
Qualifier 
422 → 130 
422 → 275 
25 
25 
20 
20 
Dideacetyl-
parasiticolide A 
1 7.0 Quantifier 
Qualifier 
387 → 217 
387 → 189 
30 
30 
40 
40 
14-deacetyl 
parasiticolide A 
2 8.7 Quantifier 
Qualifier 
429 → 217 
429 → 189 
30 
30 
40 
40 
Parasiticolide A 3 10.4 Quantifier 
Qualifier 
488 → 229 
488 → 247 
30 
30 
30 
30 
a All transitions were made from [M+H]+, except for paraciticolide A: [M+NH4]+. 
4. Conclusions 
The tremorgenic 13-desoxypaxilline has been isolated from A. oryzae RIB40 and verified under 
several different growth conditions contrary to previous studies. We believe that 13-desoxypaxilline is 
the end-product of the aflatrem biosynthesis for the RIB40 strain since no aflatrem could be detected in 
any fermentation using LC-MS/MS as detection. 
The new metabolites dide- and 14-deacetyl parasiticolide A were also found as genuine products 
from the RIB40 strain and the compounds were present in multiple fermentations, however 
parasiticolide A was only detected in trace amounts using a LC-MS/MS method. This indicates a 
defective acetylation of the 14-deacetyl parasiticolide A and the small amount of parasiticolide A in 
RIB40 could be the result of spontaneous acetylation in the cell cytosol. The mono-deacetylated analogue 
detected in both A. flavus and A. oryzae had same retention times, suggesting a selective acetylation. 
The new NRPS compounds ditryptoleucine and oryzamides A1-2 appear to be natural variants of 
known A. flavus metabolites. They share the exchange of a phenylalanine for a leucine, although they 
are believed to originate from two unrelated pathways. 
Altogether, our findings contribute to understanding why the overall chemical profiles of A. oryzae 
(RIB40) and A. flavus (NRRL 3357) appear quite different since some of the end-products usually seen 
in A. flavus are apparently not reached in A. oryzae. Whether the different chemical profiles are merely 
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the result of different regulation that can be overcome by the use of epigenetic modifiers or are a result 
of genuine mutations remains to be settled. A. oryzae RIB40 is clearly a chemically potent strain, and 
as more of its chemistry is unfolded we believe that most of the biosynthetic pathways of A. flavus will 
be found to be more or less functional. Future research will reveal whether the many different  
A. oryzae strains that are used as industrial workhorses are as chemically potent as the RIB40 strain. 
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13-Desoxypaxilline 
HRESIMS: m/z = 420.2551 [M+H]
+
, calculated for [C27H33NO3+H]
+
: 420.2533. 
NMR spectra were acquired in DMSO-d6 on a Bruker Avance 800 MHz spectrometer using standard 
pulse sequences. 
1
H-NMR (799.30 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.88 (3H, s, H-23), 1.00 (3H, s, 
H-25), 1.16 (3H, s, H-29), 1.20 (3H, s, H-28), 1.52 (1H, ddd, J = 25.4, 12.8, 4.4 Hz, H-14a), 1.60 (1H, 
m, H-14b), 1.65 (1H, m, H-15a), 1.74 (1H, d, J = 12.2 Hz, H-15b), 1.81 (1H, ddd, J = 17.9, 13.8, 4.2 Hz, 
H-6a), 1.98 (1H, ddd, J = 13.8, 13.6, 4.2 Hz, H-5a), 2.07 (1H, m, H-5b), 2.22 (1H, m, H-6b), 2.32 (1H, 
dd, J = 12.8, 11.0 Hz, H-17a), 2.53 (1H, m, H-13), 2.62 (1H, dd, J = 12.8, 6.3 Hz, H-17b), 2.71 (1H, 
m, H-16), 3.74 (1H, d, J = 1.6 Hz, H-9), 4.34 (1H, br. s, 27-OH), 4.41 (1H, m, H-7), 5.73 (1H, s, H-11), 
6.91 (1H, dd, J = 7.6, 7.6 Hz, H-21), 6.95 (1H, dd, J = 7.6, 7.6 Hz, H-22), 7.27 (1H, d, J = 7.6 Hz,  
H-23), 7.28 (1H, d, J = 7.6 Hz, H-20), 10.76 (1H, s, N-H). 
13
C-NMR (201.00, DMSO-d6, 25 °C, 39.5 ppm): 14.4 (C-25), 15.4 (C-26), 23.5 (C-15), 24.8 (C-14), 
25.5 (C-28), 25.7 (C-29), 26.7 (C-17), 29.5 (C-6), 30.7 (C-5), 41.6 (C-13), 48.5 (C-16), 49.2 (C-3), 
49.8 (C-4), 70.7 (C-27), 74.0 (C-7), 82.4 (C-9), 111.6 (C-23), 115.8 (C-18), 117.5 (C-20), 118.1 (C-21), 
119.2 (C-22), 120.7 (C-11), 124.4 (C-19), 140.2 (C-24), 150.4 (C-2), 168.6 (C-12), 196.1 (C-10). 
 
14-Deacetyl parasiticolide A 
All NMR spectra of parasiticolide A analogues were acquired in DMSO-d6 on a Varian Unity Inova 
500 MHz spectrometer with 4 mm gHX Nano probe and with a spin rate of 2 kHz for all samples, 
using standard pulse sequences. The spectra were referenced to this solvent with resonances δH = 2.50 
and δC = 39.5. 
HRESIMS: m/z = 429.1901 [M+H]
+
, calculated for [C24H28O7+H]
+
: 429.1908. 
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1
H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.96 (1H, td, J = 13.6, 3.7 Hz, H-3a), 1.01 (3H, 
s, H-13), 1.36 (1H, td, J = 13.3, 3.3 Hz, H-1a), 1.45 (1H, m, H-2a), 1.63 (1H, m, H-2b), 1.91 (1H, s,  
H-5), 1.97 (1H, m, H-3b), 2.08 (3H, s, H-17), 2.11 (1H, d, J = 13.2, H-1b), 2.36 (1H, d, J = 19.0 Hz, 
H-7a), 2.76 (1H, ddt, J = 19.0, 6.0, 3.1 Hz, H-7b), 3.14 (1H, d, J = 10.6, H-14a), 3.61 (1H, d, J = 10.6 Hz, 
H-14b), 4.67 (1H, d, J = 11.0 Hz, H-15a), 4.80 (1H, d, J = 11.0, H-15b), 4.96 (2H, m, H-11), 5.83 (1H, 
d, J = 6.0 Hz, H-6), 7.52 (2H, m, H-4′/6′), 7.67 (1H, tt, J = 7.3, 1.2 Hz, H-5′), 7.97 (2H, m, H-3′/7′). 
13
C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 17.3 (C-2), 20.6 (C-17), 28.2 (C-7), 30.7 (C-1), 
34.6 (C-3), 39.4 (C-4), 39.8 (C-10), 52.5 (C-5), 62.9 (C-14), 65.4 (C-15), 66.5 (C-6), 71.1 (C-11), 
121.2 (C-8), 128.7 (4′/6′), 129.3 (3′/7′), 129.8 (C-2′), 133.5 (5′), 165.6 (C-1′), 166.8 (C-9), 170.5 (C-16), 
173.2 (C-12). 
 
Dideacetyl parasiticolide A 
HRESIMS: m/z = 387.1817 [M+H]
+
, calculated for [C22H26O6+H]
+
: 387.1802. 
1
H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.91 (1H, ddd, J = 13.4, 13.4, 3.7 Hz, H-3a), 
0.99 (3H, s, H-13), 1.17 (1H, dd, J = 12.9, 3.5 Hz, H-1a), 1.42 (1H, m, H-2a), 1.65 (1H, m, H-2b), 1.81 
(1H, s, H-5), 1.97 (1H, d, J = 13.4 Hz, H-3b), 2.28 (1H, d, J = 12.9 Hz, H-1b), 2.31 (1H, d, J = 19.3 Hz, 
H-7a), 2.73 (1H, m, H-7b), 3.09 (1H, dd, J = 10.5, 5.3 Hz), 3.60 (1H, dd, J = 10.5, 5.3 Hz, H-14b), 
4.07 (1H, m, H-15a), 4.12 (1H, m, H-15b), 4.42 (1H, dd, J = 5.3, 5.3 Hz, 14-OH), 4.86 (1H, dd,  
J = 17.5, 2.0 Hz, H-11a), 5.06 (1H, dt, J = 17.5, 2.5 Hz, H-11b), 5.10 (1H, dd, J = 5.2, 5.2 Hz, 15-OH), 
5.80 (1H, d, J = 5.8 Hz, H-6), 7.55 (2H, m, H-4′/6′), 7.67 (1H, m, H-5′), 7.90 (2H, m, H-3′/7′). 
13
C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 17.6 (C-2), 27.3 (C-13), 28.5 (C-7), 30.5 (C-1), 
34.9 (C-3), 39.4 (C-4), 42.9 (C-10), 52.7 (C-5), 62.4 (C-15), 63.1 (C-14), 66.9 (C-6), 72.0 (C-11), 
119.5 (C-8), 128.9 (C-4′/6′), 129.0 (C-3′/7′), 129.8 (C-2′), 133.5 (C-5′), 165.7 (C-1′), 169.4 (C-9), 
173.6 (C-12). 
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18-Formyl parasiticolide A 
HRESIMS: m/z = 457.1889 [M+H]
+
, calculated for [C25H28O8+H]
+
: 457.1857. 
1
H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 1.10 (3H, s, H-13), 1.18 (1H, ddd, J = 13.7, 
13.7, 3.3 Hz, H-3a), 1.43 (1H, ddd, J = 13.2, 13.2, 2.9 Hz, H-1a), 1.51 (1H, m, H-2a), 1.71 (1H, m,  
H-2b), 1.82 (1H, d, J = 13.7 Hz, H-3a), 2.06 (1H, s, H-5), 2.09 (3H, s, H-17), 2.16 (1H, d, J = 13.2 Hz, 
H-1b), 2.43 (1H, d, J = 19.3 Hz, H-7a), 2.80 (1H, m, H-7b), 3.99 (1H, d, J = 11.0 Hz, H-14a), 4.36 
(1H, d, J = 11.0 Hz, H-14b), 4.71 (1H, d, J = 10.8 Hz, H-15a), 4.78 (1H, d, J = 10.8 Hz, H-15b), 4.98 
(2H, m, H-11), 5.83 (1H, d, J = 5.6 Hz, H-6), 7.52 (2H, dd, J = 7.6, 7.6 Hz, H-4′/6′), 7.68 (1H, dd,  
J = 7.6, 7.6 Hz, H-5′), 7.98 (2H, d, J = 7.6 Hz, H-3′/7′), 8.06 (1H, s, H-18). 
13
C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 16.9 (C-2), 20.5 (C-17), 26.6 (C-13), 27.9 (C-7), 
30.5 (C-1), 35.4 (C-3), 36.9 (C-4), 39.6 (C-10), 52.1 (C-5), 65.0 (C-14), 65.1 (C-15), 66.5 (C-6), 71.1 
(C-11), 121.0 (C-8), 128.6 (C-4′/6′), 129.0 (C-3′/7′), 129.2 (C-2′), 133.4 (C-5′), 161.6 (C-18), 165.1 (C-1′), 
165.9 (C-9), 170.1 (C-16), 172.8 (C-12). 
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Ditryptoleucine A 
HRESIMS: m/z = 625.3472 [M+H]
+
, calculated for [C36H44N6O4+H]
+
: 625.3497. 
1
H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.81 (6H, d, J = 6.4 Hz, H-21), 0.83 (6H, d,  
J = 6.4 Hz, H-20), 1.42 (H2, m, H-18a), 1.48 (H2, m, H-18b), 1.58 (H2, m, H-19), 2.44 (H4, m, H-11), 
2.80 (H6, s, H-17), 3.76 (H2, dd, J = 10.4, 3.8 Hz, H-12), 3.81 (H2, dd, J = 7.9, 6.0 Hz, H-15), 5.09 
(H2, m, H-2), 6.61 (H2, d, J = 7.8, H-5), 6.66 (H2, t, J = 7.5, H-7), 6.68 (H2, s, H-3), 7.05 (H2, t, 7.8, 
H-6), 7.23 (H2, d, J = 7.8, H-8). 
13
C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 21.9 (C-20), 22.6 (C-21), 23.7 (C-19), 31.8 (C-17), 
36.1 (C-11), 39.4 (C-18), 56.7 (C-12), 57.9 (C-10), 61.6 (C-15), 76.7 (C-2), 108.7 (C-5), 117.2 (C-7), 
124.6 (C-8), 126.7 (C-9), 129.0 (C-6), 150.9 (C-4), 165.0 (C-16), 166.1 (C-13). 
Ditryptoleucine B 
1
H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.81 (6H, d, J = 6.1 Hz, H-21), 0.83 (6H, d,  
J = 6.2 Hz, H-20), 1.42 (H2, m, H-18), 1.49 (H2, m, H-19), 2.45 (H2, dd, J = 13.5, 4.7, H-11a), 2.75 
(H6, s, H-17), 3.13 (H2, m, H-11b), 3.33 (H2, s, H-2), 3.82 (H2, t, J = 6.9 Hz, H-15), 4.23 (H2, m,  
H-12), 6.58 (H2, d, J = 7.5, H-5), 6.65 (H2, t, J = 7.1, H-7), 6.70 (H2, s, H-3), 7.01 (H2, t, 7.2, H-6), 
7.37 (H2, d, J = 7.1, H-8). 
13
C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 21.5 (C-21), 22.5 (C-20), 23.6 (C-19), 31.6 (C-17), 
37.0 (C-11), 38.0 (C-18), 55.3 (C-12), 60.8 (C-10), 61.7 (C-15), 76.3 (C-2), 108.5 (C-5), 117.4 (C-7), 
124.0 (C-8), 130.2 (C-9), 128.3 (C-6), 149.6 (C-4) 166.9 (C-16), 166.6 (C-13). 
 
Oryzamide A1 
HRESIMS: m/z = 491.26526 [M+H]
+
, calculated for [C28H34 N4O4+H]
+
: 491.26525. 
1
H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.83 (3H, d, J = 6.5 Hz, H-5′), 0.88 (3H, d,  
J = 6.6 J, H-5′), 1.36 (1H, m, H-4′), 1.59 (2H, m, H-3′), 1.77 (3H, s, H-2′′′), 2.67 (1H, m, H-3′′), 2.83 
(1H, m, H-3′′), 2.87 (3H, s, N-CH), 4.76 (1H, m, H-2′′), 5.02 (1H, m, H-2′), 6.47 (1H, d, J = 14.8,  
H-2), 6.61 (2H, d, J = 8.4 Hz, H-6′′/8′′), 7.01 (2H, d, J = 8.4 Hz, H-5′′/9′′), 7.05 (1H, m, H-8), 7.10 
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(1H, m, H-7), 7.26 (1H, m, H-1), 7.36 (1H, m, H-6), 7.41 (1H, s, H-4), 7.62 (1H, d, J = 7.9 Hz, H-9), 
8.24 (1H, d, J = 8.0 Hz, 2′′-NH), 9.16 (1H, s, 7′′-OH), 9.84 (1H, d, J = 9.8 Hz, 1-NH), 11.11 (1H, s, 4-NH). 
13
C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 21.6 (C-5′), 22.0 (C-2′′′), 22.7 (C-5′), 24.1 (C-4′), 
30.9 (C-N), 36.2 (C-3′′), 36.9 (C-3′), 50.5 (C-2′′), 54.2 (C-2′), 106.4 (C-2), 111.4 (C-3), 111.5 (C-6),114.6 
(C-6′′/8′′), 118.5 (C-9), 118.8 (C-8), 119.2 (C-1), 121.1 (C-7), 123.1 (C-4), 125.0 (C-10), 127.4 (C-4′′), 
129.7 (C-5′′/9′′), 136.9 (C-5), 156.0 (C-7′′), 167.7 (C-1′), 168.8 (C-1′′′), 172.3 (C-1′′). 
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Biosynthetic pathways of secondary metabolites from fungi are
currently subject to an intense effort to elucidate the genetic basis
for these compounds due to their large potential within pharma-
ceutics and synthetic biochemistry. The preferred method is me-
thodical gene deletions to identify supporting enzymes for key
synthases one cluster at a time. In this study, we design and apply
aDNAexpression array forAspergillus nidulans in combinationwith
legacy data to form a comprehensive gene expression compendium.
We apply a guilt-by-association–based analysis to predict the extent
of the biosynthetic clusters for the 58 synthases active in our set of
experimental conditions. A comparison with legacy data shows the
method to be accurate in 13 of 16 known clusters and nearly accu-
rate for the remaining 3 clusters. Furthermore, we apply a data
clustering approach,which identiﬁes cross-chemistry betweenphys-
ically separate gene clusters (superclusters), and validate this both
with legacy data and experimentally by prediction and veriﬁcation
of a supercluster consisting of the synthase AN1242 and the prenyl-
transferase AN11080, as well as identiﬁcation of the product com-
pound nidulanin A. We have used A. nidulans for our method
development and validation due to the wealth of available bio-
chemical data, but the method can be applied to any fungus with
a sequenced and assembled genome, thus supporting further sec-
ondary metabolite pathway elucidation in the fungal kingdom.
aspergilli | natural products | secondary metabolism | polyketide synthases
No other group of biochemical compounds holds as muchpromise for drug development as the secondary (nongrowth
associated) metabolites (SMs). A review from 2012 (1) found that
for small-molecule pharmaceuticals, 68% of the anticancer agents
and 52%of the antiinfective agents are natural products, or derived
from natural products. The fact that SMs are often synthesized as
polymer backbones that are subsequently diversiﬁed greatly via the
actions of tailoring enzymes sets the stage for combinatorial bio-
chemistry (2), because their biosynthesis is modular.
Major groups of SMs include polyketides (PKs) consisting of
-CH2-(C = O)- units, ribosomal and nonribosomomal peptides
(NRPs), and terpenoids made from C5 isoprene units. These
polymer backbones are, with the exception of ribosomal peptides,
made by synthases or synthetases and aremodiﬁed by a plethora of
tailoring enzymes, including (de)hydratases, oxygenases, hydro-
lases, methylases, and others.
In fungi, these biosynthetic genes of secondary metabolism are
organized in discrete clusters around the synthase genes. Although
quite accurate algorithms are available for identiﬁcation of possible
SM biosynthetic genes, particularly PK synthases (PKSs), NRP
synthetases (NRPSs), and dimethylallyl tryptophan synthases
(DMATSs) (3, 4), the assignment and prediction of themembers of
the individual clusters solely from the genome sequence have not
been accurate.Relevant protein domains can be predicted for some
of the genes (e.g., cytochrome P450 genes) (5); however, genes in
identiﬁed clusters often have unknown functions, which makes
predicting their inclusion impossible. Furthermore, SM gene clus-
ters often colocalize on the chromosomes (6), which makes sepa-
ration of clusters solely based on gene function predictions difﬁcult.
The efﬁcient elucidation of the biosynthetic genes for each SM
cluster has thus so far been based on laborious single gene deletion
of each of the putative members and chemical proﬁling of the SMs
of the deletion strains. This effort has been especially noticeable in
themodel fungusAspergillus nidulans, which is presently the fungal
species with the largest number (n = 25) of characterized SM
synthases/synthetases, due to amassive effort by several groups (7–
30). In recent studies, this fungus has also been shown to have
cross-chemistry between gene clusters on separate chromosomes
(8, 30). Although these reactions are highly interesting for com-
binatorial chemistry, the identiﬁcation of gene clusters involved in
cross-chemistry is cumbersome because it involves combinatorial
deletion of SM synthetic genes, thus greatly increasing the po-
tential number of candidates.
In this study, we propose a general “omics”-based method for
the accurate determination of fungal SM gene cluster members.
The method is based on an annotated genome sequence and
a catalog of gene expression, a set of information that is readily
available for many fungal species and can easily be generated for
more. To develop, benchmark, and validate this algorithm, we have
used A. nidulans as a model organism, which is especially well-
suited for this purpose due to the above-stated wealth of in-
formation. The algorithm is proven to be very powerful in identi-
fying gene cluster members. We furthermore report an extension
of the algorithm, which is proven to be successful in identifying
cross-chemistry between gene clusters.
Results
Analysis of SMs A. nidulans on Complex Solid Medium Identiﬁes 42
Compounds. Initially, we evaluated the production of SMs on four
different solid media [oatmeal agar (OTA), yeast extract sucrose
(YES), Czapek yeast autolysate (CYA), and CYA with 50 g/L
NaCl sucrose (CYAS); Materials and Methods] at 4, 8, and 10 d.
The object of this was to identify a selection of media that (i)
gave as many produced SMs as possible, (ii) showed one or more
SMs unique to each medium, and (iii) had SMs that were only
produced on two of the selected media.
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These characteristics should allow us to have as many active
gene clusters as possible, as well as ensuring unique production
proﬁles for as many SM gene clusters as possible.
From this initial analysis, we selected the YES, CYA, and
CYAS media for transcriptional proﬁling. On these media, we
were able to separate and detect 59 unique SMs, of which we
could name 42 by comparison with our extensive in-house library
of microbial metabolites (31) and the AntiBase 2010 natural
products database. The production proﬁle of the compounds
satisﬁed the three criteria listed above (Fig. 1, Fig. S1, and
Dataset S1).
Generation of a Diverse Gene Expression Compendium for A.
nidulans. Samples were taken for transcriptional proﬁling from
plates cultivated in parallel to those of the SM proﬁling above.
RNA was puriﬁed, prepared for labeling, and hybridized to cus-
tom-designed Agilent Technologies arrays based on version 5 of
the A. nidulans annotation (32).
The produced data were combined with previously published
microarray data fromA. nidulans bioreactor cultivations (33, 34) to
form a microarray compendium spanning a diverse set of con-
ditions, comprising 44 samples in total. The set includes four strains
of A. nidulans. Four different growth media are included: three
complex media (see above) and one minimal medium. Medium
variations include ﬁve different deﬁned carbon sources (ethanol,
glycerol, xylose, glucose, and sucrose), as well as yeast extract.
The combined compendium of expression data is available in
Dataset S2.
Correlation-Based Identiﬁcation of Gene Clusters. To identify gene
clusters efﬁciently around SM synthases, we developed a gene
clustering score (CS) based on the Pearson product-moment cor-
relation coefﬁcient. Our CS gives a numerical value for correlation
of the expression proﬁle of a given gene with the expression pro-
ﬁles of the three immediate neighbor genes on either side. Only
positive correlation is considered. Values for the CS are available
in Dataset S2.
Statistical simulation of the distribution of CS on the given
dataset showed that CS values ≥2.13 corresponded to a false-
positive rate of 0.05 (Fig. S2). Therefore, CS ≥ 2.13 was used as
a guideline for identifying the extent of gene clusters.
Prediction of the Extent of 51 Gene Clusters. Evaluation of the size
of the clusters around SM genes was performed using a pre-
computed list of 66 putative PKSs, NRPSs, and DMATSs from
the secondary metabolite unique regions ﬁnder (SMURF) algo-
rithm (3) based on the A. nidulans FGSC A4 gene set (35). In
addition to these 66 genes, we added one prenyltransferase gene
found in the primary literature (30) and three diterpene synthase
(DTS) genes predicted by Bromann et al. (25), resulting in 70
putative biosynthetic genes. All 25 experimentally veriﬁed PKSs,
NRPSs, DTSs, and prenyltransferases were found to be included
in this list (Tables 1–3).
For each of the 70 biosynthetic genes, we examined the genes
nearby for high CS values and inspected the expression proﬁles of
the genes manually for additional validation and reﬁnement.
Apart from 12 genes that were silent under the conditions tested
(Table S1), this allowed prediction of the sizes of gene clusters
around 58 biosynthetic genes organized in 51 clusters and counting
of a total of 254 genes included in the clusters (an example is shown
in Fig. 2). The fact that we can map expression for 58 of the 70
biosynthetic genes (a large proportion of the gene clusters) is
surprising, considering that many, or even themajority, of the gene
clusters are reported to be silent under standard laboratory con-
ditions (13, 14, 20, 36–38). An example of a cluster previously
described as silent but identiﬁed here is the inpAB cluster (39).
However, those cultivation experiments were conducted on liquid
minimal medium and not on solid complex media, where we ﬁnd
that the expression from most of these genes is most pronounced.
We therefore see the large number of active clusters as a conﬁr-
mation of adequate diversity of the cultivation conditions in our
microarray compendium.
Next, we investigated how our cluster predictionsmatched those
published in the literature. This comparison demonstrated that our
algorithm generally predicts gene clusters with excellent accuracy.
Speciﬁcally, we accurately predict the extent of 11 of the 16 known
gene clusters (Tables 1–3). In two of the remaining 5 gene clusters,
the difference is due to artifacts. For the gene sterigmatocystin
cluster (Fig. 2), the difference of 24 genes relative to 25 genes is
caused by differences in the current gene annotation compared
with the original paper from 1996 (17). Changes in gene calling are
also the reason for discrepancy in the terrequinone cluster, where
our legacy microarray data only contain data for 3 of the 5 genes,
thus impairing the prediction. For the three remaining cases, the
2 gene clusters involved in meroterpenoid (austinol and dehy-
droaustinol) biosynthesis and the aspyridone cluster, the di-
vergence seems to be biological. For the austinol/dehydroaustinol
double-cluster system, we predict 3 extra genes in one cluster
(around AN8383) and 2 extra genes in the other cluster (around
AN9259) in addition to genes identiﬁed by Lo et al. (30). We in-
dividually deleted the 3 extra genes (AN8375, AN8376, and
AN8380) in the AN8383 cluster; however, apart from differences
in the austinol/dehydroaustinol ratio, we could only conﬁrm the
results of Lo et al. (30) of these genes not being essential for
austinol/dehydroaustinol biosynthesis (Fig. S3). Because the size
of most of the clusters was accurately predicted by our algorithm,
we speculate that some or all of the extra genes are involved in
biosynthesis of derivatives of austinol/dehydroaustinol. In agree-
ment with this scenario, it is not uncommon that newly detected
compounds are linked to known PKS pathways. For example,
shamixanthones and arugusins were recently discovered to be
products derived from the monodictyphenone cluster (8, 11), and
this cluster has been redeﬁned several times (9, 10). For the
remaining case, the apdG gene of the aspyridone cluster (20),
misprediction of the cluster members is due to a complete di-
vergence between the transcription proﬁles of apdG and the re-
mainder of the gene cluster. In general, we conclude that the use of
21(8)
116(4)
1
314(4)
2(1)
YES CYAS
CYA
Fig. 1. Venn diagram of SMs found on three different solid media. The
number of different metabolites is sorted according to which media the
metabolites have been identiﬁed on. The number of metabolites unable to
be conﬁdently identiﬁed are noted in parentheses. Details can be found in
Dataset S1, and the chemical structures are illustrated in Fig. S1.
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CS values in combination with inspection of the expression proﬁles
is a very effective tool to predict the extent of gene clusters, be-
cause the borders of 13 of 16 clusters were accurately predicted
(when predictions were adjusted to compensate for the two arti-
facts discussed above) and there was near-accurate prediction of
all 16 clusters.
Diverse Gene Expression Compendium Is Important for Accurate
Prediction. To evaluate the compendium size needed for accu-
rate predictions, we used principal component analysis (PCA) on
our matrix of expression values (Dataset S2). Greater than 95% of
the variation within the set can be described in the ﬁrst three
principal components. This suggests that a theoretical lower limit
for this type of analysis would be three arrays if one could select
conditions with a near-perfect difference in expression levels,
ideally high, medium, and low expression for all genes, and with
a maximum difference between all clusters and their surrounding
genes. This would be nearly impossible to achieve for all clusters.
However, if one is only interested in a single or a few gene clusters
of interest, and has the appropriate prior knowledge, it should be
possible to select three to ﬁve conditions and achieve accurate
predictions. Very informative studies have been performed with
two conditions, but the boundaries of the cluster can be difﬁcult to
determine (e.g., ref. 25).
To test howmuch it was possible to reduce our dataset, we used an
unsupervised PCA-based analysis for incremental reduction of the
dataset. In this, we found (unsurprisingly) that our biological repli-
cate samples contain the smallest amount of unique information.
Ten of 44 samples can be removed with only an approximately 10%
loss in the data variation, and 25 of 44 samples (all replicates) can be
removedwith less than a 35% loss in data variation. The time sample
series on a solid medium presented in this study were not reduced
from the set until all biological replicates were reduced. We con-
clude that in selection of samples for cluster elucidation, one should
sample as diversely as possible. Biological replicates are not cost-
effective unless already available from prior studies.
Clustering of Synthase Expression Proﬁles Identiﬁes Superclusters.
Recent work has identiﬁed two cases of cross-chemistry between
clusters located on separate chromosomes. The production of
austinol and derived compounds (themeroterpenoid pathway) has
been shown to be dependent on two separate clusters (11, 30), and
the biosynthesis of prenyl xanthones is dependent on three sepa-
rate clusters (8). We were interested in seeing whether this is
a general phenomenon and whether such cross-chromosomal
“superclusters” could be detected using our expression data.
A full gene-to-gene comparison of expression proﬁles between
all predictedNRPSs, PKSs,DTSs, and prenyl transferases found in
the array data was conducted, and the genes were clustered (Fig.
3). This clustering is not based directly on the expression proﬁles,
because expression index variation from silent conditions distorts
clustering. Instead, we clustered on the basis of a Spearman-based
score of similarity to the expression proﬁles of the other synthases,
which effectively eliminates noise.
The method is efﬁcient for clustering the synthases and trans-
ferases according to shared products. Seven of eight sets of genes
Table 1. Prediction of PKS gene clusters
Cluster size
GeneID Gene Compound (if known) Predicted Known Medium Ref(s).
AN0150 mdpG Monodictyphenone/emodin 12 12 Solid (7–10)
AN7903 Violaceol I and II 12 ? Solid (11)
AN6448 pkbA 8 ? Solid (24)
AN7084 8 Solid
AN8209 wA Green conidial pigment 6 ? Solid
AN7909 orsA Orsellinic acid/F9975/violaceols 5 5 Solid (11–14)
AN1784 4 Solid
AN9005 4 Solid
AN6000 aptA Asperthecin 3 3 Solid (15)
AN6431 3 Solid
AN11191 2 Solid
AN7489 1 Solid
AN3273 1 Solid
AN2547 easB Emericellamide 4 4 Both (16)
AN3230 pkfA Orsellinaldehydes 6 ? Both (24)
AN7071 pkgA Alternariol/isocoumarins 7 ? Both (24)
AN7825 stcA Sterigmatocystin 24* 25 Both (17–19)
AN7815 stcJ Sterigmatocystin 24* 25 Both (17–19)
AN8383 ausA Austinol 7 4 Both (11, 24, 30)
AN2032 pkhA Unknown 10 ? Liquid (24)
AN2035 pkhB Unknown 10 ? Liquid (24)
AN8412 adpA Aspyridone 7† 8 Liquid (20)
AN6791 1 Liquid
AN8910 1 Liquid
This table contains predicted PKSs as well as PKS-like genes (AN7489 and AN7815) and a PKS/hybrid gene
(AN8412). The medium column describes under which type of medium (liquid, solid, or both) the cluster is
expressed. For gene clusters with identiﬁed functions and gene members, the number of identiﬁed cluster
members is given as well as references to the original papers. Further details on the cluster members and the
expression proﬁles of the individual clusters may be found in Dataset S2 and Fig. S4. Chemical structures of all
compounds may be found in Fig. S1.
*Difference seemingly due to the current gene calling diverging from the original paper from 1996 (17).
†Algorithm was not able to predict the inclusion of apdG, the outmost gene hypothesized to be a part of the
cluster (20). The expression proﬁle of apdG diverges from the rest of the cluster.
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predicted to be in the same biosynthetic clusters by the method
above are found to cluster together in this representation. The
exception is AN2032 and AN2035, which do not cocluster due to
very low signals from the AN2032 probes on the microarray.
Furthermore, the clustering is accurate in terms of cross-chemistry.
In examining the two examples of cross-chemistry between gene
clusters, it is found that these are predicted correctly. The mer-
oterpenoid pathway includes the PKS AN8383 and the DMATS
AN9259, which are illustrated to colocate in Fig. 3. The other ex-
ample is the prenylxanthone biosynthetic pathway, which includes
Table 2. Prediction of NRPS gene clusters
Cluster size
GeneID Gene Compound (if known) Predicted Known Medium Source
AN9226 18 Solid
AN6444 8 Solid
AN4827 7 Solid
AN8105 8 Solid
AN8513 tdiA Terrequinone A 3* 5 Solid (21, 22)
AN1242 nlsA Nidulanin A 3 Solid This study
AN6961 2 Solid
AN0016 1 Solid
AN10486 1 Solid
AN7884 14 Both
AN3495 inpA Unknown 7 7 Both (25, 39)
AN3496 inpB Unknown 7 7 Both (25, 39)
AN2545 easA Emericellamide 4 4 Both (16)
AN2621 acvA/pcbAB Penicillin G 3 3 Both (25, 27, 28)
AN3396 mica Microperfuranone 3 3† Both (29)
AN2924 2 Both
AN10576 ivoA N-acetyl-6-hydroxytryptophan 2 2 Both (23, 26)
AN0607 sidC Siderophores 1 1 Both (55)
AN10297 1 Both
AN5318 1 Both
AN1680 1 Liquid
AN2064 1 Liquid
AN9129 1 Liquid
AN9291 1 Liquid
This table contains predicted NRPSs as well as NRPS-like genes (AN3396, AN5318, and AN9291). The medium
column describes under which type of medium (liquid, solid, or both) the cluster is expressed. For gene clusters
with identiﬁed functions and gene members, the number of identiﬁed cluster members is given as well as refer-
ences to the original papers. Further details on the cluster members and the expression proﬁles of the individual
clusters may be found in Dataset S2, and Fig. S4. Chemical structures of all compounds may be found in Fig. S1.
*Extent of the gene cluster is predicted correctly. The difference is due to the absence of two of the genes on the
legacy microarray data, which removes them from the prediction.
†Yeh et al. (29), who examined this cluster, found increased transcription of the two extra genes we predict, but
they found them to be nonessential for microperfuranone production.
Table 3. Prediction of gene clusters around prenyltransferases and diterpene synthases
Cluster size
GeneID Type Gene Compound (if known) Predicted Known Medium Source
AN11194 DMATS 18 Solid
AN11202 DMATS 18 Solid
AN9259 DMATS 12 10 Both (30)
AN8514 DMATS tdiB Terrequinone A 3* 5 Solid (21, 22)
AN11080 DMATS nptA Nidulanin A 1 Both This study
AN10289 DMATS 1 Solid
AN6784 DMATS xptA Variecoxanthone A 1 1 Solid (8–10)
AN1594 DTS Ent-pimara-8(14),15-diene 9 9 Solid (25)
AN3252 DTS 7 Solid
AN9314 DTS 2 Solid
This table contains predictedDMATSs, functionally prenyltransferases, and threeDTSs predictedbyBromann et al.
(25). Themedium columndescribes onwhich type ofmedium (liquid, solid, or both) the cluster is expressed. For gene
clusters with identiﬁed functions and gene members, the number of identiﬁed cluster members is given as well as
references to the original papers. Further details on the clustermembers and the expression proﬁles of the individual
clusters may be found in Dataset S2, and Fig. S4. Chemical structures of all compounds may be found in Fig. S1.
*Extent of the gene cluster is predicted correctly. The difference is due to the absence of two of the genes on the
legacy microarray data, which removes them from the prediction.
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the PKS AN0150 and the DMATS AN6784. These two genes are
also found close to each other in Fig. 3.
We further use the maximum separation distance of two genes
in the same biosynthetic cluster in the heat map of Fig. 3 as a cutoff
distance for cross-chemistry. This allowed the genes to be sorted
into seven larger superclusters. Details on the expression proﬁles
of the individual clusters in each supercluster can be found in Fig.
S4. Although we cannot directly separate tight coregulation from
cross-chemistry with this method, the presence of these super-
clusters consisting of individual clusters with similar expression
proﬁles suggests a larger extent of cross-chemistry in A. nidulans
than what has been reported to date. To test the predictive power
of this clustering further, we performed a gene deletion study
within supercluster 5, which contains clusters located on six of the
eight chromosomes.
Identiﬁcation of the Chemical Structure of Nidulanin A Conﬁrms
Prediction of Cross-Chemistry Between NRPS AN1242 (NlsA) and
Prenyltransferase AN11080 (NptA). To test the hypothesis of super-
clusters and whether the analysis above could be used to elucidate
cross-chemistry, we constructed a deletion mutant of the NRPS
AN1242 and evaluated the SMs found in the mutant relative to
a reference strain. Four related compounds (compounds 1–4) were
found to be absent in the ΔAN1242 strain (Fig. S5). MS isotope
patterns as well as tandemMS (MS/MS) analysis showed compound
1 to have the molecular formula C34H45N5O5, with compounds
2 and 3 likely being oxygenated forms with one and two extra oxygen
molecules, respectively. Compounds 1–3 all seem to be prenylated,
as shown by spontaneous loss of a prenyl-like fragment, C5H8, in
a small fraction of the ions during MS analysis. Compound 4 has
a molecular formula of (1)-C5H8, suggesting it to be the unpreny-
lated precursor of compound 1.
We thus isolated and elucidated the structure of compound 1,
henceforth called nidulanin A, based on NMR spectroscopy. The
stereochemistry of compound 1 was examined using Marfey’s
method (40) and was supported by bioinformatic analysis of the
protein domains of AN1242 (SI Text). Altogether, nidulanin A is
proposed to be a tetracyclopeptide with the sequence -L-Phe-L-
Kyn-L-Val-D-Val- and an isoprene unit N-linked to the amino
group of L-kynurenine (Fig. 4).
Because no prenyltransferase genes are found near AN1242,
cross-chemistry catalyzed by an N-prenylating DMATS is a likely
assumption. Examination of supercluster 5 in Fig. 3, where the
NRPS AN1242 is found, shows AN11080 to be the DMATS with
the expression proﬁle most similar to AN1242. Gene deletion of
AN11080 and subsequent ultra-high-performance liquid chroma-
tography (UHPLC) high-resolution MS (HRMS) analysis of the
ΔAN11080 strain show that the deprenylated compound 4, but
none of the three prenylated forms, is present, thus conﬁrming that
nidulanin A and the two oxygenated forms (compounds 3 and 4)
are synthesized by cross-chemistry between AN1242 (now NlsA)
on chromosome VIII and AN11080 (now NptA) on chromosome
V (Fig. S5).
Furthermore, we note that the masses corresponding to com-
pound 3 (nidulanin A + O) and compound 4 (nidulanin A + O2)
are not found in the reference strain or in the ΔAN11080 strain.
This suggests that compounds 3 and 4 are oxidized after the
prenylation step.
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Fig. 2. Identiﬁcation of the sterigmatocystin biosynthetic cluster. (A) Gene expression proﬁles across 44 experiments for the 24 genes (marked in black in B)
predicted to be in the sterigmatocystin biosynthetic cluster (liquid and solid cultures are marked for reference). The expression proﬁle of AN7811(stcO) is
marked in blue. (B) Illustration of the values of the gene CS for the 24 genes and the two immediate neighbors. Genes included in the predicted cluster are
marked in black. AN7811(stcO) did not have a CS above the used cutoff of 2.13 denoting clustering but was added due to the similarity of the expression
proﬁle, as shown in blue. The predicted extent of the cluster corresponds with the cluster as originally described by Brown et al. (17), when correcting for the
fact that the gene models have changed since then. Full data for all predicted clusters may be found in Dataset S2.
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Discussion
In this study, we present a method for fungal SM cluster esti-
mation based on similarity of expression proﬁles for neighboring
genes. For the given organism A. nidulans, comparison with legacy
data has veriﬁed the method to be highly accurate and effective
for a large proportion of the gene clusters.
It is clear from our results that the composition of the gene
expression compendium has a signiﬁcant effect on cluster pre-
dictions. We show here that it is important with a diverse set of
samples, including both liquid and agar cultures as well as min-
imal medium and complex medium. This is in accordance with
previous observations (11, 13, 14, 20, 36) stating that at a given
set of conditions, only a fraction of the clusters are active. A
reduction analysis of our own data has further shown that the
inclusion of biological replicates in the dataset does not improve
the analysis as much as inclusion of more unique samples. A
diverse set of conditions should remedy regulation at the tran-
scriptional level as well as chromatin-level regulation, which has
been shown to have signiﬁcant effects in fungi (13, 41). Another
factor of importance is the quality of genome annotation. Er-
roneous gene calls inside clusters decrease the value of the CS
for genes within a distance of three genes. Furthermore, prob-
lems with gene calls can affect expression proﬁling if a non-
transcribed region is included in the gene cluster. However,
neither of these seems to be a problem in the data presented
here. Including the expression proﬁles of seven genes in the
calculation of the CS also increases the robustness of the method
toward erroneous gene calls.
The stated robustness of the CS has the disadvantage that the
CS alone performs poorly for clusters with four or fewer genes,
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Fig. 3. Cross-chromosomal clustering. Matrix diagram of the correlation between 67 predicted and known biosynthetic genes. Each square in the matrix
shows the compounded squared Spearman correlation coefﬁcient for comparison of the expression proﬁle of the genes color-coded from 0 (white) to 1
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Genes with known cross-chemistry are marked with a black bracket. An example of cross-chemistry found in this study is marked with a red bracket. Seven
putative superclusters are marked. Further details of the clusters may be found in Fig. S4.
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because the maximum value of CS for n genes is n − 1. However,
in the cases of small clusters, the clustering can still be predicted
from the transcription proﬁles, as shown in this study.
In some cases, we also see that cluster calling based on expression
proﬁles outperforms the combination of gene KO and metab-
olomics. If a given detectedmetabolite is not the end product of the
biosynthetic pathway, gene deletions will only identify a part of an
SM cluster as being relevant for thatmetabolite, thusmissing genes.
An example of this is seen in the emodin/monodictyphenone
cluster (PKS AN0150), where a subset of the genes is only required
for some of the metabolites, resulting in a two-step elucidation of
the gene cluster (7, 8). The CS method correctly calls the
full cluster.
One aspect of the method is the ability to identify gene clusters
simply from identifying groups of genes with high CS values, and
not using a seeding set of synthases as was done in this case. This
allows the unbiased identiﬁcation of gene clusters throughout the
entire genome. Although we see a surprising amount of these
clusters (Dataset S2) not limited to the predicted SM synthases, we
have not evaluated these in this study, because data for appropriate
benchmarking is not available. However, we believe that there is
great potential for biological discoveries to be made here, both in
terms of promoter and chromatin-based transcriptional regulation.
The ﬁnal extension of the algorithm is its ability to identify
biosynthetic superclusters scattered across different chromo-
somes. Although this is a recently reported phenomenon (8), we
believe that this is a common phenomenon, at least in A. nidulans
and possibly in fungi in general. It is important to note that our
method does not allow one to discriminate between tight cor-
egulation and cross-chemistry between two distant clusters. It is
therefore most efﬁcient in cases in which it is evident that a given
gene cluster does not hold all enzymatic activities required to
synthesize the associated compound. In those cases, the use of
a diverse transcription catalog, such as the one applied here, is
a powerful strategy for identifying cross-chemistry, as shown for
the NRPS AN1242 and the assisting prenyltransferase AN11080
in the synthesis of nidulanin A and derived compounds.
In summary, this study provides (i) an updated gene expres-
sion DNA array for A. nidulans, (ii) a wealth of information
advancing the cluster elucidation in the model fungus A. nidu-
lans, (iii) a powerful tool for prediction of SM cluster gene
members in fungi, (iv) a proven methodology for prediction of
SM gene cluster cross-chemistry, and (v) a proposed structure for
the compound nidulanin A.
Materials and Methods
Strains. A. nidulans FGSC A4 was used for all transcriptomic experiments in
this study. Furthermore, legacy data using the FGSC A4, A. nidulans
AR16msaGP74 (expressing the msaS gene from Penicillium griseofulvum)
(34), A. nidulans AR1phk6msaGP74 (expressing the msaS gene from P. gri-
seofulvum and overexpressing the A. nidulans xpkA) (34), and A. nidulans
AR1phkGP74 (overexpressing the A. nidulans xpkA) (33), were applied.
The A. nidulans FGSC A4 stock culture was maintained on CYA agar at 4 °C.
A. nidulans strain IBT 29539 (veA1, argB2, pyrG89, and nkuAΔ) was used for all
gene deletions. Gene deletion strains (see below) are available from the IBT
fungal collection as A. nidulans IBT 32029, (AN1242Δ::AfpyrG, veA1, argB2,
pyrG89, and nkuAΔ) and A. nidulans IBT 32030, (AN11080Δ::AfpyrG, veA1,
argB2, pyrG89, and nkuAΔ). For chemical analyses, A. nidulans IBT 28738
(veA1, argB2, pyrG89, and nkuA-trS::AfpyrG) was used as reference strain.
Metabolite Proﬁling Analysis. A. nidulans strains were inoculated on CYA
agar, OTA, YES agar, and CYAS agar (42). All strains were three-point in-
oculated on these media and incubated at 32 °C in darkness for 4, 8, or 10 d,
after which three to ﬁve plugs (6-mm diameter) along the diameter of the
fungal colony were cut out and extracted (43).
Samples were subsequently analyzed by UHPLC-UV/vis diode array detector
(DAD)-HRMS on a maXis G3 quadrupole time-of-ﬂight mass spectrometer
(Bruker Daltonics) equipped with an electrospray injection (ESI) source. The
mass spectrometerwas connected to anUltimate 3000UHPLC system (Dionex).
Separation of 1-μL samples was performed at 40 °C on a 100-mm × 2.1-mm
inner diameter (ID), 2.6-μm Kinetex C18 column (Phenomenex) using a linear
water-acetonitrile gradient (both buffered with 20 mM formic acid) at a ﬂow
rate of 0.4 mL/min starting from 10% (vol/vol) acetonitrile and increased to
100% acetonitrile in 10 min, keeping this for 3 min. HRMS was performed in
ESI+ with a data acquisition range of 10 scans per second atm/z 100–1,000. The
mass spectrometer was calibrated using sodium formate automatically infused
before each analytical run, providing a mass accuracy better than 1.5 ppm.
Compounds were detected as their [M + H]+ ion ± 0.002 Da, often with
their [M + NH4]
+ and/or [M + Na]+ ion used as a qualiﬁer ion with the same
narrow mass range. SMs with a peak areas >10,000 counts (random noise
peaks of approximately 300 counts) were integrated and identiﬁed by com-
parison with approximately 900 authentic standards available from previous
studies (31, 44) and dereplicated against the approximately 18,000 fungal
metabolites listed in AntiBase 2010 by ultraviolet-visible (UV/Vis) spectra, re-
tention time, adduct pattern, and high-resolution data (<1.5 ppm mass accu-
racy and isotope ﬁt better than 40 using SigmaFit; Bruker Daltonics) (31, 45).
Array Design. Initial probe design was done using OligoWiz 2.0 software (46)
from the coding sequences of predicted genes from the genome sequence
of A. nidulans FGSC A4 (35), using version 5 of the A. nidulans gene anno-
tation, downloaded from the Aspergillus Genome Database (32).
For each gene, a maximum of three nonoverlapping, perfect-match 60-
mer probes was calculated using the OligoWiz standard scoring of cross-
hybridization, melting temperature, folding, position preference, and low
complexity. A position preference for the probes was included in the com-
putations. Pruning of the probe sequences was done by removing duplicate
probe sequences.
Also included on the chip were 1,407 standard controls designed by
Agilent Technologies. Details of the array are available from the National
Center for Biotechnology Information Gene Expression Omnibus (accession
no. GPL15899).
Microarray Gene Expression Proﬁling. Mycelium harvest and RNA puriﬁcation.
Whole colonies from three-stab agar plates were sampled for transcriptional
analysis by scraping the mycelium off the agar with a scalpel and transferring
the agar directly into a 50-mL Falcon tube containing approximately 15 mL of
liquid nitrogen. Care was taken to transfer a minimum of agar to the Falcon
tube. The liquid nitrogen was allowed to evaporate before capping the lid
and recooling the tube in liquid nitrogen before storing the tube at −80 °C
until use for RNA puriﬁcation.
For RNA puriﬁcation, 40–50 mg of frozen mycelium was placed in a 2-mL
microcentrifuge tube precooled in liquid nitrogen containing three steel
balls (two balls with a diameter of 2 mm and one ball with a diameter of 5
mm). The tubes were then shaken in a Retsch Mixer Mill at 5 °C for 10 min
until the mycelium was ground to a powder. Total RNA was isolated from
the powder using the Qiagen RNeasy Mini Kit according to the protocol for
isolation of total RNA from plant and fungi, including the optional use of
the QiaShredder column. Quality of the puriﬁed RNA was veriﬁed using
a NanoDrop ND-1000 spectrophotometer and an Agilent 2100 Bioanalyzer
(Agilent Technologies).
Microarray hybridization. A total of 150 ng in 1.5-μL total RNA was labeled
according to the One Color Labeling for Expression Analysis, Quick Amp Low
Input (QALI) manual, version 6.5, from Agilent Technologies. Yield and spe-
ciﬁc activity were determined on the ND-1000 spectrophotometer and veri-
ﬁed on a Qubit 2.0 ﬂuorometer (Invitrogen). A total of 1.65 μg of labeled
cRNA was fragmented at 60 °C on a heating block, and the cRNA was pre-
pared for hybridization according to the QALI protocol. A 100-μL sample was
loaded on a 4 × 44 Agilent Gasket Slide situated in a hybridization chamber
(both from Agilent Technologies). The 4 × 44 array was placed on top of the
Gasket Slide. The array was hybridized at 65 °C for 17 h in an Agilent Tech-
nologies hybridization oven. The array was washed following the QALI pro-
tocol and scanned in a G2505C Agilent Technologies Micro Array Scanner.
Analysis of transcriptome data. The raw array signal was processed by ﬁrst
removing the background noise using the normexp method, and signals
between arrays were made comparable using the quantiles normalization
method as implemented in the Limma package (47). Multiple probe signals
per gene were summarized into a gene-level expression index using Tukey’s
medianpolish, as performed in the last step of the robust multiarray average
(RMA) processing method (48). The data are available from the Gene Ex-
pression Omnibus database (accession no. GSE39993).
The generated data from the Agilent Technologies arrays were combined
with legacy Affymetrix data (accession nos. GSE12859 and GSE7295) using the
qspline normalization method (46) to combine the two normalized sets of
data to onemicroarray catalog with expression indices in comparable ranges.
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Calculation of the Gene CS. The CS is calculated for each individual gene along
the chromosomes according to the following equation:
CS± 3 ¼
X3
i¼− 3

s0;i þ
s0;i
2
2
þ
X3
i¼1

s0;i þ
s0;i
2
2
; [1]
where s0,i is the Spearman coefﬁcient for the expression indices of the gene
in question and the gene located i genes away in a positive or negative
direction relative to the chromosomal coordinate of the gene. The absolute
term is added to set inverse correlations to 0. The CS assigned to a speciﬁc
gene is the average of the CS for the liquid cultures and the CS for the solid
cultures to adjust for background expression levels. Genes located less than
four genes away from the ends of the supercontigs are assigned a CS of 0. All
calculations were performed in the R software suite v. 2.14.0 (49), using the
Bioconductor package (50, 51) for handling of array data. An adaptable R
script for calculation of the CS is available on request.
Generation of Random Values for Evaluation of CS Signiﬁcance. To estimate
signiﬁcance levels of the CS, a random set of scores was generated by
selecting six genes at random as simulated neighbors for each of the 10,411
genes in the dataset. Examining this random distribution showed 95% of the
population to have a CS <2.13 (Fig. S2). This value was used to have a false
discovery rate of 0.05. All calculations were performed in R (49).
Identiﬁcation of Gene Clusters. Gene clusters were deﬁned around each NRPS,
PKS, and DMATS by examination of the transcription proﬁle of all sur-
rounding genes with a CS ≥2.13 as well as three ﬂanking genes in either
direction. All genes with similar expression proﬁles were included in
the cluster.
PCA-Based Analysis of Dataset Variation. PCA analysis was performed on the
data of Dataset S2 using the prcomp-function of R (49). For stepwise re-
duction of the dataset, all principal components were calculated in each
iteration and a sample was eliminated based on the one that had the largest
contribution to the last principal component (i.e., with the smallest amount
of unique information).
Generation of A. nidulans Gene Deletion Mutants. The genetic transformation
experiments were performed with A. nidulans strain IBT 29539 [veA1, argB2,
pyrG89, and nkuAΔ as described by Nielsen et al. (52)]. Fusion PCR-based
bipartite gene targeting of substrates using the AFpyrGmarker for selection
and deletion of AN1242 was performed as described by Nielsen et al. (52),
with the exception that all PCR assays were performed with the PfuX7 DNA
polymerase (53). The deletion construct for AN11080 was assembled by
uracil-speciﬁc excision reagent (USER) cloning. Speciﬁcally, sequences up-
stream and downstream of the gene to be deleted were ampliﬁed by PCR
using primers containing a uracil residue (Table S2). The two PCR fragments
were simultaneously inserted into the PacI/Nt.BbvCI USER cassette of
pU20002A by USER cloning (54, 55). As a result, AFpyrG is now ﬂanked by
the two PCR fragments to complete the gene targeting substrate. The gene
targeting substrate was released from the resulting vector pU20002A-
AN11080 by digestion with SwaI. All restriction enzymes are from New
England Biolabs. Primer sequences for deletion of the targeted genes and
veriﬁcation of strains are listed in Table S2. In addition, internal AFpyrG
primers were used in combination with the check primers listed in Table S2
for conﬁrmation of correct integration of DNA substrates (52). Trans-
formants and AFpyrG pop-out recombinant strains were rigorously tested
for correct insertions as well as for the presence of heterokaryons by
touchdown spore-PCR analysis on conidia with an initial denaturation at 98 °C
for 20 min.
MS/MS-Based Characterization of Compounds 1–4. Analysis was performed as
stated above for the UHPLC-DAD-HRMS but in MS/MS mode, where analysis
of the target mass and 6 m/z units up (to maintain isotopic pattern) was
performed both via a targeted MS/MS list for the target compounds of in-
terest and by the data-dependent MS/MS mode with an exclusion list, such
that the same compound was selected several times. MS/MS fragmentation
energy was varied from 18 to 55 eV.
Isolation and Structural Elucidation of Nidulanin A. Two hundred plates of
minimal medium were inoculated with A. nidulans, from which SMs were
extracted and nidulanin A was isolated in pure form. One-dimensional and
2D NMR spectra were recorded on a Bruker Daltonics Avance 800-MHz
spectrometer with a 5-mm TCI Cryoprobe at the Danish Instrument Centre
for NMR Spectroscopy of Biological Macromolecules at Carlsberg Laboratory.
Stereoisometry of the amino acids was elucidated using Marfey’s method
(40). Details are provided in SI Text, Table S3, and Figs. S6–S8.
NRPS protein domainswere predicted to identify adenylation domains and
epimerase domains (56). Adenylation-domain speciﬁcities were predicted
using NRPSpredictor (57). Details are provided in SI Text.
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SI Materials and Methods
Fungal Growth, Extraction, and Isolation of Nidulanin A. Aspergillus
nidulans (IBT 22600) was inoculated as three-point stabs on 200
plates of MM and incubated in the dark at 30 °C for 7 d. The
fungi were harvested and extracted twice overnight with EtOAc.
The extract was ﬁltered and concentrated in vacuo. The com-
bined extract was dissolved in 100 mL of MeOH and H2O (9:1),
and 100 mL of heptane was added after the phases were sepa-
rated. Eighty milliliters of H2O was added to the MeOH/H2O
phase, and metabolites were then extracted with 5 × 100 mL of
dichloromethane (DCM). The phases were then concentrated
separately in vacuo. The DCM phase (0.2021 g) was absorbed
onto diol column material and dried before packing into a 10-g
SNAP column [coefﬁcient of variation (CV) = 15 mL; Biotage]
with diol material. The extract was then fractionated on an Iso-
lera ﬂash puriﬁcation system (Biotage) using seven steps of
heptane-DCM-EtOAc-MeOH. A ﬂow rate of 20 mL·min−1 was
used, and fractions were automatically collected with 2 × 2 CVs
for each step. Solvents used were of HPLC grade, and H2O was
milliQ-water (puriﬁed and deionized using a Millipore system
through a 0.22-μm membrane ﬁlter). Two of the Isolera frac-
tions were subjected to further puriﬁcation on separate runs on
semipreparative HPLC (Waters 600 Controller with a 996-pho-
todiode array detector). This was achieved using a Luna II C18
column (250 mm × 10 mm, 5 μm; Phenomenex). A linear water-
MeCN gradient was used starting with 15% MeCN and in-
creasing to 100% over 20 min using a ﬂow rate of 4 mL·min−1.
MeCN was of HPLC grade, and H2O was milliQ-water (puriﬁed
and deionized using the Millipore system through a 0.22-μm
membrane ﬁlter); both were added to 50 ppm of TFA. The
fractions obtained from the separate runs were pooled, and
a ﬁnal puriﬁcation using the same method yielded 1.5 mg of
nidulanin A.
Marfey’s Method. Stereoisometry of the amino acids was eluci-
dated using Marfey’s method (1). One hundred micrograms of
the peptide was hydrolyzed with 200 μL of 6 M HCl at 110 °C for
20 h. To the hydrolysis product (or 2.5 μmol of standard D- and
L-amino acids) was added 50 μL of water, 20 μL of 1 M NaHCO3
solution, and 100 μL of 1% 1-ﬂuoro-2-4-dinitrophenyl-5-L-ala-
nine amide (FDAA) in acetone, followed by reaction at 40 °C for
1 h. The reaction mixture was removed from the heat and neu-
tralized with 10 μL of 2 M HCl, and the solution was diluted with
820 μL of MeOH to a total volume of 1 mL. The retention times
of the FDAA derivatives were compared with retention times of
the standard amino acid derivatives.
Analysis. Analysis was performed using ultra-high-performance
liquid chromatography (UPHLC) UV/Vis diode array detector
(DAD) high-resolution MS (HRMS) on a maXis G3 orthogonal
acceleration (OA) quadrupole–quadrupole time of ﬂight (QQ-
TOF) mass spectrometer (Bruker Daltonics) equipped with an
electrospray injection (ESI) source and connected to an Ultimate
3000 UHPLC system (Dionex). The column used was a reverse-
phase Kinetex 2.6-μm C18, 100 mm × 2.1 mm (Phenomenex), and
the column temperature was maintained at 40 °C. A linear water-
acetonitrile gradient was used (both solvents were buffered with 20
mM formic acid) starting from 10% (vol/vol) MeCN and increased
to 100% in 10min, maintaining this rate for 3 min before returning
to the starting conditions in 0.1 min and staying there for 2.4 min
before the following run. A ﬂow rate of 0.4 mL·min−1 was used.
HRMS was performed in ESI+ with a data acquisition range of
10 scans per second atm/z 100–1,000. The mass spectrometer was
calibrated using bruker daltonics high precision calibration
(HPC) by means of the use of the internal standard sodium for-
mate, which was automatically infused before each run. UV
spectra were collected at wavelengths from 200 to 700 nm. Data
processing was performed using DataAnalysis software (Bruker
Daltonics). HRMS analysis of nidulanin A was measured to
604.3497 Da corresponding to a molecular formula of C34H45N5O5
(deviation of −0.6 ppm).
NMR. The 1D and 2D spectra were recorded on a Bruker Daltonics
Avance 800-MHz spectrometer equipped with a 5-mm TCI
Cryoprobe at the Danish Instrument Centre for NMR Spectros-
copy of Biological Macromolecules at Carlsberg Laboratory.
Spectra were acquired using standard pulse sequences, and a 1H
spectrum,aswell asCOSY,NOESY,heteronuclear singlequantum
coherence (HSQC), and heteronuclear multiple bond correlation
(HMBC) spectra, were acquired. The deuterated solvent was
acetonitrile-d3, and signals were referenced by solvent signals for
acetonitrile-d3 at δH = 1.94 ppm and δC = 1.32/118.26 ppm. The
NMR data were processed using Topspin 3.1 (Bruker Daltonics).
Chemical shifts are reported in parts per million (δ), and scalar
couplings are reported in hertz. The sizes of the J coupling con-
stants reported in the tables are the experimentally measured
values from the spectra. There are minor variations in the meas-
urements, which may be explained by the uncertainty of J. NMR
data for nidulaninA are presented in Table S3, and the structure is
shown in Fig. S6.
Protein Domain Predictions. Nonribosomal peptide synthase
(NRPS) protein domains were predicted using the analysis tool of
Bachmann and Ravel (2) with the standard settings. Only do-
mains with signiﬁcant P values (P < 0.05) were included in the
analysis. Adenylation domain speciﬁcities were predicted using
NRPSpredictor (3).
Structural Elucidation. The 1H NMR spectrum of nidulanin A
displayed four resonances at δH 8.16, 7.91, 7.64, and 7.51 ppm,
which were identiﬁed as amide protons indicative of a non-
ribosomal peptide type of compound. For each resonance,
a COSY correlation to a proton further up-ﬁeld in the α-proton
area could be observed. This coupled each of the amide protons
to Hα protons at resonances of δH 4.82, 3.92, 4.56, and 3.85 ppm,
respectively. Investigation of the NOESY connectivities allowed
for assembling of the peptide backbone, which revealed a cyclical
tetrapeptide as illustrated in Fig. S7.
The two protons at δH 7.64 and 4.56 ppm were part of a larger
spin system with correlations to a couple of diastereotopic protons
at δH 3.02 [1H, doublet of doublets (dd), 14.4, 8.0] and 2.82 (1H,
dd, 14.3, 7.5) ppm, as well as ﬁve aromatic protons at δH 7.14 [1H,
multiplet (m)], 7.21 (2H, m), and 7.22 (2H, m). HMBC correla-
tions from the diastereotopic pair as well as the aromatic protons
revealed a quaternary carbon with a carbon chemical shift of 137.5
ppm. This information, put together, led to the amino acid phe-
nylalanine. The protons at δH 7.91 and 3.92 ppm, as well as the
protons at δH 7.51 and 3.85 ppm, had very similar spin systems. In
both spin systems, a single proton appeared (δH 1.93 and 1.96, both
multiplets), as well as two methyl groups as doublets (δH 0.71/0.78
ppm and 0.84/0.79 ppm). In both cases, the amino acid could be
established as valine. Elucidation of the ﬁnal part of the structure
showed that this was not one of the standard proteinogenic amino
acids. For this ﬁnal part, three different spin systems, as well as two
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isolated methyl groups, were present, which could be linked to-
gether by HMBC correlations as well as NOESY connectivities.
The ﬁrst spin system consisted of the amide proton at δH 8.16 ppm,
the Hα proton at 4.82 ppm, and a diastereotopic pair of protons at
δH 3.63 (1H, dd, 17.7, 9.7) and 3.09 (1H, dd, 17.6, 4.9) ppm. The
second spin system consisted of four aromatic protons at δH 7.79
(1H, dd, 8.2, 1.5), 7.28 [1H, doublet of doublets of doublets (ddd),
8.6, 7.0, 1.5], 6.81 (1H, dd, 8.7, 0.7), and 6.57 (1H, ddd, 8.6, 7.0, 1.1)
ppm, whereas the third and ﬁnal spin system contained three
protons located in the double-bond area at δH 5.95 (1H, dd, 17.6,
10.7), 5.13 (1H, dd, 10.7, 1.0), and 5.15 (1H, dd, 17.6, 1.0) ppm.
The latter was shown to be connected to the two methyl groups at
δH 1.39 [3H, singlet (s)] and 1.38 (3H, s) ppm, and the presence of
a quaternary carbon at δC 53.7 ppm linked this part as an isoprene
unit. The entire residue and key HMBC correlations for the
structural elucidation of this part are shown in Fig. S8. The residue
contains the amino acid L-kynurenine, which is an intermediate in
the tryptophan degradation pathway. In this structure, L-kynur-
enine has been further modiﬁed, because the aforementioned
isoprene unit has been incorporated onto the amine located at the
aromatic ring.
To establish the stereochemistry of nidulanin A, Marfey’s
analysis (1) was performed. This technique enables one to de-
termine the absolute conﬁguration of amino acids in peptides (1).
The analysis showed the phenylalanine residue present was L-
phenylalanine, whereas the analysis for valine showed equal
amounts of L- and D-valine.
We used bioinformatics prediction algorithms to identify
the stereochemistry of the added amino acids further. Both
NRPS protein domain predictions and adenylation domain
speciﬁcity predictors identify four adenylation domains, cor-
responding to the four amino acids of the cyclopeptide. By
comparison of predictions and the known sequence, the spec-
iﬁcity and sequence of the adenylation domains were assigned
as predicted to Phe-Kyn-Val-Val. The last two adenylation
domains give similar predictions, further supporting both to be
speciﬁc for valine.
The structure with the proposed absolute chemistry is given in
Fig. 4. The absolute conﬁguration of the kynurenine, as well as the
order of the L- and D-valine, which is based solely on the bio-
informatic studies, has not been veriﬁed chemically.
1. Marfey P (1984) Determination of D-amino acids. II. Use of a bifunctional reagent,1,5-
diﬂuoro-2,4-dinitrobenzene. Carlsberg Res Commun 49:591.
2. Bachmann BO, Ravel J (2009) Chapter 8. Methods for in silico prediction of microbial
polyketide and nonribosomal peptide biosynthetic pathways from DNA sequence
data. Methods Enzymol 458:181–217.
3. Rausch C, Weber T, Kohlbacher O, Wohlleben W, Huson DH (2005) Speciﬁcity
prediction of adenylation domains in nonribosomal peptide synthetases (NRPS)
using transductive support vector machines (TSVMs). Nucleic Acids Res 33(18):
5799–5808.
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Fig. S1. Chemical structures of secondary metabolites. Structures are shown in alphabetical order in columns from left to right.
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Fig. S2. Quantile plot of clustering scores (CSs). The gray line plots the quantile for a given value of the CS based on a random combination of genes (Materials
and Methods). Ninety-ﬁve percent of the values attained are 2.13 or below (as shown). The red line is a plot of the quantiles of actual values for the genes, as
can be found in Dataset S2.
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Fig. S3. Extracted ion chromatograms (EICs) for austinol and dehydroaustinol (mass tolerance ± 0.005 Da) from UHPLC-DAD-HRMS of chemical extractions
from the reference strain and the ΔAN8375, ΔAN8376 and ΔAN8382 strains. DAD, diode array detector.
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Fig. S4. Overview of the gene expression proﬁles for all predicted members of the biosynthetic gene clusters (Tables 1–3 and Dataset S2). The y axis indicates
the gene expression index on a log2 scale, and the x axis represents the 44 experimental conditions included in the microarray compendium. The biosynthetic
clusters are sorted into the Superclusters indicated in Fig. 3.
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Fig. S5. Extracted ion chromatograms (EICs) for compounds 1–4. Mass tolerance ± 0.005 Da from UHPLC-DAD-HRMS of chemical extractions from the ref-
erence strain and ΔAN1242 and ΔAN11080 strains. DAD, diode array detector.
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Table S1. List of predicted biosynthetic geneswhere low expression
indices with low variation across the 44 conditions were found
GeneID Type Gene name
Compound
(if known) Gene no. Known Refs.
AN0523 PKS 4 (1)
AN1034 PKS afoE Asperfuranone 5 7 (2, 3)
AN1036 PKS afoG Asperfuranone 5 7 (2, 3)
AN10430 PKS
AN3273 PKS
AN3386 PKS
AN3612 PKS
AN5475 PKS
AN6961 NRPS
AN9243 NRPS
AN9244 NRPS
AN6810 DTS
These genes are assumed to be silent in all 44 conditions. DTS, diterpene
synthase; NRPS, nonribosomal peptide synthase; PKS, polyketide synthase.
1. Bromann K, et al. (2012) Identiﬁcation and characterization of a novel diterpene gene cluster in Aspergillus nidulans. PLoS ONE 7(4):e35450.
2. Chiang YM, et al. (2008) Molecular genetic mining of the Aspergillus secondary metabolome: Discovery of the emericellamide biosynthetic pathway. Chem Biol 15(6):527–532.
3. Bergmann S, et al. (2010) Activation of a silent fungal polyketide biosynthesis pathway through regulatory cross talk with a cryptic nonribosomal peptide synthetase gene cluster. Appl
Environ Microbiol 76(24):8143–8149.
Table S2. Primer sequences
Primer name Sequence
AN1242-DL-Up-F GAGATCGTCGATGGAGTGGCG
AN1242-DL-Up-Rad gatccccgggaattgccatgCTGCGAGGCACATCATGTTGCC
AN1242-DL-Dw-Fad aattccagctgaccaccatgGGGTCTGGGTACGCGGGTTTG
AN1242-DL-Dw-R GATGTGTAGGCGCGACATGGG
AN1242-CHK-Up-F CCGTCATCATCGTTATAGCC
AN1242-CHK-Dw-R GCACCCGCTATCACATAC
AN1242-GAPCHK-F GGCATTATGTGAGCTGTCGTG
AN1242-GAPCHK-R GATGGAGGGCTTGGTCTTGG
AN1242-INTCHK-R GATCGAGACGGGTCGTTTAGG
AN11080-DL-Up-FU GGGTTTAAUGGCAGGTACCAATAATGA
AN11080-DL-Up-RU GGACTTAAUAGATATACGAGTATGCGG
AN11080-DL-Dw-FU GGCATTAAUAGTGCCTGATAACTCTGC
AN11080-DL-Dw-RU GGTCTTAAUGTTGAATCCCTCTGCCTT
AN11080-CHK-Up-F GGACGGCCCATATTCAGA
AN11080-CHK-Dw-R AATAAGCTGTAGCGGCGA
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Table S3. NMR data for nidulanin A in acetonitrile-d3
Atom assignment
1H-chemical shift, ppm/J
coupling constants, Hz 13C-chemical shift, ppm HMBC correlations NOE connectivities
1 8.16 (1H, d, 9.2) — — 2, 3, 3′, 35
2 4.82 (1H, ddd, 8.6, 7.0, 1.5) 48.2 — 1, 3, 3′, 18
3 3.63 (1H, dd, 17.7, 9.7) 50.0 2, 4, 17 1, 2, 3′, 6
3′ 3.09 (1H, dd, 17.6, 4.9) 50.0 4 1, 2, 3, 6
4 — 198.9 — —
5 — 116.6 — —
6 7.79 (1H, dd, 8.2, 1.5) 131.8 4, 8, 10 3, 3′, 7
7 6.57 (1H, ddd, 8.6, 7.0, 1.1) 114.3 5, 9 6
8 7.28 (1H, ddd, 8.6, 7.0, 1.5) 134.0 6, 10 —
9 6.81 (1H, dd, 8.7, 0.7) 114.9 5, 7 15, 16
10 — 148.7 — —
11 9.01 (1H, s) — 5, 9, 12 15, 16
12 — 53.7 — —
13 5.95 (1H, dd, 17.6, 10.7) 145.0 — 14, 14′
14 5.13 (1H, dd, 10.7, 1.0) 113.3 12 13
14′ 5.15 (1H, dd, 17.6, 1.0) 113.3 12, 13 13
15 1.39 (3H, s) 27.8 12, 13, 16 9, 11
16 1.38 (3H, s) 27.5 12, 13, 15 9, 11
17 — 172.1 — —
18 7.64 (1H, d, 8.4) — — 2, 19, 20, 20′
19 4.56 (1H, q, 8.0) 53.7 — 18, 28, 20, 20′
20 3.02 (1H, dd, 14.4, 8.0) * 19, 21, 22/26 18, 19, 20′
20′ 2.82 (1H, dd, 14.3, 7.5) * 19, 21, 22/26, 27 18, 19, 20
21 — 137.5 — —
22 7.22 (1H, m) 128.0 23/25 —
23 7.21 (1H, m) 127.7 21 —
24 7.14 (1H, m) 126.4 — —
25 7.21 (1H, m) 127.7 21 —
26 7.22 (1H, m) 128.0 23/25 —
27 — 172.7 — —
28 7.91 (1H, d, 9.2) — — 19, 29, 30, 31
29 3.92 (1H, d, 9.5) 59.1 27, 33 28, 30, 31, 32, 34
30 1.93 (1H, m) 26.3 — 28, 29, 31, 32
31 0.71 (3H, d, 6.6) 18.1 29, 30, 32 28, 29, 30
32 0.78 (3H, d, 6.6) 18.9 29, 30, 31 29, 30
33 — 172.2 172.6 —
34 7.51 (1H, d, 9.6) — — 29, 36
35 3.85 (1H, dd, 9.8, 10.7) 59.4 33, 39 1, 36, 37, 38
36 1.96 (1H, m) 26.9 — 34, 35, 37, 38
37 0.84 (3H, d, 6.7) 18.1 35, 36, 38 35, 36
38 0.79 (3H, d, 6.6) 18.9 35, 36, 37 35, 36
39 — 172.1 — —
1H NMR spectrum and 2D spectra were recorded at with a Bruker Daltonics Avance 800 MHz spectrometer at Carlsberg Laboratory. Signals were referenced
to the solvent signals for acetonitrile-d3 at δH = 1.94 ppm and δC = 1.32/118.26 ppm. There are minor variations in the measurements which may be explained by
the uncertainty of J. d, doublet; dd, doublet of doublet; ddd, doublet of doublets of doublets; m, multiplet; q, quartet; s, singlet.
*Cannot be unambiguously assigned.
Dataset S1. Overview of UHPLC-DAD-HRMS analysis of chemical extractions from the reference strain on three solid media after 4, 8, or
10 d (4d, 8d, and 10d, respectively)
Dataset S1
Values given are extracted ion chromatogram peak areas. DAD, diode array detector.
Dataset S2. Gene expression indices from 44 experimental conditions sorted according to chromosomal coordinates
Dataset S2
Locus names and annotation from the Aspergillus Genome Database (www.ASPGD.org) are given where available. Clustering scores and cluster members
are given.
Andersen et al. www.pnas.org/cgi/content/short/1205532110 9 of 9
8   Papers 1-12
336
   
   
 
 
 
 
 
Paper 9 
 
 
“Molecular and chemical characterization of the biosynthesis of the  
6-MSA derived meroterpenoid yanuthone D in Aspergillus niger” 
 
 
Holm, D.K.; Petersen L.M. (Joint 1
st
 author); Klitgaard, A.; Knudsen, P.B.; 
Jarczynska, Z.D.; Nielsen, K.F.; Gotfredsen, C.H.; Larsen, T.O.; Mortensen, U.H. 
 
Chemistry & Biology, 2014, 21, 519-529. 
  
PhD Thesis 
Lene Maj Petersen
337
  
 
  
8   Papers 1-12
338
Chemistry & Biology
Article
Molecular and Chemical Characterization
of the Biosynthesis of the 6-MSA-Derived
Meroterpenoid Yanuthone D in Aspergillus niger
Dorte K. Holm,1,6 Lene M. Petersen,2,6 Andreas Klitgaard,3 Peter B. Knudsen,5 Zofia D. Jarczynska,1 Kristian F. Nielsen,3
Charlotte H. Gotfredsen,4 Thomas O. Larsen,2,* and Uffe H. Mortensen1,*
1Eukaryotic Molecular Cell Biology Group, Department of Systems Biology, Center for Microbial Biotechnology, Soltofts Plads, Building 223,
Technical University of Denmark, 2800 Kongens Lyngby, Denmark
2Chemodiversity Group, Department of Systems Biology, Center for Microbial Biotechnology, Soltofts Plads, Building 221,
Technical University of Denmark, 2800 Kongens Lyngby, Denmark
3Metabolic Signaling and Regulation Group, Department of Systems Biology, Center for Microbial Biotechnology, Soltofts Plads,
Building 221, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
4Department of Chemistry, Kemitorvet, Building 201, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
5Fungal Physiology and Biotechnology Group, Department of Systems Biology, Center for Microbial Biotechnology, Soltofts Plads,
Building 223, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
6These authors contributed equally to this work
*Correspondence: tol@bio.dtu.dk (T.O.L.), um@bio.dtu.dk (U.H.M.)
http://dx.doi.org/10.1016/j.chembiol.2014.01.013
SUMMARY
Secondary metabolites in filamentous fungi consti-
tute a rich source of bioactive molecules. We have
deduced the genetic and biosynthetic pathway of
the antibiotic yanuthone D from Aspergillus niger.
Our analyses show that yanuthone D is a meroterpe-
noid derived from the polyketide 6-methylsalicylic
acid (6-MSA). Yanuthone D formation depends on a
cluster composed of ten genes including yanA and
yanI, which encode a 6-MSA polyketide synthase
and a previously undescribed O-mevalon trans-
ferase, respectively. In addition, several branching
points in the pathway were discovered, revealing
five yanuthones (F, G, H, I, and J). Furthermore, we
have identified another compound (yanuthone X1)
that defines a class of yanuthones that depend on
several enzymatic activities encoded by genes in
the yan cluster but that are not derived from 6-MSA.
INTRODUCTION
Fungal polyketides (PKs) comprise a large and complex group of
metabolites with a wide range of bioactivities. Hence, the group
includes compounds that are used by fungi as pigments for UV-
light protection, in intra- and interspecies signaling, and in chem-
ical warfare against competitors (Williams et al., 1989). Many
PKs are mycotoxins that are harmful to human health, e.g., patu-
lin and the highly carcinogenic aflatoxins (Olsen et al., 1988). On
the other hand, several PKs have a great medical potential, e.g.,
cholesterol-lowering statins (Endo et al., 1976), the antimicrobial
and immunosuppressive mycophenolic acid (Bentley, 2000), the
acetyl-coenzyme A acetyltransferase-inhibiting pyripyropenes
(Frisvad et al., 2009), and the farnesyltransferase inhibiting
andrastins (Rho et al., 1998). Although more than 6,000 different
PKs have been isolated and characterized (AntiBase 2012),
these compounds are likely only the tip of the iceberg. For
example, for each fungus analyzed, only a small part of its full
repertoire of PKs genes appears to be produced under labora-
tory conditions (Pel et al., 2007; Andersen et al., 2013). In agree-
ment with this view, genome sequencing of several fungal
species have uncovered far more genes for PKs production
than can be accounted for by the number of compounds that
they are actually known to produce. Hence, the chemical space
of PKs is far from fully known, and many new drugs and myco-
toxins await discovery.
The fungal genome sequencing projects have demonstrated
that genes necessary for production of individual PKs often clus-
ter around the gene encoding the polyketide synthase (PKS),
which delivers the first intermediate in a given PK pathway.
Although this is helpful for pathway elucidation, compounds pro-
duced by orphan gene clusters (Gross, 2007) can still not be
easily predicted by bioinformatic tools (for review, see Cox,
2007 and Hertweck, 2009). This is because most fungal PKs
are produced by type I iterative PKSs whose products are noto-
riously difficult to predict. Moreover, the specificities and the
order of actions of the tailoring enzymes that modify the PK
released from the PKS further complicate prediction of the end
products. To elucidate the biochemical pathway of an orphan
gene cluster, it is therefore necessary to create gene cluster mu-
tations and/or to genetically reconstitute the pathway in a heter-
ologous host. Subsequent analytical and structural chemistry
analyses of the compounds that are present in the reference
strain but not in the mutant strains and of compounds that accu-
mulate in the mutant strains but are absent or present in minute
amounts in the reference strain may deliver insights that can be
used for pathway elucidation.
Aspergillus niger is an industrially important filamentous fun-
gus, which has obtained GRAS status for use in several industrial
processes and is used for production of organic acids and en-
zymes. Importantly, when the full genome sequence of A. niger
was examined, a gene cluster resembling the fumonisin gene
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cluster from Gibberella moniliformis was surprisingly identified,
suggesting that this well-characterized fungus has the genetic
potential to produce the carcinogenic fumonisins (Baker,
2006). This possibility was later confirmed by genetic and chem-
ical analyses (Pel et al., 2007; Frisvad et al., 2007). The fact that
the A. niger genome contains several orphan gene clusters for
production of secondary metabolites (Fisch et al., 2009) raises
the question of whether it can produce other bioactive PKs
that could be harmful, or perhaps beneficial, to human health.
To this end, one silent cluster in A. niger was recently activated
by expression of a transcription factor-encoding gene, which
was embedded in the cluster. The resulting strain produced six
azaphilone compounds, and further studies uncovered substan-
tial new insights into the biosynthesis of this class of compounds
(Zabala et al., 2012). It is interesting to note that among the 33
predicted PKS and PKS-like genes in A. niger, one encodes a
putative PKS, which is phylogenetically close to fungal 6-meth-
ylsalicylic acid (6-MSA) synthases (Fisch et al., 2009). Impor-
tantly, the model PK 6-MSA (Wattanachaisaereekul et al.,
2008) (Figure 1A) is known to be the precursor to, for example,
the mycotoxin patulin (Beck et al., 1990) produced by many
Aspergillus and Penicillium species, substantiating the possibil-
ity that this gene could be the source of yet another unknown
bioactive PK in A. niger. Importantly, none of these 6-MSA-
derived compounds have been observed in A. niger (Nielsen
et al., 2009). We therefore investigated whether A. niger has
the potential to produce 6-MSA or 6-MSA-derived compounds.
Known yanuthones constitute a group of compounds that are
derived from a six-membered methylated ring (the C7 core
scaffold) with three side chains: one sesquiterpene and two
varying side chains (-R and R’) (Figure 1B). In this study we
demonstrate that in A. niger, 6-MSA is the precursor for forma-
tion of yanuthone D, which is an antibiotic against Candida albi-
cans, methicillin-resistant Staphylococcus aureus (MRSA), and
vancomycin-resistant Enterococcus (Bugni et al., 2000). We
also show that yanuthone D is in fact a complex meroterpenoid
synthesized by a pathway where 6-MSA is decarboxylated,
heavily oxidized, and fused to a sesquiterpene and a mevalon
moiety (the di-acid of mevalonic acid). This is surprising,
because yanuthones have been hypothesized to originate from
the shikimate pathway (Bugni et al., 2000).
RESULTS
A. niger PKS48 Encodes a 6-MSA Synthase
To investigate the possibility that the A. niger gene PKS48/
ASPNIDRAFT_44965 encodes a 6-MSA synthase, we trans-
ferred the gene to A. nidulans, which has not been shown to pro-
duce 6-MSA and which does not contain a close homolog to
known 6-MSA PKSs. To ensure a high expression level on a
defined medium, the PKS48 gene was integrated into a well
characterized integration site, IS1 (Hansen et al., 2011), under
control of the strong constitutive promoter PgpdA. As expected,
themetabolite profile obtainedwith anAspergillus nidulans refer-
ence strain (IBT 29539) did not show any indications of 6-MSA
when analyzed by ultra-high-performance liquid chromatog-
raphy (UPHLC)-UV-visible diode array detector (DAD)-high-
resolution time-of-flightmass spectrometry (TOFMS) (Figure 2A).
In contrast, the metabolite profile of the strain expressing PKS48
showed the presence of a prominent new peak, which had the
same retention time as an authentic 6-MSA standard and dis-
played the same adducts and monoisotopic mass for the pseu-
domolecular ion. We therefore conclude that PKS48 encodes a
6-MSA synthase.
Production of Yanuthones D and E Is Eliminated by
Deletion of PKS48
The fact that 6-MSA has not previously been reported from
A. niger prompted us to investigate whether this compound
could be a precursor to a known secondarymetabolite produced
by this fungus. We therefore cultivated an A. niger reference
strain (KB1001) and an A. niger PKS48D strain on four different
solid media (minimal medium [MM], CYA, YES, and MEA) that
are known to trigger the production of a wide range of metabo-
lites (Nielsen et al., 2011). The resulting UHPLC-DAD-TOFMS
metabolite profiles were almost identical (Figure S1 available
online), showing that the PKS48D mutation did not induce a
global response on the secondary metabolism. However, on
YES and MM media, we identified two compounds that were
produced by KB1001, but not by the PKS48D strain (Figures
2B and 2C; Table S1). UHPLC separation with UV-visible and
Figure 1. Chemical Structures of 6-MSA and Previously Described
Yanuthones
(A) Chemical structure of 6-MSA.
(B) Chemical structures of previously described yanuthones: yanuthones A–E,
7-deacetoxyyanuthone A, and 22-deacetylyanuthone A (Bugni et al., 2000; Li
et al., 2003).
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high-resolution MS detection as well as MS/MS suggested that
the two compounds were yanuthones D and E. This was
confirmed by isolation of the compounds, nuclear magnetic
resonance (NMR) spectroscopy, and circular dichroism (CD)
(Tables S3 and S4). Hence, production of yanuthones D and E
appears to be based on the use of 6-MSA as a key precursor.
In this scenario, one carbon must be eliminated from C8-based
6-MSA to form the C7 core scaffold of yanuthones D and E.
Yanuthones Constitute a Complex Group of Compounds
That Appear to Originate from Different Precursors
In addition to yanuthones D and E, A. niger has previously been
reported to produce yanuthones A, B, and C, 1-hydroxyyanu-
thone A, 1-hydroxyyanuthone C, and 22-deacetylyanuthone A
(Bugni et al., 2000), and 7-deacetoxyyanuthone A has been re-
ported from the genus Penicillium (Li et al., 2003) (Figure 1B).
We thus examined the extracted ion chromatograms from the
UHPLC-DAD-TOFMS profiles obtained by KB1001 for the pres-
ence of these metabolites. In extracts obtained after cultivation
on MM, YES, and CYA media, this analysis identified trace
amounts of a compound (yanuthone X1) with a mass and
elemental composition corresponding to the yanuthone isomers
A and C. The nature of this compound was further investigated
by MS/MS, and its fragmentation pattern was similar to the
pattern of other yanuthones, showing characteristics such as
loss of a sesquiterpene chain. Moreover, the UV-visible spec-
trum of the compound was similar to spectra obtained for
yanuthones D and E, substantiating that this compound was a
yanuthone. Surprisingly, when the UHPLC-DAD-TOFMSmetab-
olite profiles obtained with the PKS48D strain were examined for
the presence of this yanuthone, it was still present. This observa-
tion strongly suggested that some yanuthones are produced
independently of PKS48.
Fully Labeled 13C8-6-MSA Is Incorporated into
Yanuthones D and E In Vivo
The fact that some yanuthones could be produced indepen-
dently of PKS48, combined with the fact that yanuthones have
been proposed to originate from the shikimate pathway, raised
the possibility that the absence of yanuthones D and E in the
PKS48 deletion strain potentially could be the result of an indirect
effect. To investigate this possibility, we fed fully labeled 13C8-6-
MSA to KB1001 and the PKS48D strain at different time points
during growth (24, 48, and 72 hr; see Experimental Procedures).
The addition of 13C8-6-MSA did not seem to adversely affect the
growth rate, and the morphologies of the colonies of the two
strains were identical (Figure S2). This indicates that the amounts
of 13C8-6-MSA added (2-10 mg/ml) did not significantly influence
strain fitness. Metabolites were then extracted from the plates
and analyzed by UHPLC-DAD-TOFMS. For both strains, 13C8-
6-MSA was incorporated into yanuthones D and E, resulting in
a mass shift of 7.023 Da. This is in agreement with the scenario
described above, where one carbon atom must be eliminated
from 6-MSA in the biosynthetic processing toward yanuthones
D and E. Moreover, the MS-based metabolite profiles also
showed that 13C8-6-MSA was exclusively incorporated into
compounds related to yanuthones. These compounds are only
present in tiny amounts and are likely intermediates or analogs
of yanuthone D or E, because they share the same UV chromo-
phore and because their masses corresponded to water loss(es)
or gain from yanuthone D or E. Based on these results, we
named the 6-MSA synthase (encoded by PKS48/ASPNIDRAFT_
44965) YanA (yanuthone) and the corresponding gene yanA. On
the other hand, no labeled yanuthone X1 was observed in
KB1001 as well as in the PKS48 deletion strain after addition
of 13C8-6-MSA (mass spectra are shown in Figure S3), confirm-
ing our finding that yanuthone X1 is formed in the absence of
PKS48. Hence, we conclude that 6-MSA is not the precursor
of yanuthone X1.
The yan Gene Cluster Comprises Ten Genes
To determine whether yanA defines a gene cluster for a biosyn-
thetic pathway toward yanuthones D and E, ten genes up- and
downstream of yanAwere annotated using FGeneSH (Softberry)
and AUGUSTUS software (Stanke andMorgenstern, 2005). Sub-
sequently, these twenty putative genes were examined using the
NCBI Conserved Domain Database (Marchler-Bauer et al., 2011)
for open reading frames (ORFs) encoding activities that are typi-
cally employed for the modification of PKs. Based on these
A
B
C
Figure 2. Extracted Ion Chromatograms
(A) Extracted ion chromatogram (EIC,m/z 153.0546 ± 0.005) of an A. nidulans
reference strain (IBT 29539) and a 6-MSA producing strain (IS1-44965/yanA).
(B) Base peak chromatograms (BPC) m/z 100-1,000 of the A. niger reference
(KB1001), yanAD, and yanRD strains.
(C) EICs of yanuthone D (1) 503.2640 ± 0.005 (red) and yanuthone E (2)
505.2791 ± 0.005 (black) for KB1001, yanAD, and yanRD.
All chromatograms are to scale.
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analyses, eight additional genes could potentially belong to the
yanA cluster, including genes encoding a transcription factor
(TF), a prenyl transferase, an O-acyltransferase, a decarboxy-
lase, two oxidases, two cytochrome P450s (CYP450s), and a
dehydrogenase (Figure 3; Table S2). Together with yanA and
192604 (a gene with no known homologs), these eight genes
form a cluster of ten genes that are not interrupted by any of
the remaining eleven genes included in the analysis. The fact
that one of the ten genes in this cluster (44961) putatively en-
codes a TF raised the possibility that expression of the genes
involved in yanuthones D and E production is controlled by this
TF. In agreement with this view, deletion of 44961 resulted in a
strain that did not produce these two yanuthones (Figures 2B
and 2C). To further delineate the yanA gene cluster, we deter-
mined the expression levels of the ten cluster genes as well as
of four flanking genes by RT-quantitative PCR (qPCR) in a
44961D strain and KB1001. When the two data sets were
compared, we found, as expected, that expression from 44961
is eliminated in the 44961D strain where the entire gene is
deleted (Figure S4). More importantly, the analysis demon-
strated that expression from the other nine genes in the cluster
was significantly downregulated in the 44961D strain as com-
pared to KB1001 (p value < 0.05). Specifically, the expression
was reduced more than 10-fold for seven of the genes, including
yanA. Expression of the remaining two genes, 54844 and 44964,
was expressed at a level corresponding to 20% and 11%,
respectively, of the level obtained with KB1001. In contrast,
expression levels from the four flanking genes were not signifi-
cantly different from KB1001 (Figure S4). Next, we individually
deleted the remaining eight genes in the proposed yan gene
cluster, which encode putative activities for PK modification.
None of the resulting strains, including 192604D, produced
yanuthone D, indicating that all genes belong to the yan cluster
(Table S1). As a control, the four additional genes flanking this
cluster were also individually deleted, but all these four strains
produced yanuthone D. Based on these analyses and the results
from the RT-qPCR, we propose that the yan gene cluster is
composed by 10 genes, yanA, yanB, yanC, yanD, yanE, yanF,
yanG, yanH, yanI, and yanR, where yanR encodes a TF that reg-
ulates the gene cluster (Figure 3; Table S2). Finally, all ten genes
were simultaneously deleted in one strain. When 13C8-6-MSA
was fed to this strain, no labeled metabolites were detected,
showing that all 6-MSA-derived yanuthones depend on this
gene cluster (see above).
YanF Converts Yanuthone E into Yanuthone D
As the first step toward elucidating the order of reaction steps in
the pathway toward yanuthones D and E, we asked whether
Figure 3. The Proposed yan Cluster
The yanA 6-MSA synthase-encoding gene is
flanked by nine cluster genes (yanB, yanC yanD,
yanE, yanF, yanG, yanH, yanI, and yanR) whose
products contain all necessary activities for con-
version of 6-MSA into yanuthone D.
yanuthones D and E are two different
end products or whether one is an inter-
mediate in the pathway toward produc-
tion of the other. To this end, we note that individual deletion of
genes in the yan gene cluster generally resulted in loss of pro-
duction of both yanuthones D and E on YES medium. The only
exception is the yanFD strain, which produced substantial
amounts of yanuthone E (2), but no yanuthone D (1) (Figure 4).
These findings suggest that YanF converts yanuthone E into
yanuthone D, which is the true end product of the pathway. Inter-
estingly, the yanFD strain produced a new and unknown com-
pound, which was not detected in KB1001. Elucidation of its
structure revealed a yanuthone E analog with a hydroxylation
at C-2 at the expense of the first double bond (between C-2
and C-3) in the sesquiterpene moiety (Table S4). This compound
was named yanuthone J (9).
m-Cresol and Toluquinol Are Intermediates of the
Yanuthone D Biosynthesis
Deletion of yanB, yanC, yanD, yanE, and yanG did not produce
any detectable intermediates, and the phenotype of these muta-
tions therefore does not link any of the genes to specific reaction
steps in the pathway toward formation of yanuthoneD. However,
one of the five putative enzymes, YanC, has a defined homolog,
PatI, in the Aspergillus clavatus patulin biosynthesis pathway
(Artigot et al., 2009) where it catalyzes the oxidation of m-cresol
into toluquinol, suggesting that toluquinol and m-cresol are also
likely intermediates in the yanuthone biosynthesis. To test this
hypothesis, we fed m-cresol and toluquinol to the yanAD strain.
Analysis of the metabolite profiles of the two strains indeed
showed that addition ofm-cresol or toluquinol restored produc-
tion of yanuthones D and E in the yanAD strain (Figure 5).
In an attempt to further elucidate the role of the five enzymes,
the corresponding geneswere inserted into plasmid pDHX2 (Fig-
ure S5) and individually expressed in the A. nidulans strain
harboring the yanA gene. No new compounds were produced
in these IS1-yanA strains expressing yanC, yanD, yanE, and
yanG, despite the fact that 6-MSA was produced in high
amounts (Figure S6). Similarly, in the strain expressing yanB,
no new product was observed, but in this case 6-MSA was
absent, indicating that 6-MSA is a substrate for YanB.
Deletion of yanI and yanH Reveals Key Intermediates in
the Biosynthesis of Yanuthone D
In contrast to the yanBD-ED and yanGD strains, new products
were observed in the yanHD and yanID strains. Deletion of
yanH resulted in a strain where the most prominent compound
accumulating is 7-deacetoxyyanuthone A (3) (NMR data in
Table S4). Interestingly, we also identified two compounds in
this strain (Figure 4). Isolation and structure elucidation revealed
two C-1 oxidized yanuthone derivatives, which we named
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yanuthone F (4) and yanuthone G (5) (NMR data in Table S4).
Yanuthone G (5) is a glycosylated version of yanuthone F (4),
which can also be detected in trace amounts in KB1001 (Table
S1). Deletion of yanI resulted in a strain producing the known
compounds 7-deacetoxyyanuthone A (3) and 22-deacetylyanu-
thone A (6) (NMR data in Table S4; Figure 1B). Importantly, the
latter compound corresponds to yanuthone E (2) without the
mevalon moiety. In addition, two compounds were produced.
The structures were elucidated by NMR spectroscopy, revealing
that one, which we named yanuthone H (7), is very similar to
22-deacetylyanuthone A (6), but with a hydroxyl group at C-1
(Figure 4; Table S4). The other compound, which we named
yanuthone I (8), is a modification of 22-deacetylyanuthone A (6)
with a shorter and oxidized terpene (NMR data in Table S4). We
note that yanuthone I (8) was also detected in trace amounts in
KB1001 (Table S1).
Determination of the Yanuthone X1 Structure
Asmentioned above, yanuthoneX1 (12) has an elemental compo-
sition corresponding to yanuthone A and C but was bio-
synthesized from another precursor than yanuthone D and E.
We therefore isolatedandelucidated thestructure (Figure4; Table
S4). This analysis confirmed that yanuthone X1 (12) does not have
the same C7 core scaffold but instead has a C6 core with a
methoxygroup directly attached to the six-membered ring at the
expense of a methyl group (Figure 4). Despite the fact that yanu-
thone X1 (12) and yanuthones D and E employ different precur-
sors, they share common features like the epoxide and the
sesquiterpene side chain, and we therefore hypothesized that
they share common enzymatic steps during their biosynthesis.
In agreement with this, examination of themetabolite profiles ob-
tained with the yan gene deletion strains revealed that yanuthone
X1 (12) was absent in the yanC, yanD, yanE, and yanG deletion
strains (Table S1). In contrast, yanuthone X1 (12) is produced in
larger amounts in theyanADstrain,whichcannotproduce6-MSA.
Antifungal Activity of Yanuthones
Yanuthones have earlier been reported to display antimicrobial
activity (Bugni et al., 2000), and we therefore tested all ten yanu-
thones presented in this study for antifungal activity toward
C. albicans (Table 1). Among these compounds, our analysis
identified yanuthone D as the most toxic species in agreement
with the fact that it represents the most likely end point of the
pathway. Among the remaining yanuthones, three other species,
yanuthone G, yanuthone H, and 22-deacetylyanuthone A,
exhibited antimicrobial activity. In these cases, IC50 values
were 5- to 10-fold higher than the IC50 value determined for
yanuthone D.
DISCUSSION
Elucidation of the Biosynthetic Route from 6-MSA
toward Yanuthone D
We have used a combination of bioinformatics, genetic tools,
chemical analyses, and feeding experiments to investigate
Figure 5. Feeding with Unlabeled m-cresol and Toluquinol
Shown are EICs of yanuthone D (1) 503.2640 ± 0.005 (red) and yanuthone E (2)
505.2791 ± 0.005 (black) for KB1001 and the yanAD strain with and without
feeding. Chromatograms are to scale.
Figure 4. BPC m/z 100–1,000 of Reference Strain KB1001, yanHD,
yanID, and yanFD
All NMR-elucidated compounds are shown for comparison of intensity and
relative retention times. Below are structures of the yanuthones identified in
this study. The structures of yanuthone D (1), yanuthone E (2), 7-deacetox-
yyanuthone A (3), and 22-deacetylyanuthone A (6) are shown in Figure 1.
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whether 6-MSA is produced and whether it is used for produc-
tion of toxic secondary metabolites in A. niger. Our work demon-
strates that 6-MSA is synthesized by the YanA PKS and then
subsequently modified into the antimicrobial end product
yanuthone D. This is intriguing because yanuthones have previ-
ously been suggested to originate from shikimic acid (Bugni
et al., 2000). Yanuthones have previously been observed on
YES agar (Klitgaard et al., 2014; Nielsen et al., 2009) and a
mixture of yeast, beef, and casein extract (Bugni et al., 2000).
In this study yanuthones were detected on solid YES and MM
medium, but not on solid CYA or MEA medium, and yanuthone
synthesis is therefore conditionally induced. To this end, we
find that yanuthone D is not produced in liquid YES and MM
medium, in agreement with the fact that secondary metabolism
is generally turned off in submerged cultures (Gonza´lez, 2012;
Schachtschabel et al., 2013).
We have also shown that yanA defines a gene cluster of ten
members: yanA, yanB, yanC, yanD, yanE, yanF, yanG, yanH,
yanI, and yanR, which is regulated by YanR. In agreement
with this, YanR is homologous to Zn2Cys6 transcription factors
that are commonly involved in regulation of secondary metabo-
lite production. The fact that deletion of yanR completely abol-
ished production of yanuthone D suggests that YanR acts as an
activator of the yan cluster. Additionally, analyses of strains
where the remaining genes in the yan cluster were individually
deleted have allowed us to isolate and characterize the full
structures of three intermediates. Based on these compounds,
we propose the entire pathway for yanuthone D formation
including addition of a sesquiterpene and a mevalon to the
core polyketide moiety at different stages of the biosynthesis
(Figure 6).
In our model, the last intermediate in the pathway is yanuthone
E (2), which is converted into the end product yanuthone D (1) by
oxidation of the hydroxyl group at C-15 in a process catalyzed by
YanF. The fact that yanuthone E (2) is present in KB1001 indi-
cates that it may act as a reservoir for rapid conversion into the
more potent antibiotic compound yanuthone D. Yanuthone E
(2) is likely formed from 22-deacetylyanuthone A (6) by attach-
ment of mevalon to the hydroxyl group at C-22. Because 22-
deacetylyanuthone A (6), but not yanuthone E (2), accumulates
in the yanID strain, we propose that YanI, a putative O-acyltrans-
ferase, catalyzes this step. Intriguingly, YanI therefore appears to
be an O-mevalon transferase, an activity, which, to the best of
our knowledge, has not previously been described in the
literature. Next, we propose that 22-deacetylyanuthone A (6) is
formed by hydroxylation of C-22 of 7-deacetylyanuthone A (3).
In agreement with this view, 7-deacetylyanuthone A (3), but
not 22-deacetoxyyanuthone A (6), accumulates in the absence
of YanH.
Unfortunately we did not detect any intermediates leading
from 6-MSA to 7-deacetoxyyanuthone A (3) in any of the deletion
strains in A. niger. The remaining tentative steps in the pathway
were therefore deduced from bioinformatics and feeding exper-
iments. First, analyses of patulin formation in Aspergillus flocco-
sus (previously identified as Aspergillus terreus; Jens C. Frisvad,
personal communication) and in A. clavatus have shown that it
requires decarboxylation of 6-MSA into m-cresol (Artigot et al.,
2009; Puel et al., 2010). This step is catalyzed by 6-MSA decar-
boxylase (Light, 1969), which has been proposed to be encoded
by patG (Puel et al., 2010).m-Cresol is then converted into gen-
tisyl alcohol in two consecutive hydroxylation steps catalyzed by
the two cytochrome P450s CYP619C3 (PatH) and CYP619C2
(PatI). However, CYP619C2 may also act directly on m-cresol
to form the co-metabolite toluquinol, which is not an intermedi-
ate toward patulin. When we inspected the yan gene cluster for
similar activities, we found a putative 6-MSA decarboxylase
(YanB) and CYP619C2 (YanC), but not CYP619C3. These obser-
vations suggest thatm-cresol and toluquinol are intermediates in
yanuthone D formation. We present two lines of evidence in sup-
port of this view. First, our feeding experiments demonstrate that
both compounds can be converted into yanuthone D. Second,
heterologous expression of yanA in A. nidulans leads to produc-
tion of 6-MSA. This compound disappears if the strain also
expresses yanB, indicating that 6-MSA is a substrate for the
putative 6-MSA decarboxylase YanB. Together these results
strongly suggest that m-cresol is formed directly from 6-MSA
by a decarboxylation reaction, which is most likely catalyzed
by YanB. This reaction explains how C8-based 6-MSA can serve
as the building block for the C7-based core unit of yanuthones.
Moreover, the analyses show that toluquinol is an intermediate
in the production of yanuthone D and that it is formed from
m-cresol in a process most likely catalyzed by the putative cyto-
chrome P450 encoded by yanC. Conversion of toluquinol into
7-deacetylyanuthone A (3) requires epoxidation and prenylation.
Based on the fact that prenylated toluquinol is never observed in
KB1001 or mutant strains, we propose that epoxidation pre-
cedes prenylation. In this scenario, toluquinol is epoxidated
into (10), which is in equilibrium with the tautomer (11). This com-
pound (11) is then prenylated to form 7-deacetylyanuthone A (3)
as a sesquiterpene moiety is attached to C-13 of (11). The latter
reaction is likely catalyzed by YanG, a putative prenyltransfer-
ase. This is supported by the observation that yanuthone D (1)
and all detectable intermediates, including 7-deacetoxyyanu-
thone A (3), were absent in the yanGD strain. The identity of the
gene products(s) responsible for epoxidation of toluquinol is
less clear. Among the putative activities encoded by the genes
in the yan cluster, which have not been assigned to any reaction
step during the analyses above, we note the presence of a puta-
tive dehydrogenase (YanD) and one with an unknown activity
and with no obvious homologs (YanE) as judged by BLAST
Table 1. The Half-Maximal Inhibitory Concentration for
C. albicans Treated with a Small Library of Yanuthones
Compound Origin Isolate IC50 (mM)
Yanuthone D A. niger KB1001 3.3 ± 0.5
Yanuthone E A. niger KB1001 >100
Yanuthone F A. niger yanHD >100
Yanuthone G A. niger yanHD 38.8 ± 5.1
Yanuthone H A. niger yanID 24.5 ± 1.1
Yanuthone I A. niger yanID >100
Yanuthone J A. niger yanFD >100
7-deacetoxyyanuthone A A. niger KB1001 >100
22-deacetylyanuthone A A. niger KB1001 19.4 ± 1.8
Yanuthone X1 A. niger KB1001 >100
The IC50 values were calculated based on duplicate experiments carried
out in three independent trials and annotated with their respective SD.
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analysis of the GenBank database (Altschul et al., 1990). We
hypothesize that one or both of these enzymes catalyze epoxi-
dation. The fact that neither 6-MSA, m-cresol, toluquinol, nor
any other intermediates were detected in the yanBD, yanCD,
yanDD, and yanED strains suggests that these small, aromatic
compounds must be rapidly degraded or converted into other
compound(s), or they may be incorporated into insoluble mate-
rial, e.g., the cell wall.
Figure 6. Proposed Biosynthesis of yanuthone D
Structures and enzymatic activities in brackets are hypothesized, activities in plain text have been proposed from bioinformatics, and activities in bold have been
experimentally verified.
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Accumulation of Intermediates in the Yanuthone D
Pathway Triggers Formation of Novel Yanuthones
Disruption of the biosynthetic pathway toward yanuthone D re-
sults in formation of three branch points in the pathway toward
yanuthone D: at yanuthone E (2), at 7-deacetoxyyanuthone A
(3), and at 22-deacetylyanuthone A (6). In addition to yanuthone
E (2), yanuthone J (9) accumulates in the yanFD strain. Similarly,
yanuthone F (4) accumulates in addition to 7-deacetoxyyanu-
thone A (3) in the yanHD strain, and yanuthone H (7) accumulates
in addition to 22-deacetylyanuthone A (6) in the yanID strain. In
all cases, the sesquiterpenes of the accumulated intermediates
in the main pathway are oxidized at C-1 or C-2. Because
hydroxylation is a known detoxification mode, we speculate
that the abnormally high amount of potentially toxic intermedi-
ates 7-deacetoxyyanuthone A (3), 22-deacetylyanuthone A (6),
and yanuthone E (2) triggers the cell to initiate phase I type of
detoxification processes in which the toxic intermediates are
hydroxylated. This hypothesis is supported by the fact that there
is no obvious assignment of an enzyme with this activity, en-
coded by the yan gene cluster, and by the fact that one of the
intermediates, 22-deacetylyanuthone, is toxic to C. albicans.
An additional variant of yanuthone F (4) was identified in the
yanHD strain, in which yanuthone F (4) is glycosylated at the
hydroxyl group at C-15 to form yanuthone G (5). The glucose
moiety of yanuthone G (5) is intriguing because sugar moieties
are rare in fungal secondary metabolites, and the fact that
yanuthone G (5) is detected in KB1001 shows that it is a
naturally occurring compound (Figure 4; Table S1). Because
yanuthone G (5) production is upregulated in yanHD, we sug-
gest that glycosylation poses a second (phase II conjugation)
type of mechanism for further detoxification of possible toxic
intermediates.
The branch point at 22-deacetylyanuthone A (6) revealed a
novel compound yanuthone I (8), which is identical to 22-deace-
tylyanuthone A (6) and yanuthone H (7) but with a shorter and
oxidized sesquiterpene chain. A similar modification has been
observed in the biosynthetic pathway for production of myco-
phenolic acid (Regueira et al., 2011). Here it was proposed to
occur by oxidative cleavage between C-4 and C-5 of the sesqui-
terpene chain. Alternatively, it could occur by terminal oxidation
of a geranyl side chain.
Yanuthone X1 Defines a Novel Class of Yanuthones
Because yanuthones are based on a C7 scaffold, they were pre-
viously proposed to originate from shikimic acid (Bugni et al.,
2000). However, in our study we demonstrate that yanuthones
D and E originate from the C8 polyketide precursor 6-MSA, which
is decarboxylated to form the C7 core of the yanuthone structure.
In contrast, the novel yanuthone X1 (12) has a C6 core scaffold
that does not originate from 6-MSA and does not require decar-
boxylation by YanB. Based on this we define two classes of
yanuthones: those that are based on the polyketide 6-MSA,
class I, and those that are based on the yet unknown precursor
leading to the formation of yanuthone X1 (12), class II. The two
classes of yanuthones share several enzymatic steps. First we
note that the sesquiterpene side chain in yanuthone X1 (12) is
likely attached by YanG, as is the case for yanuthone D. Second,
it depends on enzyme activities of YanC, YanD, and YanE, but
not of YanB. Together this suggests that the precursor is a small
aromatic compound similar to 6-MSA but lacking the carboxylic
acid. Importantly, the main difference between yanuthone D and
yanuthone X1 (12) are the groups attached to C-16. In the case of
yanuthone X1 (12), this position is oxidized, whereas in yanu-
thones D and E there is a carbon-carbon bond that originates
from the methyl group of 6-MSA. Consequently, yanuthone X1
(12) cannot be mevalonated by YanI.
SIGNIFICANCE
This study has identified a cluster of 10 genes, which is
responsible for production of antimicrobial yanuthone D in
A. niger. We show that yanuthone D is based on the polyke-
tide 6-MSA and not on shikimic acid as previously sug-
gested, and we have proposed a detailed genetic and
biochemical pathway for converting 6-MSA into yanuthone
D. Interestingly, we have revealed that yanuthone X1,
although similar in structure, is not derived from 6-MSA,
but the yet unknown precursor to yanuthone X1 does employ
several enzymes encoded by the yan cluster. An important
finding in the elucidation of the biosynthesis is the identifica-
tion of yanI encoding an O-mevalon transferase, which rep-
resents a different enzymatic activity. We have discovered
that the pathway toward yanuthone D branches when inter-
mediates accumulate, because three intermediates are hy-
droxylated. Two of the hydroxylated compounds are further
modified by oxidative cleavage of the sesquiterpene and
glycosylation, respectively, resulting in five yanuthones.
The discovery of a glycosylated compound, yanuthone G,
is intriguing because glycosylated compounds are very
rare in fungal secondary metabolism. We successfully em-
ployed an interdisciplinary approach for solving the biosyn-
thetic pathway: applying gene deletions, heterologous gene
expression, UHPLC-DAD-MS,MS/MS, structural elucidation
by NMR spectroscopy and CD, and feeding experiments
with 13C-labeled and unlabeled metabolites. Together, our
analyses have cast insights into understanding the
complexity of fungal secondary metabolism.
EXPERIMENTAL PROCEDURES
Strains and Media
The strain IBT 29539 was used for strain constructions in A. nidulans.
ATCC1015-derived strain KB1001 was used for strain constructions in
A. niger. All fungal strains prepared in the present work (Table S5) have
been deposited in the IBT Culture Collection at the Department of Systems
Biology, Technical University of Denmark, Kongens Lyngby, Denmark.
Escherichia coli strain DH5a was used for propagating plasmids, except
E. coli ccdB survival2 cells (Invitrogen), which were used for plasmids carrying
the ccdB gene.
MM for A. nidulans was made as described by Cove (1966), but with 1%
glucose, 10 mM NaNO3, and 2% agar. MM for A. niger was prepared as
described by Chiang et al. (2011). YES, MEA, and CYA were prepared as
described by Frisvad and Samson (Samson et al., 2010). When necessary,
media were supplemented with 4mML-arginine, 10mM uridine, 10 mMuracil,
and/or 100 mg/ml hygromycin B (InvivoGen). Luria-Bertani (LB) medium was
used for cultivation of E. coli strains and consisted of 10 g/l tryptone (Bacto),
5 g/l yeast extract (Bacto), and 10 g/l NaCl (pH 7.0). When necessary, LB
was supplemented with 100 mg/ml ampicillin.
For batch cultivation the medium contained 20 g/l D-glucose-13C6 (99
atom % 13C; Sigma-Aldrich) or D-glucose, 7.3 g/l (NH4)2SO4, 1.5 g/l KH2PO4,
1.0 g/l MgSO4,7 H2O, 1.0 g/l NaCl, 0.1 g/l CaCl2, 0.1 ml of Antifoam 204
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(Sigma), and 1 ml/l trace element solution. Trace element solution contained
0.4 g/l CuSO4,5 H2O, 0.04 g/l Na2B2O7,10 H2O, 0.8 g/l FeSO4,7 H2O, 0.8 g/l
MnSO4,H2O, 0.8 g/l Na2MoO4,2 H2O, and 8.0 g/l ZnSO4,7 H2O.
Construction of Basic Vectors for Strain Construction
All primers are listed in Table S6. The PfuX7 polymerase (Nørholm, 2010) was
used in all PCRs. Fragments were assembled via uracil-excision fusion (Geu-
Flores et al., 2007) into a compatible vector.
pDH56 and pDH57 are designed for integration of novel genes into the IS1
site of A. nidulans. In pDH56, the AsiSI/Nb.BtsI uracil-excision cassette of
CMBU1111 (Hansen et al., 2011) is modified into a ccdB-cmR AsiSI/Nb.BtsI
uracil-excision cassette. Unlike with CMBU1111, new fragments can be intro-
duced into this cassette and cloned in ccdA-deficient E. coli strains like DH5a
without generating background because false positives resulting from incom-
plete digestion of the USER cassette are eliminated (Bernard and Couturier,
1992). Specifically, the suicide gene ccdB and the chloramphenicol resistance
gene cmR (ccdB-cmR) construct was PCR amplified (using primers 84 and 85)
from pDONR (Invitrogen) and inserted into CMBU1111 by uracil-excision clon-
ing in a manner that reconstituted the original uracil excision cassette on either
side of the insert. pDH57 was constructed from pDH56 by removing an unde-
sirable Nb.BtsI nicking site located in the ampR gene. pDH56 was PCR ampli-
fied in two pieces (81 + 76 and 75 + 80). 75 and 76were designed to introduce a
silent mutation into the Nb.BtsI recognition site. Fragments were assembled
via uracil-excision cloning, and correct clones were verified by sequencing.
The gene targeting substrate for insertion of the 6-MSA synthase gene yanA
was made by amplifying the synthase gene yanA (PKS48/ASPNIDRAFT_
44965) from IBT 29539 genomic DNA (primers 1 and 2) and inserted into
pDH57, yielding pDH57-yanA.
The pDHX2 vector is AMA1-based and designed for episomal gene
expression. pDHX2 was constructed by USER fusion of five fragments: (1)
E. coli origin of replication (oriR) and the E. coli ampicillin resistance gene
(ampR); (2) the 50 half of AMA1; (3) the 30 half of AMA1; (4) 0.5 kb of the PgpdA
promoter, an AsiSI/Nb.BtsI USER cassette containing ccdB and cmR, and
the TtrpC terminator; and (5) the A. fumigatus pyrG selection marker (Fig-
ure S5). Fragment 1 was amplified from pDH57 (primers 77 + 78); fragments
2, 3, and 5 were amplified from pDEL2 (primers 86 + 89, 87 + 88, and 82 +
83) (Nielsen et al., 2008); and fragment 4 was amplified from pDH57 (primers
79 + 80). Fragments were assembled as described by Geu-Flores et al.
(2007) using equal molar amounts of purified PCR product, and correct
clones were verified by restriction digestion. Plasmids for episomal heterolo-
gous expression of cluster genes were constructed by PCR amplification of
ORFs using primers 3–12 pairwise. Genes were inserted into AsiSI/Nb.BtsI-
digested pDHX2 as described by Nour-Eldin et al. (2006), resulting in pDHX2-
yanB, pDHX2-yanC, pDHX2-yanD, and pDHX2-yanE. Plasmids were verified
by sequencing.
Plasmids carrying gene targeting substrates for gene deletion in A. niger
were constructed by PCR amplification of upstream (US) and downstream
(DS) targeting sequences along with the hph marker, conferring resistance
to hygromycin B. US and DS targeting sequences were generated using the
primers 17–72, and hph was amplified from pCB1003 (McCluskey et al.,
2010) using primers 13 + 14. The three fragments were assembled into the
CMBU0020 vector (Hansen et al., 2011).
Strain Construction
Protoplasting and gene-targeting procedures were performed as described
previously for A. nidulans (Johnstone et al., 1985; Nielsen et al., 2006) and
A. niger (Chiang et al., 2011). NotI-linearized pDH57-yanA was transformed
into IBT 29539. Transformants were verified by diagnostic PCR as described
by Hansen et al. (2011).
Strains for episomal expression of cluster genes were constructed by
transforming the IS1-yanA strain with circular plasmids (pDHX2-yanB,
pDHX2-yanC, pDHX2-yanD, and pDHX2-yanE) using pyrG as a selectable
marker.
A. niger deletion strains were constructed by transforming KB1001 with
bipartite gene targeting substrates. The substrates were generated by PCR
amplification of the US::hph::DS cassettes of the CMBU0020-based plasmids
using primers GENE_US-FW+73 and 74+GENE_DS-RV. Deletion strains were
selected on 100 mg/ml hygromycin B and verified by diagnostic PCR.
RNA Extraction and RT-qPCR
RNA isolation from the A. niger strains and subsequent quantitative RT-PCRs
were done as previously described by Hansen et al. (2011) except that
biomass for RNA isolation was prepared with a Tissue-Lyser LT (QIAGEN)
by treating samples for 1 min at 45 MHz. The A. niger histone 3-encoding
gene, hhtA (ASPNIDRAFT_52637) and gamma-actin-encoding gene actA
(ASPNIDRAFT_200483) were used as internal standards for normalization of
expression levels. All primers used for quantitative RT-PCR are shown in Table
S6 (primers 90–121). The relative expression levels were approximated based
on 2DDc(t), with DDc(t) = Dc(t)(normalized)  Dc(t)(calibrator), where Dc(t)(normalized) =
Dc(t)(target gene)  Dc(t)(actA or hhtA).The calibrator c(t) values are those from the
A. niger reference strain KB1001. Statistical analysis of RT-qPCR results
was performed as a Student’s t test, and the error bars indicate the SD.
Chemical Analysis of Strains
Unless otherwise stated, strains were cultivated on solid MMmedia and incu-
bated at 37C for 5 days. Extraction of metabolites was performed as
described by Smedsgaard (1997). 6-MSA was purchased from (Apin Chemi-
cals). Analysis was performed using UPHLC-DAD-TOFMS on a maXis 3G
orthogonal acceleration quadrupole time-of-flight mass spectrometer (Bruker
Daltonics) equipped with an electrospray ionization (ESI) source and con-
nected to an Ultimate 3000 UHPLC system (Dionex). The column used was
a reverse-phase Kinetex 2.6 mm C18, 100 mm 3 2.1 mm (Phenomenex), and
the column temperature was maintained at 40C. A linear water-acetonitrile
(liquid chromatography-mass spectrometry grade) gradient was used (both
solvents were buffered with 20 mM formic acid) starting from 10% (v/v) aceto-
nitrile and increased to 100% in 10 min, maintaining this rate for 3 min before
returning to the starting conditions in 0.1 min and staying there for 2.4 min
before the following run. A flow rate of 0.4 ml,min1 was used. TOFMS was
performed in ESI+ with a data acquisition range of 10 scans per second at
m/z 100–1,000. The TOFMS was calibrated using Bruker Daltonics high preci-
sion calibration algorithm by means of the use of the internal standard sodium
formate, which was automatically infused before each run. This provided a
mass accuracy of better than 1.5 ppm in MS mode. UV-visible spectra were
collected at wavelengths from 200 to 700 nm. Data processing was performed
using DataAnalysis 4.0 and Target Analysis 1.2 software (Bruker Daltonics)
(Klitgaard et al., 2014). Tandem MS was performed with fragmentation en-
ergies from 18 to 55 eV.
Preparative Isolation of Selected Metabolites
The fungal strains were cultivated on 10-200 YES plates at 30C for 5 days. For
details about each extraction, see Table S3. Extracts were filtered and con-
centrated in vacuo. The combined extract was dissolved in 9:1 methanol
(MeOH):H2O, and 1:1 heptane was added, resulting in two phases. To the
MeOH/H2O phase H2O was added to a ratio of 1:1, and metabolites were ex-
tracted with dichlormethane (DCM). The phases were concentrated separately
in vacuo. The DCM phase was adsorbed onto diol column material and dried
before packing into a SNAP column (Biotage) with diol material. The extract
was fractionated on an Isolera flash purification system (Biotage) using seven
steps of heptane-DCM-EtOAc-MeOH. Solvents were of HPLC grade, and H2O
was purified and deionized by aMillipore system through a 0.22 mmmembrane
filter.
The Isolera fractions were subjected to further purification on a semiprepar-
ative high-performance liquid chromatography (HPLC), which was either a
Waters 600 controller with a 996 photodiode array detector (Waters) or a
Gilson 322 controller connected to a 215 Liquid Handler, 819 InjectionModule,
and a 172 DAD (Gilson). This was achieved using a Luna II C18 column (250 3
10 mm, 5 mm; Phenomenex) or a Gemini C6-Phenyl 110A column (250 3
10.00 mm, 5 mm; Phenomenex). 50 ppm TFA was added to acetonitrile of
HPLC grade and Milli-Q water. For choice of system, flow rate, column, gradi-
ents, and yields, see Table S3.
NMR and Structural Elucidation
The 1D and 2D spectra were recorded on a Unity Inova-500MHz spectrometer
(Varian). Spectra were acquired using standard pulse sequences, and 1H,
double quantum filtered-correlated spectroscopy, nuclear Overhauser effect
spectroscopy, heteronuclear single quantum coherence, and heteronuclear
multiple bond correlation spectra were acquired. The deuterated solvent
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was acetonitrile-d3, and signals were referenced by solvent signals for aceto-
nitrile-d3 at dH = 1.94 ppm and dC = 1.32/118.26 ppm. The NMR data was
processed in Bruker Topspin 3.1 or ACD NMR Workbook. Chemical shifts
are reported in ppm (d) and scalar couplings in hertz. The sizes of the J
coupling constants reported in the tables are experimentally measured values
from the spectra. There are minor variations in the measurements that may be
explained by the uncertainty of J. Descriptions of the structural elucidations
are shown in Table S4.
CD spectra were obtained from a J-710 spectropolarimeter (Jasco). The
methanol dissolved samples (1 mg/3 ml) were analyzed in 0.2 cm optical
path length cells at 20C, and the spectra were recorded from 200 to
500 nm. Optical rotation was measured on a PerkinElmer 321 Polarimeter.
Production and Purification of Fully Labeled 13C-6-MSA
Because fully labeled 13C8-6-MSA was not commercially available, it was pro-
duced in-house from the 6-MSA-producing strain by batch cultivation. Spores
propagated on CYAmedia plates for 7 days at 30Cwere harvested with 10ml
of 0.9% NaCl through Mira cloth. The spores were washed twice with 0.9%
NaCl. The batch fermentation was initiated by inoculation of 2,109 spores/l.
A Sartorious 1 l bioreactor (Satorious) with a working volume of 0.8 l equipped
with two Rushton six-blade disc turbines was used. The pH electrode (Mettler)
was calibrated according to manufacturer standard procedures. The biore-
actor was sparged with sterile atmospheric air, and off-gas concentrations
of oxygen and carbon dioxide were measured with a Prima Pro Process
Mass Spectrometer (Thermo-Fischer Scientific). Temperature was maintained
at 30C, and pH was controlled by addition of 2 M NaOH and H2SO4. Start
conditions were pH: 3.0, stir rate: 100 rpm, and air flow: 0.1 volume of air
per volume of liquid per minute (vvm). These conditions were changed linearly
in 720 min to pH: 5.0, stir rate: 800 rpm, and air flow: 1 vvm. The strain was
cultivated until glucose was depleted, as measured by glucose test strips
(Machery-Nagel), and the culture had entered stationary phase as monitored
by off-gas CO2 concentration.
The entire volume of the reactor was harvested, and the biomass was
removed by filtration through a Whatman 1 qualitative paper filter followed
by centrifugation at 8,000 3 g for 20 min to remove fine sediments. The
6-MSA was then recovered from the supernatant by liquid-liquid extraction
using ethyl acetate with 0.5% formic acid.
The organic extract then dried in vacuo to give a crude extract that was re-
dissolved in 20 ml of ethyl acetate and dry loaded onto 3 g of Sepra ZT C18
(Phenomenex) resin prior to packing into a 25 g SNAP column (Biotage) with
22 g of pure resin in the base. The crude extract was fractionated on an Isolera
flask purification system (Biotage) using an water-acetonitrile gradient starting
at 15:85 going to 100% acetonitrile in 23 min at a flow rate of 25 ml min1 and
kept at that level for 4 min. Fractions were collected using UV detection at 210
and 254 nm, resulting in a total of 15 fractions, of which 3 were pooled and
analyzed. 6-MSA concentration was assessed using a Dionex Ultimate
3000 UHPLC coupled with a ultimate 3000 RS diode array detector (Dionex)
equippedwith a Poroshell 120 phenyl hexyl 2.13 100mm, 2.7 mm (Agilent) col-
umn. Finally, purity (98.7%) was analyzed by UHPLC-TOFMS (Figure S3A).
Feeding Experiments
Solid YES plates were prepared using a 6 mm plug drill to make a well in the
middle of the agar. 25-100 ml of spore suspension was added to the well,
and plates were incubated at 30C for 5 days. 100 mg of 13C-6-MSA,m-cresol,
and toluquinol (ortoluquinol) was added to the plates after 24, 48, and 72 hr,
respectively. Agar plugs were taken both as reported previously (Smedsgaard,
1997) and also separately from the center, the middle, and the rim of the
colony, respectively, to verify diffusion and absorption of the 6-MSA and the
location of yanuthone production. Samples were analyzed as described in
‘‘Chemical Analysis of Strains.’’
Antifungal Susceptibility Testing
All compounds were screened for antifungal activity toward C. albicans in
accordance with the CLSI standards using RPMI 1640 medium adjusted to
pH 7 with 0.165 MMOPS buffer (CLSI, 2012). Inoculum was prepared to a final
concentration of approximately 2.5 3 103 cells per ml. Inoculated media were
seeded into 96-well microtiter plates in aliquots of 200 ml using a Hamilton
STAR liquid handling workstation with an integrated Thermo Cytomat shaking
incubator and Biotek Synergy Mx microplate reader. The pure compounds
were dissolved in Me2SO and applied at 100 to 5 mM (1% Me2SO per well).
The plates were incubated at 35C at 1,200 rpm shaking with a 2 mm ampli-
tude. Optical density was recorded every hour for 20 hr. Endpoint optical den-
sities from compound screens were normalized to the negative controls, and
susceptibility was evaluated as the percentage of reduction in optical density.
All bioactive compounds were tested in duplicate in three independent trials to
ensure reproducibility and to evaluate potency of the compound toward the
target organism. The half-maximal inhibitory concentration (IC50) was extrap-
olated from compound specific dilution sequences and annotated as the
average concentration for which 50% inhibition plus minus the SD was
observed.
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Figure S1, related to Figure 2. BPC of yanAΔ strain relative to the reference KB1001, cultivated  
on MM (A), YES (B), CYA (C), and MEA (D) for 5 days at 30°C.  
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Figure S2, related to Figure 2. The morphology of A. niger KB1001 is identical with and without 
addition of 
13
C8-6-MSA. The figure shows the top and bottom of KB1001 cultivated on YES 
medium for 5 days at 30 °C.  
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Figure S3, related to Figure 2. Positive electrospray (ESI+) mass spectrum of: (A) uniformly 
labeled 
13
C8-6-methylsalicylic acid, (B) unlabeled and labeled yanuthone D, (C) unlabeled and 
labeled yanuthone E, and (D) unlabelled yanuthone X1. The calculated shift from 
12
C7 to 
13
C7 is 
7.0234 Da.  
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Figure S4, related to Figure 3. RT-qPCR expression analysis of yanA and 13 flanking genes in a 
yanRΔ (44961Δ) strain and a reference strain, KB1001.  A. Absolute expression levels ((Δc(t))-1 
values) in KB1001 (grey bar) compared to the TFΔ strain (blue/red bar). Red bars indicate 
significant down-regulation (p-value <0.05), blue bars indicate non-significant changes (p-value 
>0.05).  Error bars indicate the standard deviation (SD). Values are normalized to expression of 
hhtA. B.  Relative expression levels (fold change, 2
ΔΔc(t)
 values) of yan cluster genes (except yanR, 
which is deleted) in the TFΔ strain relative to KB1001. Error bars indicate the standard deviation 
(SD). Expression levels are individually normalized to expression of actA and hhtA, as indicated. 
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Figure S5, related to Figure 2. (A) Gene deletion in A. niger. The ORF is replaced by the 
selectable hygromycin B phosphatase (hph) gene. Not to scale. (B) pDHX2 vector used for 
expression of all cluster genes in the A. nidulans IS1-yanA strain. The vector contains the AMA1 
sequence for autonomous replication in Aspergillus and the pyrG gene for selection. 
 
 
 
A.  
 
 
B.  
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Figure S6, related to Figure 5. Base peak chromatogram (ESI+) of the five strains that express 
putative cluster genes yanB, yanC, yanD, yanE, and yanG in the A. nidulans IS1-yanA strain (6-
MSA producing reference strain). All strains, except Oex-yanB still produce 6-MSA. IS = internal 
standard: chloroamphenicol, A = austinol, DHA = dehydroaustinol. Chromatograms are to scale.  
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Table S1, related to Figures 2 and 4. Detection of metabolites in the deletion and overexpression 
strains using extracted ion chromatograms of [M+H]
+
 ± 0.005. 
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Table S2, related to Figure 3. Overview of genes and proposed activities of the yan cluster. 
Locus 
(ASPNIDRAFT_) 
Gene name Predicted functional domains 
(CDD) 
Proposed activity 
44959 - No conservation - 
44960 - Glyoxalase - 
44961  yanR Fungal transcription factor Transcription factor  
54844  yanC CYP450 m-Cresol hydroxylase 
44963  yanB Amidohydrolase, decarboxylase 6-MSA decarboxylase  
44964  yanG UbiA-like prenyltransferase Prenyltransferase  
44965  yanA Polyketide synthase 6-MSA synthase  
193092  yanH CYP450 Cytochrome P450  
44967  yanI Membrane bound O-acyl transferase O-Mevalon transferase 
127904  yanD Short-chain dehydrogenase Dehydrogenase 
192604  yanE No conservation - 
44970  yanF FAD/FMN-containing 
dehydrogenases 
Oxidase 
44971  - No conservation -  
44972 - No conservation - 
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Table S3, related to Figure 4. Purification of metabolites 
Compound 
name 
Strain Number 
of plates 
Extraction Isolera fractionation Purification Yield 
Yanuthone D 
(1) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Waters, Luna II C18, 4 
mL·min
-1
, 40-100% 
ACN over 20 min. 
4.5 mg 
Yanuthone E 
(2) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 40-100% 
ACN over 20 min. 
2.9 mg 
7-deacetoxy 
Yanuthone A 
(3) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Waters, Luna II C18, 4 
mL·min
-1
, 40-100% 
ACN over 20 min. 
9.3 mg 
Yanuthone F 
(4) 
yanHΔ  100 EtOAc 25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 10 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 30-80% 
ACN over 18 min. 
Waters, gemini, 5 
mL·min
-1
, 40-65% 
ACN over 20 min 
1.8 mg 
Yanuthone G 
(5) 
yanHΔ 100 EtOAc 25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 10 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 30-80% 
ACN over 18 min. 
Waters, gemini, 5 
mL·min
-1
, 30-40% 
ACN over 20 min, to 
45% for 2 min. 
4.0 mg 
22-
deacetylyanu-
thone A (6) 
yanIΔ  100 EtOAc  25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 12 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 20-90% 
ACN over 17 min.  
Waters, Luna II C18, 5 
mL·min
-1
, 30-100% 
ACN over 20 min. 
7.3 mg 
Yanuthone H 
(7) 
yanIΔ 100 EtOAc  25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 12 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 30-60% 
ACN over 16 min. 
9.8 mg 
Yanuthone I 
(8) 
yanIΔ 100 EtOAc 25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 12 fractions 
Waters, Luna II C18, 5 
mL·min
-1
, 30-60% 
ACN over 16 min. 
4.7 mg 
Yanuthone J 
(9) 
yanFΔ  
 
 
150 EtOAc  
+ 1 % FA 
25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 15 fractions 
Waters, Luna II C18, 4 
mL·min
-1
, 20-100% 
ACN over 20 min. 
1.5 mg 
Yanuthone X1 
(12) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Waters, gemini, 4 
mL·min
-1
, 90 % ACN 
isocratic for 15 min, 
then to 100 % ACN for 
5 min. 
1.5 mg 
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Table S4, related to Figure 6. Spectroscopic data 
The structural elucidation of the compounds showed several similar features in the 
1
H as well as 2D 
spectra comparable to those reported for the known yanuthones(Bugni et al., 2000; Li et al., 2003). 
All compounds except yanuthone I displayed 8H overlapping resonances at δH 1.93-2.11 ppm in the 
1
H spectrum corresponding to the four methylene groups H4, H5, H8 and H9 in the sesquiterpene 
moiety. Other common resonances were from the diastereotopic pair H-12/H-12’ and 3 methyl 
groups (H-19, H-20 and H-21) around δH 1.60 ppm, whereof H-20 and H-21 were overlapping. In 
the HMBC spectrum a correlation to the quaternary C-18 around δC 194 ppm was seen and all 
compounds also had two carbons around 60 ppm (one quaternary, one methine) being the carbons 
in the epoxide ring.   
The compounds however differed greatly in the moiety attached to C-16. Yanuthone D, yanuthone 
E and yanuthone J all displayed two methylene groups around δC 45 ppm, a methyl group around δC 
28 ppm, two carbonyls around δC 171 ppm and another quaternary carbon around δC 70 ppm for the 
mevalonic acid part. 7-deacetoxyanuthone A, yanuthone F and yanuthone G all had a methyl group 
attached at C-16 while yanuthone H, yanuthone I and 22-deacetylyanuthone A had a further 
hydroxy group at C-22. The hydroxylation in this position was indicated by a significant shift 
downfield of H-22/C-22.  
Some structures had a further modification being a hydroxy group at either C-1 or C-2. The 
compounds yanuthone F, G and H all had a hydroxy group at C-1, shifting C-1 and H-1 
significantly downfield. Yanuthone J had the hydroxy group attached at C-2 which shifted the 
resonances for C-2 and H-2 downfield, and due to the lack of the double bond in those structures, 
the resonance for H-3 was no longer observed in the double bond area but at δH 1.35 ppm. 
Yanuthone I differed in this part of the structure with fewer resonances due to the shorter terpene 
chain. 
The 
1
H NMR spectrum for yanuthone G stood out from the rest due to several resonances between 
3-5 ppm. Elucidation of the structure revealed a sugar moiety attached to the hydroxy group at C-
15. The presence of this hexose unit gave rise to the additional resonances observed. 
The NMR data for yanuthone X1 displayed the same resonances for the sesquiterpene part of the 
molecule, but the methoxy group attached to C-16 is different for all other reported yanuthones, and 
was obvious from the chemical shift of C-16 which gave rise to a resonance at δC 168.3 ppm, which 
is considerable further downfield than in the other structures. Furthermore C-17 was affected 
shifting upfield to δC 100.3 ppm. NMR data for all compounds can be found in invidual tabs in this 
file. 
The stereochemistry of the compounds was investigated by circular dichroism (CD) and optical 
rotation. The CD data for yanuthone D, E and 7-deacetoxyyanuthone A showed that the positive 
and negative cotton effects were identical to those previously reported for these compounds (Bugni 
et al., 2000).  
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone D 
HRESIMS: m/z = 503.2640 [M + H]
+
, calculated for [C28H38O8+H]
+
: 503.2639.       
         
CDMeOH: [θ]213 = 12.4263, [θ]230 = -7.8722, [θ]240 = 1.1769, [θ]260 = -4.0282, [θ]298 = 0.7690 
 
 NMR data for yanuthone D 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.59 (3H, s) 17.1 2, 19 - 
2 - 132.1 - - 
3 5.10 (1H, m) 125.0 1, 19 19 
4 2.06 (2H, m) 27.3 2, 3, 5/9 20 
5 1.97 (2H, m) 40.2 3/7, 6, 4/8,20 20 
6 - 136.4 - - 
7 5.09 (1H, m) 124.9 5/9, 8, 20  9 
8 2.09 (2H, m) 27.0 5/9, 6, 7, 10  20, 21 
9 1.99 (2H, m) 40.1 7, 8, 10, 11, 21 7, 11 
10 - 141.0 - - 
11 5.03 (1H, t, 1.5) 116.4 9, 12, 21 9, 12, 12’, 14 
12 2.66 (1H, m) 25.6 10, 11, 13, 14, 15/18 11, 12’, 14, 21 
12’ 2.76 (1H, m) 25.6 10, 11, 13, 14, 15/18 11, 12, 14, 21 
13 - 63.0 - - 
14 3.68 (1H, s) 58.6 12, 13, 15/18, 16, 22  11, 12, 12’, 21 
15 - 193.2 - - 
16 - 143.9 - - 
17 6.58 (1H, t, 1.5) 133.1 13, 15/18, 22 22, 22’, 24, 28 
18 - 193.2 - - 
19 1.66 (3H, s) 25.7 1, 2, 3 3, 4 
20 1.591 (3H, s) 16.1 5, 6, 7 5, 8 
21 1.63 (3H, s) 16.2 9, 10, 11 8, 12, 12’, 14 
22 4.84 (1H, dd, 16.1, 1.5) 60.2 15/18, 16, 17, 23 17 
22’ 4.89 (1H, dd, 16.1, 1.5) 60.2 15/18, 16, 17, 23 17 
23 - 171.2 - - 
24 2.69 (2H, m) 45.6 23, 26 17, 28 
25 - 70.0 - - 
26 2.64 (1H, m) 45.1 24, 25, 28 28 
26’ 2.57 (1H, m) 45.1 27 - 
27 - 173.1 - - 
28 1.33 (3H, s) 27.6 24, 25  17, 24, 26 
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone E 
HRESIMS: m/z = 505.2791 [M + H]
+
, calculated for [C28H40O8+H]
+
: 505.2789.       
         
CDMeOH: [θ]209 = 2.1815, [θ]241 = -12.3941, [θ]340 = 7.4622 
 
NMR data for yanuthone E 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.58 (3H, s) 17.7 2, 3, 19 - 
2 - 131.8 - - 
3 5.07 (1H, m) 124.9 1, 4, 5, 19 4, 5, 19 
4 2.02 (2H, m) 27.2 2, 6 3 
5 1.96 (2H, m) 40.3 3/7, 4, 6, 20,   3, 7 
6 - 135.8 - - 
7 5.06 (1H, t, 6.4) 124.9 5/9, 8, 20 5, 9, 20 
8 2.06 (2H, m) 27.2 5/9, 6, 7, 10 - 
9 1.99 (2H, m) 40.3 6, 7, 8, 11, 21 7, 11 
10 - 139.9 - - 
11 5.04 (1H, t, 7.2) 117.7 9, 12, 13, 21 9, 12, 12’, 14 
12 2.67 (1H, m) 26.6 10, 11, 13, 14, 18 11, 12’, 14 
12’ 2.42 (1H, m) 26.6 10, 11, 13, 14, 18 11, 12, 14 
13 - 61.3 - - 
14 3.64 (1H, d, 2.8) 60.1 12/12’, 13, 15, 16, 22/22’,  11, 12, 12’ 15 
15 4.68 (1H, br. s) 65.8 16, 17 14 
16 - 154.6 - - 
17 5.86 (1H, q, 1.4) 121.6 13, 15, 16, 22, 22’ 22, 22’, 24 
18 - 194.8 - - 
19 1.66 (3H, s) 25.6 1, 2, 3 3 
20 1.581 (3H, s) 16.0 5, 6, 7 7 
21 1.62 (3H, s) 16.3 9, 10, 11 - 
22 4.82 (1H, d, 16.1) 63.6 15, 16, 17, 18, 23 17, 22’ 
22’ 4.76 (1H, d, 16.1) 63.6 15, 16, 17, 18, 23 17, 22 
23 - 171.4 - - 
24 2.69 (2H, m) 45.8 23, 25, 26, 28 17 
25 - 70.2 - - 
26 2.59 (2H, m) 45.4 24, 25, 27, 28 - 
27 - 173.5 - - 
28 1.33 (3H, s) 27.7 25, 26 - 
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone J 
HRESIMS: m/z = 523.2907 [M + H]
+
, calculated for [C28H42O9+H]
+
: 523.2901       
        
 
 
NMR data for yanuthone J 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
1 1.28 (3H, m) 29.7 - 
2 - 70.9 - 
3 1.35 (2H, m) 44.0 4, 19 
4 1.43 (2H, m) 23.1 - 
5 1.93 (2H, m) 40.5 3, 4, 6, 7, 11, 
20 
6 - 136.3 - 
7 5.08 (1H, tq, 6.3, 1.0) 124.4 - 
8 2.09 (2H, m) 26.7 6, 7, 9, 10 
9 2.02 (2H, m) 40.3 7, 8, 10, 11, 21 
10 - 139.6 - 
11 5.03 (1H, tq, 6.3, 1.0) 117.5 - 
12 2.45 (1H, m) 26.5 10, 11, 13, (18) 
12’ 2.68 (1H, m) 26.5 10, 11, 13 
13 - 61.1 - 
14 3.63 (1H, d, 2.8) 59.9 13, 15, 16 
15 4.69 (1H, m) 65.7 - 
16 - 154.7 - 
17 5.86 (1H, q, 1.5) 121.5 13, 15, 22 
18 - (194.2) - 
19 1.12 (3H, s) 29.2 1, 2, 3 
20 1.58 (3H, s) 15.9 5, 6, 7 
21 1.62 (3H, s) 16.2 9, 10, 11 
22 4.83 (1H, d, 16.0)  63.6 16, 17, 23 
22’ 4.76 (1H, d, 16.0) 63.6 16, 17, 23 
23 - 171.2 - 
24 2.681 (2H, m) 43.7 23, 25, 26, 28  
25 - 70.9 - 
26 2.61 (2H, m) 45.1 24, 25, 27, 28  
27 - 173.6 - 
28 1.33 (3H, s) 27.5 25, 26 
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Table S4, related to Figure 6. Spectroscopic data. Continued 
7-deacetoxyyanuthone A 
HRESIMS: m/z = 345.2434 [M + H]
+
, calculated for [C22H32O3+H]
+
: 345.2424       
         
CDMeOH: [θ]206 = -13.6324, [θ]242 = -25.0218, [θ]335 = 16.7472 
 
 
 
NMR data for 7-deacetoxyyanuthone A 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
1 1.67 (3H, d 1.0) 
2 - 
3 5.10 (1H, m) 
4 2.07-1.90 (2H, m) 
5 2.07-1.90 (2H, m) 
6 - 
7 5.09 (1H, m) 
8 2.07-1.90 (2H, m) 
9 2.07-1.90 (2H, m) 
10 - 
11 5.05 (1H, m) 
12 2.72 (1H, dd, 15.2, 7.9) 
12’ 2.39 (1H, dd, 15.2, 6.7) 
13 - 
14 3.62 (1H, d, 2.89) 
15 4.49 (1H, br. s) 
16 - 
17 5.70 (1H, p, 1.5) 
18 - 
19 1.60 (3H, s) 
20 1.59 (3H, s) 
21 1.64 (3H, s) 
22 2.07-1.90 (3H, m)  
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone F 
HRESIMS: m/z = 361.2373 [M + H]
+
, calculated for [C22H32O4+H]
+
: 361.2373       
         
 
 
NMR data for yanuthone F 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 3.84 (2H, br. s) 68.3 2, 3, 19 3, 5 
2 - 136.2 - - 
3 5.33 (1H, tq, 7.4, 1.5) 125.3 1, 19 1, 4, 5 
4 2.11 (2H, m) 26.8 2, 5, 6 3, 7 
5 1.99 (2H, m) 40.1 2/6, 4/8, 20 1, 3, 7 
6 - 136.2 - - 
7 5.09 (1H, tq, 6.9, 1.1) 124.9 4/8, 5/9, 20 4, 5, 8, 9 
8 2.07 (2H, m) 26.8 6, 5/9, 10 7 
9 2.01 (2H, m) 40.1 6, 8/12, 10, 21 7, 11, 14 
10 - 139.7 - - 
11 5.04 (1H, tq, 7.3, 1.2) 118.0 8/12, 9, 21 9, 12, 12', 14 
12 2.70 (1H, dd, 15.1, 8.1) 27.0 10, 11, 13 11, 12', 14 
12' 2.37 (1H, m) 27.0 10, 11, 13, 18 11, 12, 14 
13 - 61.4 - - 
14 3.60 (1H, d, 2.7) 60.2 13, 15, 16 9, 11, 12, 12', 15 
15 4.48 (1H, m) 67.6 16, 17 14, 22 
16 - 158.8 - - 
17 5.68 (1H, m) 123.2 13, 15, 22 22 
18 - 194.9 - - 
19 1.59 (3H, s) 13.5 1, 2, 3, 4 - 
20 1.591 (3H, s) 16.1 5, 6, 7 - 
21 1.62 (3H, s) 16.1 6, 10, 11, 13 - 
22 1.92 (2H, br. s) 20.0 15, 16 15, 17 
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone G 
HRESIMS: m/z = 523.2917 [M + H]
+
, calculated for [C28H42O9+H]
+
: 523.2901.       
         
 
 
NMR data for yanuthone G 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 3.86 (2H, s) 68.2 2, 3, 19 3, 19 
2 - 135.9 - - 
3 5.34 (1H, t, 6.3) 125.2 1, 4, 5, 19 1 
4 2.10 (2H, m) 26.8 2/6, 3, 5 5, 20 
5 1.99 (2H, m) 40.0 2/6, 4/8, 7, 20 4, 7 
6 - 135.9 - - 
7 5.10 (1H, t, 6.3) 124.9 4/8, 5/9, 20 5, 9 
8 2.06 (2H, m) 26.9 5/9, 6, 10 9, 20, 21  
9 2.02 (2H, m) 40.0 6, 8/12, 10, 11, 21 7, 8, 11, 14 
10 - 139.7 - - 
11 5.04 (1H, t, 6.7) 117.9 8/12, 9, 21 9, 12, 12’, 14, 15 
12 2.67 (1H, m) 26.9 10, 11, 13, 18 11, 14, 21 
12' 2.37 (1H, dd, 14.8, 6.2) 26.9 10, 11, 13, 18 11, 14, 21 
13 - 61.3 - - 
14 3.82 (1H, br. s) 59.7 15, 16 9, 11, 12, 12’, 15, 17, 21 
15 4.59 (1H, m) 76.2 23 11, 14, 17 
16 - 157.0 - - 
17  5.71 (1H, br. s) 123.9 13, 15, 22 14, 15, 27 
18 - 194.4 - - 
19 1.591 (3H, s) 13.7 1, 2, 3 1 
20 1.59 (3H, s) 15.9 5, 6, 7  4, 8 
21 1.62 (3H, s) 16.3 9, 10, 11 8, 12, 12’, 14 
22 1.97 (3H, m) 20.1 15, 16 26, 27 
23 4.56 (1H, m) 105.7 16 24, 25, 26, 27, 28, 28’ 
24 3.25 (1H, br. s) 74.6 23, 26/27 23, 25, 26, 27 
25 3.37 (1H, m) 77.2 - 23, 24, 26, 27, 28, 28’ 
26 3.35 (1H, m) 71.2 
- 22, 23, 24, 25, 27, 28, 
28’ 
27 3.35 (1H, m) 77.2 
- 17, 22, 23, 24, 25, 26, 28, 
28’ 
28 6.77 (1H, d, 10.7) 62.6 - 23, 25, 26, 27, 28’ 
28’ 3.66 (1H, d, 10.7) 62.6 - 23, 25, 26, 27, 28 
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Table S4, related to Figure 6. Spectroscopic data. Continued 
22-deacetylyanuthone A 
HRESIMS: m/z = 361.2372 [M + H]
+
, calculated for [C22H32O4+H]
+
: 361.2373       
         
 
 
NMR data for 22-deacetylyanuthone A 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.66 (3H, s) 25.8 2, 3, 19 - 
2 - 132.0 - - 
3 5.10 (1H, m) 124.9 1, 4, 5, 19 4, 5, 19 
4 2.07 (2H, m) 26.8 2, 5, 6 3, 5, 19, 20 
5 1.98 (2H, m) 40.1 4/8, 6, 3/7, 20 3, 4, 7 
6 - 136.0 -  
7 5.10 (1H, m) 124.9 4/8, 5/9, 20 8, 5/9, 20 
8 2.09 (2H, m) 26.8 5/9, 6, 7, 10 7, 9, 20, 21  
9 2.03 (2H, m) 40.1 7, 10, 11, 13, 8/12, 21 7, 8, 11 
10 - 140.2 - - 
11 5.05 (1H, ddd, 7.93, 6.71, 1.22) 118.0 9, 8/12, 13, 21 9, 12, 12’, 14, 21 
12 2.70 (1H, dd, 15.3, 7.9) 26.8 10, 13, 17, 18 11, 12’, 14, 21 
12' 2.42 (1H, dd, 15.3, 6.7) 26.8 10, 13, 17, 18 11, 12, 14, 21 
13 - 61.6 - - 
14 3.62 (1H, d, 2.8) 60.2 12,15, 16, 22 11, 12, 12’, 15 
15 4.64 (1H, m) 66.2 13, 16, 17, 18 14, 22, 22’ 
16 - 160.8 - - 
17 5.87 (1H, q, 1.73) 119.7 15, 16, 22 22, 22’ 
18 - 195.1 - - 
19 1.601 (3H, s) 17.7 1, 2, 3 3, 4 
20 1.60 (3H, s) 15.9 5, 6, 7 4, 7, 8 
21 1.63 (3H, s) 16.2 8/12, 9, 10, 11, 13 8, 11, 12, 12’ 
22 4.27 (1H, m) 62.0 15 15, 17 
22' 4.21 (1H, m) 62.0 - 15, 17 
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone H 
HRESIMS: m/z = 377.2332 [M + H]
+
, calculated for [C22H32O5+H]
+
: 377.2322.       
         
 
 
NMR data for yanuthone H 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 3.85 (2H, s) 68.3 2, 3, 4, 19 3 
2 - 136.0 - - 
3 5.34 (1H, m) 125.4 1, 4, 5, 19 1, 5 
4 2.11 (2H, m) 26.8 3, 5, 6 - 
5 1.99 (2H, m) 40.1 4/8, 6, 7, 12, 20 3 
6 - 135.9 - - 
7 5.10 (1H, t, 6.4) 124.9 4/8, 5/9, 20 9 
8 2.07 (2H, m) 26.8 5/9, 7, 10 - 
9 2.02 (2H, m) 40.1 7, 10, 11, 8/12, 21 7, 11 
10 - 139.8 - - 
11 5.05 (1H, t, 6.8) 118.0 8/12, 21 9, 12, 12’, 14 
12 2.71 (1H, dd, 15.1, 8.3) 26.8 10, 11, 13, 18 11, 12’, 14 
12' 2.40 (1H, dd, 15.1, 6.8) 26.8 20, 11, 13, 18 11, 12, 14 
13 - 60.9 - - 
14 3.62 (1H, d, 2.9) 60.4 12, 13, 15, 16 11, 12, 12’ 15 
15 4.64 (1H, br. s) 66.1 16, 17 14, 16, 17 
16 - 160.6 - 15 
17 5.87 (1H, d, 1.5) 119.7 13, 15, 16 15, 22, 22’ 
18 - 194.9 - - 
19 1.601 (3H, s) 13.5 1, 2 - 
20 1.60 (3H, s) 16.1 5/8, 7 - 
21 1.63 (3H, s) 16.2 8/12, 10, 11 - 
22 4.27 (1H, d, 17.6) 62.0 15, 16, 17, 18 17, 22’ 
22' 4.21 (1H, m) 62.0 15, 16, 17, 18 17, 22 
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone I 
HRESIMS: m/z = 325.1635 [M + H]
+
, calculated for [C17H24O6+H]
+
: 325.1646.       
         
  
 
NMR data for yanuthone I 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
5 - 177.4 - - 
6 2.28 (1H, m) 38.2 5, 7/7', 8, 20 7, 7', 8, 20 
7 1.48 (1H, m) 32.5 5, 6, 8, 20 6, 7', 8, 9, 20 
7' 1.26 (1H, m) 32.5 5, 6, 8, 20 6, 7, 8, 9, 21 
8 1.32 (2H, m) 24.5 7/7', 9, 10 6, 7, 7', 9, 11, 20 
9 1.92 (2H, t, 7.1) 38.7 7/7', 8, 10, 11, 21 7, 7', 8, 11, 14 
10 - 137.9 - - 
11 5.00 (1H, t, 7.1) 116.9 9, 12/12', 13, 21 8, 9, 12, 12', 14 
12 2.63 (1H, dd, 15.1, 7.9) 25.7 10, 11, 13, 14, 17, 18 12', 14, 17, 21 
12' 2.32 (1H, m) 25.7 9, 10, 11, 13, 14, 17, 18 12, 14, 17, 21 
13 - 60.0 - - 
14 3.59 (1H, d, 2.4) 59.1 12/12', 13/22/22', 15, 16 9, 11, 12, 12', 15, 17, 21 
15 4.61 (1H, br. S) 64.3 16, 17 14, 22' 
16 - 162.2 - - 
17 5.82 (1H, d, 1.6) 117.4 13/22/22', 14, 15, 16, 18 22' 
18 - 193.7 - - 
20 1.02 (3H, d, 6.7) 16.7 5, 6, 7 6, 7, 7', 8  
21 1.56 (3H, s) 15.6 9, 10, 11, 12/12', 13 7', 9, 12, 12', 14 
22 4.21 (1H, d, 18.5) 60.0 15, 16, 17, 18 22' 
22' 4.09 (1H, d, 18.5) 60.0 15, 16, 17, 18 15, 17, 22 
-COOH 12.01 (1H, br. s) -   
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Table S4, related to Figure 6. Spectroscopic data. Continued 
Yanuthone X1 
HRESIMS: m/z = 403.2482 [M + H]
+
, calculated for [C17H24O6+H]
+
: 403.2479       
        
 
 
NMR data for yanuthone X1 
Atom assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
correlations 
1 1.66 (3H, s) 25.6 2, 3, 19 3 
2 - 132.2 - - 
3 5.08 (1H, m) 125.0 5 1, 4/5 
4 2.05 (2H, m) 27.6 3, 5, 6  3, 5 
5 2.00 (2H, m) 40.3 6, 4/8, 7, 11 3, 4 
6 - 135.6 - - 
7 5.08 (1H, m) 125.0 5/9, 20 - 
8 2.07 (2H, m) 27.6 5/9, 6, 7 9 
9 1.95 (2H, m) 40.3 7, 8, 10, 11, 21 8, 11 
10 - 139.8 - - 
11 5.01 (1H, t, 7.3) 117.5 9, 21 9, 12, 12’ 
12 2.78 (1H, dd, 15.3, 8.2) 26.2 10, 11, 13, 14 11, 12’ 
12’ 2.45 (1H, dd, 15.3, 6.7) 26.2 10, 11, 13, 14, 18 11, 12 
13 - 60.5 - - 
14 3.59 (1H, d, 3.1) 56.3 15, 16 15 
15 5.95 (1H, d, 3.1) 66.6 16 14 
16 - 168.3 - - 
17 5.30 (1H, s) 100.3 13, 15, 16 22 
18 - 193.7 - - 
19 1.57 (3H, s) 17.6 1, 2, 3 - 
20 1.571 (3H, s) 15.8 5, 6 - 
21 1.61 (3H, s) 16.3 9, 10, 11 - 
22 3.67 (3H, s)  57.4 16 17 
23 - 170.7 - - 
24 2.14 (3H, s) 20.6 23 - 
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Table S5, related to Figures 2, 3, and 4. Fungal strains. 
Name Organism Genotype 
IBT 29539 A. nidulans argB2, pyrG89, veA1, nkuAΔ 
OE-yanA A. nidulans argB2, pyrG89, veA1, nkuAΔ S1::PgpdA::yanA::TtrpC::argB 
OE-yanG A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanG 
OE-yanC A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanC 
OE-yanB A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanB 
OE-yanD A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanD 
OE-yanE A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanE 
KB1001 A. niger pyrGΔ kusA::AFpyrG 
yanAΔ A. niger pyrGΔ kusA::AFpyrG yanAΔ 
yanGΔ A. niger pyrGΔ kusA::AFpyrG yanGΔ 
yanIΔ A. niger pyrGΔ kusA::AFpyrG yanIΔ 
yanCΔ A. niger pyrGΔ kusA::AFpyrG yanCΔ 
yanBΔ A. niger pyrGΔ kusA::AFpyrG yanBΔ 
yanHΔ A. niger pyrGΔ kusA::AFpyrG yanHΔ 
yanDΔ A. niger pyrGΔ kusA::AFpyrG yanDΔ 
yanEΔ A. niger pyrGΔ kusA::AFpyrG yanEΔ 
yanFΔ A. niger pyrGΔ kusA::AFpyrG yanFΔ 
yanRΔ A. niger pyrGΔ kusA::AFpyrG yanRΔ 
44959Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44959Δ 
44960Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44960Δ 
44971Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44971Δ 
44972Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44972Δ 
ClusterΔ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44958-44972Δ 
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Table S6, related to Figures 2, 3, and 4. Primers used in the study. See details in experimental 
section. 
# Primer name Sequence 5’→ 3’ 
1 44965-fw AGAGCGAUATGCCAGGCCTTGTACAC 
2 44965-rv TCTGCGAUTTAAGCATCCAGCTCCTTTGT 
3 44963_ORF_FW AGAGCGAUATGGACCGTATCGACGTACACC 
4 44963_ORF_RV TCTGCGAUCTAGGTACTATAAGTATGAACACGAGACTG 
5 44964_ORF_FW AGAGCGAUATGTCTACTACTAAGCGCTCGGTAAC 
6 44964_ORF_RV TCTGCGAUCTAGTATACTTTCATGGGTGCGTGA 
7 54844_ORF_FW AGAGCGAUCGGGCTAGACTTTCTCTTCCTAAG 
8 54844_ORF_RV TCTGCGAUATGGCGCTTGTTCATCTGACT 
9 127904_ORF_FW AGAGCGAUATGGTCAAGTTTTTTCAGCCCA 
10 127904_ORF_RV TCTGCGAUCTAACGGAACTGGGGAGGAA 
11 192604_ORF_FW AGAGCGAUTACTTTGCGACTACCTGCCATG 
12 192604_ORF_RV TCTGCGAUCTACTCCGACTTTTCACCTTTGG 
13 hph-1003-Fw AGCCCAATAUGCTAGTGGAGGTCAACACATCA 
14 hph-1003-Rv ATTACCTAGUCGGTCGGCATCTACTCTATT 
15 44965-chk-usF CAGTTGACTAGACTAGGAACGGTCA 
16 44965-chk-dsR AACGACCATGATGCTTGTTCAG 
17 44965_US-FW GGGTTTAAUATGACTCCACATCATCTTCCACAC 
18 44965_US-RV ATATTGGGCUGATGGTGTGTACAAGGCCTGG 
19 44965_DS-FW ACTAGGTAAUGACTGTTATGCATTGAATTTGAGC 
20 44965_DS-RV GGTCTTAAUAGATCCTGACGCTCATATCTGCT 
21 44964_US-FW GGGTTTAAUGGTCTTTCCGACACGTAAGTCTG 
22 44964_US-RV ATATTGGGCUTGGACCTCAATGGCCGCT 
23 44964_DS-FW ACTAGGTAAUGCGAGTATGAAGAAGGTGGATGA 
24 44964_DS-RV GGTCTTAAUATTCAGGGTCTTGAGATTGGC 
25 44963_US-FW GGGTTTAAUAAGTCCTCCCACGTCGGAG 
26 44963_US-RV ATATTGGGCUAGAATCTAAACCTTGTCTCTTCGCT 
27 44963_DS-FW ACTAGGTAAUGAACGTTTGATTGGTAATGGATGT 
28 44963_DS-RV GGTCTTAAUTCATCCACCTTCTTCATACTCGC 
29 54844_US-FW GGGTTTAAUGTAGAATAACAGCTACCTCGAATTTGA 
30 54844_US-RV ATATTGGGCUACGTGGTGCGTAAGCAGACAT 
31 54844_DS-FW ACTAGGTAAUCCTGCTGAATAAACACGAAGG 
32 54844_DS-RV GGTCTTAAUATGGACCGTATCGACGTACACC 
33 44960_US-FW GGGTTTAAUTGAGTACCTATCCACTCTTCCTGG 
34 44960_US-RV ATATTGGGCUGATGGAGTGTGAAGCCAATGAG 
35 44960_DS-FW ACTAGGTAAUTCATTCTAAAATTGGCGTCTTCA 
36 44960_DS-RV GGTCTTAAUCTACTGCCGCCGTCACTATCTA 
37 193092_US-FW GGGTTTAAUCATCGACATCTCTCTGCCCAT 
38 193092_US-RV ATATTGGGCUGAAAGCTGGTTGGAAGTATAAGTGG 
39 193092_DS-FW ACTAGGTAAUTGTGCAGCGGTATTGACTTCA 
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40 193092_DS-RV GGTCTTAAUCACGGAGTTATTTTCCACGCT 
41 44967_US-FW GGGTTTAAUCGTTGGCATGACAGTCTTCAA 
42 44967_US-RV ATATTGGGCUGTCTGCCATCACAACCAGTTTG 
43 44967_DS-FW ACTAGGTAAUAGCCATGTTGCCAGACACAGT 
44 44967_DS-RV GGTCTTAAUACTACCATCTCGTAACCGTCCTAG 
45 127904_US-FW GGGTTTAAUGACCGACTCTACACTACCGTTCC 
46 127904_US-RV ATATTGGGCUATTGAACTGGTAAACATGCCATG 
47 127904_DS-FW ACTAGGTAAUTAGCCCTAGGACGGTTACGAG 
48 127904_DS-RV GGTCTTAAUAACCAACTTTGTTCCATTCTATCG 
49 192604_US-FW GGGTTTAAUGACACATCGTATTGATGACGACC 
50 192604_US-RV ATATTGGGCUCATGGCAGGTAGTCGCAAAG 
51 192604_DS-FW ACTAGGTAAUAAGAGAATACGGAACACATTGACC 
52 192604_DS-RV GGTCTTAAUCGGTCCAACAGTGAGGGTCT 
53 44970_US-FW GGGTTTAAUCGTTGATAATTCCAATTCCAATTC 
54 44970_US-RV ATATTGGGCUCGTCGAAGATGACCTGATTTG 
55 44970_DS-FW ACTAGGTAAUCGGGTTATCACTGTATCAATATCG 
56 44970_DS-RV GGTCTTAAUGCTACTACTATGCCGACTGCGT 
57 44971_US-FW GGGTTTAAUGGCCACACCTCAAGTTTGTATG 
58 44971_US-RV ATATTGGGCUCGGGATTGGAGTGCTCTAGTT 
59 44971_DS-FW ACTAGGTAAUGTTGGCTGAGAGTCAGGGTTAG 
60 44971_DS-RV GGTCTTAAUCCATTAGCTTCGGAACACTGG 
61 44959_US-FW GGGTTTAAUCCTTGTATTCATATCAATTGCGA 
62 44959_US-RV ATATTGGGCUATGTGACAATGAAGAATGGTACG 
63 44959_DS-FW ACTAGGTAAUGGAAAGGATGTTCCAAACAGTT 
64 44959_DS-RV GGTCTTAAUCTTTGTTGATTACTAGTCGTAATCATATG 
65 44961_US-FW GGGTTTAAUTGTCATGTTGTATCGGAGTGTTTAG 
66 44961_US-RV ATATTGGGCUTGTAGCACAAGTGTCTCACTAGTAAATAG 
67 44961_DS-FW ACTAGGTAAUGATTGGAAGTATCCCACAGTCTG 
68 44961_DS-RV GGTCTTAAUGAGAACACCGATCTCCGACGTGGGA 
69 44972_US-FW GGGTTTAAUGACGCAGTCGGCATAGTAGTAG 
70 44972_US-RV ATATTGGGCUGGAGAAGTGGTCAAACTTGTTTCA 
71 44972_DS-FW ACTAGGTAAUACAGGTGATTAAGATGCAAGGCT 
72 44972_DS-RV GGTCTTAAUCTTGCATCATCCGTAATTATGCT 
73 Upst-HygR-N CTGCTGCTCCATACAAGCCAACC  
74 Dwst-1003HygF-N GACATTGGGGAGTTCAGCGAGAG  
75 ampR_PM_FW AGCGCTACAUAATTCTCTTACTGTCATGCCATCC 
76 ampR_PM_RV ATGTAGCGCUGCCATAACCATGAGTGATAACACTG 
77 ori_coli_FW ATCCCCACUACCGCATTAAGACCTCAGCG 
78 ampR_RV AGCTGCTUCGTCGATTAAACCCTCAGCG 
79 p71_prom-
ter_short_usF 
AGCCCAATAUTAAGCTCCCTAATTGGCCC 
80 p71_prom-ter_dsR ATTACCTAGUGGGCGCTTACACAGTACA 
81 argB_FW ACTAGGTAAUATCGCGTGCATTCCGCGGT 
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82 pyrG_FW_C1 ACTAGGTAAUATGACATGATTACGAATTCGAGCT 
83 pyrG_RV_G16 AGTGGGGAUGCCTCAATTGTGCTAGCTGC 
84 ccdB-camR-fw AGAGCGAUCGCAGAAGCCTACTCGCTATTGTCCTCA 
85 ccdB-camR-rv TCTGCGAUCGCTCTTGCGCCGAATAAATACCTGT 
86 AMA1_FW AAGCAGCUGACGGCCAGTGCCAAGCT 
87 AMA1_RV ATATTGGGCUGGAAACAGCTATGACCATGAGATCT 
88 AMA-3'-Fw ACCCCAAUGGAAACGGTGAGAGTCCAGTG 
89 AMA-5'-Rv ATTGGGGUACTAACATAGCCATCAAATGCC 
90 ANIG-actA-qFw GTATGCAGAAGGAGATCACTGCTCT 
91 ANIG-actA-qRv GAGGGACCGCTCTCGTCGT 
92 ANIG-hhtA-qFw CTTCCAGCGTCTTGTCCGTG 
93 ANIG-hhtA-qRv GCTGGATGTCCTTGGACTGGAT 
94 44959-qFw GGCAAAGTTCTAGTCATCGACGA 
95 44959-qRv CATATATCCCAGAGGCGGACAC 
96 44960-qFw GATAGAGGAGATGAGGAAGAGAGGCT 
97 44960-qRv CCTTGGGTACCATTCACAGTCAG 
98 44961-qFw ACATGGACCACCGAGTAGCGT 
99 44961-qRv TAGGGTGTGCGAGAATATCACTTG 
100 54844-qFw CGATGAAGATGGCAATCCCAT 
101 54844-qRv CTATGGCATCGCATACTGAGAAAGA 
102 44963-qFw GCGAGGAGGTAGAAAAGGCAAT 
103 44963-qRv TGAACACGAGACTGGAGTACGGA 
104 44964-qFw TCTTCTGGATACTGGGAATTGGAG 
105 44964-qRv GCGTGATGCACCCTCAACA 
106 44965-qFw TTGTCTGTCAAGGAGGACGAGATT 
107 44965-qRv CTTCACCAAATGCTGCACAGTC 
108 193092-qFw ATCACGGCAAAGAGAGCCAAGT 
109 193092-qRv GAACTGTGGCACGACCATGTC 
110 44967-qFw TGCTGGCTGCTAAGGATTGATG 
111 44967-qRv ATGTTCCAACGCAATGAACAAC 
112 127904-qFw ATGAGCAACATGCTCCCACTACAT 
113 127904-qRv CAGTGATGGTCTTATCCGCCAG 
114 192604-qFw GCCTAATCCTGGGCATCGTG 
115 192604-qRv CTGTGCTCCCCGATCTGCA 
116 44970-qFw TCTCAGGGTGTCCATCTTCCGT 
117 44970-qRv CGACACGAAATAGGCATCATTCT 
118 44971-qFw ATCTACTCCGGCTCCTGCGAT 
119 44971-qRv ACTCGCAAACAACTTCATTGCTC 
120 44972-qFw AGGTGACTCGAACTGGTATGCTG 
121 44972-qRv CAGAATATACTCGATATGATCGCCTC 
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ABSTRACT 
Four new yanuthone analogs (1-4) were isolated from the filamentous fungus Aspergillus niger. The 
structures of the new compounds were elucidated on the basis of UHPLC-DAD-HRMS data and 1D 
and 2D NMR spectroscopy. Labeling studies with 
13
C8-6-methylsalicylic acid identified three class I 
yanuthones originating from the polyketide 6-methylsalicylic acid (yanuthone K, L and M (1-3)) and a 
class II yanuthone, which was named yanuthone X2 (4). The four new compounds were tested towards 
the pathogenic yeast Candida albicans and all displayed antifungal activity. Yanuthone X2 represents 
the first example of a bioactive class II yanuthone, demonstrating the pharmaceutical potential of this 
class. 
Keywords: Antifungal agents/Aspergillus/meroterpenoid/polyketide/yanuthone 
 
INTRODUCTION 
The black fungus Aspergillus niger is a significant contaminant of food and feeds and a widely used 
cell factory for production of citric acid and  bulk enzymes.
1,2
 In this context it is important to note that 
A. niger is known to produce more than 100 secondary metabolites,
3
 including not only mycotoxins 
such as ochratoxin A and fumonisins,
3,4,5,6,7,8
 but also medically relevant compounds such as 
asperpyrone B and yanuthones targeting Candida albicans.
9,10
 Recently,  access to the full genome of 
A. niger
11,12
 has provided a platform that allows for linking genes to specific secondary metabolites. To 
this end, we have recently reported the characterization of the biosynthetic pathway towards 
antimicrobial yanuthone D in A. niger.
13
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The core structure of yanuthones constitutes an epoxylated six-membered ring, which may be further 
decorated with different side chains: one sesquiterpene (at C13) and varying side chains (at C15 and 
C16), see Figure 1. The core structure may be derived from at least two different precursors, which lead 
to formation of two classes of yanuthones. Class I yanuthones are derived from the polyketide 6-
methylsalicylic acid (6-MSA), which due to a decarboxylation event during yanuthone formation, 
delivers a six-membered methylated ring (a C7 scaffold) to the yanuthones. Class II yanuthones 
contains a C6 core scaffold derived from an unknown precursor.
13
 The additional methyl group in class 
I yanuthones controls what type of decoration is possible at C16. Despite derivation of the two classes 
of yanuthones from different precursors, they share downstream enzymatic activities toward product 
maturation. So far, 15 class I yanuthones and a single class II yanuthone have been described in the 
literature of which only yanuthone D, a class I yanuthone, has displayed strong antimicrobial 
activity.
9,13,14
  
These observations prompted us to investigate whether additional yanuthones exist in A. niger and 
whether such new compounds display antimicrobial activity. C. albicans accounts for the highest 
source of fungal infections worldwide,
15
 which is why it is of great interest to find new drug 
candidates. Here we report the structures of four new yanuthones and their bioactivities towards C. 
albicans. 
 
MATERIALS AND METHODS 
Strains, media and feeding experiments. The strains used for this study were the A. niger 
ATCC1015-derived KB1001
16
 and the yanAΔ strain (6-MSA PKS deleted).13 Solid plates with YES 
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media were prepared as described by Frisvad and Samson
17
, and feeding experiments with fully 
labelled 
13
C8-6-MSA were carried out as described by Holm et al.
13
 
Chemical analysis of strains. Strains were cultivated on solid YES media at 25 °C for 5-7 days in the 
dark. Extraction of metabolites was performed as described by Smedsgaard.
18
 Analysis was performed 
using reversed phase ultra-high-performance liquid chromatography (UPHLC) UV/Vis diode array 
detector (DAD) high-resolution time-of-flight mass spectrometer (TOFMS) on a maXis G3 orthogonal 
acceleration quadrupole time of flight (Q-TOF) mass spectrometer (Bruker Daltonics, Bremen) as 
described by Holm et al.
13
 
Preparative isolation of selected metabolites. A. niger (KB1001) was cultivated on 200 plates of YES 
medium at 30 °C for 5 days in the dark. Extraction, workup and fractionation were performed as 
described by Holm et al.
13
 Final purification was completed on a semi-preparative HPLC system, 
which was a Waters 600 Controller with a Waters 996 photodiode array detector. This was achieved 
using a Luna II C18 column (250 x 10 mm, 5 μm, Phenomenex) and a flow rate of 4 mL
.
min
-1
. Solvents 
used were acetonitrile (ACN) of HPLC grade and milliQ-water, both with 50 ppm trifluoroacetic acid. 
For the isolation of yanuthone L, M and X2 a gradient of 40-100 % ACN in 20 min was used, yielding 
2.0, 1.5 and 1.2 mg, respectively. For isolation of yanuthone K an isocratic run with 90 % ACN for 15 
min was used, yielding 6.7 mg. 
NMR and structural elucidation. The 1D and 2D spectra were recorded on a Varian Unity Inova-500 
MHz spectrometer. Spectra were acquired using standard pulse sequences, and 
1
H spectra as well as 
DQF-COSY, NOESY, HSQC and HMBC spectra were acquired. The deuterated solvent was 
acetonitrile-d3 and signals were referenced by solvent signals for acetonitrile-d3 at δH = 1.94 ppm and 
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δC = 1.32/118.26 ppm. Chemical shifts are reported in ppm (δ) and scalar couplings in hertz (Hz). The 
sizes of the J coupling constants reported in the tables are the experimentally measured values from the 
spectra. There are minor variations in the measurements which may be explained by the uncertainty of 
J. NMR data for all compounds including 
1
H and 2D spectra are found in supporting information. 
Optical rotation was measured on a Perkin Elmer 321 Polarimeter. 
Antifungal susceptibility testing. All compounds were screened for antifungal activity towards 
Candida albicans (IBT 654) in accordance with the CLSI standards, as described by Holm et al.
13
 
 
RESULTS AND DISCUSSION  
Identification and structural elucidation of four new yanuthones 
Inspired by our previous discovery of six new yanuthones in A. niger,
13
 the A. niger strain KB1001 was 
cultivated on YES, and a large extract was scrutinized for compounds that could potentially be new 
yanuthones. The UHPLC-DAD-HRMS analysis tentatively identified four yanuthone related structures. 
Their UV spectra as well as chemical compositions indicated coherence to the previously identified 
structures.
9,13,14
 The four compounds were purified and their structures elucidated from the HRMS data, 
UV data and 1D and 2D NMR experiments (see Table 1, Table 2 and further details in the supporting 
information).   
All structures contain a six-membered ring containing an epoxide, which define the core structure of 
yanuthones, but vary in their side chains, see Figure 1. Importantly, three of the compounds 
(yanuthones K-M (1-3)) contain a C7 core associated with class I yanuthones, whereas the remaining 
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yanuthone X2 (4) contains a C6 core scaffold characteristic for class II yanuthone, hence representing 
the second compound of this class. 
All four yanuthones showed several similar features in the 
1
H as well as 2D spectra. All displayed eight 
overlapping proton resonances at δH 1.41-2.08 ppm in the 
1
H spectrum, corresponding to the four 
methylene groups at C4, C5, C8 and C9, present in all structures. Other common resonances were seen 
for the diastereotopic pair H12/H12’ and the 3 methyl groups (H19, H20 and H21) around δH 1.60 
ppm, of which H20 and H21 were overlapping. Moreover, all four yanuthones showed HMBC 
correlations to a quaternary carbon (C18) around δC 194 ppm as well as two carbons around δC 60 ppm 
(one quaternary, one methine) being the carbons in the epoxide ring. 
The moiety attached to C15 varied, with yanuthone K-M having an acetoxy group attached (as also 
seen for yanuthone C 
9
), while yanuthone X2 had a hydroxyl group (as seen in yanuthone A and E 
9
). 
The structures also showed variance regarding the group attached to C16. Yanuthone K-M had a 
methyl group, while yanuthone X2 differed in having a methoxy group attached at the C16 position. 
This was obvious from the chemical shift of C16, which gave rise to a resonance at δC 172.6 ppm, 
considerably further downfield than in the other structures (yanuthone K-M). Furthermore, C17 was 
affected, shifting upfield to δC 98.8 ppm. As expected, the chemical shifts of the core structure of 
yanuthone K-M are very similar, whereas yanuthone X2 differs especially around position C16.  
The attached terpene chain also varied in the four structures. Yanuthone K and X2 proved to contain a 
non-modified sesquiterpene. Yanuthone L and M also contain a sesquiterpene chain, but this is 
oxidized at C1 and C2, respectively.  
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NOESY experiments enabled determination of the stereogenic centers of 1-4 to be similar to the 
previously described yanuthones. For all four yanuthones the NOESY data showed a strong correlation 
between H14 and H15 (see supporting information), suggesting these protons to be on the same side of 
the six-membered ring. This was further supported by the optical rotation measured, which was 
comparable to those reported for other yanuthones, altogether strongly indicating the absolute 
stereochemistry of C13, C14 and C15 is similar to other yanuthones.   
Labeling studies confirm that yanuthones K-M are class I yanuthones, and yanuthone X2 is a 
class II yanuthone 
In previous work it was demonstrated that yanuthone D, unlike the highly similar compound yanuthone 
X1, is biosynthesized from 6-MSA.
13
 To prove that yanuthones K, L, and M truly are class I 
yanuthones and that yanuthone X2 is a class II yanuthone, the A. niger strain (KB1001) and a 6-MSA 
synthase deletion strain (yanAΔ)13 were analyzed for the presence of the four new yanuthones. This 
experiment revealed that neither yanuthone K, L nor M were present in yanAΔ (data not shown) 
suggesting that these three compounds are class I compounds, biosynthesized using 6-MSA as 
precursor. In contrast, yanuthone X2 was still present in the yanAΔ strain, indicating that it is indeed a 
class II yanuthone. To further verify this, fully labeled 
13
C8-MSA was fed to yanAΔ and KB1001. 
Yanuthone L was not produced under the given conditions in this experiment, but the data confirmed 
that 6-MSA was indeed incorporated into yanuthone K and M, verifying 6-MSA as the precursor 
(Figure 2). In contrast, no 
13
C8-6-MSA was incorporated into yanuthone X2, which is in agreement with 
this compound being a class II yanuthone. 
Yanuthones K-M and X2 display antifungal activity  
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Some of the yanuthones have earlier been reported to display antimicrobial activity
9
, and in our 
previous study we reported that several of the yanuthones showed antifungal activity towards C. 
albicans, with yanuthone D being the most active with an IC50 value of 3.3 µM.
13
 We therefore tested 
the four new yanuthones identified in this study for antifungal activity towards C. albicans, see Table 
3. All three class I yanuthones showed antifungal activity in this assay. The strongest activities were 
observed with yanuthones K and L, which resulted in IC50 values that were 5-fold higher than that 
obtained with yanuthone D. The weakest activity was obtained with yanuthones M, which was 20-fold 
higher than the value obtained with yanuthone D. Importantly; yanuthone X2 also displayed an 
antimicrobial effect. With an IC50 value 15-fold higher than that of yanuthone D, it represents the first 
example of a bioactive class II yanuthone. This result demonstrates that there may be a pharmaceutical 
potential for this class of yanuthones. 
Comparison of all class I yanuthone structures to their corresponding antifungal activities revealed 
some structure-activity relationship (SAR) features that may be relevant for potency towards C. 
albicans. Firstly, yanuthone D (IC50 = 3.3 µM) and yanuthone E (IC50 > 100 µM) only differ by the 
functional group at C15. In this case, a shift from of a ketone to a hydroxyl at this position is sufficient 
to eliminate the antimicrobial effect of the most bioactive yanuthone (see Figure 3). Inspection of the 
other compounds revealed that the functional group at C15 does have a significant impact on the 
potency, as O-glycosylation increases antifungal activity (yanuthone G compared to yanuthone F), and 
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O-acetylation at C15 also increases antifungal activity compared to hydroxylation (yanuthone K and L 
compared to 7-deacetoxyanuthone A
i
 and yanuthone F, respectively). 
Secondly, hydroxylation of C22 appears to increase antifungal activity. This is seen in yanuthone H 
(IC50 = 24.5 µM) compared to yanuthone F (IC50 > 100 µM) as well as in 22-deacetylyanuthone A 
(IC50 = 19.4 µM) compared to 7-deacetoxyyanuthone A (IC50 > 100 µM) (Figure 3). In both cases, the 
structures differ only by the C22 hydroxylation. 
Lastly, two features seem to decrease antifungal activity: chain shortening of the sesquiterpene and 
hydroxylation of C2. Chain shortening of the sesquiterpene of yanuthone I (IC50 > 100 µM) decreased 
antifungal activity compared to yanuthone H (IC50 = 24.5 µM), which contains an intact C15 
sesquiterpene (Figure 3). However, this could also be connected to the level of oxidation, and not the 
chain length alone. Hydroxylation of C2 also seems to decrease the activity, as yanuthone M (IC50 = 
77.5 µM) is less active than yanuthone K (IC50 = 17.5 µM) (Figure 3). It is unclear how O-
mevalonation at C22 affects the activity as both 7-deacetoxyyanuthone A (non-mevalonated) and 
yanuthone E (mevalonated) have IC50-values above 100 µM, and thus the activities were too low to be 
measured in this assay. The same goes for hydroxylation at C1, where 7-deacetoxyyanuthone A (non-
hydroxylated) and yanuthone F (hydroxylated) have IC50-values above 100 µM. Based on the above 
correlation between structures and antifungal activities, we propose that antifungal activity of class I 
yanuthones may increase by combining 1) oxidation of the hydroxyl group at C15 with hydroxylation 
of C22, or 2) O-acetylation of C15 with hydroxylation of C22. 
                                                          
i
 7-deacetoxyyanuthone A was named by Li et al. using another numbering system for the yanuthones than the originally 
suggested by Bugni et al. According to the latter numbering system, which has also been used here, the appropriate name 
for 7-deacetoxyyanuthone A would have been 22-deacetoxyyanothone A. 
PhD Thesis 
Lene Maj Petersen
387
10 
 
For class II yanuthones, the picture is different. In contrast to class I yanuthones, O-acetylation at C15 
appears to reduce antifungal activity compared to hydroxylation (Figure 3). As class II yanuthones lack 
the C22 carbon and have a methoxy group attached to C16 instead, there may be interplay between the 
side groups, which may explain this difference. Since yanuthone X2, but not yanuthone E, shows 
antimicrobial bioactivity, it would be of great interest to synthesize a class II yanuthone with a ketone 
at C15, to investigate whether this compound shows a stronger biological effect than yanuthone D. 
In summary a large scale cultivation of A. niger has led to the discovery of four new yanuthones, which 
were all characterized by 1D and 2D NMR spectroscopy. Labeling studies with 
13
C8-6-MSA and 
comparison of the chemical profile of the A. niger strain (KB1001) and a 6-MSA synthase gene 
deletion strain (yanAΔ) revealed three class I yanuthones (yanuthone K-M) originating from 6-MSA 
and one class II yanuthone (yanuthone X2) originating from a yet unknown precursor. These results 
were in agreement with their elucidated structures, with yanuthone K-M containing a C7 core scaffold 
and yanuthone X2 a C6 core scaffold.  
Furthermore, we have tested the antifungal activity of the new yanuthones towards the pathogenic yeast 
C. albicans and found that all were active. This not only shed light on the structure-activity 
relationships, that are  relevant for the potency towards C. albicans, but also demonstrated the possible 
pharmaceutical potential of the class II yanuthones, as yanuthone X2 represents the first example of a 
bioactive class II yanuthone.  
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Figure 1. Structures of the four new compounds yanuthone K-M and X2. 
 
Figure 2. Positive electrospray (ESI
+
) mass spectrum of: (A) Unlabeled and labeled yanuthone K (1), (B) Unlabeled and 
labeled yanuthone M (3), and (C) unlabeled yanuthone X2 (3). The calculated shift from 
12
C7 to 
13
C7 is 7.0234 Da. 
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Figure 3. Overview of class I and II yanuthones as well as their IC50 [µM] towards Candida albicans. 
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Table 1. 
1
H NMR chemical shift [ppm], integral, multiplicity and J coupling constants [Hz] for yanuthone K-M and X2. 
Spectra were referenced by solvent signals for CD3CN at δH = 1.94 ppm and δC = 1.32, 118.26 ppm. 
Atom # Yanuthone K (1) Yanuthone L (2) Yanuthone M (3) Yanuthone X2 (4) 
1 1.65 (3H, s) 3.84 (2H, s) 1.11 (3H, m) 1.66 (3H, d, 0.9) 
2 - - - - 
3 5.08 (1H, m) 5.32 (1H, tq, 7.0, 1.4) 1.34 (2H, m) 5.09 (1H, m) 
4 2.02 (2H, m) 2.08 (2H, m) 1.41 (2H, m) 2.05 (2H, m) 
5 1.94 (2H, m) 1.99 (2H, m) 1.93 (2H, m) 1.95 (2H, m) 
6 - - - - 
7 5.07 (1H, m) 5.09 (1H, tq, 7.0, 1.3) 5.08 (1H, m) 5.08 (1H, m) 
8 2.06 (1H, m) 2.07 (2H, m) 2.07 (2H, m) 2.07 (2H, m) 
8’ 2.00 (1H, m)    
9 - 1.991 (2H, m) 2.00 (2H, m) 1.99 (2H, m) 
10 - - - - 
11 5.01 (1H, m) 5.01 (1H, m) 5.02 (1H, m) 5.04 (1H, m) 
12 2.69 (1H, dd, 15.3, 8.1) 2.69 (1H, dd, 15.6, 8.2) 2.69 (1H, dd, 15.4, 8.1) 2.74 (1H, dd, 15.0, 8.1) 
12’ 2.45 (1H, dd, 15.4, 6.7) 2.45 (1H, dd, 15.5, 6.7) 2.45 (1H, dd, 15.4, 6.7) 2.36 (1H, dd, 15.0, 6.6) 
13 - - - - 
14 3.65 (1H, d, 2.6) 3.66 (1H, d, 2.6) 3.66 (1H, d, 2.6) 3.58 (1H, d, 3.1) 
15 5.80 (1H, m) 5.80 (1H, m) 5.81 (1H, m) 4.58 (1H, d, 2.9) 
16 - - - - 
17 5.81 (1H, m) 5.81( 1H, m) 5.82 (1H, m) 5.18 (1H, s) 
18 - - - - 
19 1.59 (3H, s) 1.591 (3H, s) 1.11 (3H, s) 1.59 (3H, s) 
20 1.58 (3H, s) 1.59 (3H, s) 1.57 (3H, s) 1.58 (3H, s) 
21 1.62 (3H, s) 1.62 (3H, s) 1.62 (3H, s) 1.62 (3H, s) 
22 1.84 (3H, s)  1.84 (3H, t, 1.22) 1.85 (3H, m) 3.69 (3H, s) 
23 - - -  
24 2.16 (3H, s) 2.16 (3H, s) 2.16 (3H, s)  
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Table 2. 
13
C NMR chemical shifts [ppm] for yanuthone K-M and X2. Spectra were referenced by solvent signals for 
CD3CN at δH = 1.94 ppm and δC = 1.32, 118.26 ppm. 
Atom # 1 2 3 4 
1 25.7 68.1 29.2 25.8 
2 132.0 136.1 70.7 132.1 
3 125.1 125.1 43.9 124.9 
4 27.5 26.8 23.2 27.3 
5 40.4 40.0 40.5 40.4 
6 136.1 135.9 136.4 136.0 
7 125.1 124.7 124.7 124.8 
8 27.4 26.8 26.9 27.3 
9 40.4 40.0 40.3 40.4 
10 140.4 140.1 140.3 139.7 
11 117.6 117.4 117.3 118.1 
12 26.5 26.4 26.3 27.1 
13 61.0 61.0 60.8 61.1 
14 57.2 57.1 57.2 58.9 
15 69.6 69.4 69.5 65.9 
16 153.9 153.8 153.7 172.6 
17 125.2 124.9 124.9 98.8 
18 194.1 194.1 194.2 194.4 
19 17.6 13.6 29.2 17.7 
20 16.0 15.8 15.8 16.2 
21 16.2 16.4 16.3 16.4 
22 19.8 19.6 19.6 57.1 
23 171.2 171.4 171.0  
24 20.8 20.8 20.8  
 
 
 
Table 3. The half maximal inhibitory concentration (IC50) for Candida albicans treated with a small library of yanuthones 
isolated from Aspergillus niger KB1001. The IC50 values were calculated based on duplicate experiments carried out in 
three independent trials and annotated with their respective standard deviation. 
  Compound IC50 (µM)   
 
Yanuthone K (1) 17.5 ± 3.9 
 
 
Yanuthone L (2) 17.0 ± 1.9 
 
 
Yanuthone M (3) 77.5 ± 3.7 
 
 
Yanuthone X2 (4) 51.7 ± 4.7 
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S 1. Spectroscopic data for yanuthone K (1) 
HRESIMS: m/z = 387.2531 [M + H]+, calculated for [C24H34O4+H]
+: 387.2530. 
      
         (MeOH) 
 
 
Atom 
assignment 
1H-chemical shift [ppm]  
(integral, mult., J [Hz]) 
13C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.65 (3H, s) 25.7 2, 3, 19 3 
2 - 132.0 - - 
3 5.08 (1H, m) 125.1 1, 19 1, 4 
4 2.02 (2H, m) 27.5 2 3 
5 1.94 (2H, m) 40.4 3, 4, 6, 20 7 
6 - 136.1 - - 
7 5.07 (1H, m) 125.1 4/8, 5/9, 20 5, 8, 9 
8 2.06 (2H, m) 27.4 5/9, 6, 7, 10 7 
9 2.00 (2H, m) 40.4 7, 8, 10, 11, 21 7, 11 
10 - 140.4 - - 
11 5.01 (1H, m) 117.6 9, 12/12’, 13, 21 9, 12, 12’, 14 
12 2.69 (1H, dd, 15.3, 8.1) 26.5 10, 11, 13, 14, 18 11, 12’, 14, 21 
12’ 2.45 (1H, dd, 15.4, 6.7) 26.5 10, 11, 13, 14, 18 11, 12, 14, 21 
13 - 61.0 - - 
14 3.65 (1H, d, 2.6) 57.2 12/12’, 13, 15, 16 22 11, 12, 12’, 15 
15 5.80 (1H, m) 69.6 13, 14, 16, 22, 23 14, 22 
16 - 153.9 - - 
17 5.81 (1H, m) 125.2 13, 15, 16, 22 - 
18 - 194.1 - - 
19 1.59 (3H, s) 17.6 1, 2, 3 - 
20 1.58 (3H, s) 16.0 5, 6, 7 - 
21 1.62 (3H, s) 16.2 9, 10, 11 12, 12’ 
22 1.84 (3H, s)  19.8 15, 16, 17 15 
23 - 171.2 - - 
24 2.16 (3H, s) 20.8 15, 23  - 
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S 2. Spectroscopic data for yanuthone L (2) 
HRESIMS: m/z = 403.2482 [M + H]+, calculated for [C24H34O5+H]
+: 403.2484. 
      
         (MeOH) 
 
Atom 
assignment 
1H-chemical shift [ppm]  
(integral, mult., J [Hz]) 
13C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 3.84 (2H, s) 68.1 2, 3, 19 3, 4, 19 
2 - 136.1 - - 
3 5.32 (1H, tq, 7.0, 1.4) 125.1 1, 4, 19 1, 4 
4 2.08 (2H, m) 26.8 3, 5, 6, 19  1, 3 
5 1.99 (2H, m) 40.0 4, 6, 7 7 
6 - 135.9 - - 
7 5.09 (1H, tq, 7.0, 1.3) 124.7 5, 9, 20 5, 8, 9  
8 2.07 (2H, m) 26.8 6, 9 7, 11, 21 
9 1.991 (2H, m) 40.0 8, 10, 11, 21  7, 11, 14 
10 - 140.1 - - 
11 5.01 (1H, m) 117.4 9, 21 8, 9, 12, 12’, 14  
12 2.69 (1H, dd, 15.6, 8.2) 26.4 10, 11, 13, 14, 18  11, 12’, 14, 21 
12’ 2.45 (1H, dd, 15.5, 6.7) 26.4 10, 11, 13, 14, 18 11, 12, 14, 21 
13 - 61.0 - - 
14 3.66 (1H, d, 2.6) 57.1 15, 16 9, 11, 12, 12’, 15, 17, 
21 
15 5.80 (1H, m) 69.4 13, 22, 23 14, 22 
16 - 153.8 - - 
17 5.81( 1H, m) 124.9 13, 15, 22 14, 22 
18 - 194.1 - - 
19 1.591 (3H, s) 13.6 1, 3, 19 1 
20 1.59 (3H, s) 15.8 5, 6 - 
21 1.62 (3H, s) 16.4 9, 10, 11 8, 12, 12’, 14,  
22 1.84 (3H, t, 1.22) 19.6 15, 16, 17 15, 17 
23 - 171.4 - - 
24 2.16 (3H, s) 20.8 23 - 
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S 3. Spectroscopic data for yanuthone M (3) 
HRESIMS: m/z = 405.2636 [M + H]+, calculated for [C24H36O5+H]
+: 405.2635.  
      
         (MeOH) 
 
Atom 
assignment 
1H-chemical shift [ppm]  
(integral, mult., J [Hz]) 
13C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY  
connectivities 
1 1.11 (3H, m) 29.2 2, 3, 19 3, 4 
2 - 70.7 - - 
3 1.34 (2H, m) 43.9 - 1, 19 
4 1.41 (2H, m) 23.2 - 1, 19 
5 1.93 (2H, m) 40.5 3, 4, 6 7 
6 - 136.4 - - 
7 5.08 (1H, m) 124.7 - 5, 8, 9 
8 2.07 (2H, m) 26.9 5/9, 6, 7 7 
9 2.00 (2H, m) 40.3 7, 8, 10, 11, 12, 21 7, 11 
10 - 140.3 - - 
11 5.02 (1H, m) 117.3 - 9, 12, 12’ 
12 2.69 (1H, dd, 15.4, 8.1) 26.3 10, 11, 13 11, 12, 21 
12’ 2.45 (1H, dd, 15.4, 6.7) 26.3 10, 11, 13 11, 12’ 
13 - 60.8 - - 
14 3.66 (1H, d, 2.6) 57.2 16 15 
15 5.81 (1H, m) 69.5 - 14, 22 
16 - 153.7 - - 
17 5.82 (1H, m) 124.9 - - 
18 - (194.2) - - 
19 1.11 (3H, s) 29.2 2, 3, 1 3, 4 
20 1.57 (3H, s) 15.8 5, 6, 7 - 
21 1.62 (3H, s) 16.3 9, 10, 11 12 
22 1.85 (3H, m)  19.6 15, 16, 17 15 
23 - 171.0 - - 
24 2.16 (3H, s) 20.8 23  - 
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S 4. Spectroscopic data for yanuthone X2 (4) 
HRESIMS: m/z = 361.2373 [M + H]+, calculated for [C22H32O4+H]
+: 361.2373.  
      
        (MeOH) 
 
 
Atom 
assignment 
1H-chemical shift [ppm]  
(integral, mult., J [Hz]) 
13C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.66 (3H, d, 0.9) 25.8 2, 3, 19 - 
2 - 132.1 - - 
3 5.09 (1H, m) 124.9 5 4/5 
4 2.05 (2H, m) 27.3 2 3, 5 
5 1.95 (2H, m) 40.4 3, 4/8, 6 3, 4 
6 - 136.0 - - 
7 5.08 (1H, m) 124.8 5/9, 20 - 
8 2.07 (2H, m) 27.3 6, 7, 10 9 
9 1.99 (2H, m) 40.4 8/12, 10, 11, 21,  8, 11 
10 - 139.7 - - 
11 5.04 (1H, m) 118.1 9, 21 9, 12, 12’ 
12 2.74 (1H, dd, 15.0, 8.1) 27.1 10, 11, 13, 14 11, 12’, 14, 21 
12’ 2.36 (1H, dd, 15.0, 6.6) 27.1 10, 11, 13, 14 11, 12, 14, 21 
13 - 61.1 - - 
14 3.58 (1H, d, 3.1) 58.9 15, 16 12, 12’, 15 
15 4.58 (1H, d, 2.9) 65.9 16 14 
16 - 172.6 - - 
17 5.18 (1H, s) 98.8 13, 15, 16 22 
18 - 194.4 - - 
19 1.59 (3H, s) 17.7 1, 2, 3 - 
20 1.58 (3H, s) 16.2 5, 6, 7 - 
21 1.62 (3H, s) 16.4 9, 10, 11 12, 12’ 
22 3.69 (3H, s)  57.1 16 17 
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S 5. 1H NMR spectrum for yanuthone K (1) at 500 MHz in acetonitrile-d3 
  
S 6. DQF-COSY spectrum for yanuthone K (1) in acetonitrile-d3 
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S 7. HSQC spectrum for yanuthone K (1) in acetonitrile-d3 
 
S 8. HMBC spectrum for yanuthone K (1) in acetonitrile-d3 
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S 9. NOESY spectrum for yanuthone K (1) in acetonitrile-d3 
 
S 10. 1H NMR spectrum for yanuthone L (2) at 500 MHz in acetonitrile-d3 
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S 11. DQF-COSY spectrum for yanuthone L (2) in acetonitrile-d3 
 
S 12. HSQC spectrum for yanuthone L (2) in acetonitrile-d3 
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S 13. HMBC spectrum for yanuthone L (2) in acetonitrile-d3 
 
S 14. NOESY spectrum for yanuthone L (2) in acetonitrile-d3 
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S 15. 1H NMR spectrum for yanuthone M (3) at 500 MHz in acetonitrile-d3 
 
S 16. DQF-COSY spectrum for yanuthone M (3) in acetonitrile-d3 
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S 17. HSQC spectrum for yanuthone M (3) in acetonitrile-d3 
 
S 18. HMBC spectrum for yanuthone M (3) in acetonitrile-d3 
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S 19. NOESY spectrum for yanuthone M (3) in acetonitrile-d3 
 
S 20. 1H NMR spectrum for yanuthone X2 (4) at 500 MHz in acetonitrile-d3 
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S 21. DQF-COSY spectrum for yanuthone X2 (4) in acetonitrile-d3 
 
S 22. HSQC spectrum for yanuthone X2 (4) in acetonitrile-d3 
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S 23. HMBC spectrum for yanuthone X2 (4) in acetonitrile-d3 
 
S 24. NOESY spectrum for yanuthone X2 (4) in acetonitrile-d3 
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S 25. UV spectra for yanuthone K-M and X2 
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ABSTRACT 
Aspergillus aculeatus is a filamentous fungus, belonging to the Aspergillus clade Nigri, and is an 
industrial workhorse used for enzyme production. Recently we have reported a number of 
secondary metabolites from this fungus [1], however, its genetic potential for production of 
secondary metabolites is vast. In this study we have identified a 6-methylsalicylic acid (6-MSA) 
synthase from A. aculeatus, and verified its functionality by episomal expression in A. aculeatus 
and heterologous expression in A. nidulans. Furthermore, we have over-expressed a transcription 
factor, embedded in the gene cluster, and found that it activated a biosynthetic cluster responsible 
for production of two pyrrolidinones, which were found to be diastereomers of RKB-3384B. 
Feeding studies with fully 
13
C-labeled 6-MSA dismisses that 6-MSA is incorporated into the two 
pyrrolidinones, instead, 6-MSA is incorporated into three other novel compounds, which we have 
named aculins A and B, and epi-aculine A. Based on NMR data and bioinformatic studies we 
propose the structures of the compounds as well as a biosynthetic pathway leading to formation of 
aculins from 6-MSA. 
INTRODUCTION 
Aspergillus aculeatus is a filamentous fungus belonging to the group of black Aspergilli. A. 
aculeatus was recently sequenced by the DOE Joint Genome Institute (JGI), but no genes have yet 
been linked to production of metabolites. A. aculeatus is a known producer of several important 
secondary metabolites including the antiinsectan okaramines [2], the toxic secalonic acids [3] and 
recently we have reported production of the antifungal compounds calbistrins as well as several 
novel compounds including aculenes A-D with yet unknown activities [1]. 
Analysis of the published genome sequence revealed that A. aculeatus contains a gene with high 
similarity to 6-MSA synthases. No 6-MSA or obvious 6-MSA-derived compounds have been 
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detected in wildtype extracts of A. aculeatus, so it is possible that 6-MSA is highly modified into 
the final metabolite as it is the case for both yanuthone D [4],  terreic acid [5], and patulin [6].  
As no genetic techniques exist for A. aculeatus, we have used an AMA1-based episomal expression 
platform for gene expression. AMA1-containing plasmids allow for autonomous replication in 
many different Aspergilli [7,8] why this is a quick and efficient tool for expressing genes in 
organisms for which no available genetic techniques are available. Furthermore, the transformation 
efficiency with autonomous plasmids is much higher than integrating linear substrates [7] why it is 
also an efficient mean for gene expression in organisms that protoplast or transform very poorly. 
In this study we have shown that the putative 6-MSA synthase is in fact a 6-MSA synthase, by 
heterologous expression of the gene in the model fungus Aspergillus nidulans. Furthermore, we 
have used the AMA1-based expression platform in A. aculeatus for expression of a transcription 
factor embedded in the 6-MSA gene cluster. This approach activated a biosynthetic cluster with 
unknown relation to the 6-MSA gene cluster, which is responsible for production of two 
diastereomers of RKB-3384B. Furthermore, labelling studies have identified three compounds 
originating from 6-MSA, which are likely related to the gene cluster. We propose the structures of 
the compounds and suggest a possible biosynthetic pathway from 6-MSA.  
 
RESULTS AND DISCUSSION 
Heterologous expression of a putative 6-MSA synthase verifies production of 6-MSA.  
A BLAST analysis of the ASPACDRAFT_1904397 gene on all genomes in the Aspergillus 
Genome Database (AspGD) revealed a high similarity to fungal 6-methylsalicylic acid (6-MSA) 
synthases (data not shown). To verify that the gene indeed encodes a 6-MSA synthase the gene was 
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integrated into the defined and characterized locus IS1 of A. nidulans, which is a site that has 
previously been used for successful expression of PKS genes [4][9]. This approach is useful in this 
study, as A. nidulans is known not to produce 6-MSA, and does not contain any PKSs with 
homology to 6-MSA synthases. The metabolite profile of the strain was analyzed by UHPLC-DAD-
TOFMS, and a new compound was indeed produced compared to the reference (Figure 1). 
Dereplication of the compound and comparison to an authentic standard of 6-MSA verified that the 
compound was 6-MSA (1), confirming that ASPACDRAFT_1904397 encodes a 6-MSA synthase.  
 
Figure 1. BPC of the A. nidulans strain expressing the putative 6-MSA synthase 1904397 compared 
to an A. nidulans reference. 
Expression of the 6-MSA synthase in A. aculeatus results in accumulation of 6-MSA.  
Having confirmed that A. aculeatus contained a 6-MSA synthase, wildtype extracts were 
scrutinized for the presence of 6-MSA. As no 6-MSA was detected in any wildtype extracts of A. 
aculeatus, we hypothesized that either the 6-MSA synthase gene was silenced or that all produced 
6-MSA was modified into a different compound by a number of tailoring enzymes. Based on this 
hypothesis, over-expression of the 6-MSA synthase might result in production of 6-MSA or another 
compound, or in production of higher amounts of a compound that was also produced by the 
8   Papers 1-12
416
Characterization of a 6-MSA synthase gene cluster in Aspergillus aculeatus 
5 
 
wildtype strain. Accordingly, the 6-MSA synthase was expressed in A. aculeatus from the plasmid 
pDHX3, carrying the hph selection marker. Correct transformants were cultivated on solid minimal 
medium with hygromycin B and subjected to metabolite profile analysis by UHPLC-DAD-TOFMS. 
Data analysis verified that the strain produced 6-MSA (Figure 2). However, there was no significant 
change in the rest of the metabolite profile (Figure 2). The fact that the A. aculeatus pDHX3-6-
MSAS strain produced 6-MSA rather than a biosynthetic end product, indicated that no tailoring 
enzymes in the biosynthetic pathway (if any) were expressed, and that the entire proposed 6-MSA 
cluster was silent under the applied laboratory conditions. 
 
Figure 2. BPC and EIC (153.055±0.005) for A. aculeatus reference and pDHX3-6-MSAS over-
expression strain. 
 
Over-expression of a transcription factor from the proposed 6-MSA cluster results in up-
regulation of two compounds.  
Examination of the predicted gene cluster revealed that a putative transcription factor (TF) was 
located immediately downstream of the 6-MSA synthase gene, indicating that this could be a 
PhD Thesis 
Lene Maj Petersen
417
Characterization of a 6-MSA synthase gene cluster in Aspergillus aculeatus 
6 
 
regulator of the 6-MSA gene cluster. The TF was expressed from the expression platform pDHX2 
(pDHX2-TF), cultivated on minimal and YES media, and analyzed by UHPLC-DAD-TOFMS. 
Examination of the metabolite profiles revealed up-regulation of production of two compounds on 
minimal medium, (2) and (3), which were not present in the reference (Figure 3). 
The two compounds, (2) and (3), were produced by both the reference strain and pDHX2-TF when 
cultivated on YES, indicating that the biosynthesis of these compounds is normally active when 
cultivated on YES medium, but not on minimal medium. In general, cultivation on YES medium 
did not result in detectable changes in the metabolite profile (Figure 3). One explanation for this 
result might be that the plasmid is lost when proper selection is not maintained; YES provides all 
nutrients, including uridine, whereas minimal medium does not. Another explanation is that the TF 
is already highly expressed during cultivation on YES, why over-expression does not affect 
production of the compounds.  
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Figure 3. BPC of A. aculeatus expressing putative transcription factor from plasmid (pDHX2-TF) 
compared to a reference, cultivated on minimal medium (A) and YES (B). 
Elucidation of the structures revealed two diastereomers, of the patented compound RKB-3384B 
[10] (Figure 4). NMR data is available in supplementary Tables S1 and S2.  
 
Figure 4. Structure of the diastereomers of RKB-3384B (2)/(3). Stereocenters are marked with *. 
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The structures of (2) and (3), which differ only by their stereochemistry, are surprising, as it is not 
obvious how they were derived from 6-MSA, if at all. The backbone have previously been observed 
e.g. in lucilactaene produced by a Fusarium sp. [11], epolactaene from a marine Penicilium sp. [12] 
and fusarin C from Fusarium moniliforme [13]. All of these compounds contain the long 
hydrocarbon chain observed in (2) and (3), but differs in the attached moiety. Lucilactaene contains 
two fused five-membered rings, epolactaene a single five-membered lactam entailing an epoxide, 
and the fusarins display different structural features. Labeling studies have shown that the backbone 
chain of fusarins is of polyketide origin [14], and both labeling and genetic studies provided insight 
into the 5-membered ring structures, which originate from a C4-unit [15]. Assuming that (2) and (3) 
entail the same polyketide chain, the 5-membered ring must consist of a nitrogen-containing C3 unit 
e.g. serine, and the connection to 6-MSA is not obvious. 
 
The pyrrolidinones is not bioactive against cancer cells. Some of the compounds that are 
structurally similar to (2) and (3) have been reported as bioactive; Lucilactaene as a cell cycle 
inhibitor in p53-transfected cancer cell [11], epolactaene as a neuritogenic compound in human 
neuroblastoma cells [12], and fusarin C as a mutagen [13]. This prompted us to investigate the 
bioactivity. (2) was tested in a CellTiter-Glo
®
 assay [16] (Figure S2), but was found to be inactive.  
 
Fully labeled 6-MSA is incorporated into three compounds, but not the pyrrolidinones.  
To test whether 6-MSA was indeed incorporated into (2) and (3) we fed fully labeled 6-MSA (
13
C8-
6-MSA) to the TF expressing strain (Figure 5).  
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Figure 5 A. BPC (black) of pDHX2-TF on YES+
13
C8-6-MSA, EIC 374.1963±0.005 (light grey), 
EIC 472.2333 ± 0.005 (dark grey), EIC 474.2484 ± 0.005 (black). B. Mass spectra of compounds 
(4), (5), and (6). 
 
Careful inspection of the metabolite profile revealed a mass shift of 7.023 Da for three compounds: 
(4) and (5), and (6) (Figure 5). The fact that a mass shift equivalent of seven 
13
C atoms, and not the 
eight 
13
C atoms that are present in 
13
C8-6-MSA, suggests that one carbon atom is eliminated from 6-
MSA during modification into the end products. A mass shift of 7.023 Da was also observed in 
feeding studies of the yanuthone D biosynthesis, where one carbon atom is eliminated from 6-MSA 
by decarboxylation [4].  
Interestingly, but not surprisingly, 6-MSA was not incorporated into (2) and (3) (Figure S1). Thus 
(2) and (3) do not origin from 6-MSA although production of the two compounds appeared to be 
activated by expression of the TF. It is surprising that a putative TF, located immediately 
downstream of a 6-MSA synthase, controls expression of two compounds, which do not depend on 
6-MSA. Similarly, the three compounds that do contain 6-MSA, are not controlled by the putative 
TF in a simple manner, if at all. Thus, the mode of action for the putative TF is not clear. We have 
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named the gene encoding the TF arnR, and the corresponding gene product ArnR, to underline that 
the TF positively controls expression of genes involved with formation of (2) and (3), but does not 
seem to regulate the genes that are part of the 6-MSA gene cluster. 
 
Structure elucidation of degradation products lead to identification of three novel compounds.  
To elucidate the structures of (4), (5), and (6) a large scale cultivation was prepared. Purification of 
the compounds proved challenging as the compounds were unstable even under mild conditions. 
Apparently, (4) and (5) were degraded to a small acid (7)/(8) and aculene A (9), a compound that 
we have previously characterized from A. aculeatus [1]. Likewise (6) was degraded to aculene B 
and (7)/(8), and the same trend has previously been observed for other A. aculeatus metabolites, the 
acucalbistrins A-B [1]. Although impossible to isolate (4), (5), and (6), the structures of the 
degradation products were solved, see Figure 6. 
 
Figure 6. Structures of the degradation products of (4) (aculene A (9) and (7) + (8)) and the 
suggested structure of (4), (5) and (6). 
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The resonances observed from aculene A (see table S3) were comparable to those reported earlier 
[1]. The small acid (7)/(8) gave rise to two set of signals probably due to hemiacetal opening and 
closing at C1. This leads to different stereocenters at C1, resulting in diastereomers and justifying 
the observed shifts (see Tables S4 and S5). Database searches in Scifinder [17]  and Antibase [18] 
did not provide the structures of (7)/(8) or any compounds with incorporation of (7)/(8). The 
calculated mass of the suggested structure (4) is 471.2257 Da, corresponding to a m/z of [M+H]
+ 
of 
472.2330, which matches the observed m/z for compounds (4) and (5). We therefore suggest that 
the two structures are the same, and only differ at the stereocenters in (7) and (8). The m/z of (6) is 2 
Da higher than (4) and (5), why we suggest the same structure, but with incorporation of aculene B 
rather than aculene A (see Figure 6), similar to what we have proposed for the acu-calbistrins A and 
B [1]. The degradation products of (6) have not been confirmed by NMR experiments, but have 
been verified by UHPLC-DAD-HRMS data. We have named the new compounds aculin A (4) , 
epi-aculin A (5) and aculin B (6). Accordingly, the small acid that is incorporated into the three 
aculins was named aculinic acid (7)/(8). 
 
The biosynthetic pathway from 6-MSA to aculin A.  
The 6-MSA synthase gene and surrounding genes are depicted in Figure 7. We define the acu gene 
cluster as the genes acuA-acuI spanning 23.6 kb with no disruption from unrelated genes. 
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Figure 7. The acuA 6-MSA synthase encoding gene is flanked by eight genes which we define as 
the acu gene cluster. The arnR TF is not part of the acu cluster, but is located immediately upstream 
of acuA. 
Table 1. Overview of genes and proposed activities of the acu cluster 
Gene 
name 
Locus 
(ASPACDRAFT_) 
Proposed biosynthetic activity Note 
- 1904392 - Predicted ATPase 
arnR 123491 Transcriptional activator of RKB-
3384B cluster (unknown)  
Predicted fungal transcription factor 
acuA 1904397 6-MSA synthase Confirmed 6-MSA synthase (this study) 
acuE 1904400 Oxidase No homology to known activities, but 
homologous to YanE (E-value 1.91E-38) 
acuD 32595 m-hydroxybenzyl alcohol 
hydroxylase 
Predicted CYP450, PatI homolog (A. clavatus) 
acuB 45672 Decarboxylase 6-MSA decarboxylase homolog (P. expansum) 
acuC 45673 m-cresol methyl hydroxylase Predicted CYP450, PatH homolog (A. 
clavatus) 
acuF geneX Baeyer-Villiger oxidation No homology to known activities. Gene 
predicted by AUGUSTUS and FGeneSH 
acuI 1904405 Attachment of aculinic acid to 
aculene A 
Predicted carboxypeptidase 
acuG 80410 Reductase Predicted oxidoreductase.  
acuH geneY Dehydrogenase Predicted dehydrogenase. Gene predicted by 
AUGUSTUS and FGeneSH 
- 80411 - Predicted siderophore iron transporter 
- 123500 - No homology to known activities 
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Utilizing knowledge of the two other 6-MSA derived pathways towards yanuthone D [4] and 
patulin [19], as well as the predicted activities encoded by the acu cluster (Table 1), allows us to 
propose a biosynthetic pathway from 6-MSA (1) towards aculin A (4), see Figure 8. We suggest 
that after formation of 6-MSA by the AcuA PKS, 6-MSA is decarboxylated to m-cresol, followed 
by oxidations to m-hydroxybenzyl alcohol, and subsequently to gentisyl alcohol, as is described for 
the patulin and yanuthone D biosynthetic pathways [6][19][4]. In our model the AcuB 
decarboxylase converts 6-MSA to m-cresol as a first step. Subsequently, oxidation of m-cresol to m-
hydroxybenzyl alcohol and oxidation of m-hydroxybenzyl alcohol to gentisyl alcohol is catalyzed 
by AcuC and AcuD, which are homologs of PatI and PatH from the patulin pathway in A. clavatus. 
Gentisyl alcohol is then oxidized to (11) by AcuE, which is homologous to YanE from the yan 
cluster in A. niger. In the yanuthone biosynthesis it was proposed that YanE, along with another 
enzyme, YanD, catalyzes formation of the epoxide on the core aromatic moiety [4]. Thus it is likely 
that the one gene (YanE/AcuE) can catalyze hydroxylation of the aromatic ring. The aromatic 
system is opened via oxidation by a Baeyer-Villiger type of oxidation; however, there is no gene in 
the cluster that has homology to any known Baeyer-Villiger oxidase. We therefore suggest that the 
product of a cluster gene encoding an unknown activity, AcuF, may be responsible for this step. In 
this scenario, the carboxylic acid at C1 of (12) is subsequently reduced to an aldehyde by AcuG to 
form (13). Subsequently, a hemiacetal is formed, as suggested for the patulin biosynthetic pathway 
[20] and AcuH, a putative dehydrogenase, then reduces the double bond between C4 and C6. 
Finally, keto-enol tautomerism results in formation of aculinic acid (7)/(8), which exist as two 
diastereomers (both R/S configuration at C1) due to the non-enzymatic hemiacetal formation.  
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 Figure 8. Proposed biosynthetic pathway of aculin A (4). 
We propose the biosynthesis of the aculene A moiety to originate from the terpene pathway. We 
have earlier suggested this fourteen carbon moeity to originate from three isoprene units with the 
loss of one carbon atom at C9 [1]. The proposed sesquiterpene skeleton is also seen in the 
compound lasidiol angelate from Lasiantheae fruticosa [21], however with a isopropenyl moeity 
instead of the ethyl group, resulting in a C15 carbon skeleton. In this scenario the demethylation 
occurs at C19, as illustrated in Figure 8. Linking of (7)/(8) to (9) could be achieved by AcuI, which 
is predicted as a carboxypeptidase. The expected activity for a carboxypeptidase is cleavage of the 
terminal amino acid in the C-terminal of a peptide, however, the similarity to this enzymatic activity 
could also be indicative of a general affinity towards amino acids. Thus we propose that AcuI could 
be involved with attachment of an amino acid (in this case proline) to aculinic acid (7)/(8) to form 
(epi-)aculins A and B (5)/(4)/(6). 
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MATERIALS AND METHODS 
Strains and media. The A. nidulans strain IBT29539 (argB2, pyrG89, veA1, nkuAΔ) [22] was used 
for heterologous expression of 6-MSAS (AcuA). A. aculeatus ATCC16872-derived strain KB1042 
(pyr
-
) was used as reference and for expression of AcuA and ArnR. KB1042 was kindly provided 
by Kenneth S. Bruno (Pacific Northwest National Laboratory, Richland, WA, USA). Escherichia 
coli strain DH5α was used for cloning. Minimal media (MM) contained 1% glucose, 10 mM 
NaNO3, 1x salt solution [23] and 2% agar for solid media. MM was supplemented with 10 mM 
uridine, 10 mM uracil, 4 mM L-arginine, 100 µg/ml hygromycin B (Invivogen, San Diego, CA, 
USA) when necessary. 
Heterologous expression of 6-MSAS in A. nidulans. AcuA from A. aculeatus ATCC16872 
(ASPACDRAFT_1904397) was expressed heterologously in A. nidulans, using the expression 
platform developed in [9].  The 6-MSAS gene was PCR amplified using primers 
6MSAS_ORF_FW (5’-AGAGCGAUATGCCTCACTTCTCCTCTGCC-3’) and 6MSAS_ORF_RV 
(5’-TCTGCGAUGGTTAGAGATCTGATTAGCGGG-3’). Protoplasting, gene-targeting 
procedures and verification of strains were as described previously [4][24]. 
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Expression of 6-MSAS and TF in A. aculeatus. 6-MSAS (ASPACDRAFT_1904397) and TF 
(ASPACDRAFT_123491) were expressed in A. aculeatus, using the AMA1-based expression 
platforms pDHX2 and pDHX3. pDHX2 is described in [4]. pDHX3 was constructed exactly as 
pDHX2, except hph was PCR amplified from pCB1003 [25] using primers hph-pX-Fw (5’- 
ACTAGGTAAUGCTAGTGGAGGTCAACACATCA-3’) and hph-pX-Rv (5’- 
AGTGGGGAUCGGTCGGCATCTACTCTATT -3’) and inserted instead of pyrG. The 6-MSAS 
gene was PCR amplified as described above, and the TF was PCR amplified using primers 
TF_ORF_FW (5’-AGAGCGAUAAGCCATGTTCTCCACCTTCTC-3’) and TF_ORF_RV (5’-
TCTGCGAUTGTGACGGGACCCTAGATGAC-3’).  Protoplasting and transformation procedures 
were carried out as described previously [24]. Transformants were selected on MM without uracil 
and uridine (for strains carrying pDHX2) or MM with hygromycin B (for strains carrying pDHX3). 
Chemical analysis of strains. Unless otherwise stated strains were inoculated as a three point 
inoculation on solid MM media and incubated at 37 °C for 5 days. Extraction of metabolites was 
performed as described in [26]. 6-MSA was purchased from (Apin Chemicals, Oxon, UK). Analysis 
was performed using ultra-high-performance liquid chromatography (UPHLC) UV/Vis diode array 
detector (DAD) high-resolution MS (TOFMS) on a maXis 3G orthogonal acceleration quadrupole 
time of flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an 
electrospray ionization (ESI) source and connected to an Ultimate 3000 UHPLC system (Dionex, 
Sunnyvale, USA). The column used was a reverse-phase Kinetex 2.6-μmC18, 100 mm × 2.1mm 
(Phenomenex, Torrance, CA), and the column temperature was maintained at 40 °C. A linear water- 
acetonitrile (LCMS-grade) gradient was used (both solvents were buffered with 20 mM formic 
acid) starting from 10% (vol/vol) acetonitrile and increased to 100% in 10min, maintaining this rate 
for 3 min before returning to the starting conditions in 0.1 min and staying there for 2.4 min before 
the following run. A flow rate of 0.4 mL·min
−1
 was used. TOFMS was performed in ESI+ with a 
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data acquisition range of 10 scans per second at m/z 100–1000. The TOFMS was calibrated using 
Bruker Daltonics high precision calibration algorithm (HPC) by means of the use of the internal 
standard sodium formate, which was automatically infused before each run. This provided a mass 
accuracy of better than 1.5 ppm in MS mode. UV/VIS spectra were collected at wavelengths from 
200 to 700 nm. Data processing was performed using DataAnalysis 1.2 and Target Analysis4.0 
software (Bruker Daltonics).  
Feeding experiments. Feeding experiments were carried out exactly as described in [4] on solid 
YES plates. Fully labeled 6-MSA (
13
C8-6-MSA) was kindly provided by Kristian F. Nielsen 
(Technical University of Denmark), described in [4]. 
Preparative isolation of selected metabolites. A. aculeatus OeX-TF2 was cultivated on solid MM 
and incubated at 30°C for five days. The plates were harvested and extracted twice overnight with 
ethyl acetate (EtOAc) with 1 % formic acid. The extract was filtered and concentrated in vacuo. The 
combined extract was dissolved in methanol (MeOH) and H2O (9:1), and an equal amount of 
heptane was added where after the phases were separated. To the MeOH/H2O phase H2O was added 
to a ratio of 1:1, and metabolites were then extracted with dichlormethane (DCM). The phases were 
then concentrated separately in vacuo.  
The DCM phase was subjected to further purification on a semi-preparative HPLC, a Waters 600 
Controller with a 996 photodiode array detector (Waters, Milford, MA, USA). This was achieved 
using a Luna II C18 column (250 x 10 mm, 5 μm, Phenomenex), a flowrate of 4 mL/min and a 
isocratic run at 40 % acetonitrile for 18 minutes. 50 ppm TFA was added to acetonitrile of HPLC 
grade and milliQ-water. This yielded 4.4 mg of (2) and 5.0 mg of (3). 
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In another run using a Luna II C18 column (250 x 10 mm, 5 μm, Phenomenex), a flowrate of 5 
mL/min and a gradient going from 34% acetonitrile to 45 % in 25 minutes was used,  yielding 2.7 
mg of a mixture of (4), (7), (8) and (9). 
NMR and structural elucidation. The 1D and 2D spectra were recorded on a Unity Inova-500 
MHz spectrometer (Varian, Palo Alto, CA, USA). Spectra were acquired using standard pulse 
sequences and 
1
H spectra as well as DQF-COSY, NOESY, HSQC and HMBC spectra were 
acquired. The deuterated solvent was DMSO-d6 and signals were referenced by solvent signals for 
DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. The NMR data was processed in Bruker Topspin 
3.1. Chemical shifts are reported in ppm (δ) and scalar couplings in hertz (Hz). The sizes of the J 
coupling constants reported in the tables are the experimentally measured values from the spectra. 
There are minor variations in the measurements which may be explained by the uncertainty of J. 
NMR data for the compounds are found in the Supporting Information. 
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Fig. S2. Effect of increasing concentrations of (1) on CLL cell viability in a CellTiter-Glo® 
  assay. The relative cell viability is compared to DMSO control (1 %).  
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Figure S1. Mass spectra of compounds (2), (3), (4), (5), and (6), cultivated on YES or YES + 
13
C-
6-MSA. 
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Figure S2. Effect of increasing concentrations of (1) on CLL cell viability in a CellTiter-Glo® 
assay. The relative cell viability is compared to DMSO control (1 %).  
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Table S1. NMR Data for (1) (500 MHz, DMSO-d6). Signals were referenced by solvent signals for 
DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. 
 
No.  
1
H-chemical shift [ppm] 
(integral, mult., J [Hz]) 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
H2BC 
correlations 
NOE 
connectivities 
1 1.71 (dd 7.2, 1.0) 15.4 2, 3, 22 2 2, 4 
2 6.88 (m) 139.9 1, 4, 22 1 1 
3 - 129.8 - -  
4 6.22 (s) 126.8 6, 12, 22 - 1, 6, 12 
5 - 137.5 - -  
6 6.69 (d 15.4) 140.0 4, 5, 8, 9, 12  7 4, 7 
7 6.60 (m) 128.8 5, 8 6 6, 12 
8 6.83 141.0 10 7/9 6, 7 
9 6.831 (m) 128.9 7 8  
10 7.38 (m) 141.3 8, 13, 14 9 9, 15 
11 - 134.4 - -  
12 1.64 (s) 13.8 4, 5 4 4, 7 
13 1.85 (s) 11.6 10, 11, 14 10  
14 - 197.8 - -  
15 4.39 (m) 47.5 14, 16/16’, 19 16/16’ 16’ 
16 2.33 (m) 27.3 14, 15, 17, 20 15, 17 16’, 20 
16’ 1.92 (m) 27.3 - 15, 17 15, 16, 20 
17 3.54 (m) 53.6 16/16’ 16/16’,20  
18 7.84 (d 10) - 15, 16/16’,19, 20 - 20, 20’ 
19 - 173.0 - -  
20 3.35 (m) 64.4 16/16’ 17 16/16’, 18 
21 - - - -  
22 - 166.3 - -  
23 3.66 (s) 51.6 22 -  
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Table S2. NMR Data for (2) (500 MHz, DMSO-d6). Signals were referenced by solvent signals for 
DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. 
 
No. 
1
H-chemical shift [ppm] 
(integral, mult., J [Hz]) 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
1 1.71 (1H, m) 14.3 2, 3, 4, 22 
2 6.87 (1H, m) 139.2 1, 3, 22 
3 - 125.0 - 
4 6.84 (1H, m) 128.5 22 
5 - 136.7 - 
6 6.69 (dd, 15.1, 2.5) 140.0 3, 5, 12 
7 6.57 (1H, m) 137.9 5 
8 7.04 (1H, m) 123.3 - 
9 6.47 (1H, m) 123.7 8, 14 
10 7.83 (1H, m) 135.1 13 
11 - 140.0 - 
12 1.63 (3H, m) 13.2 3, 5 
13 1.85 (3H, s) 10.8 10, 11, 14 
14 - 199.8 - 
15 4.50 (1H, m) 47.3 14, 16/16’, 19 
16 2.35  26.6 14 
16’ 1.92 26.6 14 
17 3.55 (1H, m) 63.5 15, 16/16’, 20 
18 7.89 (1H, m) - 15, 16, 17 
19 - 172.2 - 
20 3.36 (2H, m) 52.9 - 
21 - - - 
22 - 166.3 - 
23 3.65 (3H, s) 50.9 22 
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Table S3. NMR Data for the aculene A part of aculin A  (500 MHz, DMSO-d6). Signals were 
referenced by solvent signals for DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. 
 
No. 
1
H-chemical shift [ppm] 
(integral, mult., J [Hz]) 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
1 - - - 
2 3.15 (1H, m) 45.1 - 
2’ 3.09 (1H, m) 45.1 - 
3 1.83 (1H, m) 22.3 5 
3’ 1.68 (1H, td, 14.3, 7.6) 22.3 4,5 
4 1.94 (1H, m) 27.6 2,6 
4’ 1.46 (1H, dt, 20.1, 7.2) 27.6 2,3,5,6 
5 4.22 (1H, t, 7.8) 58.4 6 
6 - 168.2  
7 5.33 (1H, dd, 4.3, 2.4) 72.9 - 
8 2.82 (1H, br.d., 20) 36.5 10 
8’ 2.55 (1H, m) 36.5 7,9,10,16 
9 - 141.7  
10 5.97 (1H, d, 7.3) 120.2 8,12,18 
11 6.24 (1H, d, 7.4) 118.8 12,13,16 
12 - 142.4  
13 - 175.3  
14 6.02 (1H, s) 125.3 12,13,15,16,19 
15 - 205.8  
16 - 51.9  
17 0.96 (3H, s) 17.9 7,12,15,16 
18 1.85 (3H, s) 27.1 8,9,10 
19 2.54 (2H, m) 20.2 13,14,20 
20 1.16 (3H, t, 7.4) 12.0 13,19 
-OH - - - 
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Table S4 (upper) and S5 (lower). NMR Data for aculinic acid (500 MHz, DMSO-d6). Signals 
were referenced by solvent signals for DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. 
 
 
No. 
1
H-chemical shift [ppm] 
(integral, mult., J [Hz]) 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 5.49 (1H, br. D., 3.9) 93.4 5 2,2’ 
2 2.20 (1H, m) 47.6 4,5,3 1 
2’ 2.77 (1H, m) 47.6 3,5 1,4 
3 - 205.8 -  
4 2.95 (1H, dt, 13.0, 6.8) 46.3 - 2’,5,5’,6,6’ 
5 3.77 (1H, m) 62.1 1,3 4,5’,6 
5’ 3.87 (1H, dd, 10.7, 7.0) 62.1 1,3 4,5,6 
6 2.02 (1H, dd, 17.0, 6.0) 29.2 3,4,5,7 4,5,5’,6’ 
6’ 2.49 (1H, m) 29.2 3,4,5,7 4,6 
7 - 172.8 -  
 
 
No. 
1
H-chemical shift [ppm] 
(integral, mult., J [Hz]) 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 4.85 (1H, dd, 7.4, 3.7) 94.8 - 2,5 
2 2.45 (2H, m) 49.1 5 1 
3 - 205.8 -  
4 2.77 (1H, m) 45.6 5 5,5’ 
5 3.34 (1H, m) 63.8 1 1,4 
5’ 4.05 (1H, dd, 11.3, 6.7) 63.8 3 4 
6 2.14 (1H, dd, 17.0, 6.3) 29.4 4,7  
6’ 2.44 (1H, m) 29.4 3,4,7  
7 - 172.8 -  
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Table S6. Genes and gene products predicted by AUGUSTUS [1] and FGeneSH (Softberry). 
>acuF 
atggagagagcaatcagcacgacgcccatcctcgaccaagcgctcacatgcgtgcagtcatacaaagctcttgcggcaaccgtccaagagctcgccagcc
cggagctacaacgcagcatcgaagagggccttgcgcagtttctaactcacatgcccgagttcaacatcttggtcaacgccgtcgaacccccgcacacgtcgt
gggactacctcctgcgcaacgacgccagccaacgcggggagatgaccatgctcctcatggagctgcagtgtgagatcgaccagatggccttcgcgatccg
ccaagcgatgcagcagcagcaccccgaagccgaacccctgagcaacaacagccgcctcgtcgacgcgtggacagagaacctgcgcagcgtggaggac
cacacggtgtggcgcctggccttctggcggcgcgaccatgcggtgcacacgacctacccaaccaccaatccgctggtcaaccagtccttctacttcgcgatc
cgcaacgagctcggcctcgacgtctccacgcagttccgcgagtgcatccgccgcgccatcacacaggaatgcccaaccatcaccgcgcggccggccctcc
accgccgactagtcgatctagtcgtccagcgccggcgattctggaacttccagcgccgcatccgcggactcagcaaggacgccgtgctctgggggcggga
cgcgttagcaccgccacattttgccccgggggacgagcgcttcacctgtccgttctgcttcttcgacctccccgtcgcggcctaccggactccgcgcgcgtgg
acggaccacgtgatgagcgacctggagggctacgtctgcctgtacgagacgtgctcctccacccggtcctggcccgagacctgtccgcatgcctgcacctc
cttcggcgcctggtttaccgccatggccggcagcttcgccgagggcgtcgagtggtgcagccacgcctttgcctgtgacggccgccggctggaggaggtcc
accgcccgcgctgcgccgcacctgctgtccggttggacagtgtctgtccgctgtgtggaagggagccggccgtcgaggagacggagctgcgcatggcgg
acgcggcggaccccctgcaggatgatgaccagaaccgcgcgaaggccaggctgttactgtcgcatattgccggccatctggaggtgatcacgccgatggc
gtttacctggaataccgatcggaatgccctcgatccggatcggcggctgttttggggggacattgggtcaccggggggtgctggagggtcggcgtga 
 
>AcuF 
MERAISTTPILDQALTCVQSYKALAATVQELASPELQRSIEEGLAQFLTHMPEFNILVNAVEPPHTSW
DYLLRNDASQRGEMTMLLMELQCEIDQMAFAIRQAMQQQHPEAEPLSNNSRLVDAWTENLRSVE
DHTVWRLAFWRRDHAVHTTYPTTNPLVNQSFYFAIRNELGLDVSTQFRECIRRAITQECPTITARPA
LHRRLVDLVVQRRRFWNFQRRIRGLSKDAVLWGRDALAPPHFAPGDERFTCPFCFFDLPVAAYRTP
RAWTDHVMSDLEGYVCLYETCSSTRSWPETCPHACTSFGAWFTAMAGSFAEGVEWCSHAFACDG
RRLEEVHRPRCAAPAVRLDSVCPLCGREPAVEETELRMADAADPLQDDDQNRAKARLLLSHIAGH
LEVITPMAFTWNTDRNALDPDRRLFWGDIGSPGGAGGSA 
 
>acuH 
Atgcactttcgtactgtgaacaccccggctaggctgcagtttatctcacggtttgtcctccagccactccgtccgctgctgcactataaggatcacacgatccgg
acggcggcggaggcggggctagacgtggcggagctggcggtggggcccgcgttcgtcgtggcgcgggggtatttcaccttgcggcaagcggataccag
ctcggcggagagtcgcgatcccacaaagcaacagcagctgtgggagaagacgttggagtggctggggatgaccgaggagcagggggcactttag 
 
>AcuH 
MHFRTVNTPARLQFISRFVLQPLRPLLHYKDHTIRTAAEAGLDVAELAVGPAFVVARGYFTLRQAD
TSSAESRDPTKQQQLWEKTLEWLGMTEEQGAL 
 
 
1. Stanke, M.; Morgenstern, B. AUGUSTUS: a web server for gene prediction in eukaryotes that allows 
user-defined constraints. Nucleic Acids Res. 2005, 33, 465–467.  
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Reconstitution of the cytochalasin gene cluster from Aspergillus 
clavatus in Aspergillus nidulans 
ABSTRACT: Reconstitution of gene clusters has the potential to provide access to the chemical diversity 
encoded in the genomes of otherwise unculturable filamentous fungi. Cytochalasins constitute a group of 
fungal secondary metabolites with diverse structures and bioactivities, e.g. cytochalasins produced by A. 
clavatus. In this work the cytochalasin gene cluster was reconstituted in the model organism A. nidulans by 
transformation associated recombination (TAR), resulting in production of cytochalasin K.   
1. Introduction 
1.1 Biosynthesis of cytochalasins 
Cytochalasans constitute a class of polyketide-non-ribosomal peptide (PK-NRP) hybrids containing a highly 
reduced PK backbone and an amino acid. Characteristic for the cytochalasans is their tricyclic core 
consisting of a macrocycle fused to a bicyclic lactam (isoindolone) system. The macrocycle origins from the 
reduced PK part and can be fused to the isoindolone system by a cyclic ketone, a lactone or a cyclic 
carbonate. The cytochalasans are classified based on the amino acid incorporated into the PK backbone. The 
name origins from Greek and refers to the best known property of the cytochalasans: Kytos (cell) and 
chalasis (relaxation) refers to the capping of actin filaments [1][2]. The group displays a wide range of 
biological functions. This is exemplified by the earliest reported cytochalasin A and B [3][4] which can 
repress glucose transport in human erythrocyte membrane [5] and cytochalasin E, which have been reported 
to show inhibitory activities towards ovarian, and human colon cancer [6] and possess strong anti-angiogenic 
activities [7]. A subclass of the cytochalasans is the cytochalasins, distinguishing by having the amino acid 
phenylalanine. The structures of cytochalasins E and K from Aspergillus clavatus are depicted in Figure 1.  
 
Figure 1 Structures of cytochalasins E and K from A. clavatus 
Due to the wide range of biological functions of cytochalasins, as well as their interesting and complex 
structures, their biosynthesis has been a topic of particular interest. Isotope labeling studies have revealed 
that the cytochalasans origin from malonyl building blocks as well as amino acids [8][9], suggesting the 
mixed biosynthetic pathway. The genetic and molecular basis of cytochalasin biosynthesis have been studied 
by Hertweck and co-workers for chaetoglobosin A from Penicillium expansum [10] and by Tang and co-
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workers for cytochalasin E and K from A. clavatus [11][12]. The biosynthetic genes responsible for 
cytochalasin production in A. clavatus are depicted in Figure 2. The genes ccsA-ccsG and ccsR comprises the 
ccs biosynthetic gene cluster spanning 29,819 kb of DNA. 
 
 
Figure 2 Organization of the ccs gene cluster in the genome of A. clavatus NRRL 1. Adapted from [11]. 
In Table 1 an overview of the genes from the ccs cluster is given, including locus, size and function of the 
gene, as well as a brief description of the role in the biosynthesis towards cytochalasin K.  
Table 1 Overview of genes and functions in the ccs gene cluster. Adapted from [11]. 
Gene Gene locus 
(ACLA_) 
Gene 
size(bp) 
Function Biosynthetic description 
ccsR 078640 1593 Transcription 
regulator 
Encodes a transcription factor. Cytochalasin 
pathway specific regulator, upregulates the 
production 
ccsA 078660 12374 PKS-NRPS hybrid Formation of the PK-NRP backbone 
ccsB 078650 1967 Baeyer-Villiger 
monooxygenase 
Oxidizes, forming the cyclic carbonate in 
the macrocycle 
ccsC 078700 1154 Enoyl reductase Functional enoyl reductase, facilitating 
CcsA 
ccsD 078670 1598 P450 epoxidase Introduces the epoxide 
ccsE 078680 1381 Esterase Converts cytochalasin E to K 
ccsF 078690 1190 Unknown Unknown. Perhaps post-PKS-NRPS 
tailoring, resistance or transport 
ccsG 078710 1797 P450 monooxygenase Oxidizes, Introduces a hydroxyl and keto 
group 
 
The proposed biosynthetic pathway towards cytochalasin K is depicted in Figure 3. The first step in the 
biosynthetic pathway is formation of the backbone by the PK synthase-NRP synthetase (PKS-NRPS) 
(CcsA). The PKS has the necessary domains (KS, AT, ACP) as well as reductive domains (KR, DH, ER) and 
a methyltransferase (MT). However, the ER domain is believed to be inactive due to lack of a key NADPH 
binding motif. Another enzyme encoded by the ccsC gene located downstream of ccsA, is proposed to be 
carrying out the enoyl reductions. This is also seen in the lovastatin biosynthetic pathway from A. terreus, 
where an enoyl reductase encoding gene, lovC, facilitates the PKS lovB, which has an inactive ER 
domain[13][14]. The PKS CcsA uses malonyl-CoA as a starter unit and seven malonyl-CoAs as extender 
units and forms the octaketide backbone. The level of reduction varies, from unreduced carbonyls, to 
Hypothetical protein Enoyl Reductase 
Regulator Α-β Hydrolase 
G   C   F   E       D                         ccsA                              B             R  
PKS-NRPS P450 
Baeyer-Villiger Monooxygenase 
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alcohols, enoyls and all the way to the fully saturated alkans. Furthermore three SAM donors are used, 
enzymatically incorporating three methyl groups. After formation of the PK backbone the A domain of the 
NRPS module selects one phenylalanine molecule, which is transferred to the T domain. The C domain of 
the NRPS then catalyzes the condensation between the nucleophilic amino group of Phe and the electrophilic 
carbonyl of the octaketide chain still attached to the ACP domain of the PKS. The result is the PK-NRP 
chain linked to the T domain of the NRPS as illustrated in Figure 3. Release of the chain is believed to be 
achieved by an R domain of the NRPS, making a reductive release forming an amino-aldehyde intermediate. 
This reactive intermediate can do an intramolecular aldol type of condensation, followed by loss of water, 
forming the pentaene intermediate. 
 
Figure 3 Proposed biosyntethis of cytochalsin E. The PKS-NRPS CcsA is responsible for formation of the octaketide 
with incorporation of phenylalanine in combination with CcsC a functional enoyl reductase. After release an 
intramolecular condensation followed by a Diels-Alder cyclisation is forming the tricycle core. The P450s CcsG and 
CcsD introduce a hydroxyl group, a keto group and the epoxide. Finally CcsB, a Bayer-Villiger oxidase, introduces two 
oxygens to form the carbonate moiety. CcsE converts cytochalasin E to cytochalasin K, while CcsF may be involved in 
a post-PKS-NRPS tailoring, resistance or transport. Adapted from [11]. 
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In the next step a [4+2] Diels-Alder endo cycloaddition of the pentaene intermediate is responsible for 
forming the tricyclic core, characteristic for the cytochalasins.  
To get to the structure of cytochalasin E a series of oxidations catalyzed by CcsG, CcsD and CcsB occurs. 
CcsG, a P450, performs two consecutive steps of oxidations, firstly introducing two hydroxyl groups, and 
secondly, oxidizing one of these even further to a carbonyl. Another P450, CcsD, is then mediating 
formation of the epoxide.  
Finally, two Baeyer-Villiger oxidations catalyzed by CcsB, a Baeyer-Villiger monooxygenase, introduces 
two oxygens, one at a time, on each side of the carbonyl of the 11-membered ring, forming the unique vinyl 
carbonate moiety in cytochalasin E and K [12].  
The remaining enzymes encoded by the cluster are CcsR, CcsE and CcsF. The firstmentioned, ccsR, encodes 
a transcription factor, which is a cytochalasin pathway specific regulator, found to facilitate transcription. 
The specific role of CcsE and CcsF have not been determined, but CcsE is believed to be involved in the 
conversion of cytochalasin E to cytochalasin K, while CcsF may be involved in a post-PKS-NRPS tailoring, 
resistance or transport.  
1.2 Gene cluster reconstitution by TAR  
Transformation-Associated Recombination (TAR) [15][16] is becoming a generically useful tool for 
reconstructing large biosynthetic gene clusters from genomic DNA (gDNA) and environmental DNA 
(eDNA) [17]. With TAR it is possible to explore large gene clusters (~40 kb) by reassembling them from 
sets of smaller overlapping fragments in Saccharomyces cerevisiae. This yeast is used since it has an 
extremely efficient DNA recombination system [15]. TAR was developed as a recombinational cloning 
strategy, to isolate large genomic fragments from human DNA [16][18].  
TAR has been used to reassemble eDNA derived type II PKS gene cluster from Streptomyces albus for 
production of fluostatins [19]. General descriptions of how to recover large NP biosynthetic gene clusters 
from eDNA using TAR have been described[17] and the TAR approach has been applied to several 
organisms including human [16][18], mouse [20], fish [21], parasites [22] and bacteria [19]. 
Using the TAR approach we wanted to reconstitute the ccs gene cluster in A. nidulans.  
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2. Results and discussion 
In this study TAR was used to reconstitute the cytochalasin gene cluster from A. clavatus and express it in 
the model organism A. nidulans. The workflow is illustrated in Figure 4.  
 
Figure 4 Workflow for cluster reconstitution by TAR. 
 
DNA fragments of 5 kb, spanning the entire gene cluster of interest, were first amplified by PCR. The 
primers were designed to create overlapping regions of 150-200 bp between each PCR fragment (see Figure 
5).  The resulting sets of overlapping PCR fragments and a linearized vector, engineered to carry small 
homology regions corresponding to regions of the exterior primers, were introduced in S. cerevisiae by co-
transformation. The fragments and vector recombine to yield a stable plasmid containing the targeted 
genomic region. 
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Figure 5 Custer reconstitution by PCR amplification and TAR in yeast. Primers are designed to create 150-200 bp 
overlapping regions between each PCR fragment, and with a 30-50 bp overlapping region to the linearized vector. 
The CEN-based vector, was designed for transformation in three different organisms: Transformation in S. 
cerevisiae, replication in E. coli and transformation in A. nidulans. It therefore contains elements for all three 
organisms, see Table 2. 
Table 2 Elements in the cluster capturing vector set up for transformation in A. nidulans, E. coli and S. cerevisiae. 
A. nidulans E. coli S. cerevisiae 
pyrG Selectable marker for A. nidulans ampR Antibiotic resistance 
gene. 
URA3 Selectable marker for yeast 
PgpdA Promotor  ori Origin of 
replication.  
CEN Yeast centromere sequence 
TtrpC Terminator    ARS Autonomously replicating 
sequence 
wAdown 
wAup 
Targeting sequences for integration 
in A. nidulans 
    
 
The regulator gene ccsR was amplified separately and the plasmid was constructed with the strong 
constitutive promoter PgpdA followed by the TF encoding gene ccsR and then the remaining cluster. The 
resulting plasmid, pLP1, is depicted in Figure 6. The plasmid was verified by four enzymatic digestions, 
PCR of pieces spanning the cluster and into the plasmid as well as sequencing.  
 
 
pLP1 
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Figure 6 The plasmid, pLP1, designed for rapid assembly and transformation in yeast (CEN/ARS, URA3), 
transformation in E. coli (ORI, ampR) and for integrative transformation in A. nidulans (pyrG, wA PKS targeting 
sequences). It contains the gpdA promoter directly followed by the TF encoding gene ccsR and the remaining ccs 
cluster.  
The plasmid was cleaved with SwaI creating a linearized plasmid for transformation in A. nidulans. 
Transformation in A. nidulans was achieved as earlier described [23][24][25], in the WA PKS gene wA, 
responsible for the green melanin production in A. nidulans, wherefore transformants will appear white. Four 
resulting transformants are depicted in Figure 7.  
 
Figure 7 Appearance of four transformants where the ccs cluster has been integrated into the  
A. nidulans genome. 
To determine if the ccs cluster was transcribed; RT-PCR analysis was performed. For each gene, a 600 bp 
segments was amplified, particularly around those regions having introns, to distinguish between the 
products from spliced cDNA and potential genomic DNA carryover during RNA extraction. In addition to 
the PKS-NRPS ccsA, all other genes believed to belong to the cluster were transcribed (ccsB-ccsG). The TF 
ccsR appeared to be transcribed in higher amounts, see Figure 8. 
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Figure 8 Transcriptional analysis of all genes in the ccs gene cluster in A. nidulans, showing that all cluster genes are 
transcribed. For each gene, the first band are from genomic DNA of A. clavatus for comparison. 
The transformants were incubated on solid and liquid MM and extracted, and the metabolic profile examined 
by HPLC-MS. EICs of m/z corresponding to cytochalasin E and K are depicted in Figure 9, from a liquid 
extraction after three days. 
 
 
Figure 9 EIC of m/z = 518 (the most abundant adduct for both cytochalasin E and K, [M+Na]
+
) in A. clavatus, the A. 
nidulans reference and the A. nidulans mutant containing the ccs cluster. 
Cytochalasin E and K have the same molecular formula (see Figure 1) and hence the same m/z of 518 for the 
most abundant adduct [M+Na]
+
. EICs of extracts from the host organism A. clavatus, show this was 
producing small amounts of cytochalasin K and vast amounts of cytochalasin E. In the A. nidulans 
transformants no cytochalasin E was observed, however, the end product of the pathway, cytochalasin K was 
detected. It is interestingly why cytochalasin E is favored in A. clavatus, while it is not produced even in 
trace amounts in A. nidulans. Cytochalasin E could be toxic to A. nidulans wherefore the biosynthesis is 
driven to the end product cytochalasin K. Nonetheless, the ccs gene cluster was successfully reconstituted 
and the end product cytochalasin K produced in A. nidulans.  
Cytochalasin E 
Cytochalasin K 
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3. Materials and methods 
3.1 Strains, media and fungal growth.  
The A. clavatus NRRL1 strain was used and the A. nidulans 1.49 (pyrG89, pyroA4, ΔnkuA::argB, veA) [25] 
was used for strain constructions in A. nidulans. A. clavatus was grown on MEPA (30 g/L malt extract, 3 g/L 
papaic digest of soybean meal and 15 g/L agar) at 25 ˚C, A. nidulans on glucose minimum medium (GMM) 
[26] at 37 ˚C. When necessary media were supplemented with 0.56 g uracil/L, 1.26 g uridine/L, and 0.5 µM 
pydroxine HCl.  
E. coli strains XL-1 (Stratagene) was used for routine cloning. Luria-Bertani (LB) medium was used for 
cultivation of E. coli strains (25 g/L LB) and supplemented with 100 µg/ml ampicillin when needed.   
S. cerevisiae BJ5464 was used for TAR cloning and yeast media was used (1 g bacto tech. grada cassa amino 
acid, 4 g dextrose, 4 g bacto agar,176 mL DI water, autoclaved, cooled and added 20 mL nitrogen base stock, 
2 mL trp stock and 2 mL adenine stock). 
Spheroplasts were prepared as described by Kouprina and Larionov [27].   
3.2 Fungal transformation.  
Transformation in A. nidulans was performed as earlier described [25]. 
3.3 Genetic manipulations.  
Polymerase chain reactions were performed using Phusion high-fidelity DNA polymerase (New England 
Biolabs) for amplifications, and Quick-Load Taq 2X Master Mix (New England Biolabs) for screening.  
Restriction enzymes (New England Biolabs) were used for digestions, and T4 ligase (Invitrogen) for ligation 
of DNA fragments. All primers used were synthesized by Integrated DNA Technologies and are listed in 
Table 3. 
3.4 Transcriptional analysis.  
Strains were inoculated into 10 mL LMM and cultivated at 37 ˚C for three days in the dark. Mycelia were 
harvested, dried and RNA was extracted using the Ambion RiboPure-Yeast extraction kit. RT-PCR was 
achieved using the Oligo-dT primer and Improm-II reverse transcription system (Promega). cDNA was then 
amplified with GoTaq Green Master Mix using specific primers for each gene (Table 3). 
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3.5 Small scale extraction.  
Cultures were grown on either solid or liquid MM, at 37 ˚C for 2-7 days in the dark. The cultures were 
extracted with ethyl acetate/MeOH/acetic acid (89:10:1), by ultrasonification for 1h. The organic phase was 
transferred to a clean vial and evaporated to dryness. The dried extracts were dissolved in methanol and spun 
down prior to LC-MS analysis.  
3.6 Chemical analysis.  
Chemical analysis was performed on a Shimadzu 2010 EV liquid chromatography mass spectrometer with 
positive and negative electrospray ionization. Seperation was achieved with a Phenomenex Luna 5 µm, 2.0 
mm x 100 mm C18 reverse-phase column, using a linear gradient from 5 % to 95 % with ACN/H2O + 0.05 % 
formic acid solvent system for 15 minutes using a flow rate of 0.1 mL/min. 
3.7 Yeast transformation.  
TAR was achieved by transformation in S. cerevisiae BJ5464-NpgA by using a S. c. EasyComp 
Transformation Kit (Invitrogen). DNA was transferred to 50 µL cells on ice and 500 µL solIII was added. 
The sample was incubated at 30 °C for 1 hour, with vortexing every 15 min and the plated on selective 
media.  
3.8 E. coli transformation.  
E. coli strains XL-1 Blue (Stratagene) was used for transformation. DNA was transferred to 50 µL cells and 
the sample was incubated 30 minutes on ice followed by one minute heatchock at 42 °C and finally 5 
minutes on ice. 1 mL LB was added to the sample and after incubation at 37 °C for 20 min the sample was 
plated on LB plate with 100 μg/mL ampicillin and incubated at 37 °C over night. 
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Table 3 Sequences of primers used in this study 
Primer name Sequence (5’ → 3’) 
ccsR_F cttcagtatattcatcttcccatccaagaacctttaatcatgcctttgccagaccatcg 
ccsR_R gatcagggataccgcgatgctctgattggcaactcagaccctgggagagattcaaattc 
ccsP1_F actcccgaatcgcttccatggaatttgaatctctcccagggtctgagttgccaatcagag 
ccsP1_R gccaggagtcatttgatcaaag 
ccsP2_F cgcaaggttcgagaatagcc 
ccsP2_R ggtccagcaggaattcttacgg 
ccsP3_F ccacgtaattgactctgactcg 
ccsP3_R gttcacacggctgctgaaggttg 
ccsP4_F gtagcgatcactaccatcttcc 
ccsP4_R gcaggaggatatggcgatattc 
ccsP5_F gcgtcgagtcgaagctgatgag 
ccsP5_R gccgcaagattgtggacttcac 
ccsP6_F cgtgccgaggatcgcataattc 
ccsP6_R acacaacatatttcgtcagacacagaataactctcgctagaccatccacgcaatgcactc 
Transcriptional  
analysis 
 
IccsA_F gtcgggccatttctgtgtac 
IccsA_R ctttgcattgggatcagctc 
IccsB_F caacgaccactgtggaagtg 
IccsB_R cccgtccagtgtactttctc 
IccsD_F cttgggtggagaagatccct 
IccsD_R atgttgcaggaggatatggc 
IccsE_F caacaacacggggcatatcac 
IccsE_R gcgttaccagggtacttgtatc 
IccsF_F gtgtaatgctgcatcctgcc 
IccsF_R cggctctctattgagttcgc 
IccsC_F ggtcgaatcccattcgacatg 
IccsC_R cagtactctcagaggatgcg 
IccsG_F ggttctgctacccatgaagt 
IccsG_R cccctaagcgaccaagatag 
IccsR_F cgaccactcctggtcatcaac 
IccsR_R gttcgcggatgtcctgttctc 
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